An exploration of hospital pharmacists’ attitudes and opinions towards undertaking research by Shenton, Julie Jane Louise
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is protected by copyright and other intellectual property rights and 
duplication or sale of all or part is not permitted, except that material may be 
duplicated by you for research, private study, criticism/review or educational 
purposes. Electronic or print copies are for your own personal, non-
commercial use and shall not be passed to any other individual. No quotation 
may be published without proper acknowledgement. For any other use, or to 
quote extensively from the work, permission must be obtained from the 
copyright holder/s. 
 
  
An exploration of hospital pharmacists’ attitudes 
and opinions towards undertaking research 
 
 
Julie Jane Louise Shenton 
 
Doctor of Pharmacy 
 
June 2020 
 
Keele University
i 
Abstract 
Background 
Research in the NHS is essential to provide evidence to improve services and patient 
outcomes. The Government’s continued commitment to research has been made clear 
through the inclusion of research in key NHS policy documents including the Health and Social 
Care Act 2012, the NHS Constitution and, more recently, the NHS Long Term Plan. Alongside 
these policy documents there is also an increasing body of evidence demonstrating the impact 
of research on improved quality of care. Therefore, as employees of the NHS, pharmacists 
working in the hospital sector in the UK need to engage with research not only because of the 
importance of research to the NHS but also to provide the evidence base to advance the 
practice of pharmacy. However, engagement within the profession is limited despite the Royal 
Pharmaceutical Society identifying research to be a professional expectation of pharmacists.    
Objectives 
This research aimed to explore the attitudes and opinions of hospital pharmacists to 
undertaking research to understand better the drivers, drawbacks, barriers and enablers to 
engagement of pharmacists employed in this sector and to explore the characteristics of 
research-active pharmacy departments.  
Methods 
An initial feasibility study was undertaken with a cohort of six chief pharmacists of secondary 
care NHS Trusts in the West Midlands, representing four acute Trusts and two mental health 
Trusts. Semi-structured interviews were conducted with participants to explore their attitudes 
and opinions. This feasibility study informed the research approach taken for the main 
research study which used a mixed methods research design and comprised two phases - an 
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initial qualitative phase conducted using case study research methodology followed by a 
subsequent quantitative phase employing survey research.  
For the case study research, four case study sites were identified each representing an acute 
secondary care teaching hospital NHS Trust in England where the pharmacy department had 
comparatively high levels of research activity among pharmacists together with a model of 
support for pharmacists to undertake research. At each case study site, individual semi-
structured face-to-face interviews were conducted with the chief pharmacist and a cohort of 
research-active pharmacists. Interviews were audio-recorded and transcribed verbatim, with 
thematic analysis used to analyse the data. The survey phase of the research was undertaken 
to establish how widely the case study research findings were shared among chief pharmacists 
of acute secondary care NHS Trusts in England. To conduct the survey, a structured 
questionnaire was developed based on the case study research findings, and the questionnaire 
was distributed as a self-administered web-based survey. 
Results 
Lack of time and difficulty obtaining funding appeared to be the most significant barriers to 
engagement, as well as lack of personal competence in research and organisational culture i.e. 
research not being prioritised. A lack of understanding and awareness of research within the 
profession was also identified, as was a lack of appreciation of the value of research in relation 
to improving practice. Key enablers identified included allowing pharmacists time to conduct 
research, whether that be through research being integrated into pharmacists’ roles or 
through funding enabling individuals’ roles to be backfilled, and pharmacists having access to 
individuals with research expertise within their departments. Gaining research expertise 
through postgraduate qualifications was also identified as an enabler. Research experience 
was identified as a significant driver for pharmacists to undertake further research, as was a 
pharmacy department having a culture for research. Drawbacks identified related to the 
iii 
impact of research on service delivery, and the difficulty associated with backfilling posts with 
funding from research grants.  
The pharmacy departments in the case study phase of the research all had a culture for 
research which was evident through research being made visible within departments via 
promotion of research opportunities and promotion of research activity, the existence of 
departmental research forums, and having departmental leadership for research. All four case 
study sites had mechanisms in place to support pharmacists to undertake research. These 
included allowing pharmacists time to conduct research and employing a lead pharmacist for 
research who had research expertise. The leadership of the chief pharmacist appeared to be 
key to developing a research culture within the department and to ensuring such mechanisms 
of support were in place. All of the case study sites also had a culture for research at Trust 
level. However, the influence of the Trust culture on pharmacy-led research was unclear, 
although it was recognised to potentially make such research easier to undertake suggesting it 
removed some of the contextual barriers to engagement.  
Conclusions 
To increase engagement with research among pharmacists in the hospital sector, pharmacists 
need time to conduct research and need access to research expertise. The leadership of the 
chief pharmacist appears to be key to pharmacists employed in this sector having this support. 
Pharmacists also need to better understand the importance of research to their practice and 
how to engage with research. To achieve this there needs to be a culture change at 
professional level. In addition, pharmacists lack the knowledge and skills to undertake 
research from their undergraduate degree. Exposing pharmacists to research early in their 
careers may not only equip them with the knowledge and skills to undertake research but, as 
research experience was identified as a driver for engagement, it would have the potential to 
instil in them a desire to undertake further research throughout their career.  
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1 Overview of the thesis content and structure 
The research presented in this thesis is an exploration of hospital pharmacists’ attitudes and 
opinions towards pharmacists undertaking research. This was conducted between September 
2015 and December 2019 for a Professional Doctorate in Pharmacy (DPharm) at Keele 
University. The DPharm programme at Keele University comprises two parts of which part 1 is 
undertaken during the first two years whilst part 2 is carried out from year 3 onwards. Part 1 
consists of modules relating to advanced professional practice, leadership, change 
management, and research and evaluation. A research project is undertaken for one of these 
modules and is referred to as an ‘initial study’. Part 2 consists solely of research activity (Keele 
University 2019a). Therefore, there are two elements to the research presented in this thesis – 
the initial study undertaken in part 1 and the research undertaken in part 2. Accordingly, this 
chapter has been included in the thesis to provide both an overview of the various elements to 
the research and also to outline how the thesis is structured.  
1.1 Content of the thesis 
The focus of the thesis is the research conducted in part 2 of the programme referred to 
herein as the ‘main research study’. A summary of the initial study undertaken in part 1 is also 
included as this took the form of a feasibility study to inform the research undertaken in part 
2. A brief outline of the research undertaken in each part of the programme is given below. 
For ease of reference, a flowchart is provided outlining each of the elements to the research 
(Figure 1). 
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Figure 1: Flowchart outlining the elements of the research 
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1.1.1 The initial study 
The study comprised an exploration of the attitudes and opinions of chief pharmacists towards 
pharmacists undertaking research. Qualitative methodology was used to conduct the study 
which involved semi-structured interviews with chief pharmacists of six secondary care NHS 
Trusts in the West Midlands. As the initial study took the form of a feasibility study for the 
main research study, the findings and learning from undertaking the initial study were used to 
inform the research design of research undertaken in part 2.  
1.1.2 The main research study  
Mixed methods research was used comprising two phases i.e. a qualitative phase followed by 
a quantitative phase. 
Case study methodology was used in the qualitative phase which involved the use of semi-
structured interviews with the chief pharmacist and a cohort of research-active pharmacists at 
each of four case study sites to explore their attitudes and opinions towards pharmacists 
undertaking research. The case study sites were all acute secondary care teaching hospital 
NHS Trusts in England with research-active pharmacy departments selected on the basis of 
each having different models of support for pharmacists to carry out research together with 
high levels of research activity among the pharmacists employed.  
In the subsequent quantitative phase, survey research was conducted to establish how widely 
the findings of the case study research were shared among chief pharmacists of acute 
secondary care NHS Trusts in England. To undertake the survey, an online questionnaire was 
developed based on the case study research findings. 
1.2 Structure of the thesis 
For the most part, the thesis follows a ‘traditional’ format although the structure deviates in 
parts because, as outlined above, the research was undertaken in various stages. Each stage 
4 
was informed by the findings of the previous one. Consequently the main research study 
carried out in part 2 of the programme was informed by the findings of the initial study 
undertaken in part 1. Likewise, the survey research for the main research study was informed 
by the findings of the case study research. 
The structure differs from a traditional format for the following reasons:  
 The initial study took the form of a feasibility study for the research undertaken in part 2 
of the programme, and is therefore reported separately from the main research study as a 
standalone chapter.  
 
 Two literature reviews were undertaken during the course of the research i.e. one to 
inform the initial study and the other for the main research study. Each literature review is 
reported as a separate chapter. The reasons for this are two-fold - firstly the scopes of the 
literature reviews for the initial study and main research study differed due to the findings 
of the initial study influencing the literature searched for the second review, and secondly 
the findings of the main research study are discussed in the context of the literature 
included in both reviews. 
 
 As the main research study was undertaken in two phases, the methods and results for 
each phase are reported together. Therefore, rather than there being a methods chapter 
and a separate results chapter for the main research study, there is a chapter in which the 
case study methods and results are reported, and another where the survey research 
methods and findings are reported. 
To help the reader follow the structure of the thesis, Table 1 below outlines the content of 
each chapter. In addition, Figure 1 above is repeated throughout the thesis to highlight the 
element, or elements, of the research to which particular chapters pertain.   
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Table 1: Summary of the content of each chapter 
  
Chapter 
number 
  
Chapter title Chapter content 
1 Overview of the 
thesis content 
and structure 
 
Outlines how the various elements to the research are 
presented in the thesis and how the thesis is structured 
2 Introduction  
 
Outlines the background to the research 
3 Literature 
review for initial 
study 
A review of literature relating to pharmacists’ attitudes and 
opinions towards research published before the initial study 
was undertaken 
 
4 Initial study  Outlines the methods used to undertake the study and the 
findings, and includes a discussion of the findings in the 
context of the literature reviewed in chapter 3; also outlines 
how the findings and learning from the initial study informed 
the research design of the main research study 
 
5 Main research 
study and 
objectives  
 
Outlines the main study research aims and objectives 
6 Literature 
review for main 
research study  
A review of literature relating to pharmacists’ attitudes and 
opinions towards research published since the initial study 
was undertaken together with a review of the literature 
relating to the findings of the initial study which influenced 
the design of the main research study 
 
7 Main research 
study 
methodology 
Outlines the methodology used for the main research study 
including the rationale for using mixed methods research, and 
the rationale for using case study research methodology in the 
initial qualitative phase and survey methodology in the 
subsequent quantitative phase 
 
8 Case study 
research  
Outlines the methods used to undertake the case study 
research and the findings 
 
9 Survey research Outlines the methods used to undertake the survey research 
and the results 
 
10 Discussion Includes a discussion of the main research study according to 
the research objectives 
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Table 1 continued  
  
Chapter 
number 
  
Chapter title Chapter content 
11 Reflexivity  Outlines how my professional background and experience 
may have influenced the research and the steps taken to 
minimise the effect of this on the research validity 
 
12 Limitations and 
future work 
Outlines the limitations of the main research study as well as 
suggestions for future research 
 
13 Conclusions Summarises the overall findings of the research 
 
14 References  Lists the references cited in the thesis 
 
15 Appendices Contains the appendices referred to in the thesis text 
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2 Introduction 
In this chapter I outline my professional background and the rationale for conducting research 
to explore the attitudes and opinions of hospital pharmacists towards undertaking research. 
2.1 My professional background  
To provide some context, in this section I will outline my professional background and how I 
came to study for a Professional Doctorate in Pharmacy (DPharm). 
In my current role I am Lead Pharmacist for National Institute for Health Research (NIHR) 
Clinical Research Network West Midlands (CRN WM). At the time of beginning my research, 
the NIHR was the ‘research arm’ of the NHS (NIHR 2018b) whose vision was to improve the 
health and wealth of the nation through research by providing ‘a health research system in 
which the NHS supports outstanding individuals working in world-class facilities, conducting 
leading-edge research focused on the needs of patients and the public’ (NIHR 2018c). Since 
starting the research, while the vision of the NIHR remains the same, its scope has expanded 
to include both health and social care research (NIHR 2019e).  
The Clinical Research Network is part of the NIHR, whose purpose is to provide the 
infrastructure to support patients, the public, and health and care organisations to participate 
in high-quality research. Clinical Research Network West Midlands is one of 15 geographically-
based Local Clinical Research Networks comprising the CRN in England (NIHR 2019a). My role 
as Lead Pharmacist for CRN WM is to provide professional leadership and advice to pharmacy 
staff based in the region who are involved in delivering research. When I first joined, my role 
focused mostly around supporting pharmacy staff involved in the management of clinical trials 
medicines in secondary care. However, as the role has evolved, the remit has been extended 
and now also includes provision of leadership and advice to pharmacy staff working in primary 
care, as well as working to increase involvement of pharmacists across all sectors with 
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research. Examples of such involvement include leading their own research or contributing to 
or supporting the delivery of research led by others through the identification and recruitment 
of participants into studies, prescribing in clinical trials, or as a principal investigator for a 
multi-centre study i.e. being responsible for the overall delivery of a study at a site (MHRA 
2012). 
Before working for the CRN, my career was based mainly in secondary care in roles which 
included Senior Pharmacist Patient Services and Clinical Governance for a large acute teaching 
hospital NHS Trust and as Medicines Management Interface Pharmacist. The latter role 
involved working across the interface between commissioners and the acute Trust as well as 
other providers in the local health economy. It was through these roles that I became involved 
with research, albeit different aspects of the research process.  As Senior Pharmacist for 
Patient Services I was responsible for managing clinical trials medicines for studies being 
undertaken by the Trust, and therefore involved in research delivery. In the Medicines 
Management Interface Pharmacist role, I used research evidence to develop guidelines and 
manage requests for the incorporation of new medicines onto the local health economy 
medicine formulary. For one such request, the evidence for the medicine in question was 
based on the outcomes of a study I recognised as one in which I had been involved in the 
delivery in my previous role as Senior Pharmacist Patient Services and Clinical Governance. It 
was this experience that made my contribution to research as a pharmacist feel ‘real’.  
I believe it is important to provide this background detail as it is through my involvement in 
research in these roles that I gained an awareness and understanding of the importance of 
research to the NHS. This then led me into my current role with the CRN, where my passion 
and interest in research has really grown. As outlined above, prior to working for the CRN I had 
really only undertaken roles which supported research delivery and used research in the 
context of evidence-based medicine. Since joining the network, however, I have worked 
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alongside and collaborated with individuals leading their own research in both the NHS and 
academia. This sparked my interest to undertake research myself and led me to explore 
options which would allow me to do this. I chose a Professional Doctorate as this allowed me 
to continue to practise as a pharmacist in my role with the CRN while at the same time 
undertake research, and develop my management and leadership skills.      
2.2 Overarching research aim 
The overarching aim of this research was to explore how to engage more hospital pharmacists 
with research, and it was my passion to undertake research myself that led me to conduct 
research in this area. Working for the CRN I had observed that, outside of managing clinical 
trials medicines, pharmacists did not appear to be particularly engaged with research, with 
only a limited number in the West Midlands leading their own research. The idea for this study 
therefore was to find ways to engage more pharmacists with research by exploring their 
attitudes and opinions towards undertaking research. I also wanted to focus on how to engage 
more pharmacists working in the hospital sector as this is where my professional interest 
principally lies because, as outlined above, my professional practice has been mostly based in 
secondary care. By gaining a better understanding of how to engage hospital pharmacists with 
research through this study, the intention was that I could then not only apply the findings to 
my professional practice as Lead Pharmacist CRN WM, but also that, as the need to engage 
pharmacists with research is both a local and national issue, the findings might also be used to 
inform national policy.  
In this thesis I explain how I carried out the research, and report my findings. However, in the 
sections that follow in this chapter, I first outline why research is important both to the NHS 
and to pharmacy as a profession.      
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2.3 Research and the NHS  
Research is essential in providing evidence to transform services and improve outcomes in the 
NHS (NHS England 2019b). Its importance to the NHS was made evident in the 2006 
Department of Health research strategy ‘Best Research for Best Health’ which described 
research as ‘core business’ (Department of Health 2006). Since then the Government’s 
continued commitment to research in the NHS has been made clear in the Health and Social 
Care Act 2012, which places a legal duty on the NHS to promote research and the use of 
research evidence (Act of parliament 2012). The NHS Constitution also includes a ‘commitment 
to innovation and to the promotion, conduct and use of research to improve the current and 
future health and care of the population’ (p.3) (DHSC 2015). This commitment has also been 
reaffirmed in other documents including the ‘NHS Five Year Forward View’ (NHS England 
2014), ‘Next Steps on the NHS Five Year Forward View’ (NHS England 2017) and most recently 
‘The NHS Long Term Plan’ which recognises the importance of research and innovation to 
drive future outcomes improvement (NHS England 2019a). In addition, the Government’s 
mandate to the NHS for 2018-19 also included an objective for the NHS to ‘support research, 
innovation and growth’ (p.12) (DHSC 2018).  
However, the Government also recognises that the benefits of research in the NHS are not 
limited to better health outcomes for patients. Government papers such as the ‘Plan for 
Growth’ (HM Treasury, Department for Business, Innovation and Skills 2011) and ‘Strategy for 
Life Sciences’ (Department for Business, Innovation and Skills and Office for Life Sciences 2011) 
describe the contribution of research to the economic growth of the UK via the life sciences 
industry. In 2017 the Life Sciences Industrial Strategy (Office for Life Sciences 2017) set out an 
ambition to further improve UK clinical trials capabilities, reaffirming a commitment to 
research in the NHS albeit clinical trials in life sciences. In response to the Life Science 
Industrial Strategy, a Life Sciences Sector Deal was released at the end of 2017 (HM 
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Government 2017) followed by a second deal released in 2018 which included a commitment 
to increase public and private research and development spend to reach 2.4% of GDP (Gross 
Domestic Product) by 2027 (HM Government 2018). To give some context to the contribution 
of commercially-funded clinical research to the NHS, an independent NIHR-commissioned 
report published in 2019 (KPMG 2019) found that NHS Trusts received an average of £9189 in 
revenue from life sciences companies for each patient recruited into a commercial study i.e. 
funded by either industry or a private company. In the financial year 2018/19 this equated to 
an estimated total of £355 million in commercial income. In addition, it was estimated that, for 
the same period, the pharmaceutical cost savings achieved when life sciences companies 
provided drugs free of charge to patients in clinical trials totalled £28.6 million. The overall 
economic contribution of clinical research supported by the CRN to the UK was also reported 
and stated that over the 3-year period 2016/17 to 2018/19 an estimated total of £8 billion in 
GVA (Gross Value Added) and 47,467 full-time equivalent jobs were generated by CRN-
supported clinical research activity. 
Alongside Government policy driving research activity in the NHS, there is also an increasing 
body of evidence that demonstrates the impact of research in terms of improved quality of 
care (Davies 2016). Perhaps the most significant of these studies is a large population-based 
study published in 2017 which demonstrated a strong association between research activity 
and better patient outcomes (Downing et al. 2017). Using colorectal cancer as an example, the 
study found patients treated in hospitals with high, sustained hospital-level participation in 
interventional clinical trials had lower mortality and fewer postoperative complications. 
Furthermore, the benefits applied not just to patients who had participated in a clinical trial, 
but to all patients including those with the condition but who had not participated in such a 
study. Similar findings have also been shown in relation to research activity and reduced risk of 
mortality.  For example, a study published in 2015 found that based on population data, 
research-active Trusts had a lower risk-adjusted mortality for acute admissions (Ozdemir et al. 
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2015). Likewise, a study published in 2012 also demonstrated a significant correlation between 
academic output and improved mortality rates, with academic output defined as the number 
of citations per admission as this was deemed to reflect both research activity and workload 
(Bennett et al. 2012). Improved survival of patients treated in more research-active hospitals 
has also been found in studies undertaken in the USA in coronary artery disease (Majumdar et 
al. 2008) and in ovarian cancer in Germany (Du Bois et al. 2005, Rochon, Du Bois 2011). 
Similarly, another study published in 2018 also reported a correlation between NHS Trusts’ 
clinical trials activity and lower mortality rates particularly in relation to the number of 
participants recruited into interventional studies (Jonker, Fisher 2018). As well as being linked 
to reduced mortality, research activity has also been found to be associated with better 
healthcare performance. For example, a review of the literature relating to research 
engagement published in 2015 found a positive association between research engagement by 
healthcare organisations and improvement in performance through improved processes of 
care (Boaz et al. 2015). 
Evidence of an association between research activity and better patient outcomes has led to 
there being a call for more research to be undertaken in the NHS. For example, the Royal 
College of Physicians (RCP), in response to the growing body of evidence, issued the policy 
statement ‘Delivering research for all: expectation and aspirations for the NHS in England’ 
(RCP 2019). In this the RCP not only state the importance of every clinician working in the NHS 
to be research active, but also call for Trusts to increase their research activity and support 
clinicians to pursue research to enable more patients to have the opportunity to be involved 
with, or benefit from, clinical research. Also in response to there being evidence of research 
being associated with improved outcomes for patients, the NIHR has recently announced a 
new campaign, ‘Your Path in Research’, which aims to inspire more healthcare professionals to 
become involved in research (NIHR 2019c). In a recent article published in the Health Services 
Journal, Dr William Van’t Hoff (NIHR Clinical Director for NHS Engagement) also asked ‘Why 
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isn’t every hospital and healthcare professional in the UK supporting research?’ (William Van't 
Hoff 2019). Lastly, recognition of the role of research in improving patient care has led to the 
recent inclusion of questions relating to research activity in the Care Quality Commission 
(CQC) leadership inspection framework for providers i.e. the Well Led Framework (CQC 2018, 
NIHR 2019b). Perhaps one of the most important reasons for research being undertaken in the 
NHS, however, is that patients and the public perceive it to be important. This is demonstrated 
by a survey commissioned by the Health Research Authority (HRA) and NIHR in 2017, in which 
83% of respondents were reported to have said health research was very important (Hunn 
2017).   
The reasons clinical research should be conducted in the NHS outlined in this section are those 
relating to the contribution of research to the health and wealth of the nation. In the following 
section I will outline why pharmacists need to engage more with research as a profession.  
2.4 Research and pharmacists 
Pharmacists employed in the NHS need to undertake research not only because research is 
important to the NHS for the reasons outlined above but because research is needed to 
advance pharmacy practice. The practice of pharmacy has evolved in recent decades from a 
predominantly supply and dispensing function to providing services with a greater clinical 
emphasis (Howe, Wilson 2012). For practice to continue to advance it needs to be evidence-
based. The King’s Fund defined pharmacy practice research as ‘research which attempts to 
inform and understand pharmacy and the way it is practiced, in order to support the objectives 
of pharmacy practice and to ensure that pharmacists’ knowledge and skills are used to best 
effect in solving the problems of the health service and meeting the health needs of the 
population’ (p.46) (Mays 1997). For the practice of pharmacy to be evidence-based, practice 
research is therefore needed and this need has been recognised in pharmacy literature. In an 
article published in the Pharmaceutical Journal in 2015 the ‘increasing importance of evidence-
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based interventions’ (p.683) was cited in the context of research needing to be conducted as 
part of routine pharmacy practice to provide evidence of the efficacy of interventions made by 
pharmacists (Robinson 2015). Likewise, it has been recognised in the literature that pharmacy 
practice research is needed to provide evidence for the new and extended roles for 
pharmacists associated with practice developments (Krass 2015, Roberts, Kennington 2010). 
Practice research is therefore one example of how pharmacists can engage with research.  
However, pharmacists’ involvement with research is not limited to practice research as they 
are also ideally placed to contribute to the design and delivery of research studies which 
extend beyond the scope of pharmacy practice (Department of Health 2008). This is illustrated 
in a review of post-registration career development which suggests that pharmacy research 
activity falls into four overarching and overlapping domains - practice research, 
pharmaceutical science, clinical research and trials, and inter-disciplinary research (Howe, 
Wilson 2012). Koshman and Blais (2011) in a letter to the Canadian Journal of Hospital 
Pharmacy entitled ‘What is pharmacy research?’ also suggest pharmacy research to not be 
restricted to practice research in that they say ‘not all research in which pharmacists are 
involved reflects their practice, nor can it solely reflect the practice of pharmacists, especially in 
the era of collaborative practice teams’ (p.154) and ‘research done by pharmacists may 
address important questions that facilitate improved patient care or service delivery, without 
specifically advancing pharmacy practice, but still contributing to the scientific literature as a 
whole’ (p.154). Pharmacists can therefore not only engage with the NHS research agenda by 
undertaking research into the practice of pharmacy itself, but also by leading or contributing 
to research which extends beyond the scope of the pharmacy practice into the wider 
healthcare context. 
Generating evidence is not the only reason for pharmacists employed in the NHS to engage 
with research. Research is also recognised as a fundamental part of professional practice for 
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pharmacists by their professional body in the UK i.e. the Royal Pharmaceutical Society (RPS). 
The RPS considers research to be an integral part of practice for pharmacists working across all 
sectors and at all stages of career development, as evidenced by the inclusion of research in 
both the RPS Foundation Pharmacy Framework (RPS 2014b) and RPS Advanced Pharmacy 
Framework (RPS 2013). For pharmacists working in secondary care, the RPS Professional 
Standards for Hospital Pharmacy Services includes a requirement for pharmacy teams to lead, 
actively participate in and publish research (RPS 2017). For those in more senior positions, the 
NHS Agenda for Change job profiles for ‘advanced level’ pharmacists, i.e. Band 8a/b or above, 
include a requirement for pharmacists to undertake research in their own area of practice 
(NHS Employers 2015). Likewise, the descriptor for consultant pharmacist posts also includes a 
remit to provide leadership in research (Malson 2015). Furthermore, research has also been 
recognised as one of four pillars of advanced practice in the recently published ‘Multi-
professional framework for advanced clinical practice in England’ by Health Education England 
(HEE 2017). Although not specific to pharmacists as a profession, the framework is intended to 
be multi-professional, and therefore encompasses pharmacists.    
However, despite recognition of the need for pharmacists to engage with research, as a 
profession involvement is lacking. The need for more pharmacy practice research has, for 
example, been reported in the Pharmaceutical Journal as long ago as 2006 (Bond 2006), and 
was highlighted again more recently in an article published in 2015 which reported a need to 
‘boost engagement’ with pharmacy practice research (Krass 2015). The need for increased 
research engagement was perhaps more notably emphasised in the Department of Health 
White Paper ‘Pharmacy in England: Building on strengths- delivering the future’ published in 
2008 (Department of Health 2008). This set out proposals to both increase research into 
pharmacy services i.e. pharmacy practice research, and increase engagement with research 
more widely by, for example, increasing pharmacy involvement with clinical research and 
clinical trials. In the time since its publication, engagement may have increased as a result of 
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the report. However, more recently it has been reported that pharmacists applying to join the 
RPS Faculty find the Research and Evaluation competency cluster of the Advanced Pharmacy 
Framework the most challenging to complete suggesting there is still a lack of engagement 
across the profession (Barnett et al. 2018). In addition, the NIHR conducted a review of their 
training programmes in 2017, and found pharmacy as a professional group to be 
underrepresented (NIHR 2017).  
Interestingly, the need to increase engagement with research in the NHS is not limited to 
pharmacists as a profession. The recently published NIHR Clinical Research Network Allied 
Health Professionals Strategy 2018-2020 recognises the need to strengthen the research 
capacity and capability of this group (NIHR 2018a). Likewise, regarding nurses and midwives, 
studies have identified there to be no real expectation for members of these professions to 
lead research (Moore et al. 2012) and, as professional groups, they were also identified as 
being underrepresented compared to Allied Health Professionals in the NIHR training 
programme review undertaken in 2017 (NIHR 2017). The NIHR has also recently established a 
‘Nursing and Midwifery Incubator’ to accelerate capacity building and support the 
development of a clinical academic research workforce across these professions (NIHR 2019d). 
The need for increased engagement with research also extends to the medical profession as 
illustrated by the recent publication of a paper by the RCP titled ‘Research for all: Building a 
research-active medical workforce’ which was based on the findings of a 2015 UK survey 
undertaken to explore the barriers to doctors’ engagement in medical research (RCP 2016). 
The paper included several recommendations to increase engagement among the medical 
profession therefore suggesting a need to engage more doctors with research. Also illustrating 
the need to increase engagement not being limited to pharmacists as a profession, are two 
reports commissioned to explore ways to increase NHS staff engagement with research. The 
first report was commissioned by Cancer Research UK and examined barriers to research and 
steps needed to promote a stronger research culture in the NHS (Brown et al. 2015). The 
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second was commissioned by The Healthcare Improvement Studies Institute and similarly 
explored challenges in relation to NHS engagement with research, together with potential 
enabling mechanisms (Dimova et al. 2018).    
The need to increase pharmacists’ engagement with research is not an issue limited to the UK. 
The results of a recent survey of European Statements of Hospital Pharmacy undertaken in 
2017 found only 30% of responses to the statement ‘the pharmacists in our hospital routinely 
publish hospital pharmacy practice research’ to be positive and 75% of all respondents 
indicated that they had produced less than two external presentations/papers/posters in the 
previous year and 50% said they had produced none (Horák et al. 2018). This suggests a 
European-wide lack of engagement amongst the profession. The American College of Clinical 
Pharmacy (ACCP) Research Affairs Committee also published a White Paper in 2006 entitled 
‘The State of Science and Research in Clinical Pharmacy’ (Fagan et al. 2006). The paper 
included a vision for clinical pharmacists in terms of research involvement as part of the 
ACCP’s strategic plan, and described gaps between the envisioned state of clinical pharmacy 
research in 2030 and that of 2006 with recommendations for how to narrow these gaps, 
illustrating a need to increase involvement.  
2.5 Summary  
In summary, research is important to the NHS and there is a need to engage more pharmacists 
with research. By exploring hospital pharmacists’ attitudes and opinions towards research the 
aim of this research was to better understand how to increase engagement among 
pharmacists working in this sector. As opposed to other branches of the profession such as 
community pharmacy or primary care, hospital pharmacy was chosen because, as outlined 
earlier in the chapter, this is the sector with which I am professionally most familiar and where 
my personal interest lies.   
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As outlined in chapter 1 the research presented in this thesis was undertaken in two parts: an 
initial study undertaken in part 1 of the DPharm programme and the main research study 
undertaken in part 2.  As also outlined in chapter 1, the initial study took the form of a 
feasibility study for the research undertaken in part 2, and comprised a qualitative study in 
which the attitudes and opinions of six chief pharmacists of acute secondary care NHS Trusts 
in the West Midlands were explored.  The following two chapters pertain to the initial study. In 
chapter 3 the literature review for the initial study is summarised, and in the subsequent 
chapter a précis of the study is presented. The initial study is highlighted in Figure 2 below 
within the context of the various other elements of the research presented in the thesis.  
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Figure 2: Flowchart highlighting the initial study 
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3 Literature review for the initial study  
The literature review was undertaken in two phases - the first as part of the initial study in part 
1 of the DPharm programme and the second as part of the main research study undertaken in 
part 2. The literature review undertaken as part of the initial study is presented in this chapter. 
The literature included in this phase of the review relates to pharmacists’ attitudes and 
opinions towards undertaking research published up to when the initial study was completed 
in May 2016. Relevant papers published following completion of the initial study are included 
in the second phase of the review, an account of which can be found in chapter 6. To 
undertake the literature review for the initial study, a literature search was first undertaken as 
is outlined in section 3.1 below.  
3.1 Search strategy  
To identify research papers, a search of relevant databases was undertaken using various 
software packages available through Keele University comprising but not exclusively EBSCO, 
ProQuest and Web of Science. A complete list of databases searched using these software 
packages is listed in appendix 1. The search terms used in the database searches are listed in 
Table 2 below.  
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Table 2: Search terms used in the database searches relating to pharmacists attitudes and 
opinions towards undertaking research  
Terms to which search terms used pertained  
 
Search terms used in database searches 
Pharmacists Pharmacist*  
 
Pharmacy 
 
Attitudes and opinions  Attitude* 
 
Opinion* 
 
Perception* 
 
View* 
 
Perspective* 
 
Barrier* 
 
Facilitator* 
 
Research Research* 
 
 
Searches for all search terms were limited to title and subject/keyword except for research* 
which was limited only to title. All searches were also limited to human studies only and those 
published in English. Limits to publication dates were not applied to searches. Boolean 
operators i.e. AND and OR were used to refine the search. For details of how the Boolan 
operators were used to combine and limit the search terms refer to appendix 2. Also detailed 
in appendix 2 are the numbers of references identified at each stage of the searches 
undertaken.  
Following the database searches, references duplicated between the databases were 
identified and removed, leaving a combined total of two hundred and twenty two references. 
The titles and abstracts of these remaining references were then reviewed. However, the 
majority of the studies identified from the database searches were found to be examples of 
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pharmacy practice research and were not relevant as they did not explore pharmacists’ 
attitudes and opinions towards undertaking research.  
Following this review of the study titles and abstracts, eight references were deemed relevant 
for inclusion in the literature review including a systematic review of peer reviewed literature 
(1990-2014) published in 2015 which synthesised pharmacists’ involvement in and attitudes 
towards pharmacy practice research (Awaisu, Alsalimy 2015). Further references were then 
identified from citations in these references, several of which were papers published in 
professional magazines such as the Pharmaceutical Journal. These papers would not have 
been identified through the database searches as they were not published in journals included 
in the databases. In total, eighteen primary research papers were identified for inclusion in the 
literature review, in addition to the systematic review referred to above. As the intention was 
to continue to research the same subject for the main research study in part 2 of the DPharm 
programme, alerts were set up at the time of the initial database searches to highlight any 
further papers published which met the search criteria. Relevant studies published after 
completion of the initial study then formed part of the second phase of the literature review 
as outlined above. 
A review of the research papers identified through the literature search for the initial study is 
presented in the next section.  
3.2  Summary and critical analysis of the literature for the initial study  
Eighteen primary research studies were identified from the literature search. These were 
conducted in several countries and across different sectors of practice and employed various 
methodologies including qualitative, quantitative and mixed methods approaches. Table 3 
below provides a summary of the methodological approach used, the country where the 
research was undertaken, and the area of practice to which the research pertains for each of 
these studies, listed chronologically by publication date. 
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Table 3: A summary of the studies included in the initial study literature review 
Study authors Year of 
publication  
Methodological 
approach 
Country 
research 
conducted 
 
Study participants 
Davies et al.*  1993 Mixed methods (survey 
and structured 
interviews)  
 
UK (England) Hospital pharmacists 
Ellerby et al.* 1993 Quantitative (survey) UK 
(Scotland) 
Community 
pharmacists 
 
Liddell* 1996 Quantitative (survey) UK (England)  Community 
pharmacists 
 
Krska et al.* 1998 Quantitative (survey) UK (Scotland 
and Wales)  
Community 
pharmacists  
 
Rosenbloom et al.* 2000 Quantitative (survey) UK (England) Community 
pharmacists 
 
Simpson et al.* 2001 Quantitative (survey) Canada Community 
pharmacists 
 
Saini et al.* 2006 Mixed methods (survey 
comprising qualitative 
and quantitative items) 
  
Australia Community 
pharmacists 
Armour et al.* 2007 Qualitative (focus 
groups) 
 
Australia Community 
pharmacists 
Peterson et al.* 2009 Quantitative (survey) Australia Pharmacists working 
in all sectors 
 
Cvijovic et al. 2010 Qualitative (case study 
research using semi-
structured interviews) 
 
Canada Community 
pharmacists  
Carr et al.* 2011 Quantitative (survey) USA Community 
pharmacists  
 
Perrault et al.* 2012 Quantitative (survey) 
 
Canada Hospital pharmacists  
Kanjanarach et al.* 2012 Quantitative (survey) 
 
Thailand Hospital pharmacists  
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Table 3 continued 
Study authors Year of 
publication  
Methodological 
approach 
Country 
research 
conducted 
 
Study participants 
Hebert et al.*  2013 Quantitative (survey) Canada Community 
pharmacists 
 
Elkassem et al.* 2013 Quantitative (survey) Qatar Hospital 
pharmacists^ 
 
Awaisu et al.*  2014 Quantitative (survey) Qatar Hospital pharmacists 
 
Lowrie et al.  2015 Qualitative (semi-
structured interviews)  
UK 
(Scotland)  
Pharmacists working 
in GP practices and 
hospital pharmacists 
  
Stewart et al. 2015 Quantitative (survey) Qatar Hospital pharmacists 
 
 
* studies included in the systematic review published in 2015 (Awaisu, Alsalimy 2015). 
^ study participants comprised both pharmacists and non-pharmacists (43 participants were 
pharmacists and 4 were non-pharmacists i.e. 2 physicians, 1 pharmacy technician and 1 
podiatrist). Data from all 47 participants were included in the data analysis.   
 
In summary, the primary research studies identified for inclusion in the literature review were 
conducted in six different counties but predominantly in the UK, Australia and Canada. While 
most of the studies involved community pharmacists, seven were undertaken with hospital 
pharmacists (although some of these also included pharmacists from other sectors of 
practice). In terms of research methodologies used, of the eighteen primary research studies 
identified, thirteen utilised quantitative methodology, three used qualitative methodologies, 
and two employed mixed methods. The systematic review was based on 15 of the primary 
research studies included in this literature review (the studies included in the systematic 
review are highlighted in Table 3 above). The studies identified varied in their objectives. 
While several explored pharmacists’ interest or willingness to be involved, others looked at 
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their attitudes towards research. Some specifically explored pharmacists’ attitudes in relation 
to barriers and facilitators while others included pharmacists’ motivation to participate in 
research in their objectives. Others reported pharmacists’ self-perceived confidence and 
competence and some looked at levels of involvement among participants. The literature 
review below is presented in terms of these objectives.  
Interest and willingness to be involved in research 
Levels of interest in research involvement were explored as part of the systematic review and 
the authors reported levels to vary from 28% to 83% of surveyed participants (Awaisu, 
Alsalimy 2015). However, of the more recent studies included in the systematic review 
conducted with hospital pharmacists, the reported levels of interest in research were towards 
the higher end of this range (Elkassem et al. 2013, Kanjanarach et al. 2012, Perreault et al. 
2012, Awaisu et al. 2015). Two of the studies included in the systematic review assessed 
community pharmacists’ interest in practice-based research networks (collaborations to 
support the undertaking of research) and both reported interest levels to be high (Hébert et 
al. 2013, Carr et al. 2011). However, as these studies assessed pharmacists’ interest in 
participating in these networks they did not necessarily assess pharmacists’ interest in 
undertaking research themselves. One study compared levels of interest between those with 
previous research experience and those without (Saini et al. 2006). The authors reported 
levels of interest in future research involvement to be higher amongst those with research 
experience compared to those without (77% of respondents with previous experience 
expressed interest in future research involvement compared to 34% of respondents without 
prior experience). However, the study explored participants’ levels of interest relating to their 
community pharmacy being involved in future research, and it is therefore unclear whether 
these findings could be extrapolated to their personal interest in undertaking research.  
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Attitudes towards research 
The systematic review published in 2015 concluded that pharmacists had positive attitudes 
towards participating in pharmacy practice research, and that overall pharmacists agreed that 
conducting research was important (Awaisu, Alsalimy 2015). Reasons cited for why 
pharmacists perceived research to be important included research being a professional 
responsibility, as well as the development of the profession and career progression. The 
authors also reported that pharmacists recognised the importance of research to support 
evidence-based practice and improve the quality of patient care and outcomes.  
Papers published since the systematic review have also reported positive attitudes towards 
research among pharmacists. For example, Stewart et al. (2015) reported that respondents in 
their study generally held positive attitudes towards research. Likewise, Lowrie at al. (2015) 
reported similar positive attitudes towards research, reporting participants to have expressed 
an understanding of the relevance, importance and value of research within pharmacy 
practice. They also reported that, in line with the systematic review, participants 
acknowledged the importance of research to professional standing and potential for 
contribution to patient care.   
Barriers and facilitators to research  
Several studies reported findings relating to barrier and facilitators to pharmacists undertaking 
research.  
In relation to barriers, according to the authors of the systematic review those most 
commonly reported were lack of time and workload, insufficient or lack of funding, and lack of 
research knowledge, training, mentorship and support (Awaisu, Alsalimy 2015). Other barriers 
reported in the literature included lack of confidence (Awaisu et al. 2015, Armour et al. 2007, 
Lowrie et al. 2015), lack of knowledge in relation to accessing support (Liddell 1996), lack of 
27 
awareness of opportunities or not being approached (Peterson et al. 2009), and organisational 
culture (Stewart et al. 2015, Lowrie et al. 2015). 
Presumably as a result of using a qualitative methodology, Lowrie et al. (2015) reported 
barriers to engagement not cited elsewhere in the literature. They reported lack of managerial 
support and prioritisation of immediate core daily clinical activities to be frequently cited as 
barriers. They also reported a perception of research being risky, citing there to be ‘little desire 
to ‘gamble’ on research that may result in negative outcomes’ (p.4) among participants. Lack 
of extrinsic reward in relation to career progression was reported as another barrier to 
engagement, with the authors citing research to be perceived to involve ‘substantial personal 
cost for limited personal gain’ (p.4). Fear of undertaking research was also cited to being an 
underlying fear of failure through research ideas being dismissed and a fear of the unknown. 
Interestingly, the authors also looked at the barriers reported by those they described as 
‘currently ‘and ‘not currently’ undertaking research and found more contextual barriers to be 
reported by those not undertaking research than those who were. The authors concluded 
from this that these findings suggested that ‘perceived contextual barriers are outweighing the 
personal elements to participate in research’ (p.10).  
Some studies also provided more context or insight regarding some of the barriers identified 
previously in the literature. For example, regarding lack of time being a barrier, the authors of 
a case study suggested that although lack of time was frequently cited as the main barrier to 
participation, this was a ‘socially acceptable excuse’ offered by participants (Cvijovic et al. 
2010). The study was conducted in Canada and explored community pharmacists’ perceptions 
of their participation in a particular research project for which they had undertaken data 
collection. Rather than lack of time being a barrier to research participation, the authors 
instead suggested that the barrier to research participation to be a perceived lack of value 
associated with collecting research data among their participants because the time taken to 
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collect the data was minimal and participants reported competing demands taking priority 
over data collection. However, as the study related to participant’s views and experiences of 
undertaking one particular study, the extent to which the findings relate to pharmacists’ views 
of undertaking research in general is unclear. More relevant is perhaps the findings of the 
research undertaken by Lowrie et al. (2015). They too found lack of time to be viewed as the 
main barrier to research but, like the authors of the Canadian case study, suggested that this 
‘served to mask’ other factors such as prioritisation of clinical services and fear associated with 
undertaking research. However, they also reported that a limited number of participants in 
their study had changed their working practices to enable them to undertake research. 
Examples cited included individuals using their annual leave to undertake research or 
compressing their working hours to enable them to have time in the working week to 
undertake research. I would suggest that individuals changing their working practices to 
accommodate research activity goes some way to supporting the notion that lack of time in 
the working day is a barrier to research engagement rather than lack of time masking other 
barriers as suggested by the authors. Indeed, Lowrie et al. (2015) also suggested there to be a 
tacit acceptance among participants that to undertake research they would need to do this in 
their own time, again suggesting lack of time to be a ‘real’ barrier to research engagement. In 
relation to lack of competence being an impediment to engagement, Lowrie et al. (2015) 
suggested that, given most of the NHS pharmacists interviewed in their research had 
undertaken or were undertaking research as part of a postgraduate qualification which 
incorporated a research component, the learning undertaken as part of such qualifications 
does not equip pharmacists to undertake subsequent research in the workplace.  
Few papers specifically looked at facilitators to engagement. A qualitative study undertaken in 
Australia with community pharmacies looked at pharmacists’ views relating to strategies to 
overcome barriers to research involvement (Armour et al. 2007). The strategies identified 
included students conducting research in pharmacies, pharmacy research awareness 
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programmes, research training for pharmacy staff, and more encouragement to undertake 
research training. Although the study did not cite these as facilitators to research, by their very 
nature strategies to overcome barriers or ensure individuals are not prevented from 
undertaking research represent facilitators. The only other study to look at facilitators was a 
further qualitative study undertaken more recently in the UK by Lowrie et al. (2015) which 
identified what they described as ‘perceived barriers and supports’ to research. Included in 
their findings were access to support, protected time to undertake research, job roles which 
oversee research activity and incentivising research by linking it to career progression. 
Additional funding to ensure continuity of delivery of existing roles through backfill 
arrangements was also identified in the context of protected time facilitating engagement. 
They also reported lack of time and prioritisation to be less of problem when research was 
undertaken within the context of a postgraduate qualification. From this they suggested that 
postgraduate qualifications were an enabler to engagement in terms of allowing pharmacists 
protected time to undertake research. Research networks and peer support, as well as the 
idea of a centralised research support facility, were also suggested as ways to provide 
pharmacists with support. In addition, management support was seen as a necessary pre-
requisite to research involvement. Although not cited as a facilitator to engagement per se, 
the authors of the systematic review published in 2015 advocated the creation of practice-
based research networks between academia and practice as a way to augment participation in 
research by promoting research culture and mentorship among pharmacists (Awaisu, Alsalimy 
2015).  
Motivating factors to undertake research  
Three main themes were identified from the systematic review: personal interest in a 
particular research project; belief in the importance of research and its impact on patients’ 
health; and the desire to improve the profession (Awaisu, Alsalimy 2015). Although not 
mentioned in the systematic review, increasing job satisfaction appeared to be cited as 
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another motivating factor in one study (Carr et al. 2011), and two studies reported the 
opportunity to learn more about disease management to be another factor that would 
encourage pharmacists to participate in research (Simpson et al. 2001, Peterson et al. 2009). 
Two further studies identified financial reward or incentives as motivating factors 
(Rosenbloom et al. 2000, Peterson et al. 2009). However, contradictory findings from other 
studies did not suggest involvement to be facilitated by financial incentives (Armour et al. 
2007, Krska et al. 1998, Saini et al. 2006). 
In terms of motivating factors identified in research published since the systematic review, 
Lowrie et al. (2015) reported individual motives for engaging in research which they 
categorised as personal and external rewards. External rewards included potential benefits to 
the service or interest in the research area whereas personal rewards were limited to gaining a 
postgraduate qualification. The authors suggested explicit inclusion of research in NHS 
employee pharmacists’ job roles, personal development and appraisal as ways to encourage 
research activity as well as linking research to career progression. Interestingly, the authors 
reported that participants did not make reference to any external drivers to participation and 
that, rather than their job role or other external incentive driving them to undertake research, 
‘those who had managed to incorporate research into their job roles had drawn on their 
internal drive to conduct research’ (p.11).   
Confidence and competence to undertake research  
Only one study conducted among hospital pharmacists in Qatar stated determination of 
pharmacists’ self-reported competence and confidence to undertake research to be a primary 
objective of their research (Awaisu et al. 2015). The authors found at least 20% of respondents 
reported themselves as having inadequate competence and/or confidence in several aspects 
of the research process, including developing research protocols, critically appraising the 
literature, conducting statistical analysis, and interpreting study findings.   
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Other studies have also explored participants’ self-perceived competence and confidence to 
undertake research.  In terms of competence, the authors of one study reported that only 
51.9% of participants in their study considered themselves to be adequately trained to 
conduct research (Perreault et al. 2012) and likewise the authors of another reported that 
most participants in their research perceived themselves to lack some of the skills and/or 
knowledge to carry out research (Armour et al. 2007). One study, which also reported that 
several participants did not perceive themselves as having the required skills to enable them 
to participate in research, cited research design, ethical guidance, statistics and scientific 
writing cited as areas where participants felt they needed support (Lowrie et al. 2015). 
In relation to confidence, one study reported pharmacists to lack confidence in their 
knowledge to undertake research (Kanjanarach et al. 2012) , and, as referred to in section 0, 
two further studies reported lack of confidence to be a barrier to research (Armour et al. 2007, 
Lowrie et al. 2015). On the other hand, the authors of one study reported that 95.7% of 
participants in their research felt confident to undertake research but only 34% agreed they 
had received sufficient training to undertake pharmacy practice research suggesting that, 
despite them feeling confident to undertake research, participants felt they lacked 
competence (Elkassem et al. 2013). Similarly, the authors of another study reported that 
40.8% of participants in their research agreed with the statement ‘I would require supervision 
to do research’ suggesting that either participants lacked confidence or perceived themselves 
to lack competence to undertake research (Rosenbloom et al. 2000). 
Research involvement  
The systematic review published in 2015 concluded that between 6% and 50% of surveyed 
pharmacists reported previous involvement in research and that research involvement was 
more common amongst hospital pharmacists compared to community pharmacists (Awaisu, 
Alsalimy 2015).  
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One study not included in the systematic review also explored pharmacists’ involvement in 
research, and reported 37% of participants to be involved in research at the time of the 
interviews taking place, and a further 54% of participants to have previous research 
experience but not involved in research at the time of the interviews (Lowrie et al. 2015). In 
addition, the authors reported that the majority of participants who had either previously 
undertaken or were undertaking research had done so in part-fulfilment of a work-based 
postgraduate qualification. They also reported that those with a postgraduate qualification 
were more likely to be involved in research as were those with increasing numbers of years of 
postgraduate experience. 
3.3 Relevance of the published literature to the initial study  
Previous studies have mainly sought the attitudes and opinions of community pharmacists, 
rather than those employed in the hospital sector. This is perhaps not surprising given it has 
been reported that 55% of pharmacists worldwide work in the community sector compared to 
just 18% in hospitals (International Pharmaceutical Federation 2012). Indeed, of the eighteen 
primary research studies reviewed, ten related solely to community pharmacists (Liddell 1996, 
Krska et al. 1998, Rosenbloom et al. 2000, Saini et al. 2006, Simpson et al. 2001, Armour et al. 
2007, Cvijovic et al. 2010, Carr et al. 2011, Hébert et al. 2013, Ellerby et al. 1993) of which six 
were not only undertaken with community pharmacists but also conducted outside of the UK 
(Armour et al. 2007, Cvijovic et al. 2010, Carr et al. 2011, Saini et al. 2006, Hébert et al. 2013). 
As practice varies between countries and sectors, the relevance of the findings of these 
studies to this study is unclear. The findings of the four studies undertaken with community 
pharmacists in the UK would arguably be more applicable but these studies were all 
undertaken some time ago (Ellerby et al. 1993, Krska et al. 1998, Liddell 1996, Rosenbloom et 
al. 2000). Three were published in the 1990s (Ellerby et al. 1993, Krska et al. 1998, Liddell 
1996) and even the most recent was published twenty years ago (Rosenbloom et al. 2000). As 
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pharmacy practice has evolved significantly in the last few decades (as outlined in earlier in 
section 2.4), the extent to which the findings of even these studies can be applied to current 
pharmacy practice in the UK is difficult to determine. 
Of the studies undertaken involving hospital pharmacists, the majority of these were also 
undertaken outside the UK in Canada (Perreault et al. 2012), Qatar (Awaisu et al. 2015, 
Elkassem et al. 2013, Stewart et al. 2015), Thailand (Kanjanarach et al. 2012) and Australia 
(Peterson et al. 2009). Despite these studies having involved hospital pharmacists, because 
they were undertaken outside of the UK and because practice varies between countries, the 
extent to which their findings can be applied or extended to UK practice is also unclear. 
Certainly, the authors of one study undertaken in Qatar recognised that research was not 
mandated for hospital pharmacists there, and contrasted that to the UK where a requirement 
to undertake research is specified under NHS Agenda for Change (Awaisu et al. 2015). 
Of the studies conducted in the UK with hospital pharmacists, one was undertaken some time 
ago in 1993 in the South East Thames region which used a survey and structured interviews to 
assess the level of commitment and opinions of clinical trainers and pharmacy service 
managers to pharmacy practice research within hospitals (Davies et al. 1993). Lack of time and 
funding, together with insufficient experience, were identified as the main barriers to 
research. However, the validity of the study findings as representative of current opinions is 
difficult to determine as, like the community pharmacy studies undertaken in the UK, the 
research was undertaken over 25 years ago and in the intervening period pharmacy practice 
has changed. A second study involving UK hospital pharmacists was undertaken in Scotland in 
Greater Glasgow and Clyde Health Authority and is a more recent publication (Lowrie et al. 
2015). The study explored pharmacists’ perceptions and experiences of pharmacy-led research 
in the workplace and involved 54 semi-structured face-to-face interviews with pharmacists 
working in primary care and hospitals in varying roles, numbers of years qualified, levels of 
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seniority and experience in research. The authors concluded that ‘most pharmacists realised 
the desirability and necessity of research to underpin pharmacy service expansion’ (p.1). They 
also reported the lack of research in pharmacy culture to be a combination of contextual 
barriers and more individual elements but, as cited earlier in the previous section, they also 
suggested that perceived contextual barriers to be outweighing personal elements to 
participate in research. The authors therefore suggested ‘a combination of individual and 
profession level changes is needed to increase activity’ (p.1) including changes at 
organisational level to offer practical, accessible support to individuals. However, the 
relevance of these study findings to hospital pharmacists working in the NHS in England may 
be limited because firstly, although the study was conducted with hospital pharmacists, 
primary care pharmacists also participated and differentiation was not made between the 
groups in the reporting of the findings, and secondly because the structure of the NHS in 
Scotland differs from that in England in that the Scottish healthcare system is more integrated 
(NHS Scotland 2016).   
To summarise, the relevance of previous research findings to UK hospital pharmacists’ 
attitudes and opinions towards research is limited, not only because the majority of studies 
involved community pharmacists but also because, of those undertaken with hospital 
pharmacists, the majority have been conducted outside the UK. Even the relevance of the 
findings of the studies undertaken with hospital pharmacists in the UK is potentially limited 
due to either the time elapsed since the research was published or because of differences 
between the English and Scottish healthcare systems. 
3.4 Summary 
Having reviewed the relevant published literature, a paucity of research relating to the 
attitudes and opinions of hospital pharmacists in the UK to undertaking research was 
identified. There is therefore a need to explore the attitudes and opinions of pharmacists 
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working in this sector in the UK to better understand how to increase their engagement with 
research.  
A précis of the initial study is presented in the next chapter. 
  
36 
4 Initial study 
As outlined in chapter 1, the initial study took the form of a feasibility study for the main 
research study undertaken in part 2 of the DPharm programme. This comprised semi-
structured interviews with chief pharmacists of six acute secondary care NHS Trusts in the 
West Midlands to explore their attitudes and opinions towards hospital pharmacists 
undertaking research. In this chapter I outline the study aims and methodology used to 
conduct the research as well as summarise and discuss the findings in relation to the literature 
reviewed in the previous chapter. However, as the study took the form of a feasibility study, 
learning from the initial study related to the appropriateness of the methodology for the main 
research study, together with any findings which informed the research design for the main 
study, are also presented later in the chapter, in section 4.4.   
4.1 Study aims 
The initial study aims were as follows:  
 To explore the attitudes and perceptions of chief pharmacists towards hospital 
pharmacists undertaking research 
 To establish the appropriateness of the methodology for exploring the phenomenon of 
interest and inform the research design for the main research study undertaken in part 2 
of the DPharm programme 
4.2 Methods 
The initial study was exploratory in nature. Undertaking a study of this type was appropriate 
for this element of the research as a lack of published studies relating to the phenomenon of 
interest i.e. UK hospital pharmacists’ attitudes and opinions towards research had been 
identified from the initial study literature review. Exploratory studies are cited in the literature 
as being useful ‘when not enough is known about a phenomenon’ (p.36) (Gray 2014). To 
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undertake exploratory studies, qualitative methodologies are commonly employed (Smith 
2010). A qualitative methodology was used in this initial study as semi-structured interviews 
were conducted allowing the subject to be investigated from the perspectives of participants 
(Snape, Spencer 2003). 
Chief pharmacists were chosen to be participants as I believed, as a professional group, they 
would have a broader view of the barriers and enablers to research activity as well as a greater 
insight into the political context within their organisations and the wider profession compared 
to less senior pharmacists. I felt that scoping their attitudes and opinions for my initial study 
would therefore help inform the study design for my main research study in part 2. 
Semi-structured interviews were chosen to allow flexibility in the conduct of the interviews 
and thereby enable the collection of rich data (Bryman 2012). Semi-structured interviews were 
chosen in preference to focus groups for two reasons - firstly, in group situations it can be 
harder to probe for details (Fitzpatrick, Boulton 1996), and secondly, due to the wide 
geographical spread of participants, a focus group would have been difficult to arrange. 
Interviews were undertaken face-to-face as opposed to by telephone to help build rapport and 
therefore obtain more detailed and considered responses (Smith 2010). 
Six chief pharmacists were interviewed. This sample size was selected because this was the 
maximum number of interviews that could have been conducted in the timeframe allocated to 
undertaking the initial study in the DPharm programme at Keele University. As the purpose of 
this element of the research was a feasibility study i.e. undertaken to establish if the research 
design and methodology were appropriate to inform the main research study undertaken in 
part 2 of the DPharm programme, achieving data saturation was not necessary. Conducting six 
interviews was therefore sufficient for this element of the research.  
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To identify participants, a purposive convenience sampling strategy was used (Bowling 2014). 
The sampling strategy was purposive as the aim was to achieve a ratio of chief pharmacists 
from mental health Trusts to acute Trusts roughly proportional to the ratio of mental health 
Trusts to acute Trusts in the region. To achieve this, four of the six chief pharmacists who 
participated represented acute secondary care NHS Trusts and two represented mental health 
Trusts. It was also a convenience strategy because the chief pharmacists who were 
approached to participate were those with whom I already had established working 
relationships and who were believed therefore to be most likely to take part. To recruit 
participants, I telephoned all potential participants to invite them to take part, and all agreed 
to take part. During the calls, prospective participants were given an outline of what taking 
part in the research would entail. To ensure they were able to make an informed decision 
regarding participation in the study, all potential participants were emailed a copy of the 
participant information sheet in advance of the interviews taking place, and, before being 
interviewed, were required to give their written consent to participate by way of completing 
and signing a consent form. For copies of the participant information sheet and consent form, 
refer to appendices 3 and 4 respectively. Ethics approval was sought before any contact was 
made with prospective participants. 
To provide a framework for the interviews an interview guide was developed based on the 
objectives of the studies included in the initial study literature review. All interviews were 
undertaken at participants’ workplaces and were transcribed verbatim. Refer to appendix 5 for 
a copy of the interview guide. 
To analyse the data framework analysis was used to identify themes from the interview 
transcripts (Ritchie, Spencer 1994). For further details of how the data was analysed using this 
analytical approach refer to section 8.1.4). NVivo (a software programme designed for 
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qualitative analysis) was used to help with data management (Richards 1999). Anonymised 
short quotes are used to illustrate findings. 
Ethics approval for the study was obtained from Keele University School of Pharmacy Ethics 
Committee (see appendix 6 for a copy of the ethics approval letter). However, NHS Permission 
was not required despite NHS staff being involved due to the study being a feasibility study 
(i.e. undertaken to establish the appropriateness of the research design and methodology) and 
therefore not considered to be research according to the HRA decision tool (HRA 2015). 
In the next section, the findings of the initial study in relation to the attitudes and opinions of 
the chief pharmacists who participated are presented and later discussed in the context of the 
published literature.  
4.3 Attitudes and opinions towards hospital pharmacists undertaking 
research 
4.3.1 Findings  
Four key themes were identified relating to participants’ attitudes and perceptions towards 
hospital pharmacists undertaking research were identified: involvement, drivers, barriers, and 
enablers. A summary of the findings relating to each of these four key themes are presented 
below. 
Involvement  
Only two of the chief pharmacists interviewed described pharmacists in their respective 
organisations to be undertaking research. Both were acute Trusts and at both pharmacists 
undertaking research were doing so as part of post-graduate qualifications. No pharmacists at 
any of the Trusts represented by the chief pharmacists who participated were undertaking 
research outside of postgraduate qualifications. Two of the chief pharmacists had themselves 
undertaken research but there did not appear to be any correlation between chief 
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pharmacists’ previous research experience and research activity within their departments. 
While pharmacists were not undertaking research at all Trusts, all chief pharmacists who 
participated unequivocally recognised the importance of pharmacists undertaking research.  
I2: ‘…pharmacy, certainly hospital pharmacy, really should be doing research.’ 
However, only one saw it as their duty to encourage research activity and lead by example 
though undertaking research themselves. 
When asked how pharmacists could be involved in research, participants talked about 
pharmacists leading and developing practice-based research. Participants also made reference 
to multidisciplinary collaborations which included pharmacists contributing to or supporting 
research led by other disciplines and, likewise, other disciplines supporting the delivery of 
pharmacy-led research.  
I3: ‘I think pharmacists can do everything from leading, developing, you know, every 
aspect of that research and supporting others in doing that..’ 
One also talked specifically about pharmacists being involved in designing protocols for Trust-
sponsored clinical trials. I would argue these all to be examples of pharmacists being involved 
in undertaking research. However, some also talked about pharmacists’ involvement in the 
management of clinical trials medicines which, although related to research in the widest 
sense, is a supply function, and, I would argue is therefore not an example of pharmacists 
undertaking research themselves. The potential for confusion between managing clinical trials 
medicines and other types of research-related activities constituting research involvement was 
therefore identified.  
Throughout the course of the interviews some confusion among participants regarding 
different types of scientific inquiry also became apparent. Some perceived audit and service 
evaluation to be research whereas others distinguished between research and service 
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evaluation and/or audit. Several also appeared to associate publishing work, either as journal 
publications, conference presentations or posters, as being synonymous with research when 
in reality such publications can be used to report any type of scientific inquiry.  
Drivers 
Chief pharmacists’ perceptions of the drivers for pharmacists to undertake research fell into 
two broad categories: those related to the individual i.e. personal drivers and those related to 
the organisation or the wider profession i.e. external drivers. 
Professional development, career progression, obtaining a qualification, kudos and personal 
interest were cited as personal drivers to pharmacists undertaking research. Career 
progression being a driver was not a universally shared view. Several were of the opinion that 
research was not required for career progression within the NHS, but, where it was viewed as 
an enabler to career progression, it was the qualification gained as a result of undertaking the 
research that was frequently cited as enabling career progression rather than involvement in 
research itself. In terms of personal kudos, some gave the impression that the kudos 
associated with research qualifications was less about the academic achievement and skills 
gained from undertaking research but more about attaining a personal accolade, as illustrated 
by the following quote: 
  I2: ‘It’s kudos isn’t it, that’s why we do it, we like to have doctor before our name..’ 
Gaining a postgraduate qualification therefore seemed to be more of a driver for research 
engagement than the process of undertaking research itself. 
In the context of external drivers, improving services for patient benefit was ubiquitously 
cited. When talking about research in the context of improving services, several participants 
described themselves as having a ‘gatekeeper’ function in terms of ensuring that research 
undertaken in their department was aligned to departmental priorities. Research activity being 
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associated with a good reputation of both the department and the Trust was also cited with a 
suggestion that such a reputation could facilitate staff recruitment.  
I6: ‘I think a positive profile, recruitment and retention, you know you can use it all for 
the positive things of trying to encourage people to join you because we’ve got a high 
profile ‘we’re doing this research’.’ 
Organisational culture was also identified as a driver, and several chief pharmacists recognised 
the influence of their leadership on the culture of their respective departments.  
I2: ‘…if the chief pharmacist or the leaders of the pharmacy service are not recognising 
that and not pushing pharmacy forward to do research, then it’s not going to happen.’ 
At an organisational level, one participant talked about their Trust vision and associated 
research strategy being a driver for their department to engage in research. However, another 
had a different opinion. Instead of their organisation being the driver for their department to 
be research active, they talked about research engagement within their department being 
their personal ambition. It was at these Trusts, where research strategies were in place, 
whether departmental or Trust-wide, where chief pharmacists appeared to be driving research 
or were taking steps towards this. Others, by comparison, appeared almost ambivalent and, 
consequently, the personal motivation of individuals employed in their departments to 
undertake research appeared to be a more significant driver than the contextual domain. 
Organisational culture, whether Trust-wide or departmental, was therefore recognised as 
being a potential driver. When asked about the inclusion of research in pharmacists’ job 
descriptions, the majority reported that it was, but when asked about the inclusion of research 
in staff appraisal only one said it was included in the appraisals of pharmacists at their Trust, 
and even then it was only included in the appraisals of those already undertaking research.  
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Barriers 
Chief pharmacists’ perceptions of the barriers to hospital pharmacists undertaking research 
fell into three key categories: resource, mindset and culture. 
In terms of barriers relating to resource, lack of time was cited as the largest barrier to 
undertaking research but this was mainly in the context of the competing priorities of ‘core 
duties’. Lack of time, therefore, appeared to be a barrier not only to research but to any 
activity not associated with the core pharmacy service. Lack of funding to release staff time to 
undertake research was also identified as a barrier, as was lack of available expertise to 
support research. Even chief pharmacists of Trusts where pharmacists were undertaking 
research expressed concern about the robustness of their internal mentoring arrangements, 
recognising that research expertise within their departments was limited. Although 
participants appeared to be aware that postgraduate research qualifications provided training 
in research methodology, they talked about a lack of available training and formalised support 
from universities as being barriers to research for those wanting to undertake research 
outside of such qualifications. There appeared to be a desire therefore for training and 
support to be available for pharmacists to undertake research outside of postgraduate 
qualifications. On the subject of accessing research expertise, chief pharmacists who 
participated were aware of the research expertise within academia but viewed the lack of 
engagement between universities and Trusts as a barrier to pharmacists undertaking research. 
Illustrating this, several talked about a divide or separation between academia and practising 
pharmacists, and appeared, therefore, to view the relationship between academia and 
practice as ‘them and us’. Participants also talked generally about a lack of support for 
pharmacists to undertake research. Interestingly, some did not appear to believe that support 
should be coming from themselves or others within the department but instead implied that it 
should be coming from a source external to their organisation such as a professional body 
perhaps. 
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In relation to mindset, chief pharmacists identified lack of confidence and a perceived lack of 
competence across the profession as barriers. One participant illustrated this by comparing 
the mind-set of pharmacists with that of junior medics: 
I1:  ‘Because I think sometimes, strangely as a profession, we do lack confidence.  
We...we you know, we do...we do...so a...a junior medic might go up and sort of say, 
oh, you know, I want to do a piece of research; I want to do this.  And actually, 
pharmacists are more reticent about doing that.’   
Research being perceived as complex to undertake was cited as a barrier with several 
suggesting that the prospect of undertaking research might even be something that 
pharmacists feared or perceived to be impossible.  
I1: ‘...people see research as something off in the ether that is way, way complicated 
and undoable.’ 
To counter this many believed that there was latent potential within the profession, their 
perception being that pharmacists had the level of skill required to undertake research but 
their lack of knowledge of research methodologies acted as a barrier to engagement. Several 
participants also suggested pharmacists perceived research to be ‘risky’ to undertake which 
they believed would present a barrier as they perceived pharmacists to be generally risk 
averse and conservative. Reasons suggested why pharmacists perceived research to be risky 
included pharmacists not being inclined to want to risk undertaking research which could be 
perceived to be of minimal or no value and the risk of negative feedback if they were to 
publish research that could potentially be perceived by others as controversial.  
I5: ‘..you’re going to be putting your head above the parapet once you’ve published 
something or put something out there and there may be some people who want to 
shoot down what you have put up there, especially if it’s controversial.’ 
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Pharmacists’ mindsets being more aligned to evaluation rather than questioning and exploring 
was also cited as barrier as was work-life balance, indicating that some expected research to 
be carried out, at least in part, in pharmacists’ personal time which participants believed 
pharmacists would be reluctant to do. Participants also suggested that pharmacists’ 
perceptions of the substantial personal costs associated with undertaking research compared 
to the lack of or limited financial gain to represent another barrier.  
I5: ‘You don’t get paid any more to do it, it’s often a lot of extra stress and pressure.’ 
Lack of awareness or appreciation of how research impacts on practice was also cited as a 
barrier to engagement and several reasons were suggested for this including lack of exposure 
to research and lack of research experience. Reference was also made to research not being 
part of the professional culture of pharmacists and there being a lack of awareness of the 
need for practice-led research among members of the profession.  
The culture of the Trust or department was also identified as potential barriers to research 
engagement among pharmacist. In relation to the culture of the department lack of 
prioritisation emerged as a barrier as illustrated by some participants considering research to 
be something additional to pharmacists’ roles rather than a core function.  
I3: ‘I think a big chunk of it is just the time out of the core service… it’s actually seen as 
extra to your role, rather than a key part of your role…’ 
Research not being embedded into the career structure of pharmacists was also perceived to 
be a barrier as was lack of continuity of academic study after graduation with several 
suggesting that the academic mindset learnt during undergraduate study was potentially being 
lost as pharmacists enter professional practice, as illustrated by the following quote:  
I1: ‘It gets lost in the busy day...day-to-day mundane stuff.’ 
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Enablers 
Enablers to pharmacists undertaking research could be categorised into the same key themes 
as the barriers: resource, mindset and culture. 
In relation to resource, participants talked about access to expertise being a facilitator to 
engagement, and having research-experienced pharmacists to provide mentorship to others 
was given as an example of how pharmacists could access such expertise. Identifying a 
pharmacist within the department with research expertise to provide leadership and support 
to others undertaking research was also cited in the same context.  
I6: ‘I pay [name of the pharmacist leading on research] a day a week to look at and 
lead on practice research.’ 
Undertaking postgraduate research qualifications was also recognised as not only offering 
pharmacists access to training in research methodology, but also through the course of 
undertaking the qualification, providing them with mentorship and support to carry out 
research. Participants also talked about closer collaborations between universities and Trusts 
being another way for individuals to access research expertise with academic practice units 
cited as one way to achieve this. Collaborations with other Trusts to access expertise was also 
suggested by one participant. In the context of facilitators relating to resource, obtaining 
funding to enable staff to have time to undertake research and staff having protected time for 
research were also cited. Regarding mindset, it was suggested that pharmacists with certain 
personality traits or characteristics, such as being ‘freethinking’ and less risk-averse would be 
more inclined to undertake research. In relation to culture, profession-wide changes such as 
integrating research into the career path of pharmacists were cited as potential facilitators to 
engagement. One participant illustrated this by comparing the career path of pharmacists to 
that of medics: 
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I1: ‘Erm maybe the medical profession have it slightly different in that they are 
expected to do research right from the word go, they are expected to do audit right 
from the word go and it’s just something you are expected to fit in with your 
profession, your home life et cetera.’ 
Participants also talked about organisational culture being important in terms of engaging 
pharmacists with research. However, rather than viewing it as their responsibility to bring 
about any cultural change, participants appeared to see it as something that needed to be 
changed at a professional level.  
4.3.2 Discussion 
The initial study finding that chief pharmacists recognised the importance of research was 
consistent with the findings of previous studies (Awaisu, Alsalimy 2015, Awaisu et al. 2015, 
Liddell 1996, Lowrie et al. 2015, Perreault et al. 2012, Rosenbloom et al. 2000, Elkassem et al. 
2013, Kanjanarach et al. 2012, Carr et al. 2011, Hébert et al. 2013, Krska et al. 1998). However, 
this apparent recognition of the importance of research did not appear to have translated into 
practice. Research activity across the Trusts represented by the chief pharmacists who 
participated in this study was low and involvement was limited to those undertaking 
postgraduate qualifications. Research, therefore, did not appear to be integrated into practice 
at any of the Trusts represented by the chief pharmacists who participated. In relation to 
involvement, potential for confusion in relation to activities constituting research involvement 
was also identified. For example, there was some confusion among participants in relation to 
the types of research-related activities pharmacists could be involved in which constituted 
undertaking research in that  some perceived managing clinical trials medicines to be an 
example of how pharmacists could undertake research rather than an example of pharmacists 
supporting research delivery. Also contributing to potential confusion among the profession 
regarding research involvement was the apparent difficulty some participants had 
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distinguishing between different forms of scientific inquiry as well as a perceived association 
between publishing work and research. 
Drivers for pharmacists to undertake research identified in the study and consistent with the 
systematic review published in 2015 included personal interest and the impact of research on 
patient outcomes although a desire to improve the profession, also identified as a 
motivational factor in the systematic review, was not clearly apparent (Awaisu, Alsalimy 2015). 
However, a driver for research activity identified in the study, but not previously reported in 
the literature, was an association between research activity and the reputation of the 
organisation. Much of the focus of the drivers, however, centred around outcomes of either 
the research or the research process i.e. the knowledge gained from undertaking research, 
attaining postgraduate qualifications or the kudos associated with being research active for 
the individual or organisation. Less emphasis was placed on the personal and professional 
development associated with undertaking research. Another observation was that those who 
had previously undertaken research appeared better able to appreciate these benefits. This 
raised the question of whether chief pharmacists who had not personally undertaken research 
themselves were aware of the knowledge and skills, and, to a certain extent, the mindset 
gained through undertaking research and the transferable nature of these skills.  
Although not explicit in the data, awareness of the requirement for research to be undertaken 
in the NHS appeared to be lacking among participants. Also, research did not appear to be 
considered ‘core business’, as outlined the Department of Health research strategy ‘Best 
Research for Best Health’ (Department of Health 2006). Participants also seemed unaware of 
the requirements to undertake research as outlined in the Royal Pharmaceutical Society (RPS) 
practice frameworks i.e. the Foundation Pharmacy Framework (RPS 2014b) and Advanced 
Pharmacy Framework (RPS 2013), and RPS Professional Standards for Hospital Pharmacy 
Services (RPS 2014a). Lack of awareness or recognition of these national NHS and profession-
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wide drivers was therefore identified as potentially going some way towards explaining the 
apparent disconnect between recognition of the importance of research and the integration of 
research into pharmacy practice. In addition, despite the NHS Agenda for Change (AfC) 
requirement for the inclusion of research activity in job descriptions of senior pharmacists 
(NHS Employers 2015), in the majority of cases this had not been translated into practice as 
research was not consistently reported to be included in appraisals. From the initial study 
findings it did not appear that AfC was driving research activity. 
Consistent with the systematic review published in 2015 (Awaisu, Alsalimy 2015), lack of time 
and workload, insufficient or lack of funds, and lack of research knowledge, training and 
mentorship were all evident from the data as presenting barriers to engagement. Although 
lack of time was cited as a barrier, lack of time and lack of funding appeared to be closely 
linked. Lack of prioritisation appeared to be a more significant barrier to engagement, 
evidenced not only by research not appearing to be integrated into practice, but also because 
it did not seem to be considered a core service. These findings were consistent with those of 
Lowrie et al. (2015) who suggested core daily clinical activities were a barrier to research. 
Arguably, the findings also supported those of Cvijovic et al. (2010) who suggested that lack of 
time was a ‘socially acceptable excuse’ whereas the barrier appeared more so to be competing 
priorities. Also consistent with the research undertaken by Lowrie et al. (2015) was the 
identification of lack of extrinsic reward in terms of career progression and associated financial 
gains, and work-life balance acting as barriers.  
Research being perceived to be ‘risky’ and this presenting a barrier to engagement was also 
consistent with the findings of Lowrie et al. (2015) who reported there to be reluctance to 
undertake research that may result in negative outcomes. However, the idea of pharmacists’ 
mindsets being more aligned to evaluation than questioning appeared to be a new theme to 
have emerged from the initial study data.  
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Perceived complexity of research, lack of confidence and perceived lack of competence to 
undertake research were also identified to be barriers. Again these findings were consistent 
with previous studies which also cited lack of confidence and competence to undertake 
research as being barriers to engagement (Awaisu et al. 2015, Elkassem et al. 2013, Armour et 
al. 2007, Lowrie et al. 2015). Lack of awareness among pharmacists of the impact of research 
on practice identified as a potential barrier to engagement in this study had also been 
reported in previous research (Armour et al. 2007, Peterson et al. 2009), as had a separation 
or divide between academia and practicing pharmacists posing a barrier to research (Armour 
et al. 2007). 
In terms of facilitators to research, again similarities were evident with research undertaken 
by Lowrie et al. (2015). Arguably the suggestions of more formal engagement with 
universities, as well as collaborations with other Trusts, broadly aligned to the idea of 
centralised research support suggested by the authors as they reflected the need for improved 
access to expertise. Lowrie et al. (2015) also cited protected time, job roles that oversee 
research activity and linking research to career progression as other facilitators which were 
again similar to the findings of the initial study. The findings also aligned with the views of the 
authors of the systematic review who, by advocating the creation of practice-based research 
networks, arguably suggested more formal links with universities would facilitate engagement 
(Awaisu, Alsalimy 2015). 
Culture was identified as a key theme in terms of both the drivers to pharmacists undertaking 
research and the barriers and facilitators to research engagement. Not only was the 
organisational culture of the Trust recognised by some participants as influencing research 
activity within a department, but the leadership of the chief pharmacist themselves was also 
recognised as having a significant influence on the culture of a department within the context 
of research. These influences were evident in the apparent varied reasons for some 
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departments being more research-active than others. At Trusts where research was being 
undertaken at the time the interviews were being conducted, or where there was ambition to 
further grow research in an already research-active department, the chief pharmacists 
appeared to be responding to an external driver, whether that be the motivation of individual 
pharmacists, or a Trust-wide research strategy. This seemingly reactive approach contrasted 
with a more proactive approach adopted by one chief pharmacist who personally wanted to 
drive research in their department. Changing the mind-set of chief pharmacists was therefore 
identified as a potential way to begin to alter the culture of a pharmacy department with 
respect to research. In terms of the literature, two studies referenced the influence of 
organisational culture on research activity (Lowrie et al. 2015, Peterson et al. 2009). However, 
both of these studies cited organisational culture as a barrier to research and suggested that a 
change in pharmacy culture was required to engage more pharmacists in research, whereas 
the findings of the initial study suggest that organisational culture could be both a barrier and 
a facilitator.  
4.3.3 Conclusion 
Overall the findings of the initial study were largely consistent with those reported in the 
published literature. Particularly pertinent was the similarity to the findings of Lowrie at al. 
(2015) as this research had been conducted in the UK, had included hospital pharmacists as 
participants and was published around the same time the initial study was undertaken. 
However, a key finding of the initial study was that both the organisational culture of the Trust 
and the leadership of the chief pharmacist appeared to significantly influence research activity 
within pharmacy departments.  
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4.4 Implications of the initial study for the main research study  
In this section, the findings and learning from the initial study are discussed in the context of 
how they were used to inform the research design and methodology of the main research 
study undertaken in part 2 of the DPharm programme. These are presented in two parts - the 
first part (section 4.4.1) relates to the appropriateness of the methodology to explore the 
phenomenon of interest and the second part (section 4.4.2) relates to how the findings 
influenced the research design of the main research study.  
4.4.1 Appropriateness of the methodology  
From undertaking the initial study, the following points were identified in relation to the 
appropriateness of the methodology used in the initial study to conduct the main research 
study: 
1. Semi-structured face-to-face interviews were an effective way to undertake an in-depth 
exploration of the subject with participants and were therefore an appropriate method to 
use to generate data for the main research study 
2. The questions included in the initial study interview guide had effectively explored the 
phenomenon of interest and the interview guide used in the initial study was therefore 
broadly suitable for use in the main research study 
3. Interviews took between 20 and 40 minutes to conduct and therefore more questions 
could be included in the interview guide and the interviews still take no longer than an 
hour to conduct 
4.4.2 Influence of findings on research design 
Organisational culture and the leadership of the chief pharmacist were identified as having a 
significant influence on research activity among pharmacists from the initial study. These 
findings led me to want to undertake research to explore further the influence of the 
contextual domain on research activity for the main research study. Therefore, as part of the 
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literature review for the main research study, a search was undertaken to identify studies 
relating to the influence of organisational culture and the leadership of the chief pharmacist 
on research activity among pharmacists.   
Support for research activity in terms of individuals being able to access expertise was also 
identified as potentially facilitating engagement, with academic practice units and individuals 
in research leadership roles cited as examples of how individuals might access such support 
within their department. I was therefore interested in how pharmacists in research active 
organisations were supported to undertake research. Consequently, as part of the literature 
review for the main research study, the literature was searched for models of support for 
pharmacists to undertake research.  
It was also apparent from interviewing chief pharmacists with and without personal research 
experience that those with prior experience had more insight into the factors influencing 
research engagement among pharmacists.  For the main research study I therefore wanted to 
conduct my research with pharmacists who had personal research experience.  
From the interviews undertaken for the initial study it was also apparent that all chief 
pharmacists who participated had insight regarding the culture of their organisations and the 
influence this had, or had the potential to have, on research activity among pharmacists. To 
explore the influence of organisational culture, it was therefore clear from the initial study 
that the views of chief pharmacists would need to be sought.  
Regarding other insight gained from the initial study that had implications for the main 
research study, it was also apparent that participants’ perceptions of the ways they believed 
pharmacists could be involved in research varied, as did their perceptions of the types of 
scientific inquiry constituting research. Some also perceived authorship of publications and 
conference presentations/posters to be synonymous with research. Potential for confusion in 
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relation to research involvement was therefore identified from the initial study, meaning there 
to potentially be confusion among participants in the main research study regarding their 
interpretation of the term ‘undertaking research’. Therefore, as part of the literature review 
for the main research study, the published literature relating to pharmacists attitudes and 
opinions towards research was reviewed to identify how research involvement was defined in 
these studies. The purpose of this was to either identify a definition of research involvement 
used in the literature which could then be used in the main research study or, if such a 
definition was not found to exist, explore how research involvement was perceived by authors 
of previous studies to inform a definition to use in the main research study.   
4.4.3 Summary 
Undertaking the initial study therefore had implications for both the research design of the 
main research study and the methodology to be used. In terms of the research design, not 
only did I want to explore the attitudes and opinions of hospital pharmacists towards research, 
but I also wanted to explore the contextual conditions influencing research activity among 
pharmacists working in the hospital sector. The influence of the initial study findings on the 
research design for the main research study is discussed further in chapters 7 and 8. 
In the next chapter the aims and objectives of the main research study are outlined.  
From here onwards the focus of the thesis is the main research study undertaken in part 2 of 
the DPharm programme. The main research study is highlighted in Figure 3 below within the 
context of the various other elements of the research presented in the thesis.   
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Figure 3: Flowchart highlighting the main research study 
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5 Main research study aims and objectives 
The main research study conducted in part 2 of the DPharm was an exploration of the 
attitudes and opinions of hospital pharmacists towards research. In this chapter the research 
aims and objectives are outlined.  
5.1 Research aim 
The aim of the main research study was to increase understanding of the attitudes and 
perceptions of hospital pharmacists towards undertaking research to better understand how 
to engage more hospital pharmacists with research. 
5.2 Research objectives  
The objectives of the main research study were: 
1. To explore hospital pharmacists perceptions of the drivers, drawbacks, barriers and 
enablers to hospital pharmacists undertaking research* 
2. To investigate the characteristics of research active pharmacy departments 
3. To make recommendations to potentially influence policy to engage more hospital 
pharmacists with research  
* Although the key themes identified in the initial study were involvement, drivers, barriers 
and enablers, for the main research study, drivers, drawbacks, barriers and enablers were 
investigated for the following reasons:  
 Drawbacks were explored in the main research study as participants in the initial study 
had identified drivers to pharmacists undertaking research, and it was felt therefore there 
may also be drawbacks to research engagement, drawbacks representing an antonym to 
drivers. A possible explanation for why participants in the initial study did not identify any 
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such drawbacks was that on the whole the chief pharmacists who participated were 
relatively research naïve and may not therefore have personally experienced drawbacks to 
undertaking research which may explain why drawbacks did not emerge as a theme.  
 
 Involvement was not explored in the main research study because it was felt that as the 
main research project was being conducted with pharmacists who were research 
experienced, levels of involvement were not relevant.  
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6 Literature review for main research study 
In this section the literature reviewed for the main research study is presented, and comprises 
two sections.  
The first section relates to a review of the research papers relating to pharmacists’ attitudes 
and opinions towards undertaking research published since the completion of the initial study 
i.e. between May 2016 and December 2019.  
In the second section, a review of the literature is presented relating to the initial study 
findings which informed the research design of the main study. A review of the literature 
relating to the influence of organisational culture, the leadership of the chief pharmacist, and 
models of support for research activity among pharmacists employed in the hospital sector is 
presented, together with a summary of how research involvement is defined by the authors of 
the studies identified for the literature reviews relating to pharmacists attitudes and opinions 
towards research.   
6.1 Review of literature relating to attitudes and opinions of pharmacists 
towards undertaking research 
In this section, an account of the literature relating to pharmacists’ attitudes and opinions 
towards research published since the initial study was completed is provided. 
6.1.1 Search strategy 
As outlined in section 3.1, alerts were set up at the time of the initial database searches to 
identify relevant research papers published following completion of the initial study. Twelve 
primary research papers were identified relating to pharmacists’ attitudes and opinions 
towards research. In addition a search of the grey literature was undertaken which identified a 
survey of European Statements of Hospital Pharmacy undertaken in 2017 (Horák et al. 2018), 
referred to earlier in chapter 2. To give context as to why the survey findings were relevant to 
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the literature review, the European Statements of Hospital Pharmacy are commonly agreed 
objectives designed to assist European health systems in ensuring safe, effective and optimal 
use of medicines which all European health systems should aim to achieve (The European 
Statements of Hospital Pharmacy 2014). The purpose of the survey undertaken in 2017, and 
those undertaken in years previous to this, was to measure progress of the implementation of 
the statements and to identify the key barriers to implementing them. For the survey 
undertaken in 2017 one of the sections relates to education and research, and the findings 
were therefore relevant to this research. 
6.1.2 Summary and critical analysis of the literature published since the initial study  
Similar to the studies identified for the initial study literature review, the twelve primary 
research papers identified from the database searches were conducted in several countries 
and in different sectors of practice, and used various methodological approaches. Table 4 
below provides a summary of the methodological approach used, the country where the 
research was undertaken and the area of practice to which the research pertains for each of 
the nine studies, listed chronologically by publication date. 
  
60 
Table 4: A summary of the studies included in the main research study literature review  
Study authors Year of 
publication 
  
Methodological 
approach 
Country research 
conducted 
Study participants 
Sultana et al. 2016 Quantitative (survey) Saudi Arabia Hospital 
pharmacists 
 
Fakeye et al. 2017 Quantitative (survey) Nigeria Community and 
hospital 
pharmacists 
  
Bhagavathula et al. 2017 Quantitative (survey) Ethiopia Community 
pharmacists and 
pharmacy 
technicians 
 
Crilly et al. 2017 Mixed methods 
(survey followed by 
semi-structured 
interviews) 
 
UK (England) Community 
pharmacists 
De Vera et al. 2018 Qualitative (semi- 
structured 
interviews) 
 
Canada Community 
pharmacists  
Abubakar et al. 2018 Quantitative (survey) Nigeria Pharmacists 
working in all 
sectors 
 
Lee et al. 2018 Quantitative (survey) Canada Hospital 
pharmacists  
 
Sarwar et al.  2018 Quantitative (survey) Pakistan 
 
Hospital 
pharmacists 
 
Shitu et al. 2019 Quantitative (survey) Nigeria Pharmacists 
working in all 
sectors 
 
Zeiden et al.  2019 Quantitative (survey) Lebanon Community 
pharmacists 
 
Kupiers et al. 2019 Quantitative (survey) Netherlands Community 
pharmacists  
 
Stewart et al. 2018 Quantitative (survey) UK (Scotland) Pharmacists 
working in all 
sectors 
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To summarise, the studies identified were conducted in eight different countries and varied in 
terms of the areas of practice participants were from. Seven of the studies included hospital 
pharmacists as participants. In terms of research methodologies used, ten utilised quantitative 
survey methodology, one used mixed methods, and one employed a purely qualitative 
approach.  
As per the literature review undertaken for the initial study, the twelve primary research 
studies varied in their objectives in that some looked at pharmacists’ interest in or willingness 
to be involved in research and some their attitudes towards research. Others focused on 
barriers and facilitators to engagement and/or explored factors that motivated pharmacists to 
undertake research while others looked at involvement with research. Some studies also 
looked at pharmacists’ self-perceived competence and confidence to undertake research. The 
review below is presented in terms of the study objectives listed above.  
Interest and willingness to be involved in research  
The findings of the research published since completion of the initial study were largely 
consistent with those of the systematic review published in 2015 (Awaisu, Alsalimy 2015) in 
that levels of interest in research were found to be high in all studies where this was explored 
(Sarwar et al. 2018, Crilly et al. 2017, Bhagavathula et al. 2017, Sultana et al. 2016, Abubakar 
et al. 2018, Stewart et al. 2019, Shitu et al. 2019, Zeidan et al. 2019). One study explored 
pharmacists’ willingness to be involved in research and reported that a large proportion of 
those who responded to their survey were willing to participate in research (Sarwar et al. 
2018). In line with the research undertaken by Saini et al. (2006) included in the literature 
review for the initial study, two studies compared interest in future research opportunities of 
pharmacists with previous research experience to those without, and found that pharmacists 
with previous research experience were more likely to be interested in future research 
(Sultana et al. 2016, Zeidan et al. 2019).  However, unlike Saini et al. who explored levels of 
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interest among community pharmacists who participated in their study in relation to their 
pharmacy being involved in future research, these more recent studies explored interest in 
personally undertaking research. 
Attitudes towards research 
Three studies reported pharmacists to have positive attitudes or perceptions towards research 
(Bhagavathula et al. 2017, Sultana et al. 2016, Sarwar et al. 2018). Six explored pharmacists’ 
attitudes towards the importance of research and, similar to the findings of the systematic 
review published in 2015 (Awaisu, Alsalimy 2015), reported recognition of the importance of 
research among participants (Bhagavathula et al. 2017, Sultana et al. 2016, Fakeye et al. 2017, 
Sarwar et al. 2018, Crilly et al. 2017, Zeidan et al. 2019). Their reasons were similar too. For 
example, career progression was cited (Bhagavathula et al. 2017) as was research being a 
professional duty or recognised as being part of pharmacy practice (Bhagavathula et al. 2017, 
Sultana et al. 2016, Fakeye et al. 2017) and recognition of the importance of research in 
relation to improving practice and patient care (Sultana et al. 2016, Fakeye et al. 2017, Sarwar 
et al. 2018). Two further studies also reported there to be recognition among participants of 
research being part of professional practice i.e. one study reported the majority of participants 
to believe research to be a professional duty (Shitu et al. 2019), and another reported that the 
majority of participants in their study agreed research should be part of daily practice (Kuipers 
et al. 2019). 
Barriers and facilitators to research  
Findings relating to barriers to research involvement were similar to those identified from the 
initial study literature review.  Lack of time was again identified as a common barrier to 
engagement (Abubakar et al. 2018, Crilly et al. 2017, De Vera et al. 2018, Lee et al. 2018, Shitu 
et al. 2019, Zeidan et al. 2019, Sultana et al. 2016, Kuipers et al. 2019). Other barriers reported 
included lack of funding, (Zeidan et al. 2019, Fakeye et al. 2017, Abubakar et al. 2018), 
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difficulty obtaining funding (Shitu et al. 2019), lack of remuneration (Crilly et al. 2017), 
inadequate knowledge (Abubakar et al. 2018, Crilly et al. 2017, Fakeye et al. 2017, Sarwar et 
al. 2018), insufficient training (Crilly et al. 2017, Bhagavathula et al. 2017), lack of awareness of 
the opportunities to be involved in research (Sarwar et al. 2018, Sultana et al. 2016), not being 
approached or asked to take part (Sultana et al. 2016, Sarwar et al. 2018, Crilly et al. 2017), 
and competing workload priorities (Lee et al. 2018). Several studies also reported lack of 
managerial support as a barrier to engagement (Abubakar et al. 2018, Crilly et al. 2017, Sarwar 
et al. 2018). Lack of incentives was also identified as a barrier in one study (Sarwar et al. 2018). 
As outlined above in section 6.1.1, the 2017 European Statements of Hospital Pharmacy 
Statements Survey explored barriers to pharmacists publishing pharmacy practice research 
(Horák et al. 2018). Lack of capacity was identified as the most frequent barrier reported, 
followed by lack of capability and publishing research not being considered a priority by 
management. 
In relation to lack of time being reported as a barrier to research, several study authors 
appeared to use their study findings to challenge this. For example, Fakeye et al. (2017) 
reported that time constraints were not found to be a barrier to research in their study, and 
suggested that this ‘perhaps implies that once there is interest and willingness in research, lack 
of time should not be a hindrance to conduct PPBR [pharmacy practice-based research]’ (P.8). 
Likewise, Sultana et al. (2016) reported that although lack of time was identified as a barrier in 
their study, participants were willing to make time to undertake research during working 
hours. Crilly et al. (2017) too reported very similar findings in that they also reported 
pharmacists would be willing to make time to undertake research during the working day, and 
Kuipers et al. (Kuipers et al. 2019) reported a little over half of participants in their study 
(51.6%) would be willing to find time to participate in pharmacy practice research.  Lastly, 
Abubakar et al. (2018) suggested their findings were inconsistent with those previously 
reported in the literature in that they identified lack of funding to be the biggest barrier to 
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research, rather than lack of time. However, I would argue funding and time are interlinked 
issues as funding can be used to release time for individuals to undertake research. In 
addition, as the research undertaken by Abubakar et al. (2018) used survey methodology, 
these two issues could not be reliably differentiated in the study.  
Several studies reported findings relating to facilitators to engagement. The authors of one 
study reported 69% of participants in their study felt training tools would help facilitate 
research and 52% thought protected time would be beneficial (Crilly et al. 2017). The authors 
of this study also reported that participants had suggested that if management were more 
supportive of research they in turn would be more likely to take part. Another study identified 
opportunities to join existing teams and mentorship programmes to be the most popular 
strategies for engaging pharmacists in future research (Lee et al. 2018). Of note, two further 
studies also explored facilitators to engagement (De Vera et al. 2018, Kuipers et al. 2019). 
However, De Vera et al. (2018) had undertaken their research with community pharmacists 
who had conducted a particular practice-based research study within their pharmacies, and 
the facilitators cited related specifically to the research activity undertaken for that particular 
study. For example integrating patient recruitment into the pharmacy workflow was identified 
as a facilitator. The facilitators were therefore focused more towards facilitating research 
delivery in community pharmacies rather than facilitating community pharmacists to 
undertake research. The applicability of the study findings to the pharmacists’ attitudes and 
opinions towards undertaking research in general is therefore not clear. Likewise, although 
Kuipers et al. (2019) had explored facilitators to pharmacists undertaking research, the 
purpose of undertaking the research had been to provide researchers with insight on how to 
optimise research participation among community pharmacists. The facilitators they described 
therefore related to how to optimise study designs to facilitate the delivery of studies by 
community pharmacists, as opposed to facilitators to engage pharmacists with undertaking 
research. 
65 
Motivating factors to undertake research  
Similar to the initial study literature review, improving patient care (Crilly et al. 2017, Fakeye et 
al. 2017, Sarwar et al. 2018, Sultana et al. 2016), learning more about disease management 
(Sultana et al. 2016, Fakeye et al. 2017, Lee et al. 2018), personal interest (Lee et al. 2018, 
Kuipers et al. 2019, Sultana et al. 2016) and a desire to improve the profession (Fakeye et al. 
2017, Sarwar et al. 2018, Sultana et al. 2016) were all reported to be motivating factors. Two 
studies reported that the majority of those who took part felt research would benefit their 
career (Stewart et al. 2019, Bhagavathula et al. 2017) and another reported that, second to 
personal interest, the next most common reason for conducting research among participants 
in their study was that research was part of their job requirements (Lee et al. 2018). De Vera et 
al. (2018) also reported motivations for conducting pharmacy practice research which included 
a desire to contribute to research, improve care delivery, gain more knowledge and access 
innovation. In terms of new themes, personal satisfaction was also reported to be a motivating 
factor in three studies (Fakeye et al. 2017, Sarwar et al. 2018, Lee et al. 2018) although none 
cited any specific reasons for this being the case. 
Confidence and competence to undertake research  
Only one study specifically stated determination of pharmacists’ self-perceived confidence and 
competence to undertake research to be a primary research objective (Abubakar et al. 2018). 
The study team reported that at least 70% of the participants in their study rated themselves 
as moderately to extremely competent to conduct research, meaning that up to 30% assessed 
themselves as not very competent or not competent at all. The authors also reported that the 
highest competence and confidence scores were observed for conception of research ideas, 
literature searching and critical appraisal, and the lowest were seen for research skills related 
to statistical analysis of data.  
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Other studies also explored pharmacists’ self-assessed competency and confidence to 
undertake research. In relation to self-perceived confidence, one study reported more than 
50% of participants showed confidence in their skills and ability to undertake research, 
suggesting that the rest lacked confidence (Sultana et al. 2016). On the other hand, the 
authors of another study reported higher levels of self-perceived confidence to undertake 
research, reporting that 88.2% of participants in their study perceived themselves to have 
confidence to conduct research (Shitu et al. 2019). With regards to competence, one study 
reported that 56.2% of participants in their study believed themselves to be competent to 
conduct research (Bhagavathula et al. 2017), and similarly another reported that in their 
research 60% of participants reported they had the necessary skills to do research (Crilly et al. 
2017). Slightly higher levels of self-perceived competence were reported by the authors of 
another study who found 76.4% of participants in their research believed they had the skills to 
conduct research (Shitu et al. 2019). The authors of one study also explored pharmacists’ self-
identified strengths and weaknesses in relation to research, reporting participants’ self-
identified strengths to be literature evaluation and hypothesis generation, and their weakness 
to be statistical analysis (Lee et al. 2018). 
Some studies also compared pharmacists’ self-perceived competence and confidence to 
undertake research between those with and without previous research experience. One study 
reported pharmacists with previous research experience to have higher overall confidence and 
competence scores than those without (Abubakar et al. 2018). Similarly, another reported that 
pharmacists with previous research experience were more confident in their research skills, 
ability to read and evaluate papers and to design research studies (Sultana et al. 2016). 
Involvement in research  
Several studies explored levels of previous involvement in research among surveyed 
participants, and reported that levels of involvement ranged between 40.7% and 88% (Fakeye 
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et al. 2017, Crilly et al. 2017, Abubakar et al. 2018, Kuipers et al. 2019, Sultana et al. 2016, 
Stewart et al. 2019). In these studies, levels of previous involvement therefore appeared 
comparatively higher than those reported in the systematic review published in 2015 (Awaisu, 
Alsalimy 2015). Similar to the systematic review, however, levels of involvement among 
hospital pharmacists appeared to be higher than among community pharmacists. For example, 
Fakeye et al. (2017) reported higher levels of involvement among hospital pharmacists (55.4%) 
than community pharmacists (40.75%). Sultana et al. (2016), who conducted their research 
with hospital pharmacists, also reported relatively high levels of previous research experience 
(59%) among participants in their research. In addition, Stewart et al. (2019) reported that 
participants in their research involved in conducting research or research dissemination were 
more likely to be highly qualified pharmacists in secondary care, although only 12.5% of 
participants reported current involvement at the time the research was undertaken. 
The levels of involvement reported by Crilly et al. (2017) were, however, an exception in that 
they conducted their research with community pharmacists and reported high levels of 
previous research involvement (88%). The reported levels of research involvement, however, 
related to what the authors referred to as ‘mandatory research’, which included activities such 
as the community pharmacy patient questionnaire and clinical audits undertaken as part of 
the NHS pharmacy contract. Perhaps more relevant is the reported level of involvement in 
non-mandatory research, which was 29% and therefore much lower than that reported for 
‘mandatory research’ and in line with other published work.  
Interestingly, Abubaker et al. (2018), who reported the proportion of pharmacists with 
research experience in their study to be 79.5%, suggested that the high levels of involvement 
reported in their study may be due to most pharmacy schools in Nigeria having mandatory 
research projects for final year pharmacy students. However, Fakeye et al. (2017) also 
conducted their research in Nigeria, but did not make reference to final year pharmacy 
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student projects in their discussion regarding reported levels of involvement among their 
study participants. They, however, limited participation to those with five or more years post-
qualification experience meaning that the final year student project may not have been 
perceived to be relevant.  
6.1.3 Relevance of the published literature to the main research study  
Having reviewed the literature relating to pharmacists’ attitudes and opinions towards 
research published since the initial study was completed, a number of further studies were 
identified with generally similar findings to those published before the initial study. This is 
perhaps unsurprising given that ten of the twelve studies reviewed in this part of the literature 
review employed survey methodology, and all but Lee et al. (2018) and Kupiers et al. (2019) 
based their questionnaires on survey instruments used in previous studies. Therefore, the 
concepts explored through the surveys where the questionnaires were developed based on 
ones used previously would, in all likelihood, have been the same or very similar to those 
explored in the literature reviewed for the initial study. Therefore, similarity in the findings of 
the literature reviews could perhaps be expected. Findings reported in the literature reviewed 
for the main research study not reported in the literature reviewed for the initial study 
included difficulty obtaining funding presenting a barrier to engagement (Shitu et al. 2019). 
Other findings reported in the literature published since the initial study was undertaken that 
had not been previously reported included opportunities to join existing teams and 
mentorship programmes representing strategies for engaging more pharmacists in research 
(Lee et al. 2018) and research experience being a motivating factor for pharmacists to 
undertake research (Stewart et al. 2019, Bhagavathula at al. 2017). Research being part of 
pharmacists’ job descriptions was also reported to be a motivating factor for pharmacists to 
undertake research (Lee et al. 2018) in the literature published since the initial study was 
conducted whereas this had only been suggested as a driver for engagement in the initial 
study literature review (Lowrie et al. 2015).  
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In terms of the relevance of the findings of the literature published since the initial study was 
completed to the main research study, ten of the twelve studies identified were undertaken 
outside the UK (Abubakar et al. 2018, Fakeye et al. 2017, Sultana et al. 2016, Bhagavathula et 
al. 2017, De Vera et al. 2018, Lee et al. 2018, Sarwar et al. 2018, Zeidan et al. 2019, Kuipers et 
al. 2019, Shitu et al. 2019). As per the analysis of the literature undertaken for the initial study, 
variation in practice between countries means that the applicability of research undertaken 
outside the UK to UK practice is difficult to determine.  
The only studies undertaken in the UK were those conducted by Crilly et al. (2017) and Stewart 
et al. (2019). Crilly et al. (2017) conducted their research with community pharmacists in 
England and employed mixed methods approach which took the form of a survey followed by 
interviews. Although the study was undertaken with UK pharmacists, the findings are not 
altogether relevant to this research. Firstly because the research involved community 
pharmacists, whose practice varies from that of those employed in the hospital sector, and 
secondly because, as highlighted earlier in section 6.1.2, activities such as undertaking 
mandatory audits were considered to be examples of research involvement.  
Stewart et al. (2019) on the other hand used survey methodology to explore the views and 
experiences of pharmacists on research conduct, dissemination and training among 
pharmacists working in all sectors across six Scottish health board areas. In terms of the 
relevance of their findings, although the research was conducted in the UK, I would question 
the applicability of the findings to pharmacists working in acute secondary care NHS Trusts in 
England for the same reasons I questioned the applicability of the research previously 
undertaken by Lowrie et al (2015), which was also conducted in Scotland. Firstly, pharmacists 
from all sectors participated and secondly the health system in Scotland differs to that in 
England. In Scotland, the health system is integrated whereas in England the health system is 
based on a commissioner-provider model meaning there are different organisational 
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structures between the nations. This in turn limits the transferability of research undertaken in 
Scotland to the English health system. 
Therefore, no studies published since the initial study was completed appeared to have 
specifically explored the attitudes and opinions of hospital pharmacists in England towards 
research. Of those studies undertaken in the UK their relevance to this research was limited 
either due to the research being conducted with community pharmacists, as was the case with 
the research undertaken by Crilly et al. (2017), or for the research undertaken by Stewart et al. 
(2019), because of the differing health systems in the devolved nations.  
6.1.4 Summary  
Having reviewed the literature published since the initial study was completed, a paucity of 
studies relating to UK hospital pharmacists’ attitudes and opinions towards research was 
found to still exist. Research to explore the attitudes and perceptions of pharmacists 
employed in the hospital sector in England towards undertaking research was therefore still 
needed to establish how to increase engagement with research among pharmacists working in 
this sector.  
6.2 Review of literature relating to the initial study findings which informed 
the research design for the main research study 
In this section, accounts of the literature reviews undertaken in relation to the findings of the 
initial study which informed the research design for the main research study are presented. 
Presented first is an account of the literature relating to the factors identified from the initial 
study as having the potential to influence research activity among pharmacists employed in 
the hospital sector i.e. organisational culture, the leadership of the chief pharmacist and 
models of support for pharmacists to undertake research. This is followed by an account of 
how research involvement is defined in the literature relating to pharmacists’ attitudes and 
opinions towards undertaking research.   
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6.2.1 Factors pertaining to the contextual domain 
In this section I provide an account of the literature reviewed relating to the influence of the 
factors pertaining to the contextual domain described above on research activity among 
pharmacists. 
A literature search was undertaken to identify research papers pertaining to the influence of 
organisational culture, the leadership of the chief pharmacist and models of support for 
pharmacists undertaking research on research activity among pharmacists.  
6.2.1.1 Search strategy 
To identify relevant research papers, a search of the relevant databases was undertaken using 
similar software packages as had been used to undertake the previous literature search to 
identify studies pertaining to pharmacists’ attitudes and opinions towards research i.e. EBSCO 
and Web of Science. ProQuest was not used for this literature search as the ProQuest 
database option used for the previous search was no longer available via Keele University. 
Appendix 1 provides a complete list of the databases searched using EBSCO and Web of 
Science. The search terms used in the database searches are listed in Table 5 below.  
Table 5: Search terms used in the database searches relating to factors pertaining to the 
contextual domain and their influence on research activity among pharmacists 
Terms to which search terms used pertained  
 
Search terms used in database searches 
Pharmacists Pharmac* 
 
Organisational culture  ‘’organisational culture*’’ 
 
Leadership of the chief pharmacist  Leader* 
 
Models of support ‘’model* of support’’ 
 
Research Research* 
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Searches for all search terms were limited to title and subject/topic and all searches were 
limited to human studies only and those published in English. Limits to publication dates were 
not applied to searches. Boolan operators i.e. AND and OR were used to refine the search. For 
details of how the Boolan operators were used to combine and limit the search terms, refer to 
appendix 7. Also detailed in appendix 7 are the numbers of studies identified at each stage of 
the searches undertaken.  
References duplicated between the databases were identified and removed, and the titles and 
abstracts of the remaining studies were then reviewed. However, no relevant studies were 
identified. The studies that were identified through the literature searches related to research 
undertaken to, for example, explore or measure organisational culture but not in the context 
of research. Likewise the references identified relating to leadership and models of support 
were also not relevant.  
The literature search was therefore widened to identify any relevant references relating to the 
influence of organisational culture, leadership and models of support on research generally. 
The same search terms and Boolan operators were used as in the previous search, and the 
same limits were applied. For details of the searches refer to appendix 8. Also detailed in 
appendix 8, are the numbers of studies identified at each stage of the searches undertaken. 
References duplicated between the databases were identified and removed. For the 
references relating to organisational culture and research and models of support and research, 
the titles and abstracts of the remaining studies were then reviewed and no relevant studies 
were identified. For the references related to leadership and research, because of the vast 
number of references identified, in each database the titles and abstracts a filter was selected 
to list the articles in order of relevance, and the title and abstracts of the first 250 references 
from each database were reviewed for their relevance. Again, no relevant articles were 
identified.  
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Therefore, to explore the influence of models of support on research activity among 
pharmacists, the primary research papers and systematic review relating to pharmacists’ 
attitudes and opinions towards research identified through the previous literature searches on 
this topic, were reviewed to identify any references to models of support for pharmacists to 
undertake research. The same papers were not reviewed to identify references to 
organisational culture and leadership as any references to these factors had been identified 
and included in the literature reviews pertaining to pharmacists’ attitudes and opinions 
towards undertaking research. 
6.2.1.2 Summary of references to models of support 
From the review of the primary research papers and systematic review for references to 
models of support for pharmacists to undertake research, few references were found. As 
outlined in section 3.2, the authors of the systematic review published in 2015 advocated for 
the creation of practice-based research networks between academia and practice as a way to 
augment participation in research by promoting research culture and mentorship among 
pharmacists (Awaisu, Alsalimy 2015). Likewise Lowrie et al. (2015) suggested research 
networks, as well as peer support and centralised research support facilities, as ways to 
provide pharmacists with support to undertake research. However, these were all suggested 
models of support, and rather than being in existence, were therefore hypothetical models.  
Regarding existing models of support, Rosenbloom et al. (2000) made reference to pharmacy 
Academic Practice Units (APUs) in the discussion section of their research. Although cited in 
the context of such units potentially addressing the perception among practitioners of 
academic research lacking relevance to practice, APUs were described by Rosenbloom et al. as 
enabling the sharing of ‘skills, experiences and practices of academics and practitioners’ (p. 
109). APUs therefore appeared to be perceived by the study authors to provide support to 
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pharmacists in practice by allowing them access to individuals with research expertise working 
in academia.    
No further references were made in any of the studies reviewed to other specific models of 
support for research activity among pharmacists.  
6.2.1.3 Implications for main research study 
From reviewing the literature, no studies appear to have specifically explored the influence on 
research activity of organisational culture, the leadership of the chief pharmacist or models of 
support for pharmacists to undertake research among pharmacists in the hospital sector. The 
only model of support referred to in the literature was pharmacy APUs.  
6.2.2 Review of published studies in relation to how research involvement was defined  
As potential for confusion regarding research involvement was identified from the initial 
study, all of the research papers and grey literature identified relating to pharmacists’ 
attitudes and opinions towards research were reviewed to identify how research involvement 
was defined by the authors, a summary of which can be found below.   
6.2.2.1 Summary of how research involvement was defined 
A number of definitions of research involvement were identified. For example, having 
publications in peer-reviewed journals and/or conference posters or abstracts appeared to be 
used to define research involvement of participants in some studies (Awaisu et al. 2015, 
Davies et al. 1993) and the 2017 survey of European Statements of Hospital Pharmacy (Horák 
et al. 2018). In others, research involvement encompassed experience of undertaking 
research-related activities e.g. recruitment of patients into studies or undertaking data 
collection (Saini et al. 2006, Peterson et al. 2009, Kuipers et al. 2019). In one study, research 
involvement among participants appeared to be related to very specific topics such as 
‘research on use and misuse of antibiotics’ or specific research related activities for example 
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‘collecting data using questionnaires’ (Fakeye et al. 2017). In another, a combination of 
research activity and presentation of research findings was used to categorise participants’ 
level of research involvement as high, moderate or minimal (Perreault et al. 2012). Rather 
than defining involvement by research activity or dissemination of findings, the authors of 
another study defined involvement in terms of the types of research in which participants 
were experienced and included service evaluations, clinical trials and applied health research 
(Crilly et al. 2017).  
In other studies the definition of research involvement was not made explicit by the authors. 
For example, Liddell (1996) asked participants about their involvement in research projects 
but a definition of involvement was not provided in the published report. Similarly, 
Rosenbloom et al. (2000) asked participants whether they had ‘initiated’ or ‘participated’ in 
research but again did not provide a definition of these terms. Likewise, Kanjanarach et al. 
(2012) asked about ‘experience in conducting research’, but did not define the term. To 
differentiate between participants with research experience and those without, Sultana et al. 
(2016) based their categorisation on participants’ responses to being asked ‘Have you done 
research before?’ but did not define what they meant by the term ‘done research’.  
Other studies simply reported previous research involvement (Stewart et al. 2019, Lee et al. 
2018, Ellerby et al. 1993, Lowrie et al. 2015) or experience (Awaisu et al. 2015) among 
participants but provided no detail as to how this was determined. Similarly, Abubaker et al. 
(2018) compared attitudes and opinions of those with and without previous research 
experience, but did not provide a definition of what constituted previous experience although, 
as referred to in section 6.1.2, final year undergraduate projects appeared to be included. It is 
not clear from these studies whether definitions of research involvement were provided to 
participants in these studies, but not reported, or whether participants were not provided 
with such definitions. 
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Rather than determining levels of involvement with research among participants, some 
studies recruited participants based on their previous involvement with research. For example, 
Armour et al. (2007) recruited pharmacists with previous research involvement to participate 
in their research but, like the studies outlined above, the authors did not provide a definition 
of what constituted research involvement. 
For several of the studies reviewed, participants had been recruited based on their 
involvement in specific multi-centre studies for which they had undertaken specified research-
related activities. For example, in the research undertaken by Krska et al. (1998), participants 
had recruited patients into a study. Likewise, participants in the research conducted by 
Cvijovic et al. (2010) had screened patients and collected data for another study, whilst in the 
research undertaken by De Vera at al. (2018) and Simpson et al. (2001), participants had both 
recruited patients into studies and delivered an intervention. In these studies, research 
involvement related to pharmacists undertaking activities which supported research delivery 
i.e. recruiting patients into studies, collecting data or acting in the role of a Principal 
Investigator.   
In summary, there was no consistency between studies as to how research involvement was 
defined. Some studies defined research involvement in terms of involvement in research-
related activities, some by authorship of publications or conference presentations/posters, 
and some by types of research undertaken by participants. In addition, some authors referred 
to pharmacists participating in research or having experience of undertaking research, or 
being involved in research but offered no definition of what research involvement constituted.  
6.2.2.2 Implications for main research study 
There was variation evident in the literature regarding how involvement in research was 
defined. I therefore identified a need to define research involvement for the purposes of the 
main research study. As I was interested in participants’ attitudes and opinions towards 
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pharmacists leading or collaborating in all types of research, but not pharmacists’ attitudes 
and opinions towards supporting the delivery of research through managing clinical trials 
medicines, I used a definition of exclusion i.e. my definition of research involvement 
encompassed pharmacists either leading or collaborating in all types of research but excluded 
pharmacists’ involvement in IMP management activity to support the delivery of clinical trials. 
Defining research involvement in this way aligned to the suggestion of Koshman and Blais 
(2011) referred to earlier chapter 2 i.e. that pharmacists’ involvement in research should not 
be restricted to practice research.   
6.3 Summary 
In summary, having reviewed the literature published since the initial study was completed, 
there remains a paucity of studies exploring the attitudes of UK hospital pharmacists towards 
research. In terms of models of support for pharmacists to undertake research, the only 
specific model referenced in the literature was pharmacy APUs. Lastly, there was variation 
evident in the literature regarding how involvement in research was defined. 
In the next section the methodology employed to undertake the main research study is 
outlined.  
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7 Main research study methodology 
As outlined earlier in chapter 1, the main research study comprised an initial qualitative phase 
undertaken using case study methodology followed by a subsequent quantitative phase 
employing survey research.  
Johnson et al. (2007) define mixed methods research as ‘the type of research in which a 
researcher or team of researchers combines elements of qualitative and quantitative research 
approaches (e.g. use of qualitative and quantitative viewpoints, data collection, analysis, 
inference techniques) for the purposes of breadth and depth of understanding and 
corroboration’ (p.123).  
By definition mixed methods research therefore incorporates both qualitative and quantitative 
approaches and, as the main research study included both a qualitative and a quantitative 
phase in the research design, the methodology employed to undertake this research was 
mixed methods.  
In this chapter I outline my rationale for using a mixed methods approach, as well as my 
rationale for using case study research for the qualitative phase, and survey research for the 
quantitative phase.  
7.1 Mixed methods research 
7.1.1 My worldview and how it aligns to mixed methods research  
Before I explain my rationale for choosing a mixed methods research design, it is perhaps 
useful for me to make explicit the philosophical assumptions I espouse.  
Worldviews, or ‘paradigms’ as they are also described in the literature, are ‘a basic set of 
beliefs that guide action’ (p.17) (Guba 1990), and my worldview aligns most closely to that of 
pragmatism. Based on the work of Cherryholmes (1992) and Morgan (2000), as well as his own 
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views, Creswell (2014) argues pragmatism is not committed to any one system of philosophy 
and reality. Instead it is pluralistic and oriented toward ’what works’ and solutions to problems 
and, by encompassing both qualitative and quantitative approaches to research and the use of 
multiple methods of collecting data, pragmatism allows researchers freedom in their choice of 
approach to undertaking research. Rather than focusing on research methods, researchers 
with a pragmatic worldview place their emphasis on the research problem and use all 
approaches available to understand the problem (Rossman, Wilson 1985). Pragmatism, as a 
research paradigm, accepts that there can be single or multiple realities that are open to 
empirical inquiry (Creswell, Plano Clark 2011). Pragmatists therefore reject the philosophical 
dualism of objectivity and subjectivity (Biesta 2010) allowing researchers to abandon the 
dichotomies that are postpositivism and constructivism (Creswell, Plano Clark 2011). As a 
pragmatist I therefore view postpositivism and constructivism to represent opposite ends of a 
paradigm continuum, and where my ontological beliefs lie on that continuum for any given 
research project will depend on the research question. Yefimov (2004) also writes that a major 
underpinning of pragmatist philosophy is that knowledge and reality are based on beliefs that 
are socially constructed. Individuals’ perceptions of the world are influenced by their social 
experiences, and that while each person’s knowledge is unique because it is based on their 
experiences, nevertheless much of this knowledge is shared because it is based on social 
experiences (Kaushik, Walsh 2019). Therefore, having a pragmatic worldview my 
epistemological position is that I believe that knowledge is based on experience. By conducting 
interviews with  
participants for the case study phase of the research to explore their attitudes and opinions 
towards the phenomena of interest, and similarly by conducting a survey to establish how 
widely the findings of the case study research were shared with a larger population, the 
methodological choices I made to conduct the research align to pragmatism being my 
worldview and this being my epistemological perspective. 
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I believe my worldview being aligned to pragmatism is a consequence of my professional 
discipline as a pharmacist and my research experience. Being a pharmacist, the research I am 
most familiar with is that of health research which itself is traditionally based on quantitative 
methodologies e.g. randomised controlled trials and questionnaire-based surveys (Smith 2010, 
Bowling 2014, Allsop 2013). Before embarking on the DPharm programme, the research I was 
familiar with was therefore predominantly undertaken in a positivist paradigm, where there is 
an assumption that there is an absolute truth or ‘reality’ and a belief that knowledge is 
objective and neutral (Gray 2014). However, for my initial study undertaken in part 1 of the 
programme, as described in section 4.2, I used a qualitative approach. By conducting 
interviews, the aim of the research was to explore the meaning others had about the subject 
under investigation meaning my worldview for this research was more aligned to 
constructivism, which sees truth and meaning as constructed and interpreted by individuals 
(Gray 2014). Through my research and professional practice I have therefore gained 
experience of research undertaken in contrasting paradigms using qualitative and quantitative 
approaches which, I believe, has led to my worldview being aligned to pragmatism.  
Regarding my worldview and how it aligns with a mixed methods research design, mixed 
methods research is often associated with pragmatism (Creswell, Plano Clark 2011). Indeed 
pragmatism has been described by Burke Johnson and Onwuegbuzie (2004) as ‘the 
philosophical partner for mixed methods research’ (p.16) and to me it is easy to see why. As 
stated earlier, researchers with a pragmatic worldview place their emphasis on the research 
problem and are free to use all available methods to address it. Similarly, by encompassing 
both qualitative and quantitative methodologies, mixed methods research allows researchers 
freedom in their choice of methods. Further, Burke Johnson and Onwuegbuzie (2004) suggest 
that in reference to mixed methods research ‘what is most fundamental is the research 
question- research methods should follow research questions in a way that offers the best 
chance to obtain useful answers’ (p.17). Therefore, common to both pragmatism as a 
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worldview, and mixed methods as a research approach, is the concept of the research 
problem being central to the choice of research methodology.  
In the next section, I explain my rationale for using mixed methods research to undertake the 
main research study.  
7.1.2 Rationale for mixed methods research 
As outlined earlier, the main research study was undertaken in two phases – an initial 
qualitative phase followed by a subsequent quantitative phase.  
This two-phase mixed methods research design was employed to undertake the main research 
study because qualitative methodology was most appropriate to address the research 
problem and, also as the intended audience are pharmacists, the audience is more likely to be 
accepting of research undertaken employing a quantitative approach. More detail is provided 
below regarding the rationale for using a qualitative approach to address the research 
question, and the inclusion of a quantitative phase to make the research more acceptable to 
the audience.   
A qualitative approach was needed to address the research problem because of the nature of 
the research required. As a paucity of literature had been identified from the literature 
reviews relating to hospital pharmacists’ attitudes and opinions towards research, this meant 
exploratory research was needed to gain a deeper understanding of the research problem 
(Silverman 2013). As qualitative methodologies are considered most appropriate for this type 
of research (Strauss, Corbin 1990), an initial qualitative phase was included in the study 
design. Quantitative research was needed because one of the research objectives was to 
inform policy to engage more hospital pharmacists in research. The intended audience for the 
research was therefore pharmacists who, as referred to earlier, are more familiar with health 
research which is usually undertaken using quantitative methodologies. The rationale for 
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incorporating a second phase in the research design using a quantitative methodology was to 
make the research more acceptable to the intended audience.  
Employing a two-phase design where a quantitative phase followed on from a qualitative 
phase meant the research design aligned to a recognised mixed methods design referred to in 
the literature as an ‘exploratory sequential design’ (Creswell 2014, Creswell, Plano Clark 2011). 
In mixed methods research undertaken using this design, data from an initial qualitative phase 
are used to build in to a second quantitative phase to determine in what ways and to what 
extent the quantitative results generalise or expand on the initial qualitative findings 
(Creswell, Plano Clark 2011). The methodology used for the main research study aligned to this 
specific design, because firstly the findings of the case study research were used to develop a 
questionnaire for use in survey research and secondly, the purpose of the survey research was 
to establish how widely the findings of the case study research were shared among a larger 
cohort of chief pharmacists. Interestingly, Creswell and Plano Clark (2011) suggest that the 
inclusion of the quantitative component in exploratory sequential mixed methods designs can 
make the qualitative approach ‘more acceptable to quantitative-based audiences’ (p.89). This 
gives further credence to the use of this research design for the main research study as this 
was the reason for including a quantitative phase.  
However, mixing methods using an exploratory sequential design is just one of many different 
approaches to mixed methods research. It follows therefore that there are numerous reasons 
for using mixed methods research cited in the literature, including two prominent frameworks, 
one authored by Greene et al. (1989) and another by Bryman (2006).  
Greene et al. (1989) describe five broad reasons to mix methods: triangulation, 
complementarity, development, initiation, and expansion, as outlined in Table 6 below.  
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Table 6: Reasons for mixing methods adapted from Greene et al. (1989) 
Reason 
 
Explanation 
Triangulation Seeks convergence, corroboration, and correspondence of results 
from different methods 
 
Complementarity Seeks elaboration, enhancement, illustration, and clarification of 
the results from one method with the results from one other 
method 
 
Development  Seeks to use the results of one method to help develop or inform 
the other method, where development is broadly construed to 
include sampling and implantation, as well as measurement 
decisions 
 
Initiation Seeks the discovery of paradox and contradiction, new 
perspectives of frameworks, the recasting of questions or results 
from one method with the questions or results from the other 
 
Expansion Seeks to extend the breadth and range of inquiry by using different 
methods for different inquiry components 
 
 
As outlined earlier, the reason for using mixing methods was to enable survey research to be 
undertaken to establish the extent to which the initial qualitative findings were shared among 
a larger population. Therefore, my rationale for using a mixed methods approach aligns with 
‘complementarity’ as defined by Greene et al. (1989). Complementarity is highlighted in italic 
font in Table 6 above.  
The second framework is a more detailed list developed by Bryman (2006). Several of the 16 
reasons he lists for using mixed methods relate to my research, as highlighted in italic font in 
Table 7 below. However, of these I would suggest that ‘instrument development’ and ‘context’ 
are most closely aligned to my rationale for mixing methods.  
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Table 7: Rationales for mixing methods adapted from Bryman (2006) 
Reason Explanation 
 
Triangulation or 
greater to validity 
Refers to the traditional view that quantitative and qualitative research 
might be combined to triangulate findings in order that they may be 
mutually corroborated 
 
Offset Refers to the suggestion that the research methods associated with both 
quantitative and qualitative research have their own strengths and 
weaknesses so that combining them allows the researcher to offset their 
weaknesses to draw on the strengths of both  
 
Completeness  Refers to the notion that the researcher can bring together a more 
comprehensive account of the area of inquiry in which her or she is 
interested if both quantitative and qualitative research are employed 
 
Process Refers to when quantitative research provides an account of structures in 
social life but qualitative research provides sense of purpose 
 
Different research 
questions 
Refers to the argument that quantitative and qualitative research can each 
answer different research questions 
 
Explanation  Refers to when one is used to help explain findings generated by the other 
  
Unexpected results  Refers to the suggestion that quantitative and qualitative research can be 
fruitfully combined when one generates surprising results that can be 
understood by employing the other 
 
Instrument 
development  
Refers to contexts in which qualitative research is employed to develop 
questionnaire and scale items- for example so that better wording or more 
comprehensive closed answers can be generated 
 
Sampling Refers to situations in which one approach is used to facilitate the sampling 
of respondents or cases 
 
Credibility  Refers to suggestions that employing both approaches enhances the 
integrity of the findings 
 
Context Refers to cases in which the combination is rationalised in terms of 
qualitative research providing contextual understanding couple with either 
generalisable, externally valid findings or broad relationships among 
variables uncovered through a survey 
 
Illustration Refers to the use of qualitative data to illustrate quantitative findings, often 
referred to as putting ‘meat on the bones’ of ‘dry’ quantitative findings 
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Table 7 continued 
Reason Explanation 
 
Utility or improving 
the usefulness of 
findings 
Refers to a suggestion which is more likely to be prominent among articles 
with an applied focus, that combining the two approaches will be more 
useful to practitioners and others 
 
Confirm and 
discover 
Refers to using qualitative data to generate hypotheses and using 
quantitative research to test them in a single project 
 
Diversity of views Includes two slightly different rationales- namely combining researchers’ 
and participants’ perspectives through quantitative and qualitative 
research respectively and uncovering relationships between variables 
through quantitative research while also revealing meaning among 
research participants through qualitative research  
 
Enhancement or 
building upon 
quantitative and 
qualitative findings 
 
Entails a reference to making more or augmenting either quantitative or 
qualitative findings by gathering data using a qualitative or quantitative 
approach 
 
The reasons for using mixed methods research listed in both of these frameworks therefore 
align to my rationale for using mixed methods i.e. that a quantitative component was needed 
for the research to be credible with the intended audience but, because of the lack of 
published data relating to the phenomena of interest, and in order to undertake quantitative 
research, exploratory research using a qualitative approach was required initially to identify 
the variables to study in the quantitative phase of the research. These frameworks therefore 
give further credence to my rationale for using a mixed methods approach for the main 
research study.  
In addition using mixed methods research enabled me to triangulate the data. As per Table 6 
Greene et al. (1989) defines triangulation as ‘seeks convergence, corroboration, and 
correspondence of results from different methods’. Similarly, as per Table 7 Bryman (2006) 
defines triangulation as ‘the traditional view that quantitative and qualitative research might 
be combined to triangulate findings in order that they may be mutually corroborated’. By 
86 
undertaking the second quantitative phase of the research the intention was to establish if the 
findings of the case study research were more widely applicable and a survey provided a 
method of achieving this, and again the frameworks for mixing methods developed by Green 
et al. and Bryman give credence to my rationale for using mixed methods research. 
In the following section I outline my rationale for using case study methodology for the initial 
qualitative phase. Later in the chapter in section 7.3 I outline my rationale for using survey 
methodology for the subsequent quantitative phase. 
7.2 Phase 1 methodology: case study research 
The methodology employed for the initial phase of the main research study was case study 
research using a multiple-case design. In this section I outline my rationale for using case study 
methodology for this phase of the research and why I chose to use a multiple-case design. 
Case study research is useful in research which explores the relationship between a 
phenomenon and the context in which it is occurring (Gray 2014). As outlined in chapter 4, the 
findings of the initial study suggested that the contextual domain i.e. organisational culture, 
the leadership of the chief pharmacist and mechanisms of support for pharmacists to 
undertake research appeared to influence research activity among pharmacists. Case study 
methodology was therefore employed for the initial phase of the main research study to 
explore the relationship between these contextual conditions and the phenomenon of interest 
i.e. research activity among pharmacists.   
Case study research was chosen over other qualitative methodologies as it enabled the 
relationship between the contextual conditions and research activity to be explored in more 
detail and in a more context-specific way than others would have allowed. For example, 
individual interviews or focus groups with chief pharmacists and pharmacists representing a 
large number of organisations would have allowed in-depth study of the phenomenom of 
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interest, but would not have enabled the contextual conditions to have been explored in the 
same level of detail as case study research permitted.  
Choosing a case study design to explore the relationship between contextual conditions and 
the phenomenon of interest is analogous with definitions of case study research cited in the 
literature, as outlined below.  
Yin (2014), for example, defines case study research as ‘an empirical inquiry that investigates a 
contemporary phenomenon (the ‘case’) in depth within its real-world context, especially when 
the boundaries between phenomena and context may not be clearly evident’ (p.16) 
Eisenhart (1989) defines case study as ‘a research strategy which focuses on the dynamics 
present within settings’ (p.534).  
Central to both of these definitions is the concept of case study research being focused around 
the context or setting in relation to the phenomena under study. Yin’s definition, however, 
also includes the idea of case study research being an appropriate choice of research design 
when the boundaries between the subject of the research and the context lack clarity. 
Arguably this was also the case for this research as the findings of the initial study suggested 
that the contextual domain i.e. the organisational culture, the leadership of the chief 
pharmacist, and mechanisms of support for pharmacists to undertake research appeared to 
influence research activity. However, because of the small number of Trusts represented in 
the study, the initial study findings were largely theoretical. Therefore, although the findings 
of the initial study appeared to suggest that there was a relationship between contextual 
conditions and research activity, the boundaries between these were not clear.  
Yin (2014) also makes reference to situations when case study research would be a ‘preferred 
method’ i.e. ‘when (1) the main research questions are ‘how’ and ‘why’ questions; (2) the 
88 
researcher has little control over behavioural events; and (3) the focus of the study is 
contemporary (as opposed to entirely historical) phenomenon’ (p.2).  
All three of these criteria were met for the research undertaken for the main research study. 
The research was exploratory and therefore asked ‘how’ and ‘why’ questions. As outlined in 
the next chapter (chapter 8), case study sites were selected outside the West Midlands region 
so any influence over practice I may have had in relation to my professional capacity as Lead 
Pharmacist for NIHR Clinical Research Network West Midlands was minimised. As a researcher 
I therefore had no influence on behavioural events. As also outlined in chapter 8, the basis of 
case study site selection included the pharmacy department employing pharmacists who were 
either currently undertaking research or had undertaken research recently, making the focus 
of the study contemporary.  
In addition to case study research being an appropriate methodological choice to explore the 
relationship between the phenomena of interest and associated context, my rationale for 
using case study methodology for this phase of the main research study was also because the 
intention of undertaking the research was to gain insights relating to the phenomena of 
interest. Case study research is recognised in the literature as being an appropriate 
methodological choice where generating theory is the research purpose (Eisenhardt 1989, 
Dooley 2002, Yin 2014). Case study research was therefore felt to be an appropriate 
methodology to use as, although the purpose of the research was not to build theory per se, 
the aim was to gain an understanding of the phenomena of interest due to the lack of pre-
existing knowledge relating to the subject as identified by the evident lack of published 
literature relating to UK hospital pharmacists’ attitudes and opinions towards research.  
Case study research designs can be single-case designs or multiple-case (Yin 2014). For this 
research a multiple-case study design was used as it has been suggested that multiple-case 
designs are more appropriate than single-case designs for developing theory. For example, 
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Dooley (2002) suggests that only by observing similar phenomena in similar settings ‘will 
confirmation or disconfirmation of the new theory begin to take shape and gain substance’ 
(p.336). In this research the case study sites all represented similar settings because, as was 
described earlier in chapter 1, all of the case study sites were acute secondary care teaching 
hospital NHS Trusts based in England, and therefore all represented the same type of NHS 
Trust.   
In summary, case study research using a multiple-case design was chosen over other 
qualitative methodologies for the initial phase of the main research study firstly because case 
study research is appropriate to explore the contextual domain in relation to the phenomena 
under study, and secondly because the aim of the research was to generate insights into the 
phenomena of interest, and for this multiple-case designs are more appropriate than single-
case. Interestingly, case study research as a research design has been described in the 
literature as ‘presenting a view of inquiry that takes a pragmatic view of knowledge’ (p.17) 
(Thomas, Myers 2015). This affirms alignment between my choice of methodology to 
undertake the research and my philosophical worldview. 
The methods used to undertake the case study research are outlined in the next chapter i.e. 
chapter 8 together with details of the steps taken to ensure the validity and reliability of the 
case study findings. 
7.3 Phase 2 methodology: survey research  
The methodology used for the second phase of the main research study, i.e. the quantitative 
phase, was survey research. The type of survey used to undertake the research was 
descriptive and the study was cross-sectional. In this section I explain my rationale for using 
survey research for this phase of the study, and explain why the survey was descriptive rather 
than analytical, and why the study was cross-sectional and not longitudinal. 
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Surveys can be categorised as either descriptive or analytical. Descriptive surveys are 
undertaken to measure the occurrence of certain phenomena in a population of interest (Gray 
2014). They are not designed to show causal relationships between variables (Oppenheim 
1992). Analytical surveys, on the other hand, are designed to explore and test associations 
between variables (Gray 2014). While descriptive surveys are therefore designed to measure 
‘what’ occurred, analytical surveys are designed to find out ‘why’ (Gray 2014).  As the purpose 
of undertaking a survey in this phase of the research was to establish how widely the views of 
participants in the case study research were shared among a wider population, the survey was 
descriptive in nature rather than analytical.   
Cross-sectional studies look at phenomena under study at a particular period in time (Gray 
2014). Longitudinal studies, on the other hand, follow up a sample of individuals or cases over 
a period of time (Smith 2010). Therefore, in cross sectional studies the data usually relates to a 
single point or period in time whereas in longitudinal studies data is collected on more than 
one occasion (Smith 2010). Similar to analytical surveys, longitudinal studies can be used to 
explore causation between variables. However, the purpose of the survey research was to 
measure the occurrence of certain phenomena in the population of interest and, therefore, a 
study using a cross-sectional design was most appropriate to use.  
As the purpose of the research undertaken in this phase of the study was to determine the 
extent to which the findings of the case study research were shared among a wider 
population, the sample size for this phase was larger than that used for the case study 
research. As surveys allow for the collection of large amounts of data from sizable populations 
(Gray 2014), survey research was an appropriate choice of research methodology for this 
phase of the study. In addition, survey research has also been identified in the literature as 
being appropriate to measure attitudes, knowledge and behaviour (Bowling 2014). As the 
purpose of the research undertaken in this second phase was to measure these parameters 
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among a larger sample than the case study phase, survey research was again an appropriate 
methodological choice for this phase of the research.  
Using survey methodology for this phase of the research was also appropriate because, in 
common with other quantitative research methodologies, survey methodology is cited in the 
literature as being appropriate to use in situations in which pre-existing knowledge permits 
the use of a standardised data collection method (Bowling 2014). As will be described in more 
detail later in chapter 9, the questionnaire used to collect data for this phase of the research 
was developed based on the findings of the case study research, and the method of data 
collection was standardised and developed from pre-existing knowledge.  
Survey research is also considered appropriate where the purpose of the research is to 
document prevalence or test hypotheses (Bowling 2014). As the aim of the research was to 
establish how widely the findings of the case study research were shared, the purpose of the 
research was to document prevalence. Survey research was an appropriate methodological 
choice for this phase of the research. 
The methods used to undertake the survey research are outlined later in chapter 9 together 
with details of the steps taken to ensure the validity and reliability of the survey findings. 
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8 Case study research  
This chapter pertains to the case study research undertaken in the first phase of the main 
research study. This phase of the main research study is highlighted in Figure 4 below.  
 
 
 
Figure 4: Flowchart highlighting the case study research 
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As previously outlined in section 7.2, the case study research was exploratory and therefore 
used qualitative methodology. To undertake the research, a multiple-case design was used 
where interviews were conducted with the chief pharmacist as well as a cohort of pharmacists 
with recent research experience at several case study sites all of which were acute secondary 
care teaching hospital NHS Trusts with research-active pharmacy departments. In this chapter 
I describe the methods used to undertake the case study research including the sampling 
strategies used to identify and select case study sites and research participants, and the 
methods used to collect and analyse the case study data. Later in the chapter I give an account 
of the findings from this phase of the research.  
My rationale for using case study methodology for the qualitative phase of the research is 
outlined in section 7.2 of the previous chapter. 
8.1 Methods 
In this section I outline how I selected case study sites and participants, and the methods used 
to collect and analyse the data.   
8.1.1 Case study site sampling strategy 
In this section the methods used to select, identify and recruit case study sites are outlined. 
Selection of case study sites  
In case study research, a case can be a community, organisation or person (Bryman 2012). For 
the case study phase of the main research study, such cases were the pharmacy departments 
of Trusts selected to be case study sites, where the case study sites were acute secondary care 
teaching hospital NHS Trusts based in England with research-active pharmacy departments 
and different models of support for pharmacists to undertake research.  
Acute secondary care teaching hospital NHS Trusts were selected to be case study sites 
primarily because the aim of the research was to better understand how to engage more 
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pharmacists employed in the hospital sector with research. Teaching hospitals, as opposed to 
other types of acute secondary care Trusts, were selected since according to the National 
Institute for Health Research (NIHR) Research Activity League Table for the financial year 
2015/16 (NIHR 2016), 19 of the top 20 NHS acute Trusts were teaching hospital Trusts when 
ranked by both number of NIHR portfolio studies open and number of participants recruited 
into studies. For the purposes of identifying case study sites, it was assumed that Trusts 
undertaking higher levels of NIHR portfolio research were more likely to have research-active 
pharmacy departments. League tables for the financial year 2015/16 were used as this was the 
most recent data available at the time of developing the research proposal in 2016. 
Interestingly, since the research proposal was developed, the 2017 European Standards of 
Hospital Pharmacy Statements Survey reported pharmacists based in teaching and university 
hospitals published more research compared to non-teaching hospitals, giving credence to the 
decision to select teaching hospitals to be case study sites (Horák et al. 2018). Case study sites 
were geographically restricted to Trusts in England because of the variation in models of 
healthcare in the devolved nations (Bevan et al. 2014).  
In terms of the strategy for selecting Trusts to be case study sites, Trusts were selected which 
had high levels of research activity among pharmacists and represented different models of 
support for pharmacists to undertake research. The rationale for choosing Trusts which met 
these criteria was to explore the influence of these different models of support on research 
activity and thereby identify common factors relating to these models of support which were 
associated with the higher levels of research activity among pharmacists in these 
organisations. This rationale for using Trusts with different models of support for pharmacists 
to undertake research as case study sites links back to my rationale for using a multiple-case 
study design to build theory.  
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It could be argued that selecting Trusts to be case study sites because they represent different 
models of support, contradicts the rationale for using a multiple-case study design to build 
theory outlined in the previous chapter (section 7.2). However, in relation to the selection of 
cases in multiple-case design, Yin (2014) discusses the idea of ‘replication logic’ i.e. that each 
case should be selected to either predict similar results (literal replication) or contrasting 
results for anticipatable reasons (theoretical replication). On the face of it, selecting Trusts to 
be case study sites representing different models of support for pharmacists to undertake 
research would suggest the strategy for selecting case study sites to align with the theoretical 
replication logic suggested by Yin. However, I would argue that, because all of the Trusts 
selected to be case study sites had high levels of research activity among pharmacists as well 
as a model of support, albeit different ones, the selection of case study sites aligned more to 
literal replication logic as they were selected on the premise that having a model of support 
for pharmacists to undertake research led to higher levels of research activity. Consideration 
was given to choosing other types of case study sites e.g. where the pharmacy department 
was either not research-active or had low levels of research activity. However, there were 
concerns that individuals working in such environments would not have had sufficient insight 
to be able discuss factors contributing to why they felt unable to undertake research or to 
discuss factors which would enable them to conduct research due to their lack of exposure to 
such factors.  
NB Cases were the pharmacy departments of the Trusts selected to be case study sites rather 
than the Trusts in their entirety because the pharmacy departments were the focus of the 
research. For example, the influence of Trust-level aspects of the contextual domain such as 
the organisational culture of the Trust and Trust-level models of supports for research activity 
were only explored in the context of their influence on research activity levels among 
pharmacists.  
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Identification of potential case study sites   
The strategy for selecting cases consisted of a two-stage approach i.e. maximum variation 
sampling followed by extreme or deviant case sampling. Maximum variation sampling involves 
selecting a diverse range of cases so that common patterns from this variation can be 
identified whereas in extreme or deviant case sampling, cases are selected because they are 
unusual or special in some way, with the intended purpose of doing so being to help identify 
conditions or features that might explain differences in outcomes (Gray 2014). Maximum 
variation sampling was therefore used to select Trusts to be case study sites which 
represented different models of support for pharmacists to undertake research. Extreme or 
deviant case sampling, on the other hand, was used to select those Trusts with the highest 
levels of research activity to represent each of the models of support.  
However, before Trusts could be selected as case study sites, potential sites had to be 
identified. In order to identify potential sites, a scoping exercise was undertaken in which Trust 
data relating to both levels of research activity among pharmacists and models of support for 
pharmacists to undertake research was collected. Case study sites were then selected based 
on the information obtained from the scoping exercise.  
 
Scoping exercise  
In this section the methods used and findings of the scoping exercise undertaken to identify 
potential case study sites are presented. 
Method  
To collect the data needed to identify potential case study sites, a survey was developed which 
was distributed as an email survey to chief pharmacists of acute secondary care teaching 
hospital NHS Trusts.  
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To establish levels of research activity, survey respondents were asked to provide 
demographic data relating to the number of pharmacists employed within their Trust by 
headcount, and the number of pharmacists both undertaking research at that time and within 
the preceding three years, again by headcount. In line with the definition of research 
involvement devised for the purposes of the main research study i.e. that for the purposes of 
the main research study pharmacists’ involvement in leading or collaborating in all types of 
research was included except for activities related to managing clinical trials medicines. The 
email survey stated that pharmacy clinical trials staff solely involved in IMP management 
activity to support the delivery of research should be excluded from this headcount.  
To identify case study sites with different models of support for pharmacists to undertake 
research, respondents were also asked about models of support within their organisations for 
pharmacists to undertake research. Models of support for pharmacists to undertake research 
included in the scoping exercise were organisations being part of an Academic Health Science 
Centre (AHSC) and/or the pharmacy department having an Academic Practice Unit (APU). A 
Trust being part of an AHSC was chosen as a model of support based on my personal 
knowledge gained through my role with the Clinical Research Network. APUs were chosen 
based on pharmacy APUs being identified from the literature review as a model of support for 
pharmacists to undertake research, and through my personal knowledge. Definitions of AHSCs 
and APUs and the backgrounds to their establishment are provided below.  
AHSCs are partnerships of NHS Trusts and universities designated by what is now the 
Department of Health and Social Care but which at the time of the scoping exercise being 
conducted was the Department of Health (Department of Health 2013). Such centres were 
established to research new treatments, and improve patient care and healthcare delivery as 
well as drive economic growth through partnerships with industry.  
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APUs are defined as ‘discrete centres which link academic institutions with practice, whether in 
the hospital, community, or industrial sectors…designed to blend the work of pharmacy 
academics and practitioners’ (p.188) (Wolfson 1992). Such units were originally established 
following the Nuffield Report published in 1986 which recommended that Schools of 
Pharmacy should set up academic units in hospitals to act as bases for teaching and research 
(Nuffield Foundation 1986). AHSCs are therefore organisational level academic collaborations 
whereas APUs represent collaborations with academia at departmental level.  
In addition to being asked whether the organisation had one or both of these specific models 
of support, respondents were also asked about ‘other’ models of support which were in place 
for pharmacists to undertake research by the inclusion of a free-text option in the survey 
response options for this question. For a copy of the email survey refer to appendix 9.  
Chief pharmacists were selected to be survey recipients as it was felt that they would be in the 
best position to either provide the information requested in the survey or, due to the 
hierarchical organisational structure of pharmacy departments in acute secondary care NHS 
trusts, request that a member of their staff respond on their behalf.  
The survey was distributed as an email survey via the chair of the Association of Teaching 
Hospital (ATHP) chief pharmacist network who forwarded an email to all members of the 
network on my behalf. This was because a list of acute secondary care teaching hospital NHS 
Trusts was not available and Trust membership of the Association of Teaching Hospital 
Pharmacists was therefore used as a proxy. Although the survey was distributed by the chair 
of the ATHP chief pharmacist network, responses were requested to be returned to me 
directly. Microsoft Excel was used to collate the survey responses.  
To analyse the data in relation to levels of research activity at each Trust, the ratio of the 
number of research active pharmacists at the Trust by headcount to the number of 
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pharmacists employed at the Trust by headcount was used. The number of research active 
pharmacists was defined as the number of pharmacists who were either undertaking research 
at the time of the survey or who had undertaken research in the three years preceding.     
NB As the scoping exercise was undertaken solely to identify case study sites, the ethics 
service at Keele University felt that ethics approval was not required (refer to appendix 10 for 
a copy of the email from Keele University Ethics Service confirming that ethics approval was 
not required)  
Findings 
The email survey was distributed to the chief pharmacists of 41 Trusts based in England, and 
responses were received from 10 of them. The survey response rate was therefore 24%. 
From the responses four different models of support for pharmacists to undertake research 
were identified, as listed below:  
 The Trust was part of an AHSC but the pharmacy department did not have an APU 
 The pharmacy department had an APU but the Trust was not part of an AHSC 
 The Trust was part of an AHSC and the pharmacy department had an APU 
 The department had a pharmacist with responsibility for supporting pharmacists to 
undertake research in a recognised role but the Trust was not part of an AHSC and the 
pharmacy department did not have an APU 
 
Identification and recruitment of case study sites  
Trusts were identified to be potential case study sites from the responses to the scoping 
exercise. As four models of support for pharmacists to undertake research had been identified 
from the scoping exercise, four Trusts were selected to be case study sites, each selected to 
represent one of the four identified models of support. Where several Trusts were identified 
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representing the same model of support, the Trust with the highest level of research activity 
was selected to be the case study site to represent that model of support. 
In terms of the number of cases, it has been suggested by both Eisenhardt (1989) and Stake 
(2006) that for multiple case studies between 4 and 10 cases usually works well. Eisenhardt 
(1989) for example argues that with fewer than four cases, generating theory with much 
complexity is often difficult and the empirical understanding is likely to be unconvincing, and 
with more than ten, the volume and complexity of data can become overwhelming. Four case 
study sites was therefore an appropriate number. 
To recruit case study sites, the chief pharmacists at the four potential case study sites 
identified from the scoping exercise were each emailed to ask if they would be willing to agree 
for their Trust to be a case study site. As is outlined later in the chapter in section 8.1.2.2 
because the research design required that the chief pharmacist at each case study site 
participated, chief pharmacists were also invited to take part in the study in the same email. 
Refer to appendix 11 for a copy of the email.   
8.1.2 Participant sampling strategies  
In this section the methods used to select, identify and recruit participants are outlined. 
Selection of participants 
As outlined above in the introduction to the chapter, at each case study site interviews were 
undertaken with the chief pharmacist and a cohort of research-experienced pharmacists. My 
rationale for selecting these participants is given below.  
At each case study site the chief pharmacist was interviewed because the findings of the initial 
study suggested that the leadership of the chief pharmacists themselves appeared to influence 
research activity within their departments. Interviews at each site were also undertaken with a 
cohort of pharmacists with research experience to explore the phenomena under study from 
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multiple perspectives with the aim of triangulating the data and in so doing, provide better 
substantiation of the any theory developed (Eisenhardt 1989). To be eligible to participate, 
pharmacists were required to have recent research experience and therefore be either 
undertaking research at the time of the study or have undertaken research within the 
preceding three years. This requirement ensured that the pharmacists’ views reflected current 
practice and that the research was therefore contemporary. This aligns with one of the three 
criteria that Yin (2014) set out for when case study research can be considered to be a 
preferred method i.e. when the focus of the study is contemporary phenomena as opposed to 
being entirely historical (see section 7.2). It was also felt that limiting participation to those 
with research experience would mean that participants would have a better insight into the 
factors influencing research engagement than those without experience, as it was felt that the 
chief pharmacists who participated in the initial study and who had themselves undertaken 
research, had greater insight into the factors influencing research activity among pharmacists 
compared to those who had not personally undertaken research previously. 
The eligibility criteria for both the chief pharmacist and pharmacist participant groups are 
summarised in Table 8 below.  
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Table 8: Inclusion and exclusion criteria for case study research participants 
Participant group 
  
Inclusion criteria Exclusion criteria 
Chief pharmacists Chief pharmacists of acute 
NHS teaching hospital Trusts 
in England where pharmacists 
are currently undertaking 
research and/or pharmacists 
have undertaken research 
within the previous 3 years 
 
Chief pharmacists of Trusts 
not selected as case study 
sites  
 
Pharmacists  Pharmacists who are 
currently working in an acute 
NHS teaching hospital Trust 
in England who are either 
currently undertaking 
research and/or have 
undertaken research within 
the previous 3 years    
 
Pharmacists not currently 
research-active or research-
active within the previous 3 
years 
 
 
Identification and recruitment of participants 
In this section I describe how chief pharmacists and pharmacists were identified and invited to 
participate. 
Identification and recruitment of chief pharmacists 
In terms of the identification of chief pharmacists to invite to participate, due to the 
requirement that, for a Trust to be a case study site, the chief pharmacist needed to agree to 
participate personally. The recruitment of chief pharmacists as participants was therefore an 
integral part of the process to identify and recruit case study sites. The email asking chief 
pharmacists if they were willing for their Trust to be a case study site also invited them to 
participate themselves. A copy of the participant information sheet and the consent form for 
their participant group was therefore attached to the email (see appendices 12 and 13 for 
copies of the chief pharmacists participant group participant information sheet and consent 
form respectively).  
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Identification and recruitment of pharmacists  
As outlined earlier in section 0, in addition to the chief pharmacist being interviewed, 
interviews were also undertaken with a cohort of pharmacists with recent research experience 
at each case study site. Once the chief pharmacist confirmed that they were willing for their 
Trust to be a case study site and were willing to participate themselves, pharmacists at the 
respective case study sites were invited to participate via email. However, as lists of the names 
and contact details of pharmacists at each case study site were not available, the chief 
pharmacist was asked to forward an invitation email to all pharmacists employed in their 
organisation on my behalf. Refer to appendix 14 for a copy of the invitation email to 
pharmacists at case study sites. Therefore, as the chief pharmacist at each case study site had 
a role to play in supporting the identification of pharmacists at their Trust to take part, it could 
be argued that the sampling strategy aligns most closely with that of snowball sampling where 
the researcher ‘identifies a small number of subjects, who, in turn, identify others in the 
population’ (p.223) (Gray 2014). However, as chief pharmacists played no active role in 
identifying participants other than forwarding an email on my behalf, they performed a 
‘gatekeeper’ function and therefore acted as a conduit to recruitment (Creswell 2014). 
Nevertheless their involvement meant that as a researcher, I was able to invite pharmacists to 
participate who would otherwise have been difficult to access because no usable sampling 
frames were available.  
In order to protect their identity, pharmacists interested in participating were asked to 
respond to me directly rather than through their chief pharmacist. A copy of the participant 
information sheet and the consent form for the pharmacist participant group were attached to 
the email (see appendices 15 and 16 for copies of pharmacists participant group participant 
information sheet and consent form respectively). Further details regarding how the identity 
of participants was protected can be found in section 8.1.5 which relates to research 
governance and ethics considerations for the case study research.  
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8.1.3 Data collection  
To collect data at each of the case study sites, individual face-to-face semi-structured 
interviews were undertaken with the chief pharmacist and a cohort of pharmacists with 
research experience to explore their attitudes and opinions towards pharmacists undertaking 
research.  
Interviews were used to collect data to explore the phenomena of interest from the 
respondents’ perspectives as well as to facilitate the collection of rich data by encouraging 
interviewees to share as much information as possible. Semi-structured interviews enabled 
open questions to be asked allowing respondents to describe their views and opinions in their 
own words, according to the issues important to them (Legard et al. 2003). Semi-structured 
interviews, as opposed to unstructured or structured interviews, ensured some degree of 
commonality between interviews by the use of pre-determined questions while allowing 
flexibility in the conduct of the interviews by allowing additional questions to be asked in 
response to participants’ comments and reactions (Bryman 2012, Britten 2006). Interviews 
were conducted face-to-face, as opposed to by telephone, to help build rapport and therefore 
obtain more detailed and considered responses (Smith 2010). 
Individual interviews as opposed to focus groups were undertaken for several reasons. Firstly, 
it was anticipated that pharmacists who met the inclusion criteria at each case study site 
would more than likely represent various levels of seniority, and that therefore junior staff 
may not have felt able to express their opinions openly in a focus group due to more senior 
staff being present. Similarly, if the chief pharmacist had been invited to attend the same 
focus group as other participants, those other participants may equally have not felt able to 
freely express their opinions. The presence of the chief pharmacist in a focus group at a case 
study site may therefore have inhibited discussion (Fitzpatrick, Boulton 1996). Not only could 
the use of focus groups potentially have affected the validity of the research, but may also 
105 
have posed a barrier to participation in the research for more junior members of staff. In 
addition, in group situations it can be more difficult to probe for further details than in 
individual interviews (Fitzpatrick, Boulton 1996). On a more practical level, it was anticipated 
that focus groups would also have been difficult to arrange due to the availability of 
participants, and the logistical difficulties associated with bringing staff together in the same 
location when they may be based at geographically different sites within the same Trust. 
Individual interviews, on the other hand, meant that interviews could be arranged for times 
and locations convenient to the participants.  
In the context of case study research, Yin (2014) suggests the strengths of interviews as a 
source of evidence are that they are ‘targeted’ in that they focus directly on the case study 
topic and ‘insightful’ in that they provide explanations as well as personal views (e.g. 
perceptions, attitudes and meanings). Interviews were therefore an appropriate choice of 
research method for the case study research undertaken in this phase of the research given 
that the purpose was to explore participants’ attitudes and opinions. 
To collect the data I conducted all interviews with research participants and all interviews 
were undertaken face-to-face. Provision was also made in the ethics application and the 
application for Health Research Authority (HRA) approval for the study to conduct telephone 
interviews if more than seven pharmacists at each case study volunteered to participate. This 
provision was included due to time constraints associated with undertaking the research as 
part of a part-time DPharm qualification since on each day of interviews I anticipated I could 
undertake four interviews. As the maximum time available to me to visit each site was two 
days I could undertake a maximum of eight interviews face-to-face at each case study site (the 
chief pharmacist and up to seven pharmacists). Telephone interviews would therefore have 
been employed had more than seven pharmacists at each site volunteered to participate. 
However, this was not necessary. For the convenience of participants, all interviews were 
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undertaken at their place of work and were arranged for a mutually convenient date for the 
participant and myself. Each interview took between 23 and 67 minutes. 
To give the interviews a framework and help ensure that all relevant information was 
collected, interview guides were developed for the two participant groups (see appendices 17 
and 18 for interview guides for the chief pharmacists group and the pharmacists group 
respectively). In terms of the design of the interview guides, the opening questions of both 
interview guides were designed to be relatively straightforward to answer to help put 
respondents at ease and therefore help build rapport (Britten 2006, Legard et al. 2003). 
Leading questions were avoided to reduce the risk of me, as the researcher, unduly influencing 
participants’ responses (Bryman 2012). Probing questions were also used to further explore 
interesting points made by respondents (Bryman 2012). Also, due to the iterative nature of 
qualitative research, preliminary data analysis was undertaken concurrently with data 
collection (see section 8.1.4 for more detail), amendments were made to the interview guide 
as the research progressed (DiCicco‐Bloom, Crabtree 2006). Refer to appendices 19 and 20 for 
copies of the amended interview guides for the pharmacist participant group and the chief 
pharmacist participant group respectively. To provide complete records interviews were 
audio-recorded with permission from participants and transcribed verbatim.  
As the potential for confusion in relation to research involvement had been identified from the 
initial study and literature, I applied the definition of exclusion developed for the purposes of 
the main research study, as outlined in section 6.2.2.2, to the case study research as I had 
done previously in the email survey used in the scoping exercise. However, I did not offer my 
definition of research involvement to participants upfront. Instead I decided only to offer the 
definition to participants if they sought clarification regarding activities which constituted 
research involvement during the course of their interview. If they did seek clarification I 
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explained that for the purposes of the study pharmacists’ involvement in IMP management 
activity to support the delivery of clinical trials was excluded.  
8.1.4 Data analysis 
The method of data analysis used was based on the qualitative analytic method of framework 
analysis (Ritchie, Spencer 1994). To analyse the data themes were identified from the data 
itself, in addition to the findings being compared to a priori themes identified from the 
literature review and initial study. Rather than following a purely inductive approach to data 
analysis, the approach was also deductive in nature in that themes were both identified as 
new insights emerged from the data in addition to the analytical themes derived from the 
research questions, initial study and existing literature (Ritchie, Spencer 1994).  To identify 
themes from the data, I first familiarised myself with the interview transcripts by reading them 
several times while noting down ideas. I then generated initial codes across the data set, and 
then searched for themes by collating codes into potential themes and by gathering together 
all data relevant to each theme. I then reviewed and revised these themes as I retested them 
against the data, the data analysis was therefore an iterative process. Data collection and 
analysis were not however undertaken in a purely linear fashion. Instead, in order to develop 
an emerging understanding of the data, data analysis and collection were undertaken 
concurrently i.e. interview transcripts were analysed between interviews where possible.  
As described earlier, during the course of the data analysis the findings were also compared to 
previously identified themes from both literature reviews and the initial study findings. 
Although my approach to analysing the data was mostly inductive, as it was largely grounded 
in the data, it was also to some extent deductive in that it was informed by a priori themes 
from the literature review and initial study. These a priori themes were used not only in the 
application of the principles of framework analysis to the data analysis, but also influenced the 
choice of questions included in the interview guides and in the research questions themselves. 
108 
During data analysis I also searched the data for ‘deviant cases’ i.e. cases where my 
interpretation of the data appeared weak or was contraindicated by the evidence (Mays, Pope 
1995). In this report I have tried to give a fair account and explanation of the reasons for these 
variations to enhance the data validity (see section 8.1.6 re research validity and reliability). In 
addition, to enhance the validity and reliability of the findings, I discussed the themes 
identified from the data with my supervisory team as part of the analysis. However, 
respondent validation, in terms of seeking confirmation from those who participated in the 
research that the findings from analysing the data were congruent with their views with, for 
example, participants from a particular case study site, was not possible due to the need to 
protect the anonymity of participants (Bryman 2012). 
NVivo (a software programme designed for qualitative analysis) was used to help with data 
management (Richards 1999) and anonymised short quotes were used to illustrate findings.  
Regarding the approach to data analysis, the data relating to participants’ attitudes and 
opinions to the drivers, drawbacks, barriers and enablers to pharmacists undertaking research 
was analysed separately to the data pertaining to the contextual conditions at case study sites 
and their influence on research activity among pharmacists.   
In terms of the data pertaining to the participants’ attitudes and opinions to the drivers, 
drawbacks, barriers and enablers to pharmacists undertaking research, the data from all four 
case study sites was analysed as one data set. The data from the interviews with the chief 
pharmacists was also collectively analysed, as was the data from the pharmacist participant 
groups from all four case study sites, to identify patterns across the different participant 
groups. Figure 5 below illustrates how the data pertaining to participants’ attitudes and 
opinions to the drivers, drawbacks, barriers and enablers to pharmacists undertaking research 
was analysed. 
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Figure 5: Illustration of how the data pertaining to participants’ attitudes and opinions to 
pharmacists undertaking research was analysed 
 
To analyse the data relating to the contextual conditions at case study sites and their influence 
on research activity among pharmacists, a within-case analysis was undertaken initially i.e. 
data from each case study site was analysed separately. Following this within-case analysis, 
cross-case analysis was undertaken where data from each case study site was collectively 
examined for patterns across the cases by looking for similarities and differences in the data 
from the individual sites (Eisenhardt 1989). Figure 6 below illustrates how the data pertaining 
to the contextual conditions at case study sites and their influence on research activity among 
pharmacists was analysed.  
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Figure 6: Illustration of how the data pertaining to the contextual conditions at case study 
sites was analysed 
 
8.1.5 Research ethics and governance  
In this section I outline the steps taken to ensure the research was undertaken ethically and 
complied with the regulations for undertaking research in the NHS.  
Ethical and governance considerations 
The level of risk for participants taking part in the research was relatively low. Participants 
were not from vulnerable groups, sensitive topics were not involved, the research neither 
involved participants undergoing any intrusive strategies and the research was unlikely to lead 
to participants feeling stressed, anxious or humiliated (Gray 2014). 
As the research required respondents to express their views and opinions, issues relating to 
participant anonymity and confidentiality were the most significant ethical and governance 
considerations.  
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In terms of anonymity, the possibility that participants may be identified by role was 
acknowledged. To minimise this risk, all data was anonymised and any identifying information 
was removed. In addition, to protect the identity of all participants, participating Trusts are 
not identified, and, to protect the identity of individuals in the pharmacist participant group, 
their specific job titles have not been referred to in this thesis and will not be referred to in 
any resulting publications. All participants were also given an anonymous study identification 
number which was used for audio files and transcriptions, with the list of study identification 
numbers kept separately to the audio files and transcriptions. Data containing personal 
information was therefore not able to be linked to anonymised data.  
All personal information relating to participants was kept strictly confidential with no one 
outside the research team (i.e. myself and my academic supervisors) allowed access to it. 
Electronic data containing personal information were stored on password-protected media to 
which only the research team had access. Hardcopies of data were stored in a locked 
cupboard with access again restricted to the research team.   
Informed consent was obtained from participants before interviews were undertaken.  To 
ensure participants were able to give informed consent, potential participants were provided 
with a copy of the participant information sheet for their participant group together with a 
consent form. The participant information sheets, although different for the two participant 
groups, covered the same salient points i.e. the purpose of the research, what was involved, 
any risks associated with their participation, and information relating to anonymity and 
confidentiality. The consent forms were, however, identical for both groups. As outlined 
earlier, copies of the relevant participant information sheet and consent form were attached 
to the invitation emails to ensure that potential participants had time to read them and to ask 
questions. The participation information sheets made it clear to potential participants that 
they were being invited to take part, and were therefore free to decide whether or not they 
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wished to participate. They were also given two weeks from the date of the invitation email to 
decide whether or not they wished to take part and told that they had the right to withdraw 
from the research at any point during the interview and up to 30 days from the date of the 
interview taking place. It was therefore made transparent to participants that their 
participation in the research was entirely voluntary and that they had the right to withdraw. 
To confirm their consent, potential participants were asked to sign and return a copy of the 
consent form before their interview was undertaken.  
Ethics approval  
Since the main research study was undertaken in part 2 of the DPharm programme it was 
classed as postgraduate research. Ethics approval was therefore obtained from one of Keele 
University’s Ethical Review Panels (ERPs), unlike the initial study where approval from the 
School of Pharmacy Ethics Committee had been sufficient (Keele University 2016). 
Initial approval for the research was obtained from one of the university ERPs. However, 
following ethics approval being obtained, amendments to the study were needed to meet the 
requirements of the HRA approval application using the Integrated Research Application 
System (IRAS). An application for an amendment to the original ethics approval was made and 
approval for the amendments obtained. Refer to appendices 21 and 22 for copies of the ethics 
approval letters for the original and amended applications respectively. 
As the questions to be included in the survey were dependent on the findings of the case 
study research, the survey phase of the research was not included in the application for ethics 
approval for the case study research. Instead, the inclusion of a survey was made as a 
subsequent amendment to the original ethics application, as detailed in section 9.1.4. 
 Health Research Authority (HRA) Approval 
Research studies undertaken in the NHS require HRA approval i.e. an assessment of the 
governance and legal compliance of studies (HRA 2016). The main research study therefore 
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required HRA approval, firstly because the study involved NHS staff by virtue of their 
professional role and secondly, because it was classed as research according to the HRA 
decision tool (HRA 2015). NHS Research Ethics Committee review was not required as part of 
HRA approval for the study as neither patients nor service users were involved. Refer to 
appendix 23 for copy of the HRA approval letter. 
For the survey research undertaken in phase 2 of the main research study, an amendment was 
submitted to the HRA, details of which can be found in section 9.1.4.  
8.1.6 Research validity and reliability  
In terms of research rigour some commentators argue that validity and reliability are concepts 
that are not applicable to qualitative research (Bryman 1988). However, I feel these concepts 
are applicable to research such as this undertaken using a qualitative methodology. Indeed 
Morse (2015) argues that terms including rigour, reliability and validity and generalisability can 
be applied to research undertaken using qualitative methodologies. In this section I outline the 
steps taken to help ensure rigour in the research undertaken in this phase. 
Validity relates to the extent to which the findings of a study are a true representation of the 
phenomena under study (Anderson 2010).  
Data triangulation is cited as a way to help ensure the validity of qualitative findings (Anderson 
2010, Fitzpatrick, Boulton 1996). Interviewing the chief pharmacist and a cohort of 
pharmacists at each case study site went some way towards data triangulation as data was 
collected from different staff groups at different levels in the organisations i.e. the chief 
pharmacist and their subordinates.  
Researcher bias is a major challenge to the validity of qualitative research (Roberts, Priest 
2010). To address this I have tried to be reflexive and have therefore critically reflected on my 
influence on the research process (see chapter 11 re reflexivity). To enhance the validity of the 
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data collection, interview guides were developed to ensure that the questions asked related to 
the research objectives and were based on previous research findings. In terms of the conduct 
of the interviews, techniques were used to help build rapport and trust with participants and 
therefore help them to feel comfortable and able to freely express themselves. Probing 
questions were used to prompt participants to expand on their initial responses where 
appropriate, and the time allocated to undertaking interviews was sufficiently long for topics 
to be explored in depth (Arksey, Knight 1999). Reassurance regarding the steps I would take to 
ensure anonymity and confidentiality were also outlined in the participant information sheets 
in an attempt to ensure respondents felt able to freely express themselves (Smith 1998). In 
addition, although participants could have deduced I was a pharmacist by background due to 
the participant information sheets stating that the research was being undertaken as part of a 
DPharm qualification, participants were purposefully not informed of my role within the NIHR 
to minimise any potential skewing of the data relating to my role being based in research 
delivery. 
In terms of data analysis and research validity, using framework analysis to analyse the data 
(Ritchie, Spencer 1994) and comparing the findings to previous studies also contributed to 
enhancing the validity of the findings (Gray 2014), as did searching the data for deviant cases 
(Mays, Pope 1995). Audio-recording the interviews and accurately transcribing the interview 
data verbatim also contributed to the data validity (Smith 1998). The inclusion of anonymised 
verbatim quotes to illustrate the findings in this report is a further attempt to enhance the 
research validity (Gray 2014).   
Respondent validation i.e. involving participants in checking the data for accuracy and 
interpretation is often cited as another approach to ensuring the validity of qualitative data 
(Gray 2014, Fitzpatrick, Boulton 1996, Mays, Pope 1995). Given the time limited nature of the 
study, however, this was not a viable option for this research. Other methods include 
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independent analysis of the data by another researcher to see if they come to similar 
conclusions (Gray 2014, Mays, Pope 1995). Again, this was not possible given that only my 
own time and that of my supervisors was resourced to undertake the research. 
Reliability is another concept associated with rigour, which in qualitative research refers to 
reproducibility and consistency of the findings i.e. the extent to which the findings and 
conclusions of one researcher can be replicated by another researcher doing the same 
research (Anderson 2010, Gray 2014).  
Developing and using interview guides contributed to the reliability of the data by ensuring 
that each respondent was asked the same or similar questions. However, as the interviews 
were semi-structured, as opposed to structured, the interview guide developed was used 
more as a framework to ensure that similar content was covered in each interview and there 
was some variation therefore between participants in terms of the actual questions asked.  
Personally undertaking all of the interviews would, to some degree, have enhanced the 
reliability of the research by minimising ‘interviewer bias’ (Gray 2014). 
8.2 Results 
In this section an analysis of the case study research findings is presented. The results are 
reported in three sections. In the first section (section 8.2.1) demographic data pertaining to 
the case study sites and participants is reported. In the second section (section 8.2.2) findings 
relating to participants attitudes and opinions towards the drivers, drawbacks, barriers and 
enablers to hospital pharmacists to undertake research are presented. In the third section 
(section 8.2.3) an analysis of the data relating the contextual conditions influencing research 
activity at the case study sites is presented.  
All those who volunteered to participate were interviewed. In terms of achieving data 
saturation, overall I felt this was achieved across the dataset in its entirety i.e. across the 
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collated data from all of the case sites as a point was reached where I conducted a number of 
interviews where no new themes were identified. However, I cannot be sure data saturation 
was achieved at case study site 2 due to the low number of pharmacists who volunteered to 
participate there.   
NB Data from interviews undertaken with three participants are not included in the analysis 
for reasons which became apparent through the interviews that would have led to a non-
homogenous dataset. Two participants were not practising as pharmacists at the time of the 
interviews and a third, although undertaking research as part of their role, was not employed 
by the pharmacy department but was instead employed by the clinical specialty in which they 
worked. It was therefore felt that all three participants would not have been subject to the 
same contextual conditions as other participants. I have also purposefully not reported the 
number of participants in the pharmacists’ group at each case study site to help maintain the 
anonymity of those who participated. 
8.2.1 Demographic data  
In this section demographic data relating to the case study sites and the participants is 
presented. 
8.2.1.1 Case study site demographic data 
At each case study site chief pharmacists were asked how many members of staff were 
employed in the department and of those how many were pharmacists. This data is presented 
in Table 9 below. 
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Table 9: Approximate total number of staff and number of pharmacists employed at each 
case study site 
Case study site  Approximate total  number of staff 
employed in pharmacy (headcount)   
Approximate number of 
pharmacists employed (headcount) 
 
1  230 
 
120 
2  300 
 
100 
3  320 
 
100 
4  190 
 
70 
 
8.2.1.2 Participant demographic data  
Across the four case study sites a total of eighteen participants took part comprising fourteen 
in the pharmacists’ participant group and the chief pharmacists at each of the four case study 
sites All participants in the pharmacists group at each case study site were asked how many 
years they had been qualified as a pharmacist and what postgraduate qualifications they held. 
A summary of this data collected from all four case study sites is presented in Table 10 below.  
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Table 10: Number of years qualified and level of postgraduate qualifications obtained by 
participants in the pharmacists group across all four case study sites (n=14) 
Demographic data collected  
 
Number of participants (%) 
Number of years qualified as a 
pharmacist  
0-5 
 
0 (0%) 
5-10 
 
3 (21.4%) 
10+ 
 
11 (78.6%) 
Level of postgraduate qualification*  Diploma 
 
1 (7.1%)  
Masters 
 
5 (35.7%) 
Doctoral 
 
8 (57.1%) 
 
*In relation to the academic level of postgraduate qualifications obtained only the highest level 
of qualification is included in the figures. For example, if an individual had a postgraduate 
masters and a doctorate, only the doctorate is included in the figures. 
 
Chief pharmacists were also asked whether they had personally undertaken research in their 
professional career, and 3/4 (75%) of chief pharmacists said they had personal experience of 
undertaking research. 
8.2.2 Drivers, drawbacks, barriers and enablers to hospital pharmacists undertaking 
research  
In this section an analysis of all of the data collected across the four case study sites pertaining 
to participants’ attitudes and opinions to the drivers, drawbacks, barriers and enablers in 
relation to hospital pharmacists undertaking research is presented.  
Definitions for each of the four theme categories for the purposes of this research are 
provided in Table 11 below.  
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Table 11: Theme category definitions 
Theme category  
 
Definition  
Driver 
 
Perceived to instil in an individual a desire to undertake research 
Drawback Perceived as a downside or being in some way detrimental to an 
individual undertaking research 
 
Barrier Perceived to prevent an individual from undertaking research or make 
undertaking research difficult for an individual 
 
Enabler Perceived to facilitate an individual to undertake research or allow an 
individual to undertake research 
 
 
All four of these theme categories can then be divided into the following subcategories: 
personal or external. 
Definitions for each of these theme subcategories are provided in Table 12 below. 
Table 12: Theme subcategory definitions 
Theme subcategory  
 
Definition  
Personal  
 
Perceived to relate to an individual  
External 
 
Perceived to relate to the organisation and/or profession 
 
Results pertaining to each of these theme categories are presented in turn below. Where 
appropriate, distinctions are made between the attitudes and opinions of chief pharmacists as 
a group and other participants. 
To avoid the risk of participants potentially being identified, quotes to illustrate findings have 
not been included where the quote itself could potentially identify a participant by their role. 
In addition, specific words have been removed from some quotes and replaced with more 
generic terms where there was perceived to be a risk that the quote could identify an 
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individual or case study site. For example I have replaced ‘he’ or ‘she’ to ‘they’, the names of 
any specific Trusts or academic institutions referred to by participants have been replaced by 
terms such as ‘the name of the Trust’ or ‘a named University’, and no specific grants or 
postgraduate qualifications have been named.  
8.2.2.1 Drivers  
A summary of the findings regarding the themes identified relating to drivers is presented in 
Table 13 below, which is then followed by a more detailed analysis of the data relating to each 
theme by subcategory.  
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Table 13: Summary of the themes relating to drivers  
Theme 
subcategory 
  
Theme Description of theme  
Personal 
drivers  
Job satisfaction  Job satisfaction in its entirety and job satisfaction relating 
specifically to research adding variation to an individual’s role 
 
Personal kudos Kudos associated with individual recognition through 
publications and being recognised as an expert in a field 
 
Professional 
development  
Developing professionally as a result of undertaking research 
through gaining transferable skills and research expertise; 
research helping with career progression and increasing career 
opportunities; having clearer career pathways associated with 
research 
 
Research 
experience 
Having experience of undertaking research leading to a desire to 
undertake further research  
 
Personal desire 
to change the 
practice of 
pharmacy  
 
Having a desire to improve patient care at a strategic level 
External 
drivers 
Need for 
evidence from 
research 
Examples cited included needing evidence to support business 
cases and to provide assurance that changes to pharmacy 
practice are without negative or unintended consequences 
 
Professional 
kudos 
Undertaking research giving pharmacists a better standing as a 
profession   
 
Professional 
expectation 
Research being an integral part of being a pharmacist by 
profession 
 
Expectation of 
employer 
Research being an expected part of an individual’s role by their 
employer 
 
Organisational 
reputation  
Being research active being good for the reputation of the 
department nationally, as well as the reputation of the 
department within the Trust 
 
Income 
generation  
Income for the Trust associated with successful grant 
applications  
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Table 13 continued  
Theme 
subcategory 
  
Theme Description of theme  
External 
drivers 
(continued) 
Organisational 
culture  
Departmental culture being encouraging of research cited as 
driving research activity; a requirement for the department to be 
research active by the Trust cited as a potential driver for 
departmental research activity  
 
Departmental 
leadership 
Having a pharmacist within the department whose role 
encompasses leading research 
 
Departmental 
role models 
 
Having research active pharmacists within the department 
 
Personal drivers 
In terms of personal drivers, the following themes were identified:  
 Job satisfaction 
 Personal kudos 
 Professional development 
 Having research experience  
 Having a personal desire to change practice. 
Job satisfaction associated with research was perceived to be a significant motivator for 
pharmacists to undertake research as illustrated by one participant who described job 
satisfaction as a driver to engagement to be ‘right at the top of the list’. Adding variation to 
pharmacists’ roles was cited as one reason why research would contribute to an individual’s 
job satisfaction.  
Personal kudos from research was also perceived to be a driver. Cited in this context was the 
kudos associated with being a recognised expert in a particular field and the increased 
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credibility individuals felt this gave them as a practitioner, as well as the individual recognition 
associated with having research published as illustrated by the following quote: 
P16: ‘Erm…what would motivate them to want to be involved in research? Probably 
the fact that it’s something that…like a project that could potentially be their idea and 
that they then take that through and then get it published and it’s…er….theirs for life, 
isn’t it? It’s recognition for what they’ve done.’ 
Professional development as a driver was multifaceted. Gaining research knowledge and skills 
was cited as one example of how undertaking research could support professional 
development. However, professional development associated with research was not 
perceived to be limited to the knowledge and skills gained relating specifically to research. 
Reference was also made to transferable skills gained through research such as project 
management, objective setting, writing academically, presenting data, and giving oral 
presentations. Research contributing to career progression was also cited in the context of 
professional development which some attributed to the research expertise and/or 
transferable skills gained through having undertaken research. In the context of transferable 
skills, one participant made reference to these skills making individuals ‘more attractive’ to 
employers. Likewise, as an example of how having research expertise could support career 
progression, one participant made reference to the need for individuals to have research skills 
to attain a consultant pharmacist post. However, several interviewees with research 
experience were of the opinion that undertaking research had not contributed significantly to 
their personal career progression. Indeed, of all the individuals interviewed in the pharmacists 
group, only one participant talked about research personally benefiting their career but 
recognised that this was not the case for everyone.  
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P9: ‘Em.. I mean it, it has linked into career progression and recognition…but I 
recognise that that’s not always the case, and I think for me it’s just sort of worked out 
quite well cause it complemented my teaching, my management, my clinical...’  
Several were also of the opinion that rather than research being an essential requirement to 
attain a senior position, pharmacists could progress to a relatively senior role i.e. roles graded 
at Agenda for Change Band 8, without having undertaking research.  
Linked to professional development being a driver to engagement, several participants in the 
pharmacists group suggested that a clear career pathway incorporating research would 
potentially encourage more pharmacists to undertake research. Clearer career pathways to 
senior positions combining clinical and academic roles to provide pharmacists with an 
alternative career path to that of the management route to chief pharmacist was specifically 
suggested by one participant as a way to increase research engagement.   
P11: ‘I think it’s important they are able to see a career path and that it’s a different, 
perhaps, career progression from the traditional career progression, but that it ends up 
in a position equivalent to a chief pharmacist. For me personally that’s  an important 
motivator because at the moment, I think there is some…people can visualise a career 
in clinical practice as a consultant pharmacist, but I think it’s fair to say, they wouldn’t 
be able to visualise a career pathway to a clinical academic professor position,, and for 
NHS clinical pharmacists to I think embark on these sorts of careers, it would be really 
valuable to have some established clinical academic professors who can demonstrate a 
successful career…’  
Rather than research experience leading to career progression, several participants also talked 
about research increasing career opportunities. Changing to a career in academia was cited as 
one such way that undertaking research could increase an individual’s career opportunities. 
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Many interviewees cited their personal research experience leading them to undertake further 
research. Research experience gained as part of a postgraduate qualification was commonly 
cited as the experience that had given them the desire to undertake further research. 
Interestingly, the majority of those interviewees who had been inspired to undertake further 
research as a result of gaining research experience through a postgraduate qualification, 
talked about a positive experience leading them to want to undertake further research in their 
careers. None said they had undertaken such qualification to gain research experience.  
Illustrating this, one participant described how they felt indifferent to undertaking research as 
part of a postgraduate qualification but later in the interview went on to describe how 
undertaking research as part of their qualification had led them to want to do undertake 
further research.  
Some participants also described their experience of undertaking research as part of an 
undergraduate final year project and/or pre-registration project as sparking their interest in 
undertaking further research. Linked to this, the integration of research into the professional 
practice of early career pharmacists was suggested as a way to encourage pharmacists to 
undertake research during their careers. To illustrate this, one participant compared the 
foundation training of pharmacists to that of medics which, they believed, incorporated 
research: 
P3: ‘So I think it would really help if it [research] was in some way incorporated into a 
foundation training…training and development programme after qualification like for 
doctors. So they have to do some don’t they? And that doesn’t exist for pharmacists. If 
part of the foundation training, even just for hospital pharmacists, had to be a bit of 
research it would get done and everyone would do it, and everyone would know how 
to do it, and that would carry on through…’ 
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A desire to change the practice of pharmacy to improve patient care at a strategic level was 
also commonly cited as a personal driver by those who participated in this phase of the 
research. This is illustrated by the following quotes from two participants who talked about 
research in the context of changing policy and practice: 
P9: ‘…erm it’s about being able to change policy and practice around you know how we 
provide pharmacy services or how we work with other members of the healthcare 
team.’ 
P11: ‘…er I feel that it’s a natural progression from working in a clinical role and trying 
to improve the quality of care for individual patients, to working in a…at a more 
strategic role in improving care through guidelines and auditing and feedback, and 
then the next stage for me is to carry out research to understand how we can improve 
patient care even further, and to understand the impact of interventions……and to me 
is the pinnacle of achievement...if you are generating new knowledge that will er 
inform and improve care of patients, not only at [the name of the Trust] but in other 
hospitals or even internationally that would be my long term goal.’  
Interestingly, through the course of the interviews two participants from different case study 
sites made reference to published literature relating to research active organisations being 
associated with improved outcomes for patients:  
P11: ‘…there is quite a bit of research around a growing body of evidence showing that 
hospitals that engage actively in research have better outcomes for patients, and that 
seems to be not just because of staffing, that its…or resourcing at these hospitals, that 
is because the staff there are more engaged and more determined to improve quality 
of care and work more efficiently, so I think patients probably…almost certainly benefit 
from having a research active workforce…’ 
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P13: ‘It’s about quality of care and there are so many studies that have demonstrated 
if you have a research enabled workforce the quality of the care that you deliver is so 
much better, and that for me is a really big thing. It’s just if you’re all research enabled 
you’re going to be way better at your jobs, just without even realising it.’ 
Although neither participant made any direct reference to their awareness of such research 
driving them to undertake their own research, the very fact that they mentioned these studies 
would suggest these participants had a personal desire to contribute to improving patient 
outcomes. 
External drivers 
In terms of external drivers for pharmacists to undertake research, the following themes were 
identified: 
 The need for evidence from research 
 Professional kudos 
 Research being a professional expectation for pharmacists 
 Research being an expected part of a pharmacist’s role 
 Organisational reputation 
 Income generation 
 Organisational culture 
 Departmental leadership 
 Having role models within the department 
The need for evidence from research being a driver for engagement was cited in the context of 
there being a need for an evidence base for pharmacy practice. Reference was made to 
research being required to provide assurance that changes to pharmacy services were not 
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associated with negative or unintended consequences, as well as the need for research to 
provide evidence to use in business cases.  
Professional kudos was also cited as an external driver to engagement as illustrated by 
reference made by some interviewees to an association between pharmacists undertaking 
research and professional standing.  
P3: ‘It puts us in a slightly higher standing…if we’re doing research.’ 
P4: ‘...if we undertake research on a practice-level, I think that shows the profession in 
a really positive light.’  
Proving the value of the profession was another reason cited for why pharmacists needed to 
undertake practice-based research in particular. 
Reference was also made to research being a professional expectation driving engagement. 
One participant suggested that research being a professional expectation meant all 
pharmacists should be research-active.  
P10: ‘it’s just an integral part of being a er professional and everybody should be doing 
it.’  
A requirement to undertake research being part of the RPS Foundation and Advanced 
Pharmacy Frameworks was also mentioned by several interviewees. However, some were 
sceptical about whether the inclusion of research in the RPS Advanced Pharmacy Framework 
actually drove activity. Illustrating this one participant questioned how well regarded the RPS 
Faculty membership was: 
P1: ‘So I think it’s positive that it’s in the Advanced Level Framework now for 
pharmacists but I don’t know how much weight it carries and whether people just try 
and fudge it with audits…’ 
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Likewise, another questioned how many pharmacists were using the RPS competency 
frameworks to support their professional development. Despite this, several participants 
believed that the RPS should have a role to play in driving research among members of the 
profession. The inclusion of a requirement to undertake research being made a compulsory 
part of professional practice was suggested by one participant as a way to increase 
engagement. 
P3: ‘I think it needs to be…driven more either by the professional body or…erm…as 
some kind of training programme, something needs to drive it to make it compulsory.’ 
Research being an expected part of an individual’s role by their employer was also cited as a 
driver by several participants. One participant, who held the position of consultant pharmacist, 
cited the inclusion of research in their job plan as a reason why they had undertaken research. 
P5: ‘So it really came from the fact that actually I have to do it as part of my 
job….because it’s part of the sort of makeup of a consultant pharmacist’s post, I should 
be involved in research…’ 
Likewise, several of the chief pharmacists interviewed were of the opinion that research 
experience was an essential requirement for a pharmacist to attain a very senior position. 
P3: ‘I think that if you are more and more these days applying for a very senior position 
then you need to have something around research under your belt.’ 
P12: ‘The other, the next motivation might be career development…and so increasingly 
having some sort of research track record is really required for higher level promotion, 
certainly within the hospital sector.’ 
Some participants also hypothesised that the inclusion of research in pharmacists’ annual 
appraisals would drive research activity.  
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P2: ‘…perhaps if it was more integrated, perhaps in a PDR.. so it’s always like how are 
you performing against that. If it’s not there then why would people want to…want to 
do it? Erm..so you need some kind of carrot as well erm, because some people are 
naturally interested in doing research and they’ll carry on and do it anyway regardless, 
but some people I think sit on the fence a little bit or are a bit unsure and if…if it was 
seen to be part of your performance or..then..then people would be yeah I’ll do it.’ 
From an organisational perspective, pharmacists undertaking research was perceived to be 
good for the reputation of the department. One participant attributed research activity as 
raising the profile of the department nationally. 
P12: ‘…departments with a strong research track record tend to have a high profile 
nationally.. erm and I think all that adds to the reputation.’ 
Having research published or entering posters to conference were cited as mechanisms to 
promote research activity outside of the Trust. 
Participants were also of the opinion that having a research active pharmacy department was 
positive in terms of the reputation of the department within their Trust and also for the 
reputation of the Trust itself. Successful grant applications were seen as one way that research 
gave the department and the Trust kudos. 
P2: ‘Well I hope that because perhaps some of the work that we do gets out there and 
gets published or goes to conferences more often, that..that there’s a reputation. I 
mean the [NIHR funded grant] that I’ve got is based here…er...as a site, so the money 
comes here as opposed to the University so..erm..and that has been, you know, put in 
the newsletter..and it gives something to the pharmacy department so we’ve actually 
got some research going on in [the name of the Trust], and I think that’s a good thing 
for the organisation.’ 
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Several also perceived that the prestige of having a research active department or a reputation 
for research would be attractive to potential employees and helped with recruitment and 
retention of staff.  
P16: ‘…so if you’re recognised as having a culture of research…it makes you quite an 
attractive place to come and work.’ 
Some also talked about the department having a reputation for research attracting high 
calibre staff. 
P7: ‘…a department that undertakes research will be seen as a forward thinking, 
improving department and can therefore compete for the best pharmacists to come 
and work for them…’ 
From an organisational perspective, income generation associated with research grants was 
seen as a driver for research activity within pharmacy departments. In terms of other external 
drivers for research relating to the organisation, a pharmacy department having a culture for 
research was perceived to driving research engagement by several participants at their 
respective Trusts. Making research visible appeared to be the mechanism through which 
research was encouraged. Regarding the culture of the organisation at Trust level, although no 
participants made any reference to the culture at the level directly driving pharmacists to 
undertake research, one chief pharmacist believed that a requirement from the organisation 
for pharmacists to be research active would help drive research activity in their department.  
P3: ‘…I think that would help, you know, if there was a driver from the organisation to 
say ‘well what are you doing to contribute to research?’ 
The same participant also suggested that better recognition for pharmacy-led research at 
Trust-level would also drive activity among pharmacists.   
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As well as the culture of the department, the leadership of the chief pharmacist was also cited 
as driving or encouraging research activity among pharmacists within their respective 
departments. Indeed, several of the chief pharmacists interviewed appeared to recognise the 
importance or significance of their leadership in relation to encouraging research activity. 
P6: ‘I think the chief pharmacist is quite influential…bearing in mind that every level 
down within the organisation something gets filtered out em…you’ve got to be 
enthusiastic about it at the top.’ 
Interestingly all of the chief pharmacists interviewed appeared to value research and believe 
research to be important. For example, one chief pharmacist not only felt research was 
important to the department but also recognised that the department benefitted from 
research. 
P6: ‘How do I feel about it? I think it’s really important, I think it’s great to have, I think 
it gives us a lot of benefit that we wouldn’t ordinarily have, I think if we had all the 
time in the world we’d do much more…’ 
Likewise, by saying that they wanted to put research at the ‘forefront’ of their department’s 
core activities, another appeared to value research and perceive it to be important. 
Having a pharmacist whose role was to lead research was credited with driving research by 
several interviewees, as illustrated by the following responses from two participants at 
different case study sites to being asked whether having a pharmacist in such a position 
influenced research activity among pharmacists within their departments:  
P18: ‘I think [having a lead pharmacist for research] is the key for us. I think [they] have 
been the driving force for the research agenda within our department.’ 
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P5: ‘I think it's a hugely positive thing. Erm… I think it just establishes that it's not 
something…we need to do a bit of research, let's try and find the time for it but we're 
often too busy. It gives a good focus. And I think that's part of, without having to sound 
like….saying how great your boss is, but I think that's one part of [the chief 
pharmacist’s] vision that he's always wanted to have that because he's recognised that 
actually you need to give it a focus. You need to have someone to lead.  And you need 
to, it just needs to be kept going.  And I think that role just keeps it going.’ 
Several of the chief pharmacists had delegated leadership of research to a pharmacist in such 
a role in their respective departments.  
P12: ‘…so I guess we rely on [the name of the lead pharmacist for research] to engage 
with people to try and promote development of research’ 
Having role models, i.e. research-active pharmacists within the pharmacy department, was 
also cited as a driver for pharmacists to undertake research.  
P12: ‘…they need the inclination, sometimes I think in terms of developing that 
inclination they need to see erm role models…’ 
P7: ‘…there are a few of us in the department who are role models in terms of 
research, so seeing that will make them think I can be more like them, I think that’s 
something that will encourage them.’ 
Interestingly, none of the chief pharmacists were undertaking research themselves at the time 
of the interviews, and none appeared therefore to be leading by example. However, three of 
the four lead pharmacists for research were actively undertaking research at the time of the 
interviews and were therefore acting as departmental role models. Indeed, the lead 
pharmacist at one site talked about how they felt that is was incumbent on them to be a role 
model and that having research experience gave them credibility.  
134 
P7: ‘…I have a significant role to play in influencing the culture…er so I need to be a role 
model and that’s why I’ve been doing my own research, I have to have erm.. the fact 
that I’m doing my own research gives me credibility in research…’ 
8.2.2.2 Drawbacks 
A summary of the findings regarding the themes identified relating to drawbacks is presented 
in Table 14 below, which is then followed by a more detailed analysis of the data relating to 
each theme by subcategory. 
Table 14: Summary of the themes relating to drawbacks 
Theme 
subcategory 
  
Theme Description of theme  
Personal 
drawbacks  
Reduced income Reduced income associated with salaries to undertake a PhD 
being lower than that of pharmacists’ NHS salaries and lower 
financial remuneration associated with academic careers 
 
Short contracts  Short contracts associated with academic research 
 
External 
drawbacks 
Impact on service 
delivery  
Having pharmacists in a department undertaking research taking 
resource away from delivering clinical services  
 
Difficulty in 
backfilling posts  
 
 
Short time scales associated with funding from grants being 
awarded and funding from grants not being sufficient to cover an 
individual’s full salary making it difficult to backfill posts to allow 
individuals with grant funding to undertake research  
 
 
Personal drawbacks 
Two themes were identified relating to personal drawbacks: 
 Reduced income 
 Short contracts 
Lower incomes associated with funding for PhDs was cited in reference to reduced income 
being a drawback to pharmacists undertaking research. One participant suggested that 
because pharmacists were paid comparatively higher salaries than other healthcare 
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professionals, the reduction in income associated with undertaking a PhD would represent a 
more significant reduction in income for pharmacists. Lower financial remuneration associated 
with academic careers was also cited as another potential drawback for pharmacists looking to 
pursue a career in academia.  
P10: ‘Erm…I don’t think it’s necessarily well, er recompensed….academic careers don’t 
always attract huge salaries so if somebody wanted to use it as a er route through into 
an academic career it’s not necessarily a career path paved with gold.’ 
Short contracts were also cited as a personal drawback in the context of undertaking academic 
research, illustrated by the following quote from one participant:  
P2: ‘…if you are a researcher the whole going from one project to another is very 
unsettling and not knowing where the next job is coming from isn’t a nice way of living, 
especially as you get a bit more mature and perhaps you’ve got a mortgage and 
stuff…’ 
However, some interviewees who had been employed to undertake research through such 
contracts, talked about their ability to undertake locum work as a pharmacist to counter the 
risk of being out of work at the end of their contracts.  
External drawbacks 
Two themes were identified in relation to external drawbacks, both of which related to the 
organisation: 
 Impact on service delivery 
 Difficulty backfilling posts 
External drawbacks were cited in the context of the impact on service delivery of releasing 
staff to undertake research both in terms of the immediate day-to-day impact of pharmacists 
136 
undertaking research activity during the working day, and in relation to the difficulty of 
backfilling posts from grant funding.  
The impact of research on service delivery was cited as a drawback by several of the chief 
pharmacists interviewed. To illustrate this point one chief pharmacist highlighted how 
infeasible it would be to allow all pharmacists in their department protected time to 
undertake research while delivering the core pharmacy service. 
P3: ‘Er, the only drawbacks are, I think from a purely practical point of view, it could 
distract and take away from actual service delivery…so I can’t afford for all my 
pharmacists to have a day a week dedicated to doing research for example, because 
the organisation requires us to dispense [discharge medicines] within an hour..so I 
can’t do it all.’ 
The challenges associated with backfilling posts to allow pharmacists the time to undertake 
research funded through grants related to both the difficulty identifying staff to backfill posts 
because of short time scales associated with funding being awarded, and the difficulty of 
backfilling posts where the funding awarded by a grant is only sufficient to cover a proportion 
of an individual’s salary. Interestingly, one participant perceived difficulty backfilling posts 
through research funding had negatively impacted on their career progression as they felt 
applying for funding to undertake a PhD had held back their progression from a role graded at 
Agenda for Change (AfC) Band 7 to a Band 8a because of anticipated difficulties in backfilling 
their role at a more senior level.  
P1: ‘I think it’s held me back em…applying for higher banded jobs..I feel like they held 
me back at a Band 7 because there was this feeling that if I applied for 8s and then got 
funding for the PhD that they wouldn’t support it, whereas if I stayed where I was they 
weren’t too bothered as I was easier to replace as a Band 7 than if I’d got an 8.’ 
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8.2.2.3 Barriers 
A summary of the findings regarding the themes identified relating to barriers is presented in  
Table 15 below, which is then followed by a more detailed analysis of the data relating to each 
theme by subcategory.  
Table 15: Summary of the themes relating to barriers 
Theme 
subcategory 
  
Theme Description of theme  
External 
barriers 
Resource: lack of 
time 
Lack of time to undertake research due to demands of the 
day job compounded by research being time consuming to 
undertake 
 
Resource: difficulty 
obtaining funding 
 
Difficulty obtaining funding both in terms of the time 
consuming nature of grant applications and the highly 
competitive nature of awarding of grants; lack of pharmacy-
specific grants 
 
Resource: difficulty 
accessing support 
Difficulty accessing support associated with difficulty 
accessing individuals with research expertise within the 
Trust and difficulty accessing infrastructure 
 
Organisational 
culture 
Lack of priority assigned to research; unsupportive chief 
pharmacist and unsupportive middle managers at 
departmental level 
 
Personal 
barriers 
Lack of 
competence 
Lack of research knowledge and skills cited as a barrier to 
pharmacists undertaking research 
 
Lack of confidence Individuals lacking confidence in their ability to undertake 
research 
 
Lack of awareness 
and understanding 
 
Individuals lacking an understanding and awareness of 
research, lacking appreciation of the benefits of research to 
pharmacy practice, and lacking an appreciation of the 
personal benefits to themselves from undertaking research  
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External barriers  
External barriers fell into two broad themes:  
 Resource issues 
 Organisational culture  
With regards to resource issues representing barriers to research, participants’ attitudes and 
opinions relating to this fell into three groups or sub-themes: lack of time, difficulty obtaining 
funding, and difficulty accessing support. 
Lack of time was commonly cited as a barrier so much so that it appeared to be the most 
significant issue preventing pharmacists from undertaking research. Competing demands of 
the day job was cited by many as the reason why pharmacists lacked time to conduct research.  
P17: ‘…the everyday demands of clinical practice means there is no time.’  
P6: ‘I think it’s the pressures of the day to day job…there is no downtime, there is no 
slack…’ 
This appeared to present more of a barrier to undertaking research for those in more junior 
roles with several participants in relatively junior positions, i.e. roles graded at AfC Band 6 or 7, 
describing how they had personally experienced difficulty finding time to undertake research 
because of the demands of their clinical commitments.  
P1: ‘…I didn’t have the time to do it because it was very much like ‘You need to be on 
the wards’ and I think that was very much because of being like a Band 7 and because 
being like a prescriber they’re quite keen for you to do just that.’  
Compounding the issue of a lack of time to undertake research was the perception that 
research was itself time consuming to undertake.  
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P4: ‘...all the preparation, I mean you’ll know Julie in terms of the preparation for 
research design, how much time that takes [] I think that’s why people may get 
discouraged.’ 
Long timeframes associated with obtaining research ethics and governance approvals 
appeared to be an aspect of the research process perceived to be a particular barrier. 
P2: ‘…and then the whole thing about ethics committees and what the requirements 
you need are…..it takes so much time and that just puts people off doing it in the first 
place.’ 
Changes made to the process for obtaining ethics and governance approvals to conduct 
research was cited as contributing to the time consuming nature of research, and reference 
was also made to the research approvals required for some studies being disproportionate to 
the level of risk associated with them.   
In relation to difficulty obtaining funding representing a barrier to engagement the difficulty 
obtaining grants in particular was cited. Issues with obtaining grants included the time 
consuming nature of the application process and the competitive nature of the awarding of 
grants resulting in high failure rates for applications. Many perceived these issues to 
compound one another in that the high failure rates associated with applications led 
participants to believe that the time spent on unsuccessful grant applications was wasted. 
P11: ‘…you can put a lot of effort into grant applications and be unsuccessful…and 
that’s very difficult to accept professionally and personally, and it seems like a very 
inefficient and wasteful way of spending time, and spending precious taxpayers money 
so I think that the greatest problem for me with research is the lack of guaranteed 
funding…’ 
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P17: ‘I do think the biggest barrier is the funding equation…. I think it’s very hard to get 
financial resources. I’m of the opinion it’s a hugely inefficient process. The failure rate I 
think is 1 in 8 to get a shortlist, and 1 in 3 to get through the process. To me that’s a 
huge amount of time and wasted resource for all those who didn’t get the grant.’  
Needing to have a track record in research in order to be awarded research grants was 
identified as contributing to the difficulty associated with obtaining funding as illustrated by 
one participant describing the need to have research experience to be successful in applying 
for funding as a ‘catch-22’. Another illustrated this by making reference to the inclusion of 
individuals with an academic track record on their grant applications increasing the likelihood 
of applications being funded. 
P3: ‘…research credentials to get… get grants, for better success with grants, you’ve 
got people who’ve been successful before and done a lot of research, that helps.’ 
A lack of pharmacy-specific grants was identified as another barrier as illustrated by the 
following quote from one participant who believed more specific funding for pharmacists 
would facilitate research engagement:  
P5: ‘…having more pharmacy specific funding opportunities erm the competition is 
massive, very intense, er so knowing there was perhaps an easier route to getting 
funding or less competition.’ 
Difficulty accessing support was cited by several participants as a barrier to research activity in 
the context of resource issues being barriers to engagement. Difficulty accessing individuals 
with research expertise within the Trust was identified by participants at different case study 
sites as a barrier that they had personally experienced. This was illustrated by one participant 
who described difficulty obtaining internal support from their Trust R&D department due to it 
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being aligned to supporting clinical trials rather than the types of research they were 
undertaking: 
P13: ‘So when I first started undertaking my research here I did struggle because they 
[the Trust R&D department] were built for big projects, largely clinical trials…’ 
Difficulty accessing infrastructure was also identified as a barrier to pharmacists undertaking 
research. Examples of such included access to IT software packages used to assist with both 
statistical analysis of data and qualitative data analysis.  
In terms of organisational culture representing a barrier to engagement, a lack of prioritisation 
at departmental level was cited by several interviewees as preventing engagement. Illustrating 
this was the view of one participant who hypothesised that if research was given a higher 
priority at departmental level then individuals would find time to undertake research.  
P8: ‘…if there was a higher priority coming from a…the top on research they would 
make time when pharmacists weren’t on wards, weren’t on their clinical duties to do 
research projects.’ 
Research not being seen as a core part of pharmacists’ everyday duties was also perceived to 
present a barrier as illustrated by the following quote from one participant who described a 
need for pharmacists to be ‘released’ from their duties to undertake research: 
P13: ‘…the day to day functions of pharmacy as a job just don’t allow that without 
being released to go and do it.’ 
Expecting pharmacists to undertake research in their own time was also perceived by some to 
represent a barrier to research engagement as they felt this expectation would discourage 
individuals from undertaking research. 
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P18: ‘….if you’ve got a full-time job, quite often in clinical pharmacy in hospitals you 
know, you know it’s not a 9 to 5 job really, a lot of people put in a lot of overtime so to 
do a degree or a course in your own time on top of what you’re already doing, I think 
that would probably put people off.’ 
Also in relation to organisational culture, having a chief pharmacist who was unsupportive of 
research was perceived by some to present a barrier to engagement. This is illustrated by the 
following quote from one participant who believed that an unsupportive chief pharmacist 
would prevent engagement:  
P11: ‘I hear stories of chief pharmacists who don’t support research, maybe feel 
threatened by research and don’t really actively encourage it and I’m sure that means 
it’s very hard for any pharmacist or pharmacy staff who are interested in research to 
get involved, just probably too intimidating the idea of starting up without the chief 
pharmacist’s support, so I think its deal breaker if you don’t have it.’ 
Having unsupportive middle managers was cited as a barrier. One participant appeared to 
attribute their personal experience of this to their line manager not perceiving research to be 
of value to the organisation.   
P13: ‘So people just don’t get it. Erm my line manager when I’ve asked to go to 
conferences and things like that, she goes ‘well it’s just the research…I don’t see how 
the Trust benefits from that.’ 
Personal barriers 
Participants’ opinions of personal barriers to pharmacists undertaking research fell into three 
themes: lack of competence; lack of confidence; and lack of awareness and understanding.  
In relation to lack of competence, a lack of research skills was specifically identified which 
some interviewees perceived to be endemic among members of the profession.  
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P11: ‘…I think pharmacists generally feel a bit deficient in research skills, we’re taught 
quite well to critically appraise literature, but it’s different evaluating someone else’s 
work than actually generating research yourself, developing a protocol, designing a 
research study that’s going to be good quality and deliver the correct results and also 
applying statistical analysis, and most pharmacists would confess to feeling not very, 
well not very capable of doing that sort of thing, so that’s a major barrier.’  
Difficulty formulating a research question and not knowing how to get started in research 
appeared to be particular issues which participants made reference to in the context of 
pharmacists lacking research knowledge and skills as illustrated by the following quote:  
P13: ‘…it’s difficult to get it off the ground and I think that’s what most of my 
colleagues out there would say is just ‘How do I get started? How do I get the time 
out? How do I get everything in place?’ 
Although not a skill required solely for research, participants also said that the need to be able 
to write in an academic style presented a barrier to pharmacists undertaking research. Indeed 
several of those interviewed said that learning to write in this style had been a barrier they 
had needed to overcome.    
Some participants believed pharmacists to lack the competence to undertake research 
because the undergraduate course did not equip them with the necessary skills to lead their 
own research. 
P9: ‘...it’s a massive learning curve when you first start, and I think unless you’ve done 
it as part of a postgraduate qualification, like a formal postgraduate masters or a PhD, 
I think it’s really hard to start.. I don’t think the undergraduate MPharm projects…they 
give you a tiny taste of it but they’re typically you know audit projects and very basic 
things.’  
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One participant appeared to hold a slightly divergent view. They appeared to perceive 
pharmacists to have a latent ability to conduct research due to them developing a scientific 
approach to inquiry as a consequence of practicing evidence-based medicine.  
P4: ‘….well I think in terms of the healthcare scientists, they’ve got, or they should 
have, a sort of scientific approach, they should be rational in terms of any evaluation 
that were used for medicines that’s based on the premise of research...so it makes 
sense because of that underpinning knowledge and that sort of pedigree they’ve 
already got, or should have, some underpinning that enables them to ask those 
questions in a rational way.’ 
In terms of pharmacist lacking confidence presenting a barrier to engagement, several 
participants directly referenced pharmacists’ lack of confidence in their ability to undertake 
research so much so that some felt that pharmacists would be fearful of undertaking research.  
P2: ‘I think people…er…can be scared of research.’  
Reference was also made to pharmacists perceiving research to be too difficult or complex to 
undertake.  
P5: ‘…they think it’s too hard to do research and it’s too fiddly...’ 
Regarding pharmacists lacking an awareness and understanding of research preventing 
engagement, several aspects to this were identified. There was a perception among 
interviewees that members of the profession fundamentally lacked an understanding of what 
constituted research illustrated by participants describing research as something that needed 
to be ‘demystified’. Several participants also believed there to be a lack of understanding of 
the different forms of scientific inquiry among members of the profession. However, those 
interviewed appeared themselves to be able to distinguish between audit, service evaluation 
and research. Some also referenced quality improvement as another form of inquiry used 
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within their organisation in the context of bringing about improvement and were able to 
distinguish quality improvement from other forms of inquiry. Despite appearing to be clear on 
the difference between the different forms of inquiry, some interviewees still appeared to feel 
that it was only research that could be published or presented at a conference. The term 
‘research’ also appeared to be perceived by some interviewees as an ‘umbrella’ term for all 
forms of scientific inquiry and in particular by those in the chief pharmacists group.  
P10: ‘...I think [research] in its broadest terms is just about inquiry…’ 
Rather than perceiving research to be an umbrella term, some appeared to perceive there to 
be step-wise progression from audit to service evaluation to research. 
P4: ‘So it goes through from a bit of an audit, to a bit of practice development… 
business case development, then through to you know a more formal evaluation.’  
All those interviewed also appeared to differentiate between pharmacy-led research and 
pharmacy involvement in clinical trials delivery. One participant also made reference to 
involvement in research delivery as principal investigators for multi-centre studies. Again they 
appeared to be able to differentiate between a pharmacist undertaking the role of a principal 
investigator for a study and a pharmacist being a chief investigator leading their own research. 
Their perception, however, was that this understanding of the difference between chief 
investigators and principal investigators was not widely shared within the profession.  
Lack of understanding or appreciation of the value or benefits of research to pharmacy 
practice was also identified as a factor presenting a barrier to engagement. One participant 
exemplified this in describing a situation they had witnessed where a pharmacist in the 
audience of a conference presentation did not appear to appreciate how research was used to 
inform practice. 
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P15: ‘…what this pharmacist saw was two million pounds being spent on proving 
something that she did every day, and what she didn’t get was this is an RCT, this is 
something that when published, NICE will be able to use in policy and guidelines and all 
that.. and I think if you don’t understand that, then you just see a waste of money and 
why would they bother engaging.’ 
It was interesting to note that the same participant elsewhere in the interview also appeared 
to question why pharmacists were not as research active as perhaps they would be expected 
to be considering how embedded the use of evidence-based medicine is among the 
profession.  
P15: ‘We’re such a… you know… evidence-based profession and we talk about 
evidence-based medicine all the time…we’ve pushed evidence-based guidelines for so 
long, yet conversely, we don’t do as much research as we should do…’   
One of the chief pharmacists interviewed appeared to perceive the lack of appreciation of the 
value of research to pharmacy practice to be at least in some part attributable to pharmacists 
not being familiar with the types of journal where academic research is published. They 
believed pharmacists were most likely to read professional journals but recognised that the 
aim of those undertaking research in academia was to publish in high impact factor journals. 
They appeared to suggest therefore that because the outcomes of research were not 
effectively disseminated to those in practice, pharmacists lacked an appreciation of the value 
of research to practice due to a lack of awareness of the outcomes of research being 
undertaken. 
Rather than pharmacists lacking an understanding or appreciation of the value of research, 
some participants appeared to question the value of academic research. For example, one 
participant talked about academic research having ‘no practical application whatsoever’.  
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Lack of awareness of research was also cited as a barrier which is illustrated by the following 
quotes from two chief pharmacists who appeared to recognise the need to promote the 
research undertaken within their respective departments: 
P3: ‘…we always share the research people are doing, and we could probably do more 
on that...cause at the moment we’ve got our, I was just thinking about this after our 
Trust away day last week, actually we’ve got our pharmacy R&D board, but the only 
people that come to that are the people who are already engaged, and actually we 
should promote that and share that wider so that everyone else knows what’s going 
on.’ 
P6: ‘...we have a noticeboard up in the department that’s research, but this was 
something I did discuss with [the name of the Lead Pharmacist for research] when I did 
my last 1:1, is how do we make it more mainstream in the department and how do 
they know what [you] do?’ 
Lack of awareness of research opportunities was also seen as a barrier and is illustrated by the 
following quote from a participant who believed pharmacists were not aware that they were 
eligible to apply for NIHR clinical academic careers programme fellowships: 
P11: ‘…one thing that has I think dramatically helped is the NIHR opening up clinical 
academic posts to pharmacists as a profession [] so what it means is that a pharmacist 
who’s embarked on a clinical career and is paid on agenda for change pay scales, they 
have the opportunity to do a masters in research or a PhD and carry on to post doc 
research without losing their salary, so their salary is 100% backfilled and I think that’s 
an important incentive and I don’t even think it’s fully appreciated by pharmacists 
working in the health service at the moment…’  
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There was also a widely held view among participants that the RPS should or could have a 
larger role to play in terms of raising awareness of available grants and other funding 
opportunities available to pharmacists as illustrated by the following quote:   
P1: ‘I think the RPS could certainly do more, I think they’re trying, but at the same time 
they’re… they have a research group and they don’t even advertise like funding calls 
that are open to pharmacists. I’ve been talking to a few funders like Arthritis UK, 
Dunhill that fund me, and they’re just like we don’t get any applications from 
pharmacists, and I’m like they probably don’t even know you exist. Whereas other 
professions like the NMC are quite active in promoting calls and stuff. So I think the 
professional body needs to do more em…to advertise research, advertise the 
opportunities available and advertise the point of doing it em...’ 
Lack of appreciation of the personal benefits of undertaking research among members of the 
profession was also identified as a barrier to engagement. However, rather than pharmacists 
lacking an appreciation of the personal benefits to research engagement, some believed there 
to be insufficient benefits to encourage engagement. Lack of recognition of research in terms 
of career progression was also perceived to be a barrier to engagement with several making 
reference to a lack of recognition of research in the career structure of hospital pharmacists. 
P17: ‘It’s just not recognised in terms of career structure and salary…there is nothing.’ 
P8: ‘…the NHS, it’s very much centred around clinical skills, the NHS Agenda for 
Change, and management skills.. and I don’t really feel like there’s room to recognise 
my research skills within the structure.’  
One participant illustrated this by comparing the lack of career path for pharmacists to that of 
other healthcare professions who they saw as having more defined career pathways for those 
with an interest in research.  
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P14: ‘I think if there was a better structure erm..for sort of getting involved in the first 
place like the medics have really, and the nursing sort of colleagues as well, if there 
were a sort of set pathway or just for it to be more accessible I think would be a 
massive benefit.’  
8.2.2.4 Enablers 
A summary of the findings regarding the themes identified relating to enablers is presented in 
Table 16 below, which is then followed by a more detailed analysis of the data relating to each 
theme by subcategory. 
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Table 16: Summary of the themes relating to enablers 
Theme 
subcategory  
 
Theme 
 
Description of theme  
 
External 
enablers 
Resource: having 
time 
Having time in the day job, with integration of research into job 
roles and job plans and pharmacists having protected time in 
their role cited as ways to facilitate this 
 
Resource: 
obtaining funding 
Obtaining funding from research grants to allow individuals 
time to undertake research through their roles being backfilled; 
RPS having a larger role to play in providing pharmacy-specific 
funding 
 
Resource: access 
to support 
Being able to access individuals with research expertise through 
having individuals with research expertise either within the 
organisation or through links with academia; and having access 
to infrastructure to support research activity such as access to 
software packages and library services and having physical 
space away from distractions 
 
 Organisational 
culture 
Having a departmental culture for research; having a supportive 
chief pharmacist and supportive managers 
 
Personal 
enablers  
Resilience The need for pharmacists to be resilient to undertake research 
cited in the context of participants describing research as being 
demoralising 
 
 Self-motivation The need for individuals to be personally motivated to 
undertake research  
 
 Questioning 
mindset 
Having a questioning mindset perceived to be a personal quality 
suited to undertaking research 
 
 Competence Having research knowledge and skills; postgraduate research 
qualifications and access to in-house, external training and 
integrating research into pharmacists’ postgraduate clinical 
training suggested as a way for pharmacists to gain requisite 
skills to conduct research 
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External enablers 
External enablers fell into two broad themes:  
 Resource 
 Organisational culture   
Regarding resource being an enabler to research engagement, participants’ attitudes and 
opinions fell into three groups or sub-themes: having time, obtaining funding, and being able 
to access support. 
Having time was cited as an enabler to research in the context of pharmacists having time to 
undertake research in the working day. Having time to conduct research was perceived to be 
an important enabler, illustrated by one participant who described this support as being ‘vital’. 
P11: ‘…support from the hospital, giving me time to write grant applications and carry 
out the research, that’s been really vital.’ 
Integrating research into their job plans was cited by several interviewees as having personally 
enabled them to have time within their day job to undertake research.  
P7: ‘…er so the support has been er from my job profile you know, it’s the one thing 
that has been put on my appraisal, you need to have a PhD.. so I’ve had the support in 
that I’ve had the time out to do it.’ 
The inclusion of research in consultant pharmacist job plans was also cited in the context of 
research being part of a pharmacist job plan and thus allowing pharmacists in such positions 
time to conduct research. However, there was a perception that not all consultant pharmacists 
were research active as illustrated by the following quote from one interviewee who was in a 
consultant pharmacist role: 
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P5: ‘….although to be fair, if you look over the years looking at consultant pharmacist 
colleagues, the research output is variable. And I think because nobody has the same 
job, so some people have jobs that have lent themselves to some very nice bits of 
academic collaborations and some good bits of work.’ 
Likewise, another participant appeared to be of a similar opinion as they referred to research 
as a ‘token gesture’ in consultant pharmacist posts and appeared to imply therefore that not 
all consultant pharmacists were research active.  
P8: ‘...you don’t really see it in job descriptions you know as you go up the bands, 
maybe as you get to consultant it’s in there as a sort of token gesture it seems because 
the consultant post has to have it in there I think, like 10% or something of their time.’ 
Integrating research into pharmacists job roles was also cited as a mechanism by which 
pharmacists were allowed time in the working day to conduct research. Combined clinical 
academic appointments were cited as examples of how research could be integrated into 
pharmacists’ job roles and several of those interviewed had such appointments. However, 
despite having such a role, one participant talked about how they still had difficulty protecting 
their time to undertake research due to clinical commitments taking priority.  
P11: ‘…it can be difficult to juggle a clinical role, a demanding clinical role with 
research… often deadlines can conflict and it’s difficult to ring fence time that would be 
protected for one role or another…often there are interruptions from the clinical side or 
from the academic side…’ 
Employing pharmacists with research as their primary role was also cited as facilitating 
engagement. Research being the primary purpose of their role was perceived by those in such 
roles as supporting them to undertake research. This is illustrated by the following quote from 
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one participant who appeared to imply that being employed in such a role meant that the 
clinical service offered by the department did not take priority over their research activities:  
P18: ‘Well, I’m in a research role, that’s a major support in itself erm…without having a 
manager that has created a job for me to actually be in, you know, we would be doing 
research as part of our clinical duties, you know research would be a small part of your 
work whereas research is the main part of my job.’ 
Other participants not employed in such roles were also of the opinion that having posts 
where research was the primary role of the individual would enable research activity. One 
interviewee made reference to a different Trust to that in which they were employed where 
they perceived research to be the full time role of several pharmacists as an example of where 
this model had been successful elsewhere.  
P13: ‘[name of Trust] have a research institute as part of their service design, and as 
part of their research institute they have three pharmacists, three full time research 
pharmacists who do a bit of clinical but primarily research, and they do all the research 
in the department which leaves the clinical experts to carry on and do that..so there’s 
the infrastructure there that isn’t here…but we need to start building that 
infrastructure in some way.’ 
In the context of pharmacists having time to conduct research in the working day, having a 
senior position within a department was also cited as a facilitator due to pharmacists in more 
senior roles having autonomy in terms of how they managed their time. This was illustrated by 
the following quote from one chief pharmacist who believed research-active staff in their 
department to be of a level where they could ‘make the discretionary time needed to do it’: 
P6: ’…I expect they’re of a level that they can make the discretionary time needed to do 
it…’ 
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However, at one of the case study sites, pharmacists were allowed to undertake research, 
regardless of their grade, if the research they were undertaking aligned to the departmental 
business priorities. This represented another mechanism through which pharmacists were 
afforded the time to conduct research during the working day. Undertaking research as part of 
postgraduate qualification was also seen by some participants as another mechanism through 
which they had been allowed time to undertake research as part of their working day.  
P5: ‘So I think it would be interesting that if you change my diary and carve out a day 
where I was just doing research for a day, I think looking back when I did my masters 
and I had time from the department to do that.’ 
Several participants also cited protected time to undertake research as having the potential to 
enable research engagement. To illustrate this several interviewees drew comparisons 
between pharmacists and medics, who they perceived to have protected time which allowed 
them to undertake research.   
P4: ‘…and when I compare it to medicine they will have their established senior 
registrar posts some of which, yes, you’ve got some clinical sessions but you’ve got 
some dedicated time.’ 
P3: ’...there’s not the same protection as for doctors around academic stuff for 
pharmacists, so there is no protected time or allowed time, it has to be begged, stolen 
and borrowed from somewhere to do it.’  
Research funding was also cited as facilitating research engagement in the context of 
individual grants or fellowships enabling posts to be backfilled thus allowing the individual 
awarded the funding the time to undertake the research for which the funding was awarded. 
Illustrating this several of the chief pharmacists interviewed made reference to allowing staff 
to undertake research if they obtained funding to backfill their post.  
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P3: ‘So we try and erm…I guess permit it if you like by saying ‘yes we will backfill’...we 
don’t say ‘no you can’t do it because we can’t backfill your role. If they get funding 
we’ll…we never say no you can’t do it.’  
P12: ‘…we would always try and encourage [managers] to release staff to be able to 
do research activities, funded research activities, and so we’re quite happy to be 
flexible if someone wanted to go part-time, you know, we would be happy…we’ve 
never refused anybody the opportunity to do that’ 
Medical charities were cited as examples of funding sources for research as were grants from 
Health Education England. NIHR Research Fellowships were also cited as examples of sources 
of funding. Several also made reference to internal sources of funding allowing pharmacists to 
have their time backfilled to enable them to undertake research with internships offered by 
the Trust given as an example.  
To overcome the lack of pharmacy-specific funding opportunities identified as a barrier to 
research (see section 8.2.2.3) several participants suggested that the RPS should identify more 
pharmacy-specific research funding. 
In terms of access to support enabling research engagement, access to individuals with 
research expertise within the department was cited by several as a facilitator to pharmacists 
undertaking research. Developing research ideas and putting together grant applications were 
cited as specific examples of types of support that having individuals with research expertise in 
the department provided, as were help with writing conference abstracts and journal 
publications. Signposting to support outside the department was also cited in reference to 
having a lead pharmacist for research suggesting that in terms of having individuals with 
research expertise within the department being an enabler, their support was not limited to 
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their knowledge and skills related to the research process, but also encompassed their wider 
understanding of the system of support available to researchers. 
Academic Practice Units (APUs) were cited as a mechanism through which staff were able to 
access individuals with research expertise within their department, as illustrated by the 
following responses from chief pharmacists to being asked how they felt having an APU 
influenced research activity within their department:  
P6: ‘Erm… I think people who are thinking about research have got people to go and 
talk to about it, I think people who have got research ideas can go and bounce them 
off people, I think if somebody’s  interested in [undertaking research] we’ve got an 
invaluable set of knowledge that they can just drop somebody an email and you know 
have a conversation with if that makes sense, erm.. and some people come from their 
pre-reg year knowing that they want to do a PhD, erm..  they’ve got that seed inside 
them that says I want to do research erm… but erm… erm… so I think if they’ve got an 
inkling they can find somebody to go and speak to, whether they would find somebody 
to speak to whether we would have local expert knowledge, I don’t know, they 
probably would actually erm… but erm… erm… yeah, I think it’s just local easy access 
to people who do research who can talk about research and help you.’ 
P3: ‘...it enables pharmacists when they have a research idea and don’t know where to 
start, they know there’s an expert in the department.’ 
Likewise departmental research forums were also cited as providing mechanisms through 
which individuals were able to access research expertise within the department.  
Having individuals with research expertise in the department was also cited as providing 
support through more formal mechanisms such as mentorship and research supervision,  
illustrated by the following quote from one participant who perceived identifying individuals 
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able to offer this support to be a challenge for those employed in departments without 
individuals with research expertise:   
P11: ‘…finding research active colleagues who can mentor or supervise is a challenge, 
not every department… we’re lucky [here]…I think any pharmacist who chooses to 
embark on this journey has a number of people they can go to…’ 
Departmental research forums and the presence of research-experienced staff in the 
department were also cited as supporting research through individuals having peer support as 
illustrated by the description of the function of the research group in their department offered 
by one interviewee:  
P14: ‘So from my perspective it’s a good opportunity to meet up with likeminded 
pharmacists…it’s good to meet up, hey what’s going on around the rest of the 
pharmacy and sort of contribute if we can towards helping others if they’ve got issues, 
if they’ve got problems.’  
Undertaking research as part of a postgraduate qualification was also cited as providing 
individuals with support to conduct the research element of their qualification. 
Access to infrastructure through academic links with universities was mentioned in the context 
of access to support enabling research activity. Examples given of infrastructure provided by 
universities included access to software packages and library access.  
P11: ‘…the university provides all the software I need and the library access which is 
more than the hospital can provide...so statistical analysis software, the reference 
managing software, the qualitative research software, and the library access is better 
than the NHS library access so all the structures are there.’ 
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Reference was also made to access to the facilities available in universities and to the research 
expertise not available in the department such as support with statistics.   
P3: ‘…so it provides…erm things that we haven’t got like experts in some of the, you 
know, statistics and it’s provides us with pharmaceutical labs that we haven’t got, so 
erm… facilities and expertise really that we haven’t got.’  
Universities providing physical space outside of the department was also cited by several as 
enabling them to undertake research due to there being fewer distractions and interruptions 
compared to their Trust-based departmental offices.  
P13: ‘I get an awful lot done when I’m at the University because I’m not distracted, and 
that’s something else, it is very difficult to commit a block of time to a single project 
while I’m here [at the Trust] because of the milieu of day-to-day clinical care delivery, 
it’s impossible for me to get a day off the rota.’  
P11: ‘It’s also important to have a quiet place to go and work in and a computer that 
works, and is fast, I know that sounds like detail, but if it’s not present it just makes 
everything so much more difficult. I’ve got a university office, there’s only 4 other 
people in that office, it’s a quiet environment, I can do thinking, I can be really 
productive and write reports, write manuscripts...’ 
In addition to academic links providing support, one participant also made reference to the 
support offered by the their local NIHR Research Design Service in relation to an application 
they had submitted for a research grant.  
P11: ‘…the support for designing good grant applications and rehearsing for grant 
interviews with the Research Design Service, that’s been fantastic…’ 
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Regarding organisational culture being an enabler to engagement, having a culture for 
research at departmental level was regarded as enabling research engagement. Several 
participants cited the need for the culture to be supportive of research as illustrated by the 
view of one chief pharmacist who believed individuals would experience difficulty undertaking 
research if the culture was not supportive of such activity. 
P10: ‘I think if you’re a jobbing pharmacist working in an organisation and the culture 
isn’t there within the service then it must be bloody hard work, well virtually 
impossible.. where would you go for support? What would you do in terms of finding 
time… you know that would be a hell of a challenge for someone who’s massively 
motivated to do that work [research]…if the organisation doesn’t support it.’ 
Key to developing or creating a research culture appeared to be the leadership of the chief 
pharmacist. Indeed one chief pharmacist interviewed appeared to believe it was their role to 
develop a culture that was supportive of research. 
P10: ‘I see my job as erm being required to make the right environment within which 
people can develop, and people can develop in the way and deliver good stuff er, they 
don’t have to be pushed that hard to do it because the environment’s there to support 
them...’ 
Another chief pharmacist appeared to refer to developing a research culture by saying they 
wanted staff to feel supported to undertake research. 
P3: ‘…by making sure that people know that it’s okay and the department does support 
it, and we will allow it, and we will help.’ 
Rather than seeing their role as developing a research culture per se, several also saw their 
role as facilitating research activity by supporting their staff by allowing them to undertake 
research. One chief pharmacist illustrated this by making a clear distinction between 
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supporting research by enabling research to take place in the department and being able to 
support through having research expertise themselves.  
P6: ‘…am I a source of ideas for research…no, am I knowledgeable on how to do 
research…no, could I be a facilitator for people to do it, I hope so, yes.’ 
Another chief pharmacist appeared to be of the opinion that giving pharmacists the 
opportunity to undertake research was so important that it was incumbent on chief 
pharmacists to support it.  
P12: ‘I think it’s beholden on them [chief pharmacists] as part of them being a 
professional leader to make sure that their team have the opportunity to go and do the 
research, and give them, promote to them, the opportunities within the organisation 
that there might be to follow up funded research opportunities.’  
However, it was not only chief pharmacists themselves who recognised the role of their 
leadership in supporting research activity, as other participants at all four case study sites also 
perceived having a chief pharmacist who supported research was essential for research 
activity. Several participants also made reference to the chief pharmacist needing to value 
research.  
P5: ‘I think we’re very lucky with [the name of the chief pharmacist] that [they are] a 
very forward thinking person. [They] see the value of being seen as having an 
academic department and, and you know, an academically active department where 
people do research.’ 
P4: ‘I think that’s down to [the name of the chief pharmacist] as chief pharmacist 
because [they’ve] got that ethos…and if the chief pharmacist doesn’t have it, and they 
don’t see the value in it, I don’t know that anything would develop.’  
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One participant was of the opinion that organisational culture and departmental leadership to 
be the most significant enablers of research activity among pharmacists. 
P13: ‘…I think that’s the biggest enabler is your leadership [the leadership of the chief 
pharmacist] and the culture within the organisation…’  
However, it appeared that it was not only the chief pharmacist who needed to be supportive 
of research, as several participants cited the need for support for research to extend to the 
wider management team, as illustrated by the following quote: 
P9: ‘…a lot of that [the research culture of the department] is about the leadership and 
the capability of the seniors, and if they don’t know how to do research or why it might 
be valuable they’re not going to pass that down culturally.’  
Several participants made reference to the support they had received from their line manager 
having enabled them to undertake research.  
P11: ‘…the support has been from my line management in the hospital encouraging me 
to continue and accepting it would take time and the managers being patient and 
encouraging, that’s been absolutely vital, if we would have had a constant struggle 
against managers who didn’t agree with the strategy I don’t know if I’d still be doing it, 
so support from line management has been critical.’ 
P17: ‘I’ve had, I’ve been lucky to have a chief pharmacist and a clinical pharmacy 
manager who’ve been willing to let me do it in terms of time out of the system and the 
opportunity to get it resourced by the department.’ 
However, both were in senior positions, so their line managers in turn would in all likelihood 
have been part of the departmental senior management team.   
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Interestingly, one of the chief pharmacists interviewed perceived it to be their role to ensure 
line managers in their department were supportive of individuals undertaking research. 
P3: ‘I think generally it’s just encouraging and allowing, and enabling it to 
happen. So if there’s an individual line manager saying ‘no we can’t do it, we 
don’t have the time’ actually resolving those barriers.’   
Regarding the culture being supportive of research, interviewees, when asked how 
they had been personally supported to undertake research, used language which 
suggested that they felt they had been permitted or allowed to undertake research, 
rather than being actively encouraged to do so.  
P13: ‘Erm... well the support of my employer has been to allow me to do 
it……..so just them allowing me to do that [undertaking a postgraduate 
qualification] and develop myself has allowed them to, you know, they’ve 
shown they’re happy to invest in me and give me the time of day basically and 
that’s the most important bit of support they’ve given me.’  
Some participants therefore believed that having a culture where research was allowed or 
permitted was an enabler in itself.  
Regarding the research culture of organisations at Trust level, some perceived this to have a 
role in enabling research activity among pharmacists by suggesting that the Trust having a 
research culture made it ‘easier’ for pharmacists to undertake research.  
P16: ‘So this trust I work in has a very positive culture about research.  So that just 
makes it so much easier to get involved….’ 
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Personal enablers 
Participants’ opinions of personal enablers to pharmacists undertaking research fell into four 
themes 
 Resilience 
 Self-motivation 
 Questioning mindset 
 Competence 
Regarding resilience, several participants were of the opinion that pharmacists needed to have 
a certain degree of resilience to undertake research. One participant talked about needing to 
be resilient in the context of dealing with the disappointment of unsuccessful grant 
application.  
P7: ‘…that’s one of the things that puts people off, that being, you know, failure in 
terms of getting a grant…. so needing to be resilient.’ 
Comment was also made that undertaking research was demoralising, with unsuccessful 
ethics applications and attempts to get research published cited as examples of how research 
could be perceived as such.  
P9: ‘I think sometimes people feel knocked back, you know at the start you don’t get 
ethics approval for something, you write up your work for publication and it gets 
rejected [] and I think sometimes that can feel quite demoralising…’ 
Research findings not being translated into practice was another reason cited as to why 
pharmacists could find research demoralising.   
P16: ‘I mean some people like me get demoralised if they do a bit of work and it 
doesn’t lead to anything.’  
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Research being perceived as demoralising also suggests that resilience is a personal attribute 
which would help an individual to conduct research. References made to the multiple barriers 
individuals needed to overcome to conduct research, similarly suggested that resilience was a 
personal attribute required to undertake research. 
P4:  ‘...unless you’re really determined if you come across a series of barriers and then 
you’ve got competing priorities, are you really going to expend an awful lot of energy 
to try and overcome those barriers when you’ve got the day job to do or not enough 
hours in the day anyway...I think inevitably people put it in the too hard to do box, oh 
that’s for other people and leave it.’  
P9: ‘…things around writing, getting ethics approval…all these things are massively 
daunting even if you’ve done them before, so to do it for the first time just feels like 
barrier after barrier…’ 
In addition to resilience being a necessary personal attribute to conduct research, a perception 
that pharmacists needed to be self-motivated was also cited.  This appeared to be a view 
shared by all the chief pharmacists as they all talked about individuals needing to be self-
motivated to undertake research. Illustrating this two chief pharmacists were of the opinion 
that to undertake research the desire or drive to do so had to come from the individual 
themselves.  
P6: ‘So I think they’ve got to have the desire in them to do it in the first place erm...’  
P3: ‘…the drive comes from the individuals that want to do it, erm as a chief 
pharmacist I want to encourage it and allow it…to happen but I’m not going to enforce 
it on anyone.’ 
Most of the chief pharmacists interviewed also appeared to be of the opinion that not all 
pharmacists would be interested in undertaking research and therefore supporting those 
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interested in undertaking research appeared to be the approach taken by the majority. This is 
illustrated by the following quote from one chief pharmacist interviewed: 
P6: ‘...you are going to get some people who will just say I want to go and do a PhD 
erm..you know there will be a whole range in between erm..and there’s an awful lot of 
pharmacists who’ve got no interest in research at all I suspect…erm and I suppose 
what we’ve got to try and do is try and capture, find the ones that have and give them 
the opportunities we can….I think what we’ve got to do is if we are talking about trying 
to encourage research is find those people who’ve already got those little seeds that 
are already planted and make sure they’re watered and grow…’   
Taken together these findings arguably suggest that rather than believing their role to be to 
drive research activity among pharmacists employed in their organisation, chief pharmacists 
perceived their role to be to support those interested in undertaking research. 
Having a questioning mindset was also cited by some as being a personal attribute which 
enabled pharmacists to undertake research. Being inquisitive in nature appeared to be a 
quality that chief pharmacists as a group perceived to be important as illustrated by the 
following quotes from two chief pharmacists:  
P3: ‘…also thinking about which pharmacist…erm could be research active but aren’t, 
and trying to encourage them. We generally, generally we know the people who are 
inquisitive and want to do things that are related to that, and it’s perhaps giving them 
that support and just enabling.’ 
P12: ‘Erm, I think research requires a degree of self-motivation…and self-direction, and 
not all pharmacists, or anybody necessarily has that self-direction, self-motivation to 
do it, or level of inquisitiveness which takes them down that route…so not everybody is 
going to be a natural researcher….’ 
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In term of competence as an enabler, this was cited in the context of individuals needing to 
possess research knowledge and skills to undertake research. Several suggestions were made 
by participants in relation to how they believed pharmacists could gain research skills. 
Postgraduate qualifications such as Masters or PhDs were cited by several as a way that 
pharmacists could learn research skills. Indeed the majority of those interviewed who were 
research active said they had personally gained their research skills through undertaking 
postgraduate qualifications.   
P11: ‘…well I suppose my PhD gave me the training and the post doc helped me 
develop research skills and writing skills particularly, paper writing…’ 
Rather than pharmacists undertaking formal qualifications, some participants suggested that 
departmental in-house training could potentially be another way for pharmacists to learn such 
skills. However, it appeared to be training in ‘softer’ research skills which interviewees 
perceived could be delivered in house, rather than training in research methodology. For 
example, training in academic writing was suggested as a skill that could be taught through in-
house training.   
P8: ‘…the lunchtime training is always clinical, well it would be good if they did some 
research training, you know, ‘how to write a paper’ because people have probably 
have done things that they could write up but they won’t write them up because they 
don’t know how.’ 
P1: ‘….you know, we do a lot of clinical training, we do the lunch time training is 
always clinical, well it would be good if they did some research training, you know 
‘how to write a paper’ because people probably have done things that they could write 
up but they won’t write them up because they don’t know how and they don’t know 
where and they don’t know how to look for a journal.’  
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Indeed at one of the case study sites, in-house training was already being delivered but it 
related to publishing research. The intention of the training appeared to be to encourage more 
people to try to get research published rather than to develop their research skills per se.  
In the context of accessing training in research skills, several participants also referred to 
training available within their Trust and via links with academia. Rather than accessing training 
to learn the skills required to conduct research, participants said having research experience 
had enabled them to learn these skills. 
At a more strategic level, integrating research into pharmacists’ training at postgraduate level 
was suggested as a way to give pharmacists the competence to undertake research in their 
practice. However, rather than pharmacists undertaking postgraduate research qualifications 
to gain research skills, some participants were of the opinion that research should be 
incorporated into pharmacists’ postgraduate clinical training.   
P1: ‘So I think incorporating it as a normal part of training. I also think the Diploma 
could do with a bit more research in because you could combine the two you know 
rather than expecting people to do an MRes, erm.., you know if the clinical diploma 
just had a couple of units in, or incorporated into a couple of units about research, that 
would probably encourage more people to do it, as well I think. I think that’s it.’ 
Another suggestion was that research could be integrated into pharmacists training by 
postgraduate research qualifications being recognised as an alternative to postgraduate 
clinical qualifications, rather than postgraduate research qualifications being undertaken in 
addition to clinical qualifications.   
P11: ‘I’d like to see the MRes given almost equal weighting or equal importance to a 
postgraduate diploma in clinical pharmacy so that pharmacists can really see both are 
equally important and valuable…’ 
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P1: ‘…so when I did the MRes, when I came back they were saying we want more 
people to do the MRes and I was like ‘well put it in the job descriptions for some 7s that 
you’ll accept that over a diploma because I don’t think it’s fair that you expect people 
to do a two-year diploma and then an MRes and prescribing.’ 
8.2.3 Contextual domain at case study sites  
In this section an analysis of the case study research data pertaining to the influence of the 
contextual domain on research activity is presented, beginning with a within-case analysis of 
the interview data from each case study site. This is then followed by a cross-case analysis of 
the data. 
As per the analysis of the data relating to participants perceptions of the drivers, drawbacks, 
barriers and enablers to pharmacists undertaking research presented in section 8.2.2, quotes 
to illustrate findings have not been included where the quote itself could potentially identify a 
participant by their role. For some quotes, specific words have also been removed and 
replaced with more generic terms where there was a perceived risk that the quote could 
identify an individual or case study site. In addition, for this section of the analysis any quotes 
used have not been attributed to individuals’ roles or levels of seniority to avoid the risk of 
participants being identified by their colleagues. Likewise, attitudes and opinions of members 
of staff in roles which are unique within a department such as chief pharmacists have also not 
been reported to avoid the risk of individuals being identified by their colleagues. A different 
coding system has also been used to that used in section 8.2.2 to prevent any possibility of 
cross-referencing between the two analyses. 
8.2.3.1 Within-case analysis 
As outlined in section 7.2, the contextual domain at case study sites was perceived to relate to 
the organisational culture, leadership of the chief pharmacist and mechanisms of support for 
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research activity. The within-case analysis of the data from each case study site is therefore 
presented in these sections.  
For each case study site, the section of the within-case analysis pertaining to organisational 
culture includes an analysis of the interview data collected from participants in response to 
questions relating to research strategies at Trust and departmental level. Research strategies 
at both of these levels were identified as influencing research activity in pharmacy 
departments in the context of organisational culture in the initial study. In the section relating 
to mechanisms of support, an analysis of the data pertaining to the model of support which 
led the Trust to be selected as a case study site is reported together with an analysis of the 
data pertaining to other mechanisms of support specifically explored through the interviews. 
These included the inclusion of a requirement to undertake research in job descriptions, the 
inclusion of research in annual appraisals and departmental academic links with universities. 
Additional factors perceived to support research activity at case study sites which became 
apparent through the course of the interviews are also included in this section of the within-
case analysis for each case study site.  
Table 17 below indicates the model of support for pharmacists to undertake research in place 
at each case study site. These were the models of support on which the Trusts were selected 
to be case study sites as previously outlined in section 8.1.1. The subsequent table (Table 18) 
provides a summary of the findings of the within-case analysis with respect to the factors 
pertaining to the contextual domain enquired about during the interviews and other 
mechanisms of support which became apparent through the course of the interviews, 
whether these factors were perceived to influence research activity among pharmacists, and if 
they were perceived to influence research activity, how they were perceived to do so. 
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Table 17: Models of support for pharmacists to undertake research on which case study site 
selection was based 
Case study site Model of support on which case study site selection was based 
 
Trust was part of an 
Academic Health 
Science Centre (AHSC) 
 
Pharmacy department 
had an Academic 
Practice Unit (APU)  
Lead Pharmacist for 
research employed  
1 
 
Yes Yes No 
2 
 
Yes No No 
3 
 
No Yes No 
4 
 
No No Yes 
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Table 18: Summary of findings of within-case analysis relating to factors pertaining to the contextual domain and their perceived influence on research 
activity among pharmacists 
Factor  
 
Perceived influence of factor on research activity among pharmacists 
 
Case study site 1 
 
Case study site 2 Case study site 3 Case study site 4 
Research culture 
at Trust level 
Yes: research culture at Trust 
level indirectly  influenced 
research activity via the AHSC 
Yes: research culture at Trust 
level indirectly  influenced 
research activity; AHSC 
perceived to have little/no 
influence 
Yes: research culture at Trust 
level indirectly influenced 
research activity by making 
research ‘easier’ to undertake 
Yes: research culture and/or 
improvement culture at Trust 
level indirectly influenced 
research activity by making 
research ‘easier’ to undertake 
Research culture 
at departmental 
level 
Yes: research culture within 
department influenced 
research activity by supporting 
and encouraging activity 
Yes: research culture within 
department influenced 
research activity by supporting 
and encouraging activity  
Yes: research culture within 
department influenced 
research activity by supporting 
and encouraging activity 
Yes:  research culture within 
department influenced 
research activity by supporting 
and encouraging activity 
Trust research 
strategy 
No: unclear if a strategy existed 
and no reference made to a 
Trust strategy influencing 
activity 
No: the Trust had a research 
strategy but no reference were 
made to this influencing activity 
No: the Trust had a research 
strategy but no reference was 
made to this influencing activity 
No: the Trust had a research 
strategy but no reference was 
made to this influencing activity 
Departmental 
research strategy  
No: the department did not 
have a strategy per se although 
the APU had a strategy but no 
reference was made to this 
influencing activity  
No: research a strategic aim of 
the department but no 
departmental strategy in place  
No: research integrated into 
department strategy but no 
reference was made to this 
influencing research activity  
Yes: integrated research into 
the departmental business 
priorities was perceived to 
strengthen engagement 
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Table 18 continued  
Factor Perceived influence of factor on research activity among pharmacists  
 
Case study site 1 
 
Case study site 2  
 
Case study site 3  
 
Case study site 4  
Leadership of the 
chief pharmacist  
Yes: through being supportive 
of research activity  
Yes: through being supportive 
of research activity  
Yes: through being supportive 
and encouraging of research 
activity 
Yes: through being supportive 
of research activity, driving 
engagement and creating a 
research culture within the 
department  
Trust being part 
of an AHSC 
No: no reference to this 
enabling research activity, 
although the Trust being part of 
an AHSC perceived to indirectly 
influence research activity (NB 
the Trust being part of an AHSC 
was a model of support on 
which case study site selection 
was based)  
No: no reference to this 
enabling research activity, 
although the Trust being part of 
an AHSC perceived to indirectly 
influence research activity 
(NB the Trust being part of an 
AHSC was the model of support 
on which case study site 
selection was based) 
Not applicable: Trust was not 
part of an AHSC 
Not applicable: Trust was not 
part of an AHSC 
Department 
having an APU 
Yes: by positively influencing 
the departmental research 
culture and providing support 
for research activity 
(NB the department having an 
APU was a model of support on 
which case study site selection 
was based) 
Not applicable: Department did 
not have an APU 
Yes: by positively influencing 
the departmental research 
culture and providing support 
for research activity 
(NB the department having an 
APU was the model of support 
on which case study site 
selection was based) 
Not applicable: Department did 
not have an APU 
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Table 18 continued  
Factor Perceived influence of factor on research activity among pharmacists 
 
Case study site 1 
 
Case study site 2 
 
Case study site 3 
 
Case study site 4 
 
Lead pharmacist 
for research  
Yes: by providing access to 
research expertise and driving 
research activity  
(NB existence of role became 
apparent through course of 
interviews conducted at the 
site i.e. it was not a model of 
support on which case study 
site selection was based) 
Yes: by providing access to 
research expertise and 
encouraging research activity 
(NB existence of role became 
apparent through course of 
interviews conducted at the 
site i.e. it was not a model of 
support on which case study 
site selection was based) 
Yes: by providing access to 
research expertise and 
encouraging research activity 
(NB existence of role became 
apparent through course of 
interviews conducted at the 
site i.e. it was not a model of 
support on which case study 
site selection was based) 
Yes: by providing access to 
research expertise, driving 
engagement and contributing 
to the departmental research 
culture 
(NB unlike case study sites 1,2, 
and 3 the department having a 
lead pharmacist for research 
was the model of support on 
which case study site selection 
was based) 
Academic links  No: no reference to academic 
links providing support 
Yes: by providing access to 
support through honorary 
contract through lead 
pharmacist  
Yes: by providing access to 
research expertise and facilities 
not available within the Trust  
Yes: by providing access to 
support 
Inclusion of 
research in 
pharmacists’ job 
descriptions 
No: no reference to this 
influencing research activity  
No: no reference to this 
influencing research activity 
No: no reference to this 
influencing research activity 
No: no reference to this 
influencing research activity 
Inclusion of 
research in 
pharmacists’ 
appraisals 
No: no reference to this 
influencing research activity 
No: no reference to this 
influencing research activity 
No: no reference to this 
influencing research activity 
No: no reference to this 
influencing research activity 
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Table 18 continued  
Factor Perceived influence of factor on research activity among pharmacists 
 
Case study site 1 
 
Case study site 2 
 
Case study site 3 
 
Case study site 4 
 
Other 
mechanisms of 
support i.e. those 
which became 
apparent through 
the interviews  
Yes: posts funded through 
programme grants allowing 
pharmacists to be employed 
with research as their primary 
role; through research being 
part of individuals’ job plans; 
through research being 
undertaken as part of a 
postgraduate qualification 
Yes: through individuals being 
allowed time through backfill 
arrangements from research 
funding; through individuals 
having joint appointments with 
academia; and through 
research being undertaken as 
part of a postgraduate 
qualification 
Yes: through individuals being 
allowed time through backfill 
arrangements from research 
funding; through research 
being part of individuals’ job 
plans; through clinical academic 
appointments; through 
research being undertaken as 
part of a postgraduate 
qualification; and through  
departmental research forums 
providing support for research 
activity and encouraging staff 
to engage with research  
Yes: through individuals being 
allowed time in the working 
day to undertake research 
which aligned to the 
departmental business 
priorities; and through 
departmental research forums 
providing support for research 
activity 
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Case study site 1 
Case study site 1 was selected to be a case study site as the Trust was part of an Academic 
Health Science Centre (AHSC) and the pharmacy department had an Academic Practice Unit 
(APU).  
Organisational culture 
At Trust level the organisation had a culture for research, as illustrated by one participant who 
described the Trust as being ‘committed to research’. However, the culture for research at this 
level did not appear to extend to pharmacy-led research as exemplified by the suggestion of 
one participant that the Trust paid ‘lip service’ to research led by pharmacists. Instead the 
culture at Trust level was perceived to be dominated by clinical trials and research led by 
medics which some perceived to be to the exclusion of not only pharmacy-led research but all 
other research. 
PA: ‘...if you’re talking about clinical trials…great, if you’re talking about other things 
like what we might want to do like looking at processes or systems, or improvements 
or whatever… I think it gets forgotten…I think people think of research as clinical trials.’ 
Reference was also made to confusion at Trust level between pharmacy-led research and 
pharmacy support for research in terms of managing clinical trials medicines suggesting that at 
Trust level pharmacy engagement with research was perceived to be limited to supporting the 
delivery of clinical trials. 
PA: ‘…there’s always some confusion in this organisation because when anybody talks 
about pharmacy research, they just talk about clinical trials.’ 
No reference was made to the Trust culture per se influencing research activity among 
pharmacists, although some perceived the Trust being part of an AHSC indirectly influenced 
the research culture within the pharmacy department as illustrated by the following quote: 
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PB: ‘I think indirectly it does. I think it’s quite subtle in the way it influences 
em….because it creates all of these different opportunities where people are often 
encouraged and supported to have a multidisciplinary approach….but it is quite 
indirect I would say.’ 
However, any influence the Trust had on pharmacy research, by being part of an AHSC, 
appeared to be negligible as most felt the AHSC had little or no influence on research activity 
among pharmacists. Several attributed this lack of influence to pharmacists being unaware of 
its existence.    
A research culture was also apparent at departmental level. Research was described by one 
participant as the departmental ‘ethos’ suggesting  they perceived the culture for research 
within the department to be deeply embedded. 
By making research more visible, having an APU within the department was perceived by 
some to contribute to the culture for research.  
PB: ‘Em…well… so having an actual unit and research team at the Trust…certainly for 
our department, people are aware that we exist, so they, they know that there are 
research opportunities...’ 
In terms of the influence of this culture on research activity, descriptors such as ‘supportive’ 
and ‘encouraging’ were used to describe the culture at departmental level, suggesting the 
culture was perceived to both enable and drive research activity within the department. 
Despite the culture being pro-research, research was still not perceived to be a departmental 
priority by one participant.  
PB: ‘I think at the end of the day, we are still in a very tight financial situation, 
resources are scarce, patient demand on the service is high... so research is something 
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that is seen as important, it’s em helpful and useful em…but may not always be a 
priority and quite often may be deprioritised.’ 
In relation to a Trust level research strategy, it was unclear whether the Trust had such a 
strategy as participants were unsure about the existence of a strategy at Trust level. Some 
assumed that the Trust would have a research strategy but of those who assumed this to be 
the case, several believed any reference to pharmacy would be in relation to pharmacy 
support for clinical trials. In terms of a research strategy at departmental level, such a strategy 
did not appear to exist. However, reference was made to the annual objectives of the APU by 
some interviewees, suggesting that the APU objectives were viewed as a proxy for a 
departmental research strategy. Therefore, neither a Trust level research strategy nor a 
departmental research strategy appeared to be driving research activity among pharmacists. 
Leadership of the chief pharmacist 
All participants felt the leadership of the chief pharmacist influenced research activity. The 
chief pharmacist was described as ‘supportive’ of research activity within the department 
suggesting their leadership influenced research activity by enabling research to be undertaken. 
Mechanisms of support  
The Trust being part of an AHSC was described as a partnership between the Trust and a local 
university with some citing its purpose as being to integrate clinical practice and research.   
PB: ‘It helps to connect relevant people within academia to those er clinicians and 
managers in practice so we can better translate research into practice, but also help 
use the practice-based knowledge to direct and guide research priorities as well.’ 
However, the Trust being part of an AHSC did not appear to be a mechanism through which 
pharmacists were supported to undertake research, which one participant appeared to 
attribute to the AHSC structure being aligned to that of the medical profession.  
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PJ: ‘…but I think [the AHSC] has quite a big focus on the medical profession and medical 
research….and in a way pharmacy practice research and health services research 
doesn’t really fit this sort of medically dominated set of groupings.’  
With regard to the pharmacy department having an APU, all participants referred to the APU 
as a collective of researchers undertaking research relating to pharmacy practice, extensively 
comprising pharmacists but also including researchers from other professional backgrounds. 
Although the APU comprised a discrete group of individuals, it was viewed as part of the 
department rather than being seen as separate to it. In terms of the APU being a mechanism 
of support, the APU provided staff within the department with access to individuals with 
research expertise and with whom they could discuss their research ideas. In addition, 
participants cited the APU as enabling research activity through the promotion of research 
opportunities. As cited earlier, the department having an APU was perceived to also have a 
positive influence on the culture of the department by making research visible. 
In addition to the APU, the department also had a lead pharmacist for research whose role 
was to support those interested in undertaking research. Examples of the types of support 
they provided specifically referred to by participants included discussing research ideas, 
providing help to design studies, and support in writing grant applications. Several also 
credited the lead pharmacist for research with driving research activity within the department.  
PB: ‘I think that’s the key for us. I think that [the lead pharmacist for research] has 
been the driving force for the research agenda within our department for pharmacy.’ 
The position was graded at a senior level according to NHS AfC banding and the individual in 
post at the time of the interviews was personally experienced in research, having a doctoral 
level postgraduate research qualification.   
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Regarding the inclusion of research in pharmacists’ job descriptions, most participants thought 
research was included in the job descriptions of all pharmacists employed at the Trust. 
However, no reference was made to this enabling or driving research activity or making 
research an expected part of pharmacists’ roles. The inclusion of research in pharmacists’ job 
descriptions did not therefore appear to influence research activity. Likewise, despite all those 
interviewed in the pharmacists group reporting that research formed part of their annual 
appraisals, none referred to the inclusion of research in pharmacists’ appraisals influencing 
research activity.  
In terms of academic links as a potential mechanism of support, it was via the APU that the 
department had developed formal links with a School of Pharmacy. Interestingly these links 
were with a different university to that which the Trust had links as part of the AHSC. 
However, on the whole participants did not appear to view these academic links as directly 
providing support. Instead the Lead Pharmacist for research and other members of the APU 
appeared to be viewed as more of a support mechanism.  
In relation to other mechanisms of support at departmental level, pharmacists were 
supported to undertake research through funding from programme grants enabling 
pharmacists to be employed with research as their primary role. Reference was also made to 
pharmacists being allowed time to undertake research in the working day where research was 
being undertaken as part of postgraduate qualification and through research being part of 
individuals’ job plans e.g. those in consultant pharmacist posts. 
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Case study site 2 
Case study site 2 was selected to be a case study site because the Trust was part of an AHSC. 
However, unlike case study site 1, the pharmacy department did not have an APU. 
Organisational culture  
Participants perceived there to be a culture of research at Trust level within the organisation 
as illustrated by the following quote from one participant who, in reference to the Trust 
research culture, described research to be a core activity at Trust level. 
PO: ‘I would say pretty strong, and we’ve got a very strong desire from the chief 
executive and the executive team to have research as a core activity of the 
organisation.’ 
Despite there being a culture for research at this level within the organisation, the Trust 
culture was not perceived to have any direct influence on research activity among 
pharmacists. However, some participants felt the Trust being part of an AHSC indirectly 
influenced research activity in the department. For example, the influence of the AHSC on 
research activity within the department appeared to be suggested by one participant to be 
subliminal. 
PK: ‘I don’t know how meaningful it is on the ground but I’m sure those kind of things 
feed down…without us knowing.’  
Contrary to this, others appeared to feel it had no influence on research activity which one 
participant attributed to those staff not engaged with research lacking an understanding of 
what the AHSC was.  
PO: ‘I don’t think it has. Certainly from my experience here it hasn’t...I guess their 
impact has been variable and their visibility down into departments like pharmacy I 
think has been, has been variable as well. And certainly within [name of Trust] it’s I 
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think pretty confusing for non-research immersed people to understand what the 
Academic Health Science Centre is…’ 
Like the culture at Trust level, the pharmacy department was also perceived to have a 
research culture as illustrated by references made by participants to feeling allowed to 
undertake research.  
PN: ‘Erm.. well the support of my employer has been to allow me to do it……..so just 
them allowing me to do that [undertaking a postgraduate qualification] and develop 
myself has allowed them to, you know, they’ve shown they’re happy to invest in me 
and give me the time of day basically and that’s the most important bit of support 
they’ve given me.’  
Reference was also made to research opportunities being promoted within the department 
which suggesting that research was not only supported but encouraged. Having a 
departmental culture for research therefore appeared to influence research activity among 
pharmacists. However, not everyone interviewed appeared to believe the culture was as 
embedded as perhaps it could be. For example, one participant felt that research was 
deprioritised in favour of delivering the core service. 
PK: ‘…but staffing is an issue, so the first thing to go is research unfortunately, you’ve 
got to do your core service, you’ve got to deliver patient care first and foremost...’  
Likewise, another perceived the research culture in the department to be ‘naïve’. 
PO: ‘Erm..pretty research naïve actually…. It’s probably not a strong cultural thing at 
all.’ 
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The same participant also felt more could be done to develop the departmental research 
culture, even though they perceived the culture of the department to be comparatively better 
to that of other Trusts.  
PK: ‘Comparatively to other Trusts I imagine we’re pretty…er very good erm, but I still 
think there’s things that need to be done to develop that culture even more.’ 
In terms of research strategies, it appeared from participants’ responses that a research 
strategy was in existence at Trust level. However, the aim of the strategy was perceived to be 
to increase Trust revenue from research.  
PN: ‘Er.. so the Trust as a whole certainly has a research strategy……er it’s part of the 
core values of the organisation is to be the best healthcare provider in the world, or 
one of the best healthcare providers in the world…but again as I’ve said before their 
research strategy primarily is targeted at the big bucks, the big grants, the professors 
bringing in millions of pounds a year.’ 
Although not cited explicitly by any participants, I would suggest it can be assumed that 
increasing pharmacy-led research was not perceived to be part of the research strategy for the 
Trust and therefore it is fair to assume that the Trust research strategy was not driving 
research engagement among pharmacists. 
Regarding a departmental research strategy, such a strategy did not appear to be in place. 
Therefore a research strategy at this level was not driving research activity within the 
department. Research did however appear to be strategic aim of the department as a desire 
to increase research activity within the department was cited as being an aspiration in the 
pharmacy business plan. 
PO: ‘So we would have a pharmacy business plan…and the only element in that 
business plan around research is an aspiration to develop our research activities…but I 
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guess that aspiration has never been formalised into ‘right okay what’s our action plan 
for doing that?’ 
Leadership of the chief pharmacist 
The chief pharmacist was perceived to be supportive of research activity within the 
department and their leadership appeared to enable research activity to take place. 
Mechanisms of support   
In reference to the model of support on which the case study site was selected i.e. the Trust 
being part of an AHSC, most participants believed the AHSC to represent a collaboration 
between the Trust and academia with the purpose of developing clinical academic research.  
PN: ‘So it’s a collaboration between [the Trust] and the [a named university] so it builds 
that clinical academic aspect.’  
However, the Trust being part of an AHSC did not appear to represent a mechanism of support 
for pharmacists to undertake research as several participants made reference to the personal 
difficulty they had experienced accessing support for pharmacy-led research within the Trust.   
PK: ‘There’s a big...they do a lot of research, a lot of clinical trials…my research falls 
within health services research and I think it falls between the cracks…’ 
Reference was also made to the existence of formal organisational structures within the Trust 
to support research but these again were not perceived to support pharmacy-led research. 
PO: ‘They [the divisional leads for research] don’t have a role in terms of encouraging 
non-traditional departments to engage in research activity… they’re there really I think 
to support clinicians, medics with their research and make sure the Trust captures that 
research activity so it can reflect it in its reporting back,..erm on the Trust’s overall 
research activity.’ 
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In terms of support at departmental level, although not a model of support on which the Trust 
was site was selected to be a case study site, a lead pharmacist for research was employed 
whose role appeared to be to encourage and support research activity. Promoting research 
opportunities to staff, helping staff to apply for research grants, providing advice in terms of 
designing research studies, and signposting staff to other sources of help and advice in relation 
to research were all cited as examples of how having an individual in this role supported 
pharmacists to undertake research. The individual in post at the time of the interviews being 
undertaken was experienced in undertaking research with doctoral level postgraduate 
research qualifications. 
With regard to academic links, the department had established formal links with a School of 
Pharmacy at the same university that the Trust was partnered with as part of the AHSC. These 
academic links were cited to be part of a reciprocal arrangement between the Trust and the 
university in that the university provided the pharmacy department with support for research 
in return for the pharmacy department providing support for teaching. The support provided 
by the university took the form of a lead pharmacist for research in that they were employed 
by the university, but had an honorary contract with the Trust which allowed them to work in 
the pharmacy department on a part-time basis.  
In terms of the inclusion of a requirement for research in pharmacists’ job descriptions and 
annual appraisals, research did not appear to be routinely included in either. These were not 
therefore mechanisms of support for research activity at this case study site.  
Other mechanisms of support for pharmacists to undertake research at departmental level 
included support for postgraduate research qualifications and funding from NIHR fellowships 
allowing staff to undertake research through backfill arrangements. Joint appointments with 
academia also allowed individuals time to undertake research. 
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Case study site 3 
Case study site 3 was selected to be a case study site because the pharmacy department had 
an APU. However, unlike case study site 1 the Trust was not part of an AHSC.    
Organisational culture 
The Trust was perceived to have a research culture as exemplified by one participant who 
described research as a ‘core activity’ for the organisation. However, the culture at this level 
was aligned to the income associated with commercial research as illustrated by the following 
quote:  
PL: ‘I think the focus is on research income and participation in multi-centre studies 
that are commercial studies, more so than kind of investigator-led research to answer 
questions for the hospital in particular…’ 
Reference was also made to the culture being more aligned to medic-led research as 
illustrated by the following quote from another participant who made reference to the 
personal difficulty they had experienced accessing support from an academic unit in their 
Trust. They attributed this to the research activity in the Trust being aligned to research led by 
medics.   
PP: ‘…if you’re trying to go to these academic units and trying to ask people things, 
they just, they just don’t get back to you [] maybe it’s a prejudice against pharmacists, 
well not just a prejudice against just pharmacists but I guess other professions because 
it’s medically-led’  
However, the research culture at Trust level within the organisation did not appear to 
encompass pharmacy-led research as illustrated by the following quote from a participant: 
PG: ‘I don’t think anybody knows that we even do it, but people think research and 
they think pharmacy, they just think supplies of clinical trials drugs.’  
186 
They appeared to be of the opinion that not only was there a lack of awareness of pharmacy-
led research at Trust level within the organisation but that at Trust level pharmacy 
involvement in research was associated only with the management of clinical trials medicines. 
Not only was there a perception that the Trust research culture did not extend to pharmacy-
led  research it was also perceived to have no direct influence on research activity among 
pharmacists as illustrated by one participant who said there to be no mechanism by which the 
department was held accountable for research activity at Trust level.  
PG: ‘…the Trust doesn’t require us to be particularly research active in research….it 
would never appear in a report or anything like that…’  
However, the same participant recognised that the Trust having a research culture made 
research easier to conduct at departmental level.  
PG: ‘So it helps being in a research focused organisation because that gives you 
permission...so if you’re putting something forward that’s saying as a pharmacy 
department we want to support this individual to have the time off to do research, the 
organisation understands that.’  
Therefore, although not directly cited, the Trust culture appeared to be perceived to indirectly 
influence research activity among pharmacists by removing some or all of the contextual 
barriers preventing engagement. 
There was also a culture for research within the pharmacy department which was perceived to 
both support and encourage research activity. References were made to the culture being 
permissive of research in that, for example, individuals felt allowed to apply for research 
grants. Research opportunities appeared to be actively promoted within the department to all 
staff.  
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However, despite there being a departmental culture for research, some participants were of 
the opinion that the culture was in the early stages of development.  
PM: ‘…I think at the moment it’s [the research culture of the department] very much in 
its infancy.. I hope it develops and continues to grow…’ 
Also supporting this was the view of another participant who believed research to be 
undertaken by only a minority of staff within the department. 
PG: ‘…it’s still very much a minority…specialist thing that a few get involved with but 
the majority don’t…’ 
With regard to a Trust research strategy, it seemed that although the Trust had such a strategy 
in place, it did not appear to influence research activity among pharmacists as those familiar 
with it believed it did not specifically make reference to pharmacy-led research.  
PG: ‘Erm.. there’s definitely a strategy. It’s about increasing patient recruitment…. It 
doesn’t specifically exclude pharmacy but it doesn’t particularly mention 
pharmacy…they do talk about making it more inclusive, research for all, not just about 
doctors…multiprofessional so it has that element in it.’ 
In terms of a departmental research strategy, rather than the strategy being a standalone 
document, research appeared instead to be integrated into the overall departmental strategy. 
PG: ‘...we have within our overall pharmacy strategy.. we have bits that talk about us 
wanting to be research active, to bring research into mainstream pharmacist practice.’ 
No reference was made however to the incorporation of research into the departmental 
strategy influencing research activity among pharmacists. 
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Leadership of the chief pharmacist 
All participants perceived the chief pharmacist to be supportive of research. Some also 
described their leadership as encouraging research.  
PC: ‘I think the chief pharmacist needs to be someone that encourages research and 
encourages career development in that way, erm and they…I do feel that is the case 
here, yeah.’ 
The leadership of the chief pharmacist did appear therefore to be perceived to influence 
research activity among pharmacists by enabling and encouraging research in the department. 
Mechanisms of support 
In terms of the pharmacy department having an APU, participants referred to this as being a 
collective of researchers extensively, but not limited to, pharmacists by profession. A 
researcher who was not a pharmacist by profession, but who had a background in qualitative 
research, was also employed as part of the APU to support qualitative research being 
undertaken by members of the APU.  
Although a distinct group, the APU was not seen as being separate to the pharmacy 
department. 
PC: ‘…so it’s relatively nebulous in terms of its physical appearance, it’s a group of 
dedicated staff keen to promote research among the department….it’s part of the 
department, it’s not a discrete thing.’ 
The APU appeared to be perceived to have a positive influence on research activity among 
pharmacists, illustrated by the following quote from one participant who believed the APU 
increased research engagement among pharmacy staff.  
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PC: ‘I think it increases the chances of [the department] getting pharmacists and other 
pharmacy staff to undertake research……so it has a positive effect on influencing them, 
so as members of pharmacy, they know where to come, I hope if they have an idea we 
can signpost them and help and encourage them.’ 
Reasons offered as to why it was felt that having an APU influenced research activity included 
the existence of the unit raising awareness of research opportunities among staff as well as 
the unit allowing staff access to individuals with research expertise who could provide support 
and signpost to other sources of help. Several also made reference to the APU having a 
positive influence on the departmental culture by suggesting that having an APU encouraged 
research activity within the department.  
PG: ‘So I think it [the APU] provides [pharmacists] with erm…it provides [pharmacists] 
with an incentive that I said is kind of missing, somebody at the unit is there prodding 
saying ‘Do you want to do research, we can help you, this is what has been done 
before erm and these are the resources available in the Trust to help you with 
research.’ 
In terms of other mechanisms of support for pharmacists to undertake research at 
departmental level, in addition to establishing an APU, the chief pharmacist had also created a 
role which encompassed the provision of leadership for research. As well as supporting 
research activity within the department by providing staff interested in undertaking research 
with access to research expertise, leading the APU and developing a research culture within 
the department were also cited as part of the role of the individual in post. 
The post was graded at a senior level according to NHS AfC banding and the individual in this 
role at the time the interviews were undertaken was themselves experienced in undertaking 
research and had a doctoral level postgraduate research qualification.  
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Several participants also appeared to view formal departmental research meetings as another 
mechanism for support. Such meetings were held on a monthly or bi-monthly basis and were 
attended by the chief pharmacist, the lead pharmacist for research, and those pharmacists in 
the department undertaking research. In terms of how the meeting supported research 
activity, most referred to the meetings as a forum for discussing current research and grant 
applications as well as new research ideas. Peer support was also cited as another way 
through which the departmental research meetings provided support. Such meetings were 
also perceived to be a mechanism through which research activity was encouraged within the 
department. 
PL: ‘…we meet I think it’s twice a month, and we have a deliberate research strategy 
and that is to encourage pharmacy staff, pharmacists and pharmacy technicians, to 
become research active, we’ll either support them ourselves, those of us who are more 
senior in the group, or we can signpost them.’ 
Regarding academic links, the department had established formal links to a School of 
Pharmacy via the APU which appeared to support research activity within the department by 
providing pharmacists with access to research expertise and facilities not available within the 
Trust. Reference was also made to collaborative research undertaken jointly between the 
department and the university. Interestingly, the academic links at Trust-level were aligned to 
a university with a School of Medicine but not a School of Pharmacy meaning the 
departmental academic links were with a different university to the university linked with the 
organisation at Trust-level.  
In terms of whether a requirement to undertake research was included in pharmacists’ job 
descriptions, such a requirement was included in the job descriptions of those who had 
research as a formal part of their role but this appeared be no more than in recognition of it 
being part of their role. No references were made to the inclusion of a requirement to 
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undertake research in the job descriptions of those with research as a formal part of their role 
driving or enabling such individuals to undertake research. For staff where research was not a 
formalised part of their role, it was unclear whether a requirement to undertake research was 
in their job descriptions. Some were of the opinion that a requirement to undertake research 
was not included while others believed a requirement to undertake research was a general 
clause included in all pharmacists’ job descriptions. However, one participant was of the 
opinion that even if this was the case this requirement did not translate into an expectation of 
research activity.  
PM: ‘For a lot of us, although it might be in our job description it’s not an expectation 
of our day to day work that we do research. So it’s sort of an extra.’  
Including a requirement to undertake research in pharmacists’ job descriptions did not appear 
to be perceived to influence research activity within the department. 
Regarding the inclusion of research in appraisals, research appeared only to be routinely 
included in appraisals of those where research was a formal part of their role but no reference 
was made to this driving them or enabling them to undertake research. The inclusion of a 
requirement to undertake research in pharmacists’ appraisals did not appear to influence 
research activity.  
In terms of other ways that staff in the department were supported to undertake research, 
some participants interviewed were allowed time to undertake research though backfill 
arrangements as a result of research funding from individual grant applications. Some 
participants had also been allowed time at work to undertake research as part of postgraduate 
research qualifications while others had been allowed time to undertake research because 
research was either included in their job plan or they had a clinical academic appointment. 
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Case study site 4 
Case study site 4 was selected to be a case study site because the pharmacy department had a 
lead pharmacist for research. Unlike the other case study sites the pharmacy department did 
not have an APU and neither was the Trust part of an AHSC.  
Organisational culture  
The Trust was perceived to have a positive culture for research with participants using 
descriptors such as ‘supportive’ and ‘encouraging’ to describe the culture.  
PH: ‘So this Trust I work in has a very positive culture about research…the Trust, as a 
whole, it’s always very erm encouraging about research work.’ 
Although clinical trials appeared to dominate the culture, other types of research also 
appeared to be supported within the organisation, as illustrated by the following quote:   
PD: ‘So we’ve got a lot of trials on-going. There’s a good mix of qualitative and 
quantitative, new drugs and experimental treatments.’  
Regarding participants’ opinions in relation to whether they felt having a research culture at 
Trust level influenced research activity among pharmacists, although no participants made 
reference to any mechanisms through which the research culture in pharmacy was directly 
influenced by that at Trust level, several believed the culture for research at Trust level made 
it easier to undertake research at departmental level. 
PH: ‘So, the Trust having a positive culture for research, so that just makes it easier to 
get involved and the get the whole team involved.’ 
Rather than the Trust culture for research influencing research activity within pharmacy, some 
participants perceived the Trust having a culture for improvement enabled research activity 
among pharmacists. The following quote from one participant illustrated this. Although they 
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were explicit in their belief that the culture for improvement within the organisation was not 
driving research activity within the department, they appeared to feel it meant there were no 
or fewer barriers to overcome for the department to be research active. 
PE: ‘I do know within the organisation, not all services are like our service...there are 
services that aren’t focused in this way at all. So it is possible to sit within a broader 
organisational culture and not be doing what we’re doing…so we’re not doing what 
we’re doing because the Trust has its culture as I’ve described, it just makes it easier to 
do what we want to do.’ 
Likewise, another participant also appeared to recognise that the culture for improvement at 
Trust level facilitated research activity in that they described the organisation as having a ‘can 
do’ attitude which they related to research activity being supported within the Trust. 
PD: ‘So [the Trust is] very supportive of research...it’s got a very ‘can do’ attitude…’ 
It was therefore unclear as to whether it was a research culture or improvement culture at 
Trust level that was influencing research activity among pharmacists but either way the 
influence appeared to be indirect in nature.  
With regards to departmental culture, all interviewees appeared to view the culture as being 
positive towards research with several describing the departmental culture as actively 
encouraging research activity.  Raising awareness of research activity in the department was 
cited as contributing to the culture for research.  
PD: ‘Obviously the department gets research, not everybody does it, but we do 
understand that this is something that’s important to us…sticking up posters 
everywhere, sticking our papers on the research notice board…all that keeps that 
subliminal message of we’re a research er friendly department and we want to be 
active in research, and we want to support new people to be research active.’ 
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Research appeared to be perceived to be an expectation of pharmacists as illustrated by the 
following quote:    
SH: ‘So it’s [research is] almost seen as an expectation almost, that if you come to work 
for us that that will be something that you will be undertaking.’ 
Research was also believed to be an integral part of pharmacy practice at the Trust.  
PF:’ …it’s just part and parcel of what we do. It’s not…it’s gone beyond that we have to 
focus on it. It’s actually, yeah, just business as usual’ 
Regarding the Trust having a research strategy, although some appeared to be aware of the 
existence of a strategy, most appeared to be unsure but were inclined to assume the Trust 
would have one. Those who assumed the Trust to have a strategy appeared also to assume 
that it would be aligned to clinical trials, and for this reason believed pharmacy-led research 
would not be included.  
PE: ‘Erm…yeah I’m tempted to say it must have…but I don’t know off the top of my 
head…erm I would say that the Trust’s research strategy is more likely…to be aligned 
to the clinical trials strategy….so actually our, our research is probably erm, it wouldn’t 
be seen as part of that’ 
Another participant, who appeared familiar with the strategy, believed that although there 
was no explicit mention of pharmacy-led research in the strategy, it was not excluded. 
However, regardless of whether participants perceived the Trust strategy to include 
pharmacy-led research or not, none made any reference to Trust research strategy influencing 
research activity in pharmacy. 
195 
In terms of a departmental research strategy, rather than there being a standalone strategy, 
research was instead integrated into the department’s business priorities meaning that 
research and the department’s business priorities to be inextricably linked. 
One participant appeared to suggest that this approach had helped, or was helping, to 
engender a research culture within the department.  
PE: ‘So it strengthens engagement…’cause it means research isn’t just one person’s 
business it’s everybody’s business…’ 
Leadership of the chief pharmacist  
All participants were of the opinion that the chief pharmacist was supportive of research. They 
were also perceived to be driving research activity and credited with creating a positive 
research culture within the department.  
PR: ‘I think erm certainly [the name of the chief pharmacist] has been the driving force 
here as chief pharmacist.’  
Therefore the chief pharmacist appeared to be influential in terms of the department being 
research active through both supporting and driving engagement.  
Mechanisms of support  
The Trust was selected to be a case study site based on the department employing a lead 
pharmacist for research. The role encompassed the development of research activity among 
pharmacists as illustrated by the following quote from one participant who was of the opinion 
that the role was driving research activity with the department: 
PE: ‘…[the lead pharmacist for research] stimulates research…[they] are like a 
conductor of an orchestra [they] support and encourage others…’ 
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The role was also perceived to be contributing to the development of research culture within 
the department by making research visible as illustrated by the following quotes: 
PE: ‘…[the lead pharmacist for research] has a got a presence er and a title that goes 
with it and people in the organisation understand that. Therefore erm, research isn’t 
seen as being something that is nice to do, it’s something that has to be done.’ 
PD: ‘…and because [the lead pharmacist for research role is] visible, [pharmacists] see 
it almost as a thumbs up for them to do stuff…it’s a green light to go.’ 
Another participant suggested that having the role made undertaking research more 
accessible for staff. 
PR: ‘People see [the Lead Pharmacist for research] as a role model to say ‘well I could 
do some of that, that doesn’t seem to be too difficult’…….that’s very sort of tangible to 
people that they can do this with the right sort of encouragement.’ 
The role itself appeared to be an established post, having been in existence for a number of 
years, and was graded under NHS AfC banding at a relatively senior level. The individual in 
post at the time of the interviews had expertise in research, having both a doctoral level 
research qualification and significant personal experience of undertaking research.  
When asked whether having the role influenced research activity within the department, 
participants were unanimous in their view that it did. One participant suggested that for 
research to be undertaken within the department, the role was essential.  
PR: ‘…so without the [lead pharmacist for research] I don’t think it [research] would 
happen’ 
In terms of how the role influenced research activity, most participants talked about how the 
role supported staff to undertake research. Access to someone with research expertise who 
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could help in developing research ideas, advise with research methodology, and help with 
developing posters and writing publications were all cited as examples of how the role 
supported research activity within the department. Reference was also made to the post 
helping to bring academic rigour to research being undertaken within the department.  
PE: ‘…having people like [the lead pharmacist for research] who bring in more of an 
academic understanding to, to bring some rigour to the evaluation...’ 
One participant also referred to the individual in post providing mentorship to others 
regarding research.  
PF: ‘...basically [the lead pharmacist for research] is the ultimate pharmacist 
researcher, expert mentor…’ 
Regarding other mechanisms of formal support for research, the department had an 
established academic research group attended by the chief pharmacist and other senior 
leaders, which met monthly or bi-monthly. The purpose of the group was two-fold: it served a 
kind of gatekeeper function in that it enabled research activity being undertaken within the 
department to be prioritised and also for potential new areas for research to be identified, and 
the group members provided support for those interested in undertaking research. 
PE: ‘…we’ve got the [departmental research group] and that’s…that basically 
coordinates our work or tries to coordinate the work erm for the whole of the service.’ 
In-house training sessions were also facilitated by the lead pharmacist to support staff to 
publish their work.  
Regarding academic links, the department had informal links with several local universities 
through which staff had accessed support for research which included statistical support for 
projects. In terms of formal academic links, however, although such links were not yet 
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established, the department was in the process of developing links with a local School of 
Pharmacy. Participants viewed this as an opportunity for the department to develop their 
research portfolio, as opposed to solely a way of accessing research expertise.  
PE: ‘…erm things are looking quite bright in terms of future practice 
opportunities…clearly we’re going to have a much stronger relationship with [the 
name of the School pf Pharmacy] than we did with [the name of the university through 
which the department had established informal academic links].. so we’re quite excited 
about that…’ 
In terms of whether a requirement to undertake research was included in pharmacists’ job 
descriptions, all those interviewed in the pharmacist participant group said they had research 
in their job descriptions and it was cited as being in the job descriptions of all pharmacists 
above a certain grade, regardless of whether or not they were research active. With regard to 
annual appraisals, again, research appeared to be included in the appraisals of all those who 
were interviewed in the pharmacist participant group. However, no reference was made to 
either the inclusion of research in job descriptions or annual appraisals representing 
mechanisms through which research activity was influenced within the department. 
Regarding how pharmacists were supported to undertake research, those interviewed 
appeared to be allowed time to conduct their research as part of their working day. However, 
a caveat to being allowed time to undertake research appeared to be that the research they 
conducted was aligned to the departmental business priorities.  
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8.2.3.2 Cross case analysis  
In this section a cross-case analysis of the data relating to the contextual domain from all four 
case study sites is presented. 
From the within-case analysis it was apparent that the factors pertaining to the contextual 
domain explored through the case study research were either perceived to enable research 
activity and/or drive research activity, or appeared to have no influence. The findings are 
therefore presented in terms of these themes: factors perceived to drive activity; factors 
perceived to enable activity; and factors which appeared to have no influence on research 
activity. 
Factors perceived to drive research activity  
A department having a culture for research drove research activity among pharmacists 
through the encouragement of research. Making research activity ‘visible’ in the department 
was one way that research activity was encouraged at all four case study sites. Having a lead 
pharmacist for research, the department having an APU and departmental research forums 
were also cited as mechanisms through which research was made visible. Research activity 
was also perceived to be encouraged through the promotion of research opportunities within 
the department at two of the case study sites (case study sites 2 and 3) and at case study site 4 
reference was made to promotion of departmental research activity being a way that research 
activity was encouraged. 
Having a lead pharmacist for research was also perceived to be a driver of research activity 
among pharmacists at three of the four case study sites (sites 1, 3 and 4). At all of these sites 
reference was made to the individual in post personally driving research activity. Reference 
was also made at two of the case study sites (sites 3 and 4) to the existence of these posts 
influencing research activity through making research visible.  
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The leadership of the chief pharmacist was perceived to be driving engagement at case study 
site 4 and therefore appeared to be taking an active role in driving research within the 
department. This was not apparent at other sites. However, case study site 4 was not only 
different to the other case study sites in this respect but also differed because research was 
integrated into the departmental business priorities. At other sites research was described as a 
priority or strategic aim of the department but this did not appear to be perceived to drive 
engagement as no reference was made to this directly influencing activity at any of the sites. 
Integrating research into the departmental research strategy arguably did however appear to 
influence research activity as it was cited as ‘strengthening engagement’ at the site. 
Regarding the research culture of the Trust, a Trust having a culture for research was 
perceived to indirectly influence research activity within the department at all four sites. 
However, a Trust having a culture for research did not appear to directly drive research activity 
among pharmacists as, at all four case study sites, a culture for research was perceived to exist 
in the organisation at this level but no reference was made at any of the sites to this directly 
influencing research activity among pharmacists. Presumably this was because pharmacy-led 
research was not perceived to be a priority at any of the sites at this level as at all four sites 
the Trust culture was perceived to be aligned to clinical trials and/or medic-led research.  
Factors perceived to enable research activity  
Having a departmental research culture was perceived to support research. This was 
exemplified by individuals at case study sites 2 and 3 making reference to their department 
having a culture for research meaning they felt ‘allowed’ to undertake research. Similarly, all 
of the chief pharmacists were described as being supportive of research, suggesting their 
leadership also enabled activity within their department.  
Research activity among pharmacists was also facilitated to some extent by the Trust having a 
culture for research as at two of the case study sites (sites 3 and 4) participants made 
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reference to the Trust having a culture for research making it ‘easier’ for pharmacists to 
undertake research. However, as no reference was made to the Trust having a research 
culture directly supporting pharmacy-led research it is perhaps reasonable to assume that a 
Trust having a culture for research made it easier for pharmacists to undertaken research 
because they were able to overcome contextual barriers to research engagement as opposed 
to being actively supported to undertake research. Indeed, support for pharmacy-led research 
at Trust level did not appear to be apparent at case study sites 2 and 3 as at these sites 
participants made reference to the difficulties they had personally experienced in accessing 
support at this level within the organisation. 
Access to individuals with research expertise within the department was also perceived to 
enable research activity among pharmacists at all four case study sites, and at all four case 
study sites a lead pharmacist for research was cited as providing this internal support. At all 
four sites the individuals in these posts were experienced in undertaking research and either 
had, or were studying for, doctoral level research qualifications and thus had the research 
knowledge and skills to personally support research activity within the department, as well as 
being able to signpost individuals to other sources of help and support. APUs were similarly 
cited as providing access to individuals with research expertise, as were departmental 
research forums where these had been established. Links with academia were also perceived 
to provide staff not only with access to support, but also with access to infrastructure not 
available within the Trust such as IT software. It was interesting to note that reference was 
also made to these academic links providing staff with physical space away from the pharmacy 
department to enable them to work on their research undisturbed. Academic links therefore 
provided more than solely access to research expertise. Also of note was that at all four case 
study sites the academic links they had developed were with Schools of Pharmacy meaning 
that in some instances these links were with a different university to the university linked to 
the Trust at Trust level. Schools of Pharmacy appeared therefore to be perceived to specifically 
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offer the external support that pharmacists needed to conduct research. It was also 
interesting to note that peer support and mentoring arrangements through individuals with 
research experience being employed within the department were also perceived to be support 
mechanisms for pharmacist interested in research, and that, presumably by helping staff to 
identify those with research experience in the department, APUs and research forums were 
cited as providing staff with access to peer support. 
Allowing pharmacists time to conduct research in the working day also appeared to facilitate 
research activity at all four case study sites. Several mechanisms to allow this were cited 
including the inclusion of research in individuals’ job plans, research being a formal part of an 
individuals’ role, research undertaken as part of a postgraduate qualification (sites 1, 2 and 3). 
By allowing individuals time to conduct research, it was also apparent that research funding 
facilitated research engagement at three of the four case study sites (sites 1, 2 and 3). In terms 
of how funding allowed pharmacists research time, case study sites 2 and 3 were similar in 
that individuals who had obtained research funding themselves through for example research 
grants or personal fellowships meant their posts were backfilled to allow them time to 
undertake research. However, at case study site 1 programme grants were cited as enabling 
pharmacists to be employed whose primary role was to conduct research. Either way research 
funding appeared to facilitate research at these sites. Case study site 4 was however very 
different. At this site pharmacists who did not have research included in their job plan or for 
whom research was not a formal part of their role were allowed to undertake research outside 
of postgraduate qualifications without obtaining funding to backfill their role, with the caveat 
that the research aligned to the departmental business priorities.  
Factors which appeared to have no influence on research activity  
Some of the factors identified in the initial study as having the potential to influence research 
activity among pharmacists were not evident in the case study research. These included the 
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inclusion of a requirement to undertake research in pharmacists’ job descriptions and 
appraisals. Trust level research strategies were also not perceived to influence research 
activity among pharmacists at any of the sites. Likewise, departmental research strategies per 
se did not appear to influence research activity as none of the case study sites had a current 
standalone strategy.  
A summary of the within-case analysis of the factors pertaining to the contextual domain and 
their perceived influence on research activity are presented in Table 19 below. 
In the next section, the methods used to undertake the survey research and findings of this 
phase of the study are reported. The findings of the case study research and the survey 
research are then discussed together in chapter 10.  
.
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Table 19: Summary of the cross-case analysis of case study research data relating to factors pertaining to the contextual domain and their perceived 
influence on research activity among pharmacists 
Factor  Case study sites where 
factor was apparent  
 
Perceived influence of factor on research activity and pharmacists 
 
Perceived to drive activity  
 
Perceived to enable activity 
Culture for research at Trust level All 4 sites  No reference was made to this being the 
case at any site 
Yes: perceived to enable research activity 
at sites 2 and 3 
Culture for research at 
departmental level 
All 4 sites  Yes: described as encouraging research at 
all 4 sites 
Yes: described as supporting research at all 
4 sites  
Research strategy at Trust level Sites 1, 2 and 3 had a 
Trust strategy; unclear if 
one in existence at case 
study site 4 
No reference was made to this being the 
case at any site 
No reference was made to this being the 
case at any site 
Research strategy at departmental 
level 
Sites 1,3 and 4 had 
research integrated into 
departmental strategy or 
business priorities; none 
had a standalone strategy 
Yes: at site 4 integration of research into 
departmental business priorities perceived 
to strengthen engagement  
No reference to this at any site 
Leadership of chief pharmacist  All 4 sites  Yes: perceived to encourage engagement 
at site 3 and drive engagement at site 4 
Yes: perceived to be supportive of research 
at all 4 sites   
Trust being part of an AHSC i.e. a 
collaboration between the Trust 
and a local university  
Sites 1 and 2 only Possibly: perceived to potentially 
contribute by the Trust culture indirectly 
influencing research activity  
Possibly: perceived to potentially 
contribute by the Trust culture indirectly 
influencing research activity  
Department having an APU i.e. a 
collective of researchers 
comprising mostly or all 
pharmacists  
Sites 1 and 3 only Possibly: described as positively influencing 
the research culture at departmental level 
Yes: described as providing support for 
research activity 
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Table 19 continued 
Factor Case study sites where 
factor was apparent 
 
Perceived influence of factor on research activity and pharmacists 
 
Perceived to drive activity 
 
Perceived to enable activity 
Having a lead pharmacist for 
research i.e. a pharmacist with 
responsibility for leading research  
All 4 sites Yes: described as driving or encouraging 
research activity at all 4 sites 
Yes: described as supporting research 
activity at all 4 sites  
Departmental research groups i.e. 
forums attended by staff 
undertaking research +/-members 
of senior management team 
Sites 3 and 4 only  Yes: perceived to encourage research 
activity at site 3 
Yes: perceived to support research activity 
at sites 3 and 4 
Departmental academic links with 
universities i.e. links with Schools 
of Pharmacy  
All 4 sites  No reference was made to this being the 
case at any site 
Yes: described as enabling access to 
infrastructure and support 
Inclusion of a requirement to 
undertake research in pharmacists’ 
job descriptions 
All 4 sites (ranged from 
inclusion in job 
descriptions of all 
pharmacists to only those 
with research as a formal 
part of their role) 
No reference was made to this being the 
case at any site 
No reference was made to this being the 
case at any site  
Inclusion of research in 
pharmacists’ annual appraisals  
Sites 1, 2 and 4 (although 
only reported by those 
interviewed; no reference 
to research being part of 
other pharmacists’ 
appraisals) 
No reference was made to this being the 
case at any site 
No reference was made to this being the 
case at any site 
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Table 19 continued 
Factor Case study sites where 
factor was apparent  
 
Perceived influence of factor on research activity and pharmacists 
 
Perceived to drive activity 
 
Perceived to enable activity 
Individuals being allowed time to 
undertake research  
All 4 sites No reference was made to this being the 
case at any site 
Yes: through either research funding; the 
inclusion of research in job plans; research 
being a formal part of individuals’ roles; or 
through research being part of a 
postgraduate qualification 
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9 Survey research  
This chapter pertains to the survey research undertaken in the second phase of the main 
research study. This phase of the main research study is highlighted in Figure 7 below.  
 
 
 
Figure 7: Flowchart highlighting the survey research 
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As previously outlined in chapter 7, survey methodology was used in this second phase of the 
research to establish how widely the findings of the case study research were shared among a 
larger population. To undertake this phase of the research, a structured questionnaire was 
developed which was distributed as a self-administered web-based survey to chief pharmacists 
of acute secondary care NHS Trusts. As previously described in section 7.3 the questionnaire 
used to collect the data was developed based on the findings of the case study research. 
In this chapter I outline the methods used to undertake the survey research and present the 
survey results. For an explanation of my rationale for using survey methodology for this phase 
of the study refer to section 7.3. 
9.1 Methods  
In this section I outline the methods used to recruit participants and the methods used to 
collect and analyse the survey data. 
9.1.1 Participant sampling strategy  
Selection of participants 
The population of interest for the survey was chief pharmacists of all acute secondary care NHS 
Trusts in England but not just teaching hospitals.  
Chief pharmacists were selected to be the population of interest for two reasons: 
Firstly, it was felt that their collective attitudes and opinions would give greater insight into the 
factors influencing research activity among pharmacists. The reasoning for this was two-fold:  
the findings of the case study research suggested that the leadership of the chief pharmacist 
was highly influential in terms of research activity among pharmacists employed within their 
respective organisations and the case study research suggested that organisational culture was 
also a factor that could influence research activity among pharmacists. It was felt therefore that 
chief pharmacists would have comparatively more insight into the culture of their organisations 
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at Trust level and would have more insight into the influence the culture of their organisation 
had, or had the potential to have, in relation to research activity among pharmacy staff.  
Secondly, it was believed that the collective attitudes and opinions of chief pharmacists would 
carry more gravitas within their professional group. This was important for two reasons: as the 
findings of the case study research suggested that the chief pharmacists’ leadership was 
influential in terms of research activity among pharmacists, it was felt that to engage more 
pharmacists with research it was chief pharmacists who would be most likely to be in a position 
to change local policy within their respective organisations and it was felt that collectively they 
would also be in a position to influence policy nationally. 
Chief pharmacists of mental Health Trusts and other NHS Trusts e.g. community Trusts were 
excluded as it was felt that the organisational culture of these would be too different to acute 
secondary care Trusts. Including them would have meant that the population of interest would 
not have been homogenous.  The survey was limited to chief pharmacists of secondary care 
NHS Trusts in England for the same reason as the case study sites were geographically 
restricted to those in England, which was because of the variations in the models of healthcare 
in the devolved nations.  
NB Chief pharmacists who participated in the case study research were excluded from the 
survey phase of the research as it was felt that their responses may have biased the results. 
Identification of participants 
The intention was for the survey to be available to chief pharmacists of all acute secondary care 
NHS Trusts in England. The sampling frame i.e. the list of population members from which the 
sample was drawn (Bowling 2014) was therefore the same as the population of interest. Rather 
than using a sampling strategy to identify a sample of chief pharmacists, the survey was more 
akin to a ‘census’ i.e. a study of every member of a given population (Gray 2014). 
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To identify potential survey respondents, an invitation to participate was placed in the NHS 
England and NHS Improvement (NHSEI) Chief Pharmacists’ monthly newsletter by the Director 
of Hospital Pharmacy at NHSEI. The Director of Hospital Pharmacy at NHSEI therefore acted in 
the capacity of a gatekeeper in that they allowed me access to the chief pharmacists of acute 
secondary care Trusts in England (Creswell 2014). This approach was used because a list of 
chief pharmacists of these types of Trusts was not available in the public domain.  
9.1.2 Data collection  
As the purpose of undertaking the survey was to measure the occurrence of certain 
phenomena in a population of interest, the intention was to collect mostly quantitative data. 
For this reason a structured questionnaire i.e. a questionnaire comprising the use of fixed 
questions presented in the same way with no variation in question wording and with mainly 
pre-coded response choices, was appropriate to use as the survey instrument (Bowling 2014). 
Data was collected via a self-administered questionnaire i.e. a questionnaire which 
respondents completed themselves, as opposed to using structured interviews i.e. where the 
interview schedule is administered by an interviewer either face-to-face or by telephone. This 
was primarily because structured interviews undertaken either by telephone or in person 
would have been impractical due to the high number of potential respondents, and 
correspondingly large amount of time which would have been required to undertake the 
interviews. The wide geographical dispersion of potential participants would also have meant 
that face-to-face interviews were not a viable option due to the time and cost of travel (Bryman 
2012). 
A web-based survey was chosen to distribute the questionnaire, as opposed to a postal survey, 
as online surveys are cheaper and more convenient to administer. Using a web-based survey 
also allowed respondents’ answers to be downloaded into a database, eliminating the need to 
code the data and thereby reducing the likelihood of errors in the data processing, as well as 
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saving time. A web-based survey was also selected to distribute the survey over other online 
methods, such as an email survey where a questionnaire is embedded in the email itself or sent 
as an attachment, to again assist with the speed and accuracy of data analysis as they too do 
not allow respondents answers to be downloaded into a database and therefore rely on 
manual data entry to analyse the results (Robson 2011, Bryman 2012). In addition, a web-based 
survey offered the advantage over an email survey of allowing the use of filter questions to 
enable some questions to be automatically skipped by respondents where appropriate (Bryman 
2012, Gray 2014). 
The questionnaire developed to collect the survey data was based on the findings of the case 
study research. Concepts identified from the case study research findings were used to develop 
the indicators included in the questionnaire (Calnan 2013). The questionnaire comprised only 
closed questions i.e. questions where respondents were required to select one or more 
responses from a number of alternative answers (De Vaus 2014). In terms of the types of 
response alternatives provided, checklist response formats, binary choice formats and multiple 
choice formats were used (De Vaus 2014). Questions with multiple choice formats were of two 
different types: those where respondents were asked to choose between multiple nominal 
categories i.e. where the responses had no set order and could not be ranked in any sense from 
high to low; and those where respondents were asked to choose between ordinal categories 
i.e. where the responses could be ranked from high to low. To ensure the response alternatives 
were exhaustive a catch-all category of ‘other’ was included for some questions with multiple 
choice and checklist response formats so that respondents could provide their own response if 
the set of responses provided did not cover all categories. ‘Don’t know’ was not used as a 
response category to any questions as it was felt that, because research is considered to be 
part of the professional practice of pharmacists, chief pharmacists would hold opinions in 
relation to the concepts covered by the survey. To have included a ‘don’t know’ response 
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category would have introduced the risk of participants selecting this response out of satisficing 
or ‘laziness’ (De Vaus 2014).  
The questionnaire comprised a mixture of questions relating to their attitudes i.e. questions 
that tried to establish what respondents thought was desirable, beliefs i.e. questions that tried 
to ascertain what respondents thought was true, knowledge i.e. questions that tried to 
discover respondents knowledge of particular facts, and their attributes i.e. questions that 
were designed to obtain information about respondents characteristics (Dillman 1978). 
Questions relating to knowledge were only asked where it was felt respondents were likely to 
have the necessary knowledge to help ensure the validity of the results. Consideration was also 
given to the wording of the questions to help ensure the validity of the findings. Simple 
language was used to word the questions to avoid confusion in terms of the meaning of 
questions and negatively framed questions i.e. questions using ‘not’ were avoided as they can 
be difficult for respondents to understand. Leading questions i.e. questions where the question 
structure or wording pushes people to provide a response they would not have given had the 
question been asked in a neutral way, were also avoided. The questionnaire was also designed 
so that there was a logical flow to the questions being asked. In addition, the first question was 
perceived to be an ‘easy’ question, with questions deemed more difficult to answer being 
included later in the survey. A variety of question formats was used to help maintain 
respondents’ interest (De Vaus 2014). The questionnaire was designed in this way to make it as 
pleasant and rewarding experience as possible for the respondents to help ensure a good 
response rate to the survey. In addition, the number of questions included was limited to 
ensure the questionnaire was relatively short to reduce the burden on respondents (De Vaus 
2014).  For a discussion as to why a good response rate was important in terms of the validity 
of the research findings refer to section 9.1.5 below. Survey participants were informed that for 
the purposes of the study the term ‘undertaking research’ referred to pharmacists carrying out 
their own research as opposed to managing clinical trials medicines to ensure continuity with 
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the case study research. For a copy of questions and response formats used in the 
questionnaire refer to appendix 24. 
The questionnaire was created using SurveyMonkey, an online questionnaire and survey tool 
(Bell 2014). SurveyMonkey then created a web address to which potential respondents could 
be directed to access and complete the questionnaire online.  
Before the questionnaire was distributed it was piloted with two ex-chief pharmacists who had 
recently left their roles either due to retirement or to take up other positions as it was believed 
that they would have similar characteristics to the survey population (Gray 2014). The decision 
was made not to pilot the questionnaire with a cohort of chief pharmacists from the population 
of interest as this would have reduced the sample size for the survey. Consideration was given 
to piloting the questionnaire with the chief pharmacists who participated in the case study 
research but it was felt that as a cohort the chief pharmacists who had participated in the case 
study research would have been less objective in their critique of the questions included in the 
questionnaire. 
As outlined earlier in section 9.1.1, chief pharmacists were invited through an invitation placed 
in the NHSEI Chief Pharmacists’ monthly newsletter. The text included in the newsletter 
contained a link to the web-based survey, and also directed participants to a document 
repository where they were able to access a copy of the participant information sheet for this 
phase of the research. For copies of the email sent to the Director of Hospital Pharmacy at 
NHSEI which includes the wording for the invitation placed in the chief pharmacists’ newsletter, 
and the participant information sheet for this phase of the research please refer to appendices 
25 and 26 respectively. A reminder was placed in the subsequent newsletter to the issue which 
included the invitation to participate in an attempt to maximise the survey response rate. 
Further reminders were not placed in the NHSEI newsletters as the first reminder did not 
increase the number of responses to the survey to a significant degree. It was also not possible 
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to email non-responders directly as the survey responses were anonymised, and even if they 
had not been anonymised the email addresses of chief pharmacists of acute secondary care 
NHS Trusts are not available in the public domain as outlined previously in section 9.1.1. To 
ensure chief pharmacists who participated in the case study research did not submit a response 
to the survey, they were individually emailed in advance of the newsletter being distributed, to 
ask them not to participate in this phase of the research.  
9.1.3 Data analysis 
Descriptive statistics were used to analyse the data. Descriptive statistics are used to 
summarise patterns in responses and were therefore appropriate to use to analyse the survey 
data because the survey was descriptive in nature i.e. it was undertaken to measure certain 
phenomena in the population of interest (Gray 2014). The use of descriptive statistics therefore 
enabled patterns in terms of the findings relating to these phenomena to be described.  
To analyse responses a coding frame was developed. As the questionnaire comprised closed 
questions this allowed most responses to be pre-coded before the questionnaire was 
distributed. For questions with a checklist response format i.e. questions that allowed more 
than one response each possible response was coded as a separate variable for ease of 
analysing the data (Smith 2010).  For the multiple choice and checklist response format 
questions where an ‘other’ category was included in the response categories a coding frame 
was developed based on participants’ responses.  
Microsoft Excel was used to help manage the data analysis.  
9.1.4 Research ethics and governance 
Ethical and governance considerations 
For the same reasons outlined in section 8.1.5 for the case study research, the level of risk for 
participants taking part in the research was relatively low. However, all data collected for the 
survey was anonymous and no personal information relating to participants was collected. No 
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steps were required therefore to protect participants’ anonymity or to maintain confidentiality 
of data.  
Informed consent was however obtained from participants. To ensure participants gave 
informed consent a participant information sheet was made available to participants which, 
like the participant information sheets used in the case study research, detailed the purpose of 
the research, what was involved, any risks associated with their participation, and information 
relating to anonymity and confidentiality. Participants were then asked a question as part of 
the online survey to confirm that they had read the participant information sheet and were 
voluntarily participating before they could begin the questionnaire. Both the participation 
information sheet and introductory words to the questionnaire made it clear to potential 
participants that they were being invited to take part, and were therefore free to decide 
whether or not they wished to participate. It was therefore made transparent to participants 
that their participation in the research was entirely voluntary.  
Ethics approval  
Ethics approval was obtained from Keele University. As outlined in section 8.1.5 to obtain ethics 
approval for the survey research, an amendment to the approval obtained for the case study 
phase of the research was submitted. Rather than submitting the amendment to the ethics 
approval to one of Keele University Ethics Review Panels, however, the application to amend 
the ethics approval was submitted to the university Faculty of Medicine and Health Sciences 
Faculty Research Ethics Committee as Keele University ethics service had updated their 
processes in the time between obtaining approval from the case study phase of the research 
and approval for the survey phase (Keele University 2019b). Refer to appendix 27 for a copy of 
the ethics approval letter for the amendment. Following the pilot of the survey questions 
subsequent amendments were made to the questionnaire which required approval by the 
ethics committee, and a copy of this ethics approval letter can be found in appendix 28.  
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Health Research Authority (HRA) Approval 
To ensure the survey research complied with the regulations for undertaking research in the 
NHS, HRA approval was sought. As outlined previously in section 8.1.5, an application to amend 
the HRA approval obtained for the case study research was submitted to obtain HRA approval 
for the survey research. A copy of the approval letter for the amendment can be found in 
appendix 29.  
9.1.5 Research validity and reliability 
Validity and reliability, as concepts relating to research rigour, were discussed in the context of 
the case study research undertaken using a qualitative methodology in section 8.1.6. Applying 
these concepts to quantitative research is however different, and in this section I therefore 
outline the steps taken to ensure the validity and reliability of the research undertaken in this 
phase of the research.  
In survey research, validity refers to the extent to which the questions collect accurate data 
relevant to the study objectives. Reliability, on the other hand, relates to the extent to which 
the findings are repeatable or reproducible (Smith 2010).  
To improve the validity and reliability of the questionnaire, as outlined in section 9.1.2, the 
questionnaire was piloted with two ex-chief pharmacists. Piloting the questionnaire was 
important as it meant that ambiguous or misleading questions could be detected, and likewise 
questions that respondents seemed not able to understand could be identified, any of which 
had the potential to reduce the reliability of the results (Gray 2014, Bryman 2012). Undertaking 
a pilot was particularly important because the survey was administered as a self-completion 
questionnaire, meaning that no interviewer was present to clear up any confusion with 
questions (Bryman 2012). In addition, the validity of questionnaire data depends on shared 
assumptions and understandings of the questions and response categories. A basic assumption 
underlying the use of structured questions is that respondents interpret the words, phrases and 
217 
concepts in the same way as the researcher, and the question wording, form and order can 
therefore potentially affect the validity of survey data by affecting responses. Piloting the 
questionnaire therefore enabled these influences and any subsequent biases in the data to be 
minimised (Bowling 2014), as well as ensuring that the questions covered all relevant issues 
identified from the case study research. Following the pilot, the questionnaire was modified to 
address any issues identified. As outlined previously in section 9.1.2, to help ensure the validity 
of the questionnaire consideration was also given to the wording of questions to ensure they 
were easy to understand and were not leading, and questions that relied on participants’ 
knowledge for them to be able to respond were only asked where it was felt that all 
respondents would have the required knowledge to be able to respond.   
Non-response to questionnaires can affect the validity of a surveys by introducing bias as there 
is an argument that non-responders may differ to responders so that the results do not 
represent the population as a whole (Smith 2010). As self-administered surveys typically have 
low response rates (Robson 2011), steps were taken in the survey design and administration to 
minimise non-response. The questionnaire was designed to be easy to complete and was 
relatively short to minimise both non-response to the questionnaire as a whole, and non-
response to individual questions (Robson 2011). In addition, the newsletter article and the 
participant information sheet detailed the reasons for the research being undertaken, as well 
as outlining why potential respondents had been invited to participate and stating how the 
results would be used. The participant information sheet also addressed issues relating to data 
confidentiality and anonymity. Furthermore, as the invitation to participate was part of a NHSEI 
Chief Pharmacist monthly newsletter, it was implicit it had the approval of the Director of 
Hospital Pharmacy at NHSEI and would thereby encourage chief pharmacists to participate.  
Interviewer effects can also affect the validity of surveys. Although undertaking the survey 
using a self-completion questionnaire, as opposed to structured interviews, should have 
reduced any interviewer effects (Bryman 2012) chief pharmacists, certainly of Trusts in the 
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West Midlands, would more than likely have recognised my name due to my role with the NIHR 
Clinical Research Network. Arguably this may have influenced their responses i.e. this could 
have introduced some potential for social desirability response bias which could potentially 
therefore have affected the research validity (Robson 2011). However, as it was made clear to 
respondents that all responses were anonymised in SurveyMonkey, this may have helped to 
negate any risk of this happening.  
9.2 Results 
Twenty-two responses to the survey were completed. In England there are 152 acute 
secondary care NHS Trusts (NHS Confederation 2017). Excluding the four chief pharmacists who 
participated in the case study research, the sample size for the survey was 148 giving a 
response rate of 14.9%. All but one participant answered all of the questions. Responses to the 
incomplete survey are however included in the analysis.  
9.2.1 Demographic data  
Respondents were asked questions relating to their current personal research activity and 
previous research experience during their professional career. Their responses are presented 
below in Table 20 and Table 21 respectively.  
Table 20: Chief pharmacists’ current research activity (n=21) 
Research activity 
 
% (n) 
Being conducted as part of a postgraduate clinical qualification   
 
0% (0) 
Being conducted as part of postgraduate research qualification  
 
4.8% (1)  
Being conducted as  part of a postgraduate management qualification  
 
4.8% (1) 
Being conducted outside of a formal postgraduate qualification  
 
19.1% (4) 
No 
 
71.5% (15) 
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Table 21: Chief pharmacists’ personal research experience during their professional career 
(n=21) 
Research experience 
 
% (n) 
Gained as part of a postgraduate clinical qualification   
 
38.1% (8) 
Gained as part of postgraduate research qualification  
 
33.3% (7)  
Gained as part of a postgraduate management qualification  
 
19.1% (4) 
Gained but outside of a formal postgraduate qualification  
 
28.6% (6) 
No 
 
23.8% (5) 
 
Most respondents were not research active at the time of the survey being undertaken (15/21, 
71.5%).  However, the majority (16/21, 76.2%) had personally undertaken research in their 
professional career.  
Respondents were also asked about research activity among pharmacists in their departments. 
The majority (16/21, 76.2%) reported pharmacists in their department to be actively 
undertaking research at the time of completing the survey or in the three years previous to the 
survey being conducted.  
9.2.2 Participants’ attitudes towards research  
Respondents’ opinions regarding the importance of pharmacists undertaking research are 
presented in Figure 8. 
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Figure 8: Respondents’ opinions regarding the importance of pharmacists undertaking 
research (n=22) 
The vast majority of respondents (21/22, 95.5%) said they felt it was either very important or 
important that hospital pharmacists conducted research. 
9.2.3 Participants’ attitudes and opinions towards factors perceived to influence research 
activity  
Participants were asked questions pertaining to their attitudes and opinions towards factors 
perceived to motivate, encourage and discourage research activity among pharmacists, their 
attitudes and opinions towards factors perceived to be barriers and enablers to research, and 
the influence of organisational culture on research activity. Their responses to these survey 
questions are presented in this section. For all of the questions, apart from those relating to 
respondents’ opinions of the significance of motivating factors and the influence of 
organisational culture on research activity, participants were invited to select all responses they 
perceived to apply. They could therefore select multiple responses.   
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Factors perceived to motivate or encourage research activity 
Respondents were asked what they thought was the most significant motivator for pharmacists 
to undertake research: an individual’s personal desire to undertake research; individuals 
believing research to be a professional expectation of them as a pharmacist; or individuals 
believing research to be an expectation or requirement of their role by their employer. 
Responses to this survey question are presented in Figure 9. 
 
Figure 9: Respondents’ opinions regarding the significance of motivating factors (n=22) 
The vast majority of respondents (19/22, 86.4%) were of the opinion that a personal desire to 
undertake research was the most significant motivator for an individual to undertake research. 
Only three respondents (3/22, 13.6%) were of the opinion that either research being a 
professional expectation of being a pharmacist by profession, or research being an expectation 
or requirement of their employer was the most significant motivator. 
Respondents were also asked what factors they perceived would encourage more pharmacists 
to undertake research, and their responses are presented in Figure 10.  
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Figure 10: Factors perceived to encourage research activity (n=21) 
Having pharmacists with research experience in the department and more promotion of 
research opportunities were perceived to be the most likely factors to encourage pharmacists 
to undertake research as 71.4% (15/21) of respondents felt these factors would encourage 
activity. More than half also felt that having a pharmacist whose role it was to lead research, 
and there being a clearer career pathway for those interested in undertaking research would 
motivate pharmacists to conduct research i.e. 61.9% (13/21) and 57.1% (12/21) respectively.  
Factors perceived to discourage research activity  
Respondents were asked what factors they felt discouraged pharmacists from undertaking 
research, and their responses are presented in Figure 11.  
*other: inclusion in job plans; having more funding opportunities; having more time 
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Figure 11: Factors perceived to discourage research activity (n=21) 
The vast majority (20/21, 90.5%) felt research being perceived as difficult to undertake 
discouraged activity. Lack of access to individuals with research expertise was also felt to 
discourage activity by over half (12/21, 57.1%) of respondents.  
Factors perceived to be barriers to research activity 
Respondents were asked what factors they perceived to prevent research activity among 
pharmacists. Their responses are presented in Figure 12. 
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*other: lack of training at undergraduate level; research not integrated into postgraduate 
qualifications; lack of time in day job; lack of benefits to department; lack of benefits to 
individual 
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Figure 12: Factors perceived to prevent research activity (n=21) 
All of the barriers to research engagement explored through the survey research were 
perceived by the majority of respondents to prevent engagement. The vast majority (20/21, 
95.3%) felt lack of time was a barrier to research engagement. Most also felt lack of research 
knowledge and skills, difficulty getting funding and lack of access to research expertise to 
undertake research to also represent barriers i.e. 76.19% (16/21), 76.19% (16/21) and 61.90% 
(13/21) respectively. 
Factors perceived to be enablers of research activity  
Respondents were asked what factors they felt would enable pharmacists to undertake 
research, and their responses are presented in Figure 13.  
 
 
*other: lack of prioritisation; lack of time in day job; deflects from clinical role 
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Figure 13: Factors perceived to enable research activity (n=21) 
Integrating research into pharmacists’ roles was the factor most widely perceived to enable 
research activity among pharmacists i.e. 90.5% (19/21) of respondents identified this to be an 
enabler. Having more pharmacy-specific funding opportunities, access to individuals with 
research expertise, and better access to research training were also factors perceived to be 
enablers by most participants (18/21, 85.7%; 17/21, 80.1%; and 15/21, 71.4% respectively). 
These findings therefore reinforce the barriers identified in the survey as these enablers 
represent factors that would overcome the barriers identified.  
Influence of organisational culture on research activity  
Survey respondents were asked whether they felt the Trust culture and department culture 
encouraged, discouraged or had no influence on research activity among pharmacist. 
Responses to these survey items are presented in Table 22.  
 
  
*other: employing a lead pharmacist for research; split posts with academia; protected time 
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Table 22: Responses to survey items relating to the influence of organisational culture on 
research activity (n=22) 
Level of culture 
within the 
organisation  
Influence on research activity among pharmacists % (n) 
 
Encourages 
 
No influence Discourages 
Trust 
 
45.4% (10) 31.8% (7) 22.7% (5) 
Departmental 
 
59.1% (13) 9.1% (2) 31.8% (7) 
 
In terms of the culture at both Trust and departmental level, the majority (15/22, 68.18% and 
20/22, 90.9%) felt these influenced research activity among pharmacists i.e. the culture either 
encouraged or discouraged activity. However, respondents felt that departmental culture to be 
more influential on research activity among pharmacists than the Trust culture and, in terms of 
the influence of the culture at these levels on research activity among pharmacists, more 
respondents perceived the culture at both Trust and departmental level to encourage rather 
than discourage activity.  
Regarding organisational culture, respondents were also asked to rank the following factors in 
terms of their significance in determining the research culture of a pharmacy department: 
research culture at Trust-level; the leadership of the chief pharmacist; staff employed within 
the pharmacy departments. Responses to this question are presented in Table 23. 
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Table 23: Significance of factors in determining research activity (n=22) 
Factor determining 
research activity 
Respondent’s ranking of significance of factor in determining 
research activity (1-= most significant; 3= least significant) % (n)  
 
1  
 
2 3 
Research culture at 
Trust-level 
 
22.7% (5) 31.8% (7) 45.5% (10) 
Leadership of chief 
pharmacist  
 
40.9% (9) 45.5% (10) 13.6% (3) 
Staff employed in 
pharmacy department 
  
36.4% (8) 22.7% (5) 40.9% (9) 
  
Similar numbers of respondents ranked the leadership of the chief pharmacist and the staff 
themselves as the most significant factor determining research activity among pharmacists 
(9/22, 40.9% and 8/22, 23.4% respectively). More respondents ranked the leadership of the 
chief pharmacist as the most or second most significant factor determining research activity 
when compared to those who ranked the staff employed in first or second place i.e. 86.4% 
(19/22) compared to the 59.1% (13/22). The research culture at Trust-level was perceived to be 
the least significant of the three factors in terms of determining research activity among 
pharmacists as 45.5% (10/22) ranked it as least significant, and only 22.7% (5/21) ranked it as 
the most significant.  
9.2.4 Participants’ perceptions of pharmacists competence to undertake research 
Respondents were asked whether they felt newly-qualified pharmacists had the knowledge and 
skills to undertake research. The majority felt pharmacists lacked such knowledge and skills at 
this stage of their career (16/21, 76.2%). 
The sixteen respondents who felt newly-qualified pharmacists did not have the necessary 
knowledge and skills to undertake research were then asked how they felt additional training 
should be delivered after pharmacists had graduated from their undergraduate degree. To 
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answer this question they were asked to rank the following methods of delivering research 
training in terms of their preference: in-house research training (i.e. training delivered within 
the pharmacy department); incorporating research into pharmacists’ postgraduate clinical 
training; and pharmacists undertaking postgraduate research qualifications. Responses to this 
question are presented in Table 24. 
Table 24: Methods for delivering additional research training (n=16) 
Methods to deliver additional 
research training  
Respondent’s preference of methods (1-= most preferred 
method; 3= least preferred method) % (n)  
 
1  
 
2 3 
In-house research training  
 
12.5% (2) 37.5% (6) 50.0% (8) 
Incorporating research into 
postgraduate clinical training 
 
75.0% (12) 18.8% (3) 6.3% (1) 
Undertaking postgraduate 
research qualifications 
 
12.5% (2) 43.8% (7) 43.8% (7) 
 
Incorporating research into pharmacists’ postgraduate clinical training was the most preferred 
method to deliver additional research training to pharmacists with 75% (12/16) of respondents 
ranking this as their first preference. Research training delivered in-house and pharmacists 
undertaking postgraduate research qualifications were similarly rated as only two respondents 
(2/16, 12.5%) ranked in-house training as their most preferred method and the same number 
of respondents (2/16, 12.5%) ranked postgraduate research degree as theirs.    
9.2.5 Chief pharmacists’ perceptions of their ability to support research within their 
respective departments  
Respondents were asked whether they personally felt able to support research activity within 
their department, and the majority (17/22, 77.2%) felt they were. The five respondents who 
felt they were unable to do so were asked a follow up question to find out the reason they felt 
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this to be the case. Their responses are presented in Figure 14. For this question respondents 
were invited to select all responses they perceived to apply and were therefore able to provide 
multiple responses.  
 
 
Figure 14: Factors identified by chief pharmacists as contributing to them feeling unable to 
support research activity (n=5) 
All respondents said their department lacked the capacity to allow pharmacists to undertake 
any other activities other than to deliver the core service. The vast majority (4/5, 80%) also felt 
a lack of staff with research expertise and difficulty in backfilling posts with grant funding 
meant they were unable to support research activity.  
All respondents were asked what measures they would put in place to develop or increase 
research activity among pharmacists in their department. Their responses are presented in 
Figure 15. Similar to the previous survey question, respondents were invited to select all 
responses they perceived to apply and were therefore able to provide multiple responses.  
*other: lack of support 
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Figure 15: Measures chief pharmacists felt would increase research activity (n=21) 
To develop or increase research activity the vast majority of respondents (18/20, 90%) said 
they would establish or further develop links between their department and academia. 80% 
(16/20) also said they would provide staff with in-house training in research skills. However, 
only 60% (12/20) said they would support staff to undertake postgraduate qualifications or 
employ a pharmacist whose role it was to lead research. 
  
*other: promote research activity within the department; give pharmacists protected time to 
undertake research; support pharmacists to undertake research qualifications; have a 
research strategy 
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10 Discussion 
In this chapter the findings of the case study research and survey research are discussed in the 
context of the research objectives stated in section 5.2.  
10.1 Drivers, drawbacks, barriers and enablers to pharmacists undertaking 
research 
In this section the findings relating to participants’ perceptions of the drivers, drawbacks, 
barriers and enablers to hospital pharmacists undertaking research are discussed. For each of 
these key themes, the findings are discussed as follows: the case study findings are compared 
to those of the initial study; the survey findings are compared to the case study findings; the 
case study and survey findings are compared to the published literature.  
10.1.1 Drivers  
Regarding drivers to pharmacists undertaking research, the themes identified from the case 
study research fell into two categories: those relating to the individual referred to as personal 
drivers, and those relating to either the organisation or the profession referred to as external 
drivers.  
Comparison of the case study findings to the initial study findings  
In terms of the personal drivers, compared to the initial study findings job satisfaction and 
research experience emerged as new themes from the case study research. However, several 
other personal drivers identified in the case study research had also been cited previously in 
the initial study. These included personal professional development, personal kudos, and 
having a personal desire to change practice. Interesting to note was that the reasons for 
personal kudos and personal professional development motivating pharmacists to undertake 
research cited in the case study research were different to those in the initial study. In the 
initial study, personal kudos appeared to be related to the accolade of gaining a postgraduate 
qualification, as did professional development, in that participants perceived career 
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progression to be related to possession of such qualifications. In the case study research 
however, individual recognition gained through having research published was cited in the 
context of personal kudos. Similarly, in the context of professional development, reference was 
made to the research skills and transferable skills gained through research contributing to 
career progression rather than the possession of a postgraduate qualification. Participants in 
the case study research therefore appeared to perceive the benefits of research experience to 
be more far reaching than those in the initial study, which is perhaps attributable to those who 
took part in the case study research being more research experienced through either having 
conducted research themselves and/or being the chief pharmacist of a research active 
pharmacy department. This might also explain why job satisfaction and research experience 
were identified as drivers in the case study research but not in the initial study.   
With regard to external drivers, some themes identified in the case study research were the 
same as those identified in the initial study. Organisational culture, organisational reputation 
and the need for evidence from research were identified as external drivers in both the case 
study research and the initial study, albeit in the initial study the need for evidence from 
research was referred to as improving services for patients. However, the case study research 
offered more insight or a different perspective in relation to organisational culture being a 
driver compared to the initial study. In the case study research this related mainly to 
departmental culture as no reference was made to the Trust culture driving research activity 
among pharmacists per se whereas in the initial study the organisational culture at Trust level 
and departmental level both appeared to drive engagement. However, new themes also 
emerged from the case study research which were not apparent in the initial study findings. Of 
these new themes, some related to the organisation (i.e. income generation, research being an 
expectation of the employer, departmental leadership, and departmental role models) while 
other themes related to the profession (i.e. research being an expectation of the profession 
and the perceived association or relationship between research and the reputation of the 
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profession itself). I would suggest that income generation and research being an expectation of 
the employer to be new themes because again the case study participants were more research 
experienced on a personal level and/or were the chief pharmacist of a research active 
pharmacy department and were therefore more likely to be aware of these factors compared 
to the initial study participants who were mostly research-naïve. Departmental leadership and 
departmental role models may be new themes in the case study research because at all of the 
case study sites a pharmacist was employed with responsibility to lead research and all of the 
pharmacy departments were research active. Those who participated in the case study 
research had personal experience therefore of working in environments where departmental 
leadership for research and role models were present. This was not the case in the initial study 
as research activity among pharmacists was described at only two of the six Trusts represented 
by chief pharmacists, and none of the chief pharmacists interviewed made reference to having 
employed a pharmacist whose role was to lead research.   
Research being a professional expectation was also identified as an external driver in the case 
study research but was not apparent in the initial study. This may again have been due to 
participants in the case study research being more research experienced when compared to 
those who took part in the initial study. However, it may also have been due to the time lapse 
of around two years (between May 2016 and early 2018) between data collection for the initial 
study and the case study research. In the intervening period, the Royal Pharmaceutical Society 
(RPS) Faculty may have been promoted within the profession which may have raised awareness 
among members that research was an expected part of their professional practice with 
research as evaluation is one of the clusters of the Advanced Pharmacy Framework on which 
RPS Faculty Membership is based. Likewise, the RPS Foundation Pharmacy Framework may 
have also been promoted in this timeframe. In relation to research being an expectation of the 
employer, it was interesting that, in the case study research, chief pharmacists perceived 
research experience to be a requirement to attain a very senior position within the 
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management structure in secondary care. However, although career progression was cited as a 
personal driver to engagement, several in the pharmacist participant group believed it was 
possible to attain a pharmacist post banded at NHS Agenda for Change Band 8 without 
research experience. The dichotomy between the groups may suggest that chief pharmacists 
perceived there to be a ceiling effect to how far a hospital pharmacist could progress in their 
NHS career without research experience that lower graded staff were perhaps not aware of. 
Regarding research being either a professional expectation or an expectation of their employer, 
it is also interesting to note that, consistent with the initial study findings, participants in the 
case study research seemed to lack awareness of there being a requirement to undertake 
research in the NHS and no direct references were made to this or any of the related policy 
documents. However, unlike the initial study, case study participants were aware of the 
inclusion of research in NHS Agenda for Change role outlines for pharmacists employed at Band 
8a or above. Likewise, although the RPS Faculty and Foundation and Advanced Level 
Frameworks were cited in the case study research, no references were made to the 
requirement to undertake research outlined in the RPS Standards for Hospital Pharmacy 
Services which was a finding similar to that found in the initial study. The extent to which 
engagement with research was being driven through research being an expectation of 
pharmacists employed in the hospital sector, either because research was an expectation of 
them as an NHS employee or because research was a professional expectation, was therefore 
unclear.  
Some of the initial study findings were not apparent in the case study research. For example, 
although the findings of the initial study appeared to suggest that having a research strategy at 
Trust or departmental level was a driver for research among pharmacists, the findings of the 
case study research did not support this theory as no participants cited research strategies at 
either level as driving research activity. Not only this, none of the case study sites had a 
standalone departmental research strategy. However, at three of the four case study sites 
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participants made reference to research being part of the departmental strategy or business 
priorities. The lack of standalone research strategies at the case study sites may have been due 
to the pharmacy departments at all four sites being research active which meant there was no 
need for a standalone strategy at any of the sites. In contrast, those chief pharmacists 
interviewed for the initial study who made reference to research strategies were actively 
looking to increase research activity levels within their departments. Likewise, at Trust level, 
although research strategies appeared to exist at several of the case study sites, as no 
reference was made to these directly influencing research activity among pharmacists at any of 
these sites, it can be inferred from the case study research that Trust-level research strategies 
did not appear to be directly driving research activity among pharmacists.  
Comparison of the survey findings to the case study findings 
In relation to external drivers for research, the survey findings aligned with the findings of the 
case study research in that departmental leadership for research and departmental role models 
were perceived by the majority of survey respondents to encourage research activity among 
pharmacists (Figure 10). Regarding research being an expectation of an individual’s role, this 
appeared less so to be perceived to encourage activity as only around half of respondents 
identified the inclusion of research in pharmacists’ appraisals and job descriptions as drivers.    
The influence of organisational culture on research activity was also explored through the 
survey. In the case study research, organisational culture at both Trust and departmental levels 
were identified as drivers for research engagement, with departmental level culture perceived 
to be more influential than the culture at Trust level. The survey research supported this finding 
in that more respondents felt the culture at departmental level was encouraging of research 
compared to the Trust culture (Table 22). Interestingly, a sizable proportion of survey 
participants also felt that both the Trust culture and departmental culture discouraged research 
activity among pharmacists which, although a similar finding to the initial study, was not similar 
to the case study findings as no participants in the case study research described the culture at 
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either Trust or departmental level as discouraging of research. A possible explanation for this 
may be that the chief pharmacists who participated in the survey phase of the main research 
study and in the initial study represented a mixture of pharmacy departments that were 
research active and departments that were not, whereas in the case study research all 
departments were research active. As a result, some participants in both the survey research 
and initial study may have felt the Trust or departmental culture not to be encouraging of 
research.  However, slightly contradictory to this explanation for the difference between the 
survey results and the case study findings, was that the majority of departments represented 
by the chief pharmacists who participated in the survey were research active i.e. the majority 
of survey respondents (76.2%) said pharmacists in their department were either undertaking 
research at the time of the survey being conducted or in the preceding three years. Levels of 
research activity among pharmacists in those departments represented by participants were 
not explored through the survey research and, as case study sites had been selected based on 
their high levels of research activity among the pharmacists employed, it is reasonable to 
assume that levels of activity within the research-active departments represented by survey 
participants may have been comparatively lower than those at the case study sites. Perhaps 
most significant though is the relatively low response rate to the survey which means it is 
difficult to determine the representativeness of survey respondents to the population of 
interest. Survey respondents were a self-selecting group and those who responded may 
therefore have been those most interested in or passionate about the importance of 
pharmacists undertaking research. Certainly the vast majority of those who did respond 
(95.5%) felt it was either very important or important that pharmacists engaged with research 
(Figure 8), which would support this idea that those who participated were those who felt 
strongly that pharmacists should undertake research. If this was the case, respondents who 
represented departments with no or low research activity levels may have felt their 
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departmental culture discouraged research among pharmacists. Likewise they may have been 
more likely to feel their Trust culture was discouraging of research.  
Personal drivers for research engagement identified in the case study research were not 
specifically explored through the survey. However, having a personal desire to undertake 
research was overwhelmingly identified from the survey research to be the most significant 
motivating factor for pharmacists to undertake research compared to research being a 
professional expectation or an expectation of an individual’s employing organisation (Figure 9). 
It could also be argued that the survey findings supported the finding of the case study 
research that having research experience was a driver for individuals to undertake further 
research in their careers as the majority of respondents (76.2%) were research experienced i.e. 
they had undertaken research in their professional careers (Table 21) and almost a third 
(28.5%) were undertaking research at the time of the survey (Table 20). 
Comparison of the research findings to the literature  
Similarity was evident in the drivers identified in the case study research to the motivational 
factors for pharmacists to participate in research cited in the literature. For example, inclusion 
of research as a requirement of an individual’s role as a driver had previously been identified in 
the literature (Lee et al. 2018, Lowrie et al. 2015), as had job satisfaction (Carr et al. 2011). 
Likewise, the suggestions to increase engagement with research by linking research to career 
progression and including research in appraisals as identified by Lowrie et al (2015), were also 
cited in the case study research. However, perhaps more significant was the survey finding that 
personal desire to undertake research was perceived to be by far the most significant 
motivator. This aligns with the observation that ‘those who had managed to incorporate 
research into their job roles had drawn on their internal drive to conduct research’ (p.11) 
reported by Lowrie et al. (2015). This suggests that, to increase engagement among members 
of the profession, more needs to be done at both professional level and organisational level to 
drive activity to overcome this reliance on individual desire.  
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In addition to there being similarity with the motivating factors and other factors perceived to 
encourage activity cited in the literature, the reasons for research being important reported in 
the literature are also very similar to those cited as drivers or motivating factors in the case 
study research. For example, the reasons for the importance of research cited in the literature, 
such as improving practice and patient care (Lowrie et al. 2015, Awaisu, Alsalimy 2015, Fakeye 
et al. 2017, Sarwar et al. 2018, Sultana et al. 2016), research being a professional responsibility 
or part of professional practice (Bhagavathula et al. 2017, Fakeye et al. 2017, Awaisu, Alsalimy 
2015, Sultana et al. 2016), and research being important to professional standing (Lowrie et al. 
2015), were all identified in the case study research. Career progression was also cited in the 
literature as a reason why engagement in research was important (Bhagavathula et al. 2017, 
Awaisu, Alsalimy 2015). This was also cited in the case study research in the context of personal 
professional development. However, some motivating factors reported in the literature were 
not identified in the case study research. Personal interest in a research area (Awaisu, Alsalimy 
2015, Lowrie et al. 2015) and learning about disease management (Peterson et al. 2009, 
Simpson et al. 2001, Sultana et al. 2016, Fakeye et al. 2017, Lee et al. 2018), are examples of 
motivating factors identified in the literature but not in the case study research. Although 
participants did not directly cite these factors, I would argue that they were cited indirectly as 
reference was made by some participants to them being regarded as an expert in their field 
driving them to want to undertake research in the context of personal kudos being a driver. 
Likewise, gaining a postgraduate qualification was cited by Lowrie et al. (2015) as being a 
motivating factor. Again this was not a finding of the cases study research although personal 
professional development was, and I would argue that gaining postgraduate qualifications is 
inherently perceived to be part of professional development.  
Research experience was a new theme to emerge from the case study research not found in 
the literature. However, two previous studies had compared levels of interest in research 
among those with prior research experience and those without, and in both instances levels of 
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interest in future research had been found to be higher among those with experience (Saini et 
al. 2006, Sultana et al. 2016). Therefore, I would suggest that although research experience 
being a driver for engagement was identified as a new theme, it is consistent with the findings 
of previous studies. Other drivers identified in the main research study and not previously cited 
included departmental leadership and role models, research being good for an organisation’s 
reputation, the association between research and income generation, and the organisational 
culture at Trust level and departmental level all having a role to play in influencing research 
activity among pharmacists. I would suggest these all to be apparent in the case study research 
but not previously cited in the literature for similar reasons to some not being apparent in the 
initial study i.e. because all of the case study participants worked within or were the chief 
pharmacist of pharmacy departments with high levels of research activity, and, therefore, had 
experience of working in environments where these factors were present. Recognition of 
research being a professional expectation was also a factor not previously cited although 
research being a professional responsibility had been identified in the literature in relation to 
why undertaking research was important for the profession (Awaisu, Alsalimy 2015). Likewise, 
professional kudos was identified in the case study research as a driver for research 
participation and the importance of research to professional standing had previously been 
cited in the context of the importance of research (Lowrie et al. 2015).   
10.1.2 Drawbacks 
Like the drivers for pharmacists to undertake research, the perceived drawbacks to research 
engagement identified through the case study research fell into the same two categories i.e. 
personal drawbacks relating to the individual and external drawbacks relating to the 
organisation.  
Comparison of the case study findings to the initial study findings 
No drawbacks to engagement were identified in the initial study meaning the findings of the 
case study research cannot be compared directly to those of the initial study. 
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Comparison of the survey research findings to the case study findings 
Some of the drawbacks identified in the case study research were explored through the survey 
research albeit in the context of factors perceived by chief pharmacists as contributing to them 
not being able to support research activity in their respective departments. Difficulty backfilling 
posts with grant funding was identified by the majority of respondents to be a factor they 
believed prevented them from feeling able to support research activity within their 
department. One participant in the survey research also identified research as deflecting from 
pharmacists’ clinical roles as a factor preventing research activity. It can therefore be argued 
that these survey findings align to the drawbacks identified in the case study research relating 
to difficulty backfilling posts with grant funding and the impact on service delivery associated 
with pharmacists undertaking research.  
Comparison of the research findings to the literature  
None of the studies identified in the literature specifically explored the drawbacks to 
pharmacists engaging with research. A direct comparison of the main study research findings to 
the literature cannot therefore be made. However, some of the drawbacks identified in the 
case study research relate to perceived barriers to engagement identified in the literature. For 
example, lack of capacity (Horák et al. 2018) was identified as a barrier to engagement in the 
literature which has some similarity to the external drawback relating to the impact on service 
delivery associated with research identified in the case study research. Likewise, lack of 
remuneration (Crilly et al. 2017) was identified as a barrier in the literature which could be 
argued aligns to the personal drawback identified in the case study research relating to reduced 
income being associated with research. My thoughts are that participants in the case study 
perceived these to be drawbacks rather than barriers because they were research experienced 
and that these factors had therefore not prevented their engagement with research. Rather 
than perceiving them to be barriers to be overcome, they viewed them instead as downsides to 
research.  
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10.1.3 Barriers 
Barriers to engagement identified by the case study research again fell into the same two 
categories as the drivers and drawbacks i.e. personal barriers relating to the individual and 
external barriers relating to either the organisation or profession.  
Comparison of the case study findings to the initial study findings 
Concerning external barriers, consistent with the findings of the initial study, barriers relating 
to time, funding, and accessing support were identified. Organisational culture was also 
identified as another external barrier. However, compared to the initial study findings, the case 
study research offered more insight or a different perspective in relation to all of these. In the 
context of time presenting a barrier to engagement, in both the initial study and the case study 
research, lack of time to undertake research appeared to be related to competing demands of 
the day job. Therefore in both studies lack of time did not appear to be a barrier to research 
specifically, but a barrier to any activities perceived to be outside core duties. However, the 
case study research offered greater insight as lack of time was identified to be more of an issue 
for those in more junior roles due to their clinical commitments. Also apparent from the case 
study research was that lack of time appeared to be compounded by several other factors 
including the time consuming nature of applying for funding and the time consuming nature of 
research itself. Reference was also made to the long time frames associated with the research 
ethics and governance processes, to the extent that some participants appeared to call into the 
question the value of undertaking research of an academic nature. Similarly lack of funding was 
identified as a barrier in the initial study whereas in the case study research it was more 
specifically difficulty obtaining funding and lack of pharmacy specific funding which were 
identified. Also consistent with the initial study, access to support was identified as a barrier in 
the case study research but this appeared to be specific to accessing internal support for 
research within the Trust. Reference was not made to difficulty accessing support at 
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departmental level or through academic links to universities which the findings of the initial 
study suggested were barriers. 
These differences in the findings of the case study research compared to the initial study in 
relation to the factors identified as contributing to time and funding being barriers perhaps 
reflect the fact that, as cited earlier in section 0, participants in the case study research were 
more research experienced than those in the initial study. Case study research participants 
were therefore more likely to have personal experience of applying for research funding and 
ethics and governance approvals, and therefore have experienced difficulties in relation to such 
applications. However, as the finding that difficulty accessing support at departmental level or 
through academic links was identified in the initial study but not in the case study research, I 
would suggest is more likely to be a consequence of those in the case study research working in 
research-active departments where support mechanisms were already in place than to be 
because case study research participants were more research experienced compared to those 
in the initial study. Indeed all four case study sites were selected on the basis that their 
pharmacy departments were research active and had models of support for pharmacists to 
undertake research.  
With regard to organisational culture being a barrier, the findings of the case study research 
and initial study were again similar. Research was not perceived to be a core part of 
pharmacists’ roles in either study and in both studies was illustrated by a suggestion that there 
was an expectation for pharmacists to undertake research in their own time.  In both studies, 
lack of prioritisation of research at departmental level was also cited as another barrier to 
engagement, with reference made to clinical services taking priority as the reason. In the case 
study research lack of managerial support was also reported as a barrier in the context of 
organisational culture, and similarly was perceived to be due to research not being perceived to 
be part of the core pharmacy service. Research therefore appeared to be deprioritised at both 
a day-to-day level and at a more strategic level within the department in favour of delivery of 
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the core clinical service. Lack of managerial support was not a finding of the initial study which, 
I would suggest may be due to those who participated in the case study research being more 
research-experienced and therefore more likely to have personally experienced this to be a 
barrier.  
Regarding the personal barriers identified in the case study research, once again there was a 
high degree of similarity between the findings of this phase of the research and the initial 
study. Lack of confidence was identified as a barrier in both studies, and the reasons for this 
were the same i.e. pharmacists were fearful of undertaking research and perceived research to 
be complex to undertake. Lack of competence was also identified in both studies, but so too 
was a perception that pharmacists had a latent ability to undertake research. Reference to this 
latent ability was in relation to the level of skill required to conduct research and the scientific 
approach required since participants in the case study research made reference to pharmacists 
being familiar with the practice of evidence-based medicine.  
Lack of awareness and understanding was also a theme identified in both studies, and the 
reason for this preventing engagement was multifactorial. However, more insight as to why this 
was a barrier was found in the case study research as not only were more factors identified as 
contributing to this but, in relation to the factors consistent in both, the case study research 
findings offered more insight into why some represented barriers. For example, although a lack 
of understanding of the benefits of research to pharmacy practice was a finding in both studies, 
in the case study research a lack of appreciation of the value of research in practice was 
perceived to contribute to this and was attributed to a disconnect between the research 
undertaken by academia and practice. The reasons for this disconnect included a perception of 
academic research not being relevant to practice, differences in the types of journals in which 
researchers were looking to publish their work, and the long timescales associated with 
academic research impacting on the use of such research in practice. Interestingly, a lack of 
appreciation of the value of research was identified as a barrier in the case study research 
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despite there being a recognition among participants that pharmacists routinely practiced 
evidence-based medicine. Although not explicit from the interviews, this could suggest that 
pharmacists see evidence-based medicine and the use of clinical trials data relating to the use 
of medicines as being distinct from using practice-based research to inform service delivery. 
Pharmacists lacking a fundamental understanding of research, lacking awareness of research 
opportunities, the personal benefits of research, and different types of scientific inquiry were 
also identified as factors contributing to lack of awareness and understanding being a barrier in 
the case study research but not in the initial study. Some of these factors may not have been 
apparent in the initial study for the reason as given earlier in relation to the drivers and barriers 
i.e. that the case study participants were employed in research active departments. For 
example, participants in the initial study may have been unaware of the existence of research 
opportunities whereas those in the case study research appreciated their awareness of such 
opportunities because they were employed in a research active department. This was 
illustrated by reference being made in the case study research to research opportunities being 
promoted within departments. In relation to the other factors identified in the case study 
research but not in the initial study, although some were not cited in the initial study per se, 
they were nevertheless apparent. For example in relation to insufficient personal benefits, lack 
of career progression and career pathways were identified as contributing to this in the case 
study research which align with the absence of research in career structures and limited 
financial gains associated with research cited as barriers to engagement in the initial study. 
Similarly, the finding of pharmacists lacking an understanding of the different forms of scientific 
inquiry, was also evident in the initial study as some of the chief pharmacists who participated 
were unable to distinguish between audit, evaluation and research. Likewise, a perception that 
research was the only type of inquiry that could be published was similar to the finding of the 
initial study where authorship of publications was perceived to be synonymous with research.  
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Interestingly, some of the barriers cited in the initial study were not apparent in the case study 
research and included a perception of research being ‘risky’ and a lack of engagement between 
universities and Trusts. Presumably these were not cited in the case study research because 
participants were research-experienced and therefore not afraid of conducting research that 
may have negative findings and because at all of the case study sites the pharmacy 
departments were engaged with local universities either through formal or informal 
arrangements. Confusion between research-related activities that constituted support of 
research delivery rather than undertaking research, such as managing clinical trials medicines, 
was also apparent in the initial study but not in the case study research. Again I would suggest 
this was because all participants in the case study research had either undertaken research 
themselves or were the chief pharmacist of a research active pharmacy department and so 
understood the difference.  
Comparison of the survey findings to the case study findings  
In line with the case study research, the survey also found that lack of time was the most 
commonly perceived barrier as over 95% of respondents perceived this to prevent pharmacists 
undertaking research (Figure 12). Similar findings were found when chief pharmacists were 
asked why they felt unable to support research activity within their respective departments. 
Although the numbers were small (n=5), all respondents said a lack of capacity for pharmacists 
to undertake activities other than delivering the core service prevented engagement (Figure 
14). Lack of research knowledge and skills and difficulty obtaining funding were also perceived 
by survey respondents to be barriers and the survey findings therefore also aligned with those 
of the case study research. The case study finding that lack of understanding of research was a 
barrier to engagement was also supported by the survey as respondents perceived pharmacists 
‘having a better understanding of what research is’ to be an enabler (Figure 13). 
Factors perceived to discourage research activity were also explored in the survey research, 
and again the findings were also consistent with the case study research. Research being 
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perceived to be difficult to undertake was identified by the vast majority (90.5%) of 
respondents and although fewer respondents perceived lack of understanding of the benefits 
to pharmacy practice and lack of perceived benefits to career progression to discourage 
activity, nevertheless both were identified as factors which discouraged activity by just under 
half of the participants (Figure 11). Several responses were also provided to the ‘other’ 
category to the survey question relating to the factors which discouraged activity, suggesting 
there to be breadth of reasons for pharmacists being discouraged from undertaking research. 
Lack of access to individuals with research expertise was perceived to prevent engagement in 
the survey, being identified as both a barrier to engagement and a factor which discouraged 
activity (Figure 12 and Figure 11 respectively). However, this finding did not support the case 
study research findings per se, as lack of access to individuals with research expertise was not 
identified in the case study research to be a barrier to engagement since all the case study sites 
had an individual with research expertise. 
Comparison of the research findings to the literature  
In terms of the case study findings relating to the barriers of lack of funding and difficulty 
accessing support, similar themes were identified in the case study research to those previously 
reported in the literature, but the case study research gave more insight or offered a different 
perspective. For example, although difficulty accessing funding (Shitu et al. 2019) and lack of 
funding (Awaisu, Alsalimy 2015, Abubakar et al. 2018, Fakeye et al. 2017, Zeidan et al. 2019) 
had been previously identified as barriers, the time consuming nature of grant applications and 
the high failure rates of such applications were a level of detail not cited elsewhere in the 
literature. Similarly, although lack of support had been reported previously in the literature as a 
barrier (Awaisu, Alsalimy 2015), difficulty accessing support from Trust R&D departments 
identified in the case study research was a level of detail that had not previously been 
reported. Likewise, lack of time had been previously cited in many studies (Awaisu, Alsalimy 
2015, Lowrie et al. 2015, Abubakar et al. 2018, Crilly et al. 2017, De Vera et al. 2018, Sultana et 
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al. 2016, Lee et al. 2018, Shitu et al. 2019, Zeidan et al. 2019, Kuipers et al. 2019), but the time 
consuming nature of research itself compounding the issue had not been reported. Also in 
relation to lack of time being a barrier, the case study research findings give further credence 
to other findings previously reported in the literature. For example, the case study research 
finding that a lack of time presented a barrier in the context of the competing demands of the 
day job aligns with other workload priorities presenting a barrier to engagement previously 
cited in the literature (Lee et al. 2018). In addition, as those who participated in the case study 
research were either research active at the time of the case study research being undertaken, 
or had been in the preceding three years, I would also suggest that the case study research 
findings give credence to the suggestion made in several previous studies that pharmacists 
interested in undertaking research would be willing to find time to do so (Fakeye et al. 2017, 
Crilly et al. 2017, Kuipers et al. 2019, Sultana et al. 2016). 
In terms of how the case study research and survey findings regarding organisational culture 
relate to the published literature, the findings are again consistent in that lack of priority 
(Lowrie et al. 2015), lack of managerial support (Lowrie et al. 2015, Abubakar et al. 2018, Crilly 
et al. 2017, Sarwar et al. 2018), and organisation culture itself (Lowrie et al. 2015, Stewart et al. 
2015) have all been cited previously as factors preventing engagement. The case study research 
findings also give credence to the suggestion previously reported in the literature that, rather 
than lack of time being a barrier to engagement, the barrier was instead that research was not 
being prioritised (Lowrie et al. 2015). However, the case study research findings also add more 
depth to understanding why prioritisation of clinical services prevents pharmacists engaging 
with research as it was apparent that clinical services were prioritised both at a departmental 
strategic level and day-to-day level. Not only was managers not prioritising research identified 
as a barrier but research was not perceived to be a core part of pharmacists’ roles was also 
identified. Arguably these barriers are linked to the lack of awareness of some of the 
organisational and professional drivers for pharmacists to undertake research i.e. if individuals 
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and managers are not aware of the requirements for pharmacists to undertake research under 
NHS Agenda for Change, and if they are not aware of the RPS requirements for research to be 
part of pharmacists’ professional practice, research will not be seen to be a core duty. 
In terms of how the research findings relating to personal barriers compare to the literature, 
the case study research findings are consistent with the literature. Lack of confidence reported 
in the case study research had previously been identified to be a barrier to engagement 
(Armour et al. 2007, Awaisu et al. 2015, Lowrie et al. 2015), and fear associated with research 
identified as a factor contributing to pharmacists lacking confidence had also been previously 
cited (Lowrie et al. 2015). Likewise, lack of competence identified as a barrier in both the case 
study research and survey had also been reported previously (Awaisu, Alsalimy 2015), as had 
inadequate knowledge (Lowrie et al. 2015, Abubakar et al. 2018, Crilly et al. 2017, Fakeye et al. 
2017, Sarwar et al. 2018). However, a new finding of this research was a perception that newly-
qualified pharmacists lacked the necessary skills and knowledge to undertake research. Couple 
this with the findings of Lowrie et al. (2015) who reported that postgraduate qualifications did 
not equip pharmacists to undertake subsequent research in the workplace, it is clear that 
training in research knowledge and skills is lacking in the profession. Lack of understanding and 
awareness of research had not been identified previously as a barrier in its own right, although 
some of the factors identified in the case study research as contributing to this preventing 
engagement had. For example, lack of awareness of opportunities (Sarwar et al. 2018, Peterson 
et al. 2009, Sultana et al. 2016), lack of extrinsic rewards (Lowrie et al. 2015) and lack of 
incentives (Sarwar et al. 2018) previously identified in the literature align to the case study 
research finding that insufficient personal benefits prevented engagement. Other factors, 
however, had not. For example, a fundamental lack of understanding among members of the 
profession about what research is, was identified as a barrier to engagement in both the case 
study research and the survey which had not been previously reported. Confusion over those 
activities which constituted research involvement was another barrier identified in the case 
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study research not found in the literature. This included confusion between the different types 
of scientific inquiry, confusion between research and authorship of publications and/or 
conference posters and abstracts, and confusion between the role of chief investigator and 
principal investigator. None of these findings had been cited previously in the literature 
although Lowrie et al (2015) reported that some participants experienced difficulty in 
distinguishing between different forms of investigation but did not report this as a barrier 
(Lowrie et al. 2015). Variation evident in the literature regarding how involvement in research 
is defined was also identified through the literature review for the main research study as 
outlined in section 6.2.2.1. It is perhaps no surprise, therefore, that there is confusion among 
members of the profession regarding both what constitutes research and ways in which 
pharmacists can be involved in research through the course of their practice. To address this 
confusion, pharmacists need to be provided with clarity in terms of the activities they can be 
involved in which constitute research involvement and the different types of scientific inquiry 
which constitute research. The Royal College of Physicians (RCP) have developed a Research 
Engagement Toolkit (RCP 2017), now in its second edition, to provide doctors who are 
interested in research with comprehensive up-to-date guidance and support. Pharmacists may 
perhaps need a similar toolkit.  
10.1.4 Enablers 
Like the drivers, drawbacks and barriers to engagement, the enablers identified by the case 
study research fell into the same two categories i.e. personal enablers relating to the individual 
and external enablers relating to either the organisation or profession.  
Comparison of the case study findings to the initial study findings  
External enablers also fell into the same themes as external barriers i.e. resource and 
organisational culture.  
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In terms of resource, allowing pharmacists the time in their day jobs to conduct research was 
seen to facilitate engagement in the case study research and in the initial study. Protected time 
and obtaining funding to backfill posts were identified in both studies as ways to allow 
pharmacists to undertake research. As in the initial study, time and funding therefore appeared 
to be closely linked, with funding appearing to facilitate pharmacists having the time to 
undertake research. However, the case study research offered further insight regarding how 
pharmacists were allowed time to undertake research as the backfilling of posts was not the 
only way mentioned. Reference was made to several others ways to achieve this, presumably 
because participants in the case study research were more research experienced and were 
working in research active environments. In the case study research, integrating research into 
pharmacists’ job roles was cited as an enabler. Consultant pharmacist posts and combined 
clinical academic posts were cited as examples of where research was incorporated into the job 
roles of pharmacists. Research being a pharmacist’s primary role was also cited as allowing 
pharmacists the time to conduct research but appeared to relate to funding facilitating time to 
undertake research as pharmacists in such positions were funded through programme grants. 
Reference was also made to having protected time to undertake research by some of those 
who had undertaken research as part of a postgraduate qualification. Although not apparent 
from the interviews, I would suggest this may be because the department had invested money 
in individuals to fund their qualification and were therefore willing to allow them time to 
conduct their research during the working day. Having a senior position was also identified in 
the case study research to enable individuals to find time to undertake research in the working 
day. This appeared to be due to those in senior positions having more autonomy in their time 
management compared to those in junior roles. Demographic data collected from participants 
in the case study research also suggested an association between seniority and research 
activity as the majority of participants in the pharmacists group (78.6%) had been qualified for 
10 years or more and were therefore more likely to be in more senior roles (Table 10). In 
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addition, in relation to a lack of time being a barrier to engagement, this appeared to present a 
barrier more so to those in junior positions as those in more junior roles appeared less able to 
personally prioritise research. Individuals in junior positions not having sufficient autonomy 
over their time management to incorporate research into their working day perhaps implies 
that research was not prioritised, and again supports the idea that lack of prioritisation rather 
than lack of time is a barrier to engagement. 
In relation to obtaining funding being an enabler to engagement, it was interesting to note that 
in the case study research this was cited as an enabler but difficulty backfilling posts from grant 
funding was also identified as a drawback. Reference was made to both the short timeframes 
associated with grant funding and with the funding from some grants only being sufficient to 
cover a proportion of an individual’s salary as reasons why departments had difficulty 
backfilling posts from grants. However, as difficulty backfilling posts was identified as a 
drawback rather than a barrier to engagement suggests it is a difficulty departments are able to 
overcome.   
Consistent with the initial study findings, access to research expertise was identified as enabling 
research engagement in the case study research. Access to individuals with research expertise 
in the department was referred to in both studies in the context of individuals with research 
expertise providing peer support and mentorship to others undertaking research, and also 
helping others with aspects of the research process. It was interesting to note that the aspects 
of the research process where access to research expertise in the department could help i.e. 
writing grant applications, developing research ideas and writing conference abstracts and 
publications identified in the case study research were similar to the aspects that had been 
identified as preventing barriers to engagement. This suggests that pharmacists having access 
to individuals with research expertise within their department enables them to overcome 
barriers associated with their lack of research knowledge and skills.  
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Some of the suggestions made by participants in the initial study to enable pharmacists to 
undertake research were also apparent in the case study research. For example, in the initial 
study, a suggestion was made to identify a pharmacist in the department whose role was to 
provide leadership in research, and at all four case study sites a pharmacist had been identified 
whose role encompassed leading research. Another suggestion in the initial study to facilitate 
engagement was closer collaborations with universities. This was apparent in the case study 
research as all four departments had established links with Schools of Pharmacy at local 
universities. However, the establishment of centralised research support facilities and 
collaborations with other Trusts which had been suggested as ways to facilitate research 
activity in the initial study, were neither apparent in the case study research nor were 
suggested by participants in this phase of the research. This may have been because, by virtue 
of all of the Trusts selected to be case study sites having research active pharmacy 
departments, meant that all participants in the case study research had access to individuals 
with research expertise within their departments which meant they did not identify a need to 
access such support through external collaborations.  In addition, as referred to above, a 
pharmacist was employed at all four case study sites with responsibility to lead research and 
who provided individuals with access to research expertise. Where departments at case study 
sites had academic practice units, these too provided individuals with access to research 
expertise through staff who were part of the academic practice unit having research expertise. 
Consequently, I would suggest participants in the case study research did not perceive there to 
be a need for any additional support for them to undertake research over and above that which 
was already on offer in their departments.  
New themes to emerge from the case study research relating to access to support referenced 
to the way departmental links with academia supported research as, through such links, 
individuals in practice had access to IT infrastructure and access to physical space to undertake 
research away from distractions. The fact that academic links were cited as facilitating access to 
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undisturbed physical space for staff, may give further credence to the idea that lack of 
prioritisation at departmental level presents a barrier to engagement, in that, for some 
participants in the case study research, it seemed that within the departmental environment 
their clinical work was perceived by others to take priority, even when their research time was 
funded by academia.   
Organisational culture was also cited as an enabler to research engagement in the case study 
research as it had been in the initial study. However, like the enablers relating to resource, the 
case study research offered more insight as to how the culture of the organisation enabled 
research activity. In the case study research, the need to have a chief pharmacist who was 
supportive of research, as well as the need to have supportive management, were identified. 
For the culture of a department to enable research activity, the case study findings suggested 
that support for research needed to be apparent through the management team and not 
limited to the chief pharmacist.  
In terms of personal enablers, the idea that individuals needed to have certain personal 
attributes or qualities to undertake research, as identified in the case study research, 
reaffirmed the finding of the initial study that individuals with certain mindsets were more 
likely to undertake research. However, none of the attributes needed that were identified in 
the case study research were the same as those in the initial study. Being ‘free-thinking’ and 
less risk-averse were identified in the initial study as necessary whereas in the case study 
research the need to be resilient, self-motivated and having a questioning mindset were found. 
There were some similarities though. For example, having a questioning mindset arguably 
aligned to the finding of the initial study which suggested that pharmacists who were ‘free-
thinking’ were more inclined to undertake research. Likewise, although the need to be resilient 
and self-motivated were not identified in the initial study, the perceived complexity of research 
was identified as a barrier in the initial study. Reference was also made in the initial study by 
some of the chief pharmacists who had research-active pharmacists employed in their 
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respective departments, that pharmacists being research active in their department was a 
consequence of them as chief pharmacists responding to the personal desire of such individuals 
to undertake research rather than because they had encouraged them to undertake research. 
This suggests that although resilience and self-motivation were not made explicit as personal 
attributes by participants in the initial study, they were perhaps apparent. However, the key 
difference between the personal attributes identified in the case study research and the initial 
study was that those identified in the case study research were either observations or were 
described by participants as their personal experience, whereas in the initial study chief 
pharmacists thought these to be the personality traits of pharmacists who would be more 
inclined to undertake research. I would therefore suggest this was why the findings of the case 
study research differed to those of the initial study.  
Individuals being competent to undertake research was also identified as an enabler in the case 
study research, as it had been in the initial study. Undertaking postgraduate qualifications was 
cited in both studies to represent a way that pharmacists could acquire these skills and, giving 
credence to this, was the finding that the vast majority (92.8%) of those who participated in the 
case study research in the pharmacists group had either Masters or Doctoral level postgraduate 
qualifications (Table 10). As had been found in the initial study, postgraduate qualifications 
were suggested as a way for pharmacists not only to gain research skills but also as a means of 
having access to mentorship and to have protected time to undertake research. However, 
other methods of accessing training were also identified in the case study research which had 
not been identified in the initial study with delivery of ‘in-house’ training being one suggestion 
and integration of research into postgraduate training being another. Indeed, at one case study 
site, training in ‘softer’ research skills was already in place in that training in how to get 
research published was delivered in-house to pharmacy staff by the lead pharmacist for 
research.   
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Comparison of the survey findings to the case study findings 
The survey findings aligned with those of the case study research in that the factors most 
commonly perceived to enable research activity in the survey research were the integration of 
research into pharmacists’ roles, having more pharmacy-specific funding opportunities and 
pharmacists having access to individuals with research expertise (Figure 13). Therefore, the key 
themes identified in the case study research which related to resource enabling research 
activity were similarly identified in the survey component. Better access to research training 
was also identified as a factor perceived to enable research activity from the survey which had 
also been a finding of the case study research.  
Chief pharmacists also identified access to training and support as a measure they would put in 
place to increase activity (Figure 15). Interestingly, more said that they would offer staff in-
house training in research skills and establish, or further develop, links with academia than said 
they would support more staff to undertake postgraduate qualifications, or employ a 
pharmacist whose role it was to lead research. The measures that they more commonly 
identified were those which were less resource intensive, which may reflect the current climate 
of cost saving being a priority in the NHS. Arguably these survey findings were different to 
those of the case study research as all of the pharmacy departments at the case study sites had 
a lead pharmacist for research. In addition, as referred to in the previous section, most of those 
who participated in the case study research in the pharmacists group had postgraduate 
qualifications. These findings suggest that having a lead pharmacist for research within a 
pharmacy department and postgraduate qualifications are factors which enable research 
activity. However, in the case study research, reference made to the support provided through 
academic links was mainly in respect of these links offering individuals access to infrastructure 
and physical space away from the Trust to undertake research free from distractions, and in-
house training in research skills was only offered at one of the sites. 
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A question was also included in the survey relating to chief pharmacists’ perceptions of the 
competence of newly-qualified pharmacists to undertake research. The majority of 
respondents (76.2%) felt that they lacked the knowledge and skills to undertake research which 
suggests that the undergraduate curriculum does not equip pharmacists to undertake research. 
Although this was not directly cited in the case study research, it could be argued it was 
inherently apparent as there was a perception that pharmacists lacked the competence to 
undertake research, and if the undergraduate curriculum did deliver adequate training in 
research skills then this would not have been identified. As previously highlighted, the majority 
of those interviewed in the case study research also held a postgraduate research qualification 
and perceived such qualifications to be how they personally gained their research skills, rather 
than them making reference to gaining such skills at undergraduate level. Taken together these 
findings suggest that the undergraduate degree does not equip pharmacists to undertake 
research. Those in the survey research who felt newly-qualified pharmacists to lack research 
knowledge and skills were asked a follow up question regarding how they felt additional 
training should be delivered. There was a strong desire for such training to be incorporated into 
pharmacists’ postgraduate clinical training (Table 24) and was in preference to pharmacists 
undertaking postgraduate research qualifications or accessing training in-house.  
Comparison of the research findings to the literature  
Similarity was evident between the research findings and the literature. Protected time to 
undertake research had been identified previously as a facilitator (Crilly et al. 2017, Lowrie et 
al. 2015), as had access to training (Crilly et al. 2017) and the necessity of management support 
(Crilly et al. 2017, Lowrie et al. 2015). Particularly pertinent is the similarity to the findings of 
Lowrie et al. (2015) who cited access to support, job roles which oversee research activity, 
funding to allow backfill of roles, peer support, and access to individuals with research 
expertise as facilitators to engagement, all of which were apparent in the case study research. 
Lowrie et al. also explored pharmacists’ involvement in research and reported that the majority 
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of participants who had either previously undertaken or were undertaking research, had done 
so in part fulfilment of a work-based postgraduate qualification, and that those with a 
postgraduate qualification were more likely to be involved in research, along with those with 
increasing numbers of years of postgraduate experience. The case study research also aligns to 
these findings in that the vast majority (93%) of participants in the case study research had 
undertaken research as part of postgraduate qualification, and the majority (79%) of those who 
participated in the case study research had been qualified as a pharmacist for ten or more 
years (Table 10). Lowrie et al. also concluded that the findings of their research suggested that 
‘perceived contextual barriers were outweighing personal elements to participate in research’ 
(p.10). I would suggest that the case study finding that individuals need to be resilient to 
undertake research gives this credibility.  
New themes to emerge as enablers were the idea that an individual needs to have certain 
personal attributes or qualities to undertake research, the need for a pharmacy department to 
have a culture for research and for chief pharmacists to be supportive of research. None of 
these themes had been previously reported.  
10.1.5 Similarity of the research findings to literature relating to other healthcare 
professions  
The RCP paper ‘Research for all: Building a research-active medical workforce’, referred to 
earlier in chapter 2 cited barriers and drivers to research engagement among the medical 
profession based on the findings of a survey undertaken in 2015 (RCP 2016). The largest 
barriers to engagement were reported to be time and funding followed by a perception that 
the ethics approval system was excessively onerous. These findings were not dissimilar to those 
reported by pharmacists in this research. In terms of drivers, research adding variety to roles 
and individuals finding research rewarding were reported to be most appealing. However, 
when analysed by career stage, the authors reported these findings to apply more so to 
consultants than trainees. Gaining a competitive edge in terms of employment was more 
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important for trainees. Not only are the findings reported in the paper similar to the findings of 
this research, the reference made to research being linked to employability for doctors perhaps 
also gives credence to the perception from the case study research that research is more 
integrated into the career path of doctors compared to pharmacists. However, the finding that 
time was one of the largest barriers to doctors undertaking research does not give credence to 
the perception that pharmacists had of doctors having protected research time.  
Rather than focusing on doctors, two other reports which spanned multiple health professions 
were identified in the literature.   
The first is the report commissioned by Cancer Research UK entitled ‘Every patient a research 
patient?’ (Brown et al. 2015). Two areas of focus were particularly pertinent to this study: the 
barriers to research in the NHS and the steps needed to be taken to promote a stronger culture 
of research in the NHS. The authors of the report provided a definition of how the term 
‘research’ had been applied in their study in recognition of the scope of possible research 
activities and ambiguities in interpretation of the term. For their study, the term research was 
applied specifically to the conduct of clinical research within the NHS which included 
observational studies and interventional clinical trials. Although the definition of research used 
was relatively narrow in focus compared to the one used in this research, it was interesting to 
note that several of their findings resonated with those of this study. For example, the capacity 
of the NHS to give people time to commit to research was described as the most frequently 
mentioned challenge to research engagement. The authors also reported consensus among 
participants that all providers, regardless of their size, would have difficulty prioritising research 
given their clinical commitments and the pressures on their services. They also reported service 
requirements to encroach on the research time of even those in clinical academic posts. 
Barriers to engagement identified in the report were therefore apparent in the case study 
research findings. Additionally, some of the drivers or motivators for undertaking research 
identified in the report also resonated with the findings of the case study research. For 
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example, a strong research culture being good for the reputation of the organisation and 
thereby attracting high calibre staff was cited in the report and aligns with the case study 
research findings relating to professional kudos being a driver for research engagement among 
pharmacists. Having the opportunity to do something different from routine clinical work, and 
making a contribution to delivering better care, were also identified as powerful motivators to 
engage with research which again aligned with some of the personal drivers identified in the 
case study research. The authors also reported that many of the interviewees talked about a 
need to instil a culture of research in the pre-registration training of doctors, nurses and AHPs 
and again this aligns with the suggestion in the case study research that integrating research 
into professional practice of early career pharmacists would drive engagement. However, it 
does not support the perception among case study participants that incorporating research 
into the early career training of medics led them to want to undertake research as by including 
medics among the professions in which a culture needed to be instilled at the pre-registration 
stage of their career, the report findings implied medics were one of the professions in which a 
culture for research needed to be developed. Some of the enablers identified in the case study 
research also resonated with the report findings. For example, the authors reported that 
‘education should be focused on the centrality of research within the day-to-day treatment and 
care of patients, in order to make the relationship explicit’ (p.29) was a suggestion made by 
interviewees. Also reported was a ‘need to demonstrate to all staff that research should be seen 
as part of the ‘day job’ and not an ‘add on’, with the contribution of research to the care of 
patients and the value of the organisation as a whole being seen and understood’ (p.33). 
Although not identified as enablers to research engagement in the case study research, lack of 
awareness of the benefit of research to practice was identified as a barrier, as was research not 
being perceived to be a core part of pharmacists’ roles, thus suggesting that raising awareness 
of these would have the potential to increase engagement among the profession.     
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The second report identified was the research commissioned by The Healthcare Improvement 
Studies Institute (THIS Institute) (Dimova et al. 2018) which comprised a review of the evidence 
base on NHS involvement in research. However, because the aim of the review was to inform 
the institute’s strategy for engaging staff, it focused on staff engagement in helping inform or 
shape study design, driving research implementation and informing research priority-setting 
processes. It therefore had a much broader focus in terms of how involvement with research 
was defined than this study. Nevertheless many of the findings of the review relating to what 
motivates staff to be involved with research, how staff involvement with research can be 
enabled and rewarded, and the challenges that need to be addressed resonate with the finding 
of this research. For example, personal interest in a topic, belief in the importance of research, 
a positive previous experience of research, and prospects for career development as well as 
reputational or financial benefit were identified in the report as reasons why NHS staff engage 
with research which broadly align to the drivers for research engagement identified in this 
study. Interestingly, cultural expectations in some medical disciplines that research is part of 
the job was also reported, as was doctors being more likely to be exposed to research training 
earlier in their career and be involved in research-related activities through clinical audits and 
quality improvement projects and evaluations. This resonates with the findings of my research 
in that there appeared to be a perception that research was more embedded into the training 
of doctors than the training of pharmacists. Professional development opportunities, 
recognition and kudos within professional communities and organisations, seeing the impact 
on practice and financial rewards were also cited and, although referred to as rewards rather 
than drivers for engagement, broadly align with some of the personal drivers identified in this 
study. Enablers to research involvement included the need for guidance for staff regarding how 
to develop and implement research, organisational practice which allows staff time and 
headspace to engage with research, user-friendly platforms for engaging staff, and mechanisms 
for raising awareness of involvement opportunities, most of which were similar to the findings 
261 
of the case study research. Access to training for staff to develop research skills, mentoring, 
integration of research within clinical practice through the promotion of evidence-based 
practice, and collaborations with research-active organisations were also identified as research 
enablers and were again broadly similar to the case study research findings. Likewise, 
organisational leadership that values and supports research, recognition and reward for 
involvement in research (including career progression), and a culture of feedback and 
information-sharing about the impact of research on health service improvement were also 
identified and were again broadly similar to the case study findings. Challenges to engagement 
identified in the report were also broadly similar to the barriers identified from the case study 
research in that the challenges reported to be frequently mentioned included lack of time, lack 
of funding, lack of knowledge, skills and confidence, difficulty in accessing relevant training or 
mentorship support, and lack of support by leadership.  
10.1.6 Summary 
In summary, the findings of the case study research relating to the drivers, drawbacks, barriers 
and enablers to engagement resonate widely with the previous literature and largely reaffirm 
the findings of the initial study. Differences between the findings of the case study research, 
and both the initial study and the relevant studies identified in the literature, can largely be 
explained by the fact that all participants in the pharmacists group had personally undertaken 
research while those in the chief pharmacists group were all chief pharmacists of research-
active departments. Most of the chief pharmacists who participated In the case study research 
had also undertaken research in their professional careers. Participants in the case study 
research were therefore more research experienced than participants in the initial study and in 
previous published studies.  Accordingly participants in the case study research had greater 
insight into some of the issues identified. Although the response rate to the survey was 
relatively low, on the whole the survey findings confirmed the findings of the case study 
research and, therefore, give further credence to the case study research findings.  
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It was interesting to note that many of the enablers to research engagement identified through 
this research represented factors that would overcome the barriers identified, as illustrated in 
Table 25 below.  
Table 25: Similarity between the factors identified as barriers and those identified as enablers 
Factor identified as barriers to engagement  
 
Factor identified as enablers to engagement  
Lack of time Pharmacists being allowed time to undertake 
research in the working day 
 
Lack of funding RPS having a larger role in providing 
pharmacy-specific research funding  
 
Lack of support Access to individuals with research expertise 
 
Departmental culture where research is 
deprioritised and managers are unsupportive 
Departmental culture supportive of research 
and managers are supportive 
 
Chief pharmacist unsupportive of research  Chief pharmacist supportive of research  
 
Pharmacists lacking research skills Access to training in research 
 
 
Also of note was the similarity that was evident between some of the factors perceived to be 
drivers and some of the barriers and enablers to research engagement. For example, using 
evidence to inform pharmacy practice was identified as a driver to engagement. However, a 
lack of appreciation of the benefits of research to pharmacy practice was identified as a barrier. 
This suggests that by raising awareness among members of the profession of the value of 
research to practice would encourage more pharmacists to undertake research. Clearer career 
pathways for pharmacists interested in undertaking research were identified as both a driver 
and an enabler to engagement, as was research being an expected part of an individual’s role. 
Similarly, having individuals in a department with research expertise was also found to both 
drive and enable research activity. Access to individuals with research expertise was identified 
as an enabler to engagement while having departmental role models was identified as a driver. 
To be a role model a pharmacist would need to have research experience, suggesting that they 
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would have research expertise and thereby allow others in the department to benefit from 
their support. The similarity in these findings suggests that by putting in place enablers to 
research activity within organisations or within the profession would also drive more 
pharmacists to engage with research.  
The discussion which follows relates to the characteristics of research active organisations and 
aims to identify the factors that have led to the case study site pharmacy departments being 
research active.  
10.2 Characteristics of research-active pharmacy departments 
In this section the contextual conditions evident within the pharmacy departments at the case 
study sites and their perceived influence on research activity among pharmacy staff are 
discussed. Relevant findings from the survey research are included where they have not 
already been covered in the previous section of the discussion in the context of drivers, 
drawbacks, barriers and enablers to engagement.  
10.2.1 Perceived influence on research activity of contextual domain at case study sites 
As outlined previously in section 7.2, for the purpose of undertaking the case study research 
the contextual domain at case study sites was perceived to relate to the organisational culture, 
leadership of the chief pharmacist and mechanisms of support for research activity. From the 
case study data all four sites were the same in that they all had a culture for research within the 
department. This culture was made apparent by research being made visible. Having a lead 
pharmacist for research in the department, the department having an APU, the existence of 
departmental research forums, and the promotion of research opportunities among staff were 
all ways in which research was made visible. In addition, at all four sites there were 
mechanisms in place to not only support those interested in undertaking research through 
them being able to access expertise within the department but mechanisms were also in place 
to allow pharmacists time to undertake research even when it was not a formal part of their 
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role. Examples included backfill arrangements to allow those individuals who had obtained 
research funding the time to undertake research, research being undertaken as part of 
postgraduate qualifications and, at case study site 4, through staff being allowed time to 
undertake research if their research aligned to departmental business priorities. Key to 
developing a research culture within the department was the leadership of the chief 
pharmacist. At all four case study sites, the chief pharmacist was described as encouraging and 
supportive of research, and at case study site 4, was also credited with creating a research 
culture in the department and driving the departmental research agenda. Another observation 
was that, in terms of the approximate total number of staff employed in the pharmacy 
department and the approximate total number of pharmacists employed, all of the case study 
sites appeared to be comparatively large in size, which may have been to be expected with the 
case study sites all being teaching hospital Trusts (Table 9). The size of the pharmacy 
departments may have been significant in terms of the higher levels of research activity among 
pharmacists employed in these organisations. From my personal knowledge, and the 
knowledge of my supervisors, there tends to be greater delineation of pharmacists’ roles in 
larger Trusts. Therefore, pharmacists tend to have more specialist roles in larger Trusts 
compared to smaller Trusts, and which may mean there is more opportunity and/or drive for 
pharmacists to undertake research in Trusts that are larger in size. 
Having a research culture in the organisation at Trust level was perceived to influence research 
activity among pharmacists at all of the case study sites. However, a research culture at Trust-
level did not appear to be as important as the leadership of the chief pharmacist as any 
influence research culture at Trust-level was perceived to have on research activity among 
pharmacists was only believed to be of an indirect nature. In addition, a culture for research at 
Trust-level only appeared to enable research activity by removing or making it easier for 
pharmacists to overcome some or all of the contextual barriers to research engagement as no 
reference was made at any of the sites to Trust-level support for research being available for 
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pharmacy-led research. Not only this, but where the Trust had links with a university without a 
School of Pharmacy, the pharmacy department had established links with a School of Pharmacy 
at a different university to that linked with the Trust thereby suggesting that Trust-level 
academic links did not offer support for pharmacy-led research. From the case study findings, a 
Trust having a research culture did not appear to be a prerequisite for pharmacists to 
undertake research, but having a supportive chief pharmacist was. The survey findings support 
this as over 95% of respondents perceived that, compared to the research culture at Trust level 
or the staff themselves, the leadership of the chief pharmacist was either the most significant, 
or second most significant, factor influencing the departmental research culture (Table 23). 
Similarly from the survey research the Trust culture was perceived to be less influential in terms 
of research activity among pharmacists than the department culture (Table 22).  
However, despite there being significant commonalities between the sites, I would suggest that 
case study site 4 was a deviant case as a different approach was being taken to increasing 
research engagement among pharmacists. By integrating research into the business priorities 
and allowing pharmacists time within the working day to undertake research if the research 
aligned to these priorities then the research that was being undertaken by pharmacists within 
the department seemed to be used to influence practice. Linking research and practice in this 
way, appeared not only to help pharmacists understand the importance of research to 
pharmacy practice, but also to understand the value of research in improving services for 
patients. At case study site 4 the chief pharmacist was personally driving the research agenda 
within the department whereas at the other sites there appeared to be a reliance on 
individuals having a desire to undertake research. Therefore, at case study sites 1, 2 and 3, 
personal desire to conduct research appeared to be the predominant driver whereas at case 
study site 4 the predominant driver appeared to be research being an expectation of the 
employer which, I would argue, can be assumed to be a direct result of the chief pharmacist 
driving research activity.  
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10.2.2 Comparison of the research findings to the literature 
The literature relating to organisational theory aligns to the case study research findings 
pertaining to the case study site pharmacy departments all having research cultures and why 
case study site 4 was a deviant case in terms of the approach being taken at this site to increase 
research activity among pharmacists.   
Many definitions of organisational culture can be found in the literature but, at its simplest, 
organisational culture has been defined as ‘the way we do things around here’ (p.4) (Deal, 
Kennedy 1982) or as the common practices, attitudes, behaviours, beliefs and values that are 
shared between organisational members (Schein 2010). 
Schein developed a framework for conceptualising organisational culture (Schein 2010). In this 
framework Schein suggests that culture is evident at different levels within an organisation with 
the term ‘level’ referring to the degree to which the cultural phenomenon is visible to the 
observer. Schein’s framework is outlined in Table 26 below.  
Table 26: Cultural framework developed from Schein (2010) 
Level Description Examples 
 
Artefacts Observed actions, rituals and 
outcomes 
Physical environment; language; 
technology; myths and stories about 
the organisation  
 
Espoused values Beliefs and key practices 
spoken initially by the 
leader/founder and then 
validated by the group  
 
Mission statements; strategies and 
goals; what people say in particular 
situations 
Basic assumptions The unspoken and 
unconscious beliefs and 
expectations shared by 
people 
 
Values that guide behaviour; values 
shared and therefore reinforced 
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This framework can be used to illustrate how the pharmacy departments at all four case study 
sites had developed research cultures. Cultural ‘artefacts’ were evident at all of the case study 
sites and mainly related to how research was made visible in the department. Mechanisms 
through which research was made visible that were apparent at the case study sites included 
having a pharmacist employed whose role was to provide leadership for research, holding 
departmental research forums, promoting research opportunities and the department having 
an APU. Mechanisms were also in place at all four case study sites to support departmental 
research activity and included staff having access to research expertise within the departments 
and pharmacists being allowed time to conduct research. These mechanisms were also 
examples of artefacts’ according to Schein’s framework (Schein 2010). Making research visible 
and having mechanisms to support research in place would have served to make staff aware 
that research was supported and that the culture was permissive of research.  
Schein’s framework can also be used to illustrate why case study site 4 was a deviant case. As 
stated earlier, at this site research was integrated into the business priorities of the department 
suggesting that the outcomes of research were being used to inform practice. This implies that 
the departmental culture at this site was at the ‘espoused values’ level of Schein’s framework. 
There is an argument that research was more deeply embedded at the site i.e. that research 
was a ‘basic assumption’ of those employed in the department, as reference was made to 
research being ‘business as usual’ and an ‘expectation’ of pharmacists. However, integrating 
research into the business priorities implies that the culture for research was not at the 
unconscious level Schein suggests it would be for it to be at the level of the framework referred 
to as ‘basic assumptions’. Nevertheless the culture for research within the department at case 
study site 4 was at a deeper level compared to the others. Certainly at case study sites 1 and 2 
reference was made to the core service taking priority and suggesting thereby that research 
was not valued at these sites to the same extent as it perhaps was at case study site 4.  
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Another possible explanation for case study site 4 being a deviant case, was that at case study 
sites 1, 2 and 3 the culture for research was a subculture within the department as opposed to 
case study site 4 where the intention appeared to be to integrate research into pharmacy 
practice. Subcultures have been suggested in the literature to be ‘small groups within an 
organisation that have their own cultural characteristics’ (p.247) (King, Lawley 2016). The 
implication of suggesting that research was a subculture at case study sites 1, 2, 3 is that the 
research culture was limited at these sites to only those engaged with research whereas at case 
study site 4 the research culture was more widespread. Illustrating that the culture for research 
may be a subculture within the department at case study site 2 was the reference made by one 
participant to the department culture for research being ‘naïve’ which implied they did not 
perceive there to be a culture for research throughout the department. Likewise, at the same 
case study site another participant believed more could be done to ‘develop’ the culture which 
again suggested that they did not perceive the culture to be embedded across the whole 
department. Similar perceptions were apparent at case study site 3 as illustrated by one 
participant who described the departmental research culture as being in ‘its infancy’ and 
another perceiving research to be undertaken only by the ‘minority’ of pharmacists in the 
department. At case study site 1, research appeared only to be undertaken by those for whom 
research was a formal part of their role or job plan. None of those interviewed made reference 
to backfill arrangements allowing staff time to conduct research. Also no reference was made 
to any mechanisms, or indeed drive, for research to be part of all pharmacists’ roles at any of 
case study sites 1, 2 or 3. However, at case study site 4 this was explicitly the case as illustrated 
by the reference made to research being ‘business as usual’ for the department and an 
‘expectation’ of pharmacists employed in the department as referred to above. The research 
culture within the pharmacy department therefore appeared more mainstream at case study 
site 4 than at case study sites 1, 2 and 3.  
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The case study finding that the leadership of the chief pharmacist was key to developing a 
research culture within the department also aligns with the literature relating to organisational 
theory. For example, it is suggested in the literature that culture can be managed if culture is 
viewed as something an organisation ‘has’ rather than ‘is’ (Buchanan, Huczynski 2019). The 
has-view holds that the culture of an organisation can be managed whereas the is-view sees 
organisational culture as something that an organisation is, which emerges as a matter of 
course and is not capable of being managed. Using the theory that culture is something an 
organisation has and is something that can be managed, suggests a culture can be developed 
within a department using a ‘top-down’ approach. This aligns with the case study research 
finding that the leadership of the chief pharmacist is key to developing a research culture 
within a pharmacy department in secondary care. It is also recognised in the literature that 
leaders can change culture (Schein 2010). Schein (2010) lists what he describes as primary and 
secondary embedding mechanisms to achieve culture change which align to some of the 
mechanisms of support and drivers for research engagement identified through the case study 
research and evident at case study site 4. For example, included in the primary embedding 
mechanisms suggested by Schein is ‘how leaders allocate resource’ and in the secondary 
embedding mechanisms is ‘organisational design and structure’. These align to the case study 
research findings that allowing individuals time to undertake research and having internal 
support for research enable research activity among pharmacists. It is also suggested in the 
literature that leaders ‘create the conditions for culture formation’ (p. 257) (Schein 2010) which 
implies that leaders can not only manage cultures but can also create them. Due to the 
hierarchical management structure existent within pharmacy departments in secondary care it 
can be assumed that chief pharmacists who assume the role of both a leader and manager in a 
pharmacy department would be able to foster a culture of research within their respective 
departments. 
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Interestingly, similarities are also evident between the case study findings pertaining to the 
contextual domain of research-active pharmacy departments and published literature relating 
specifically to research engagement and NHS staff i.e. the same two reports referred to earlier 
in the discussion in section 10.1.5.  
The report commissioned by Cancer Research UK (Brown et al. 2015) cited an association 
between leadership and culture which aligns with the case study research finding that the 
leadership of the chief pharmacist was key to a pharmacy department having a research 
culture. Also cited in the report was a finding that ‘strong leadership at senior levels of the 
health system and a commitment to research by individuals at a local level’ was critical to 
fostering a strong research culture. Similarity is again evident with the case study research 
findings as the chief pharmacists’ commitment to research was clearly evident at all four case 
study sites. The role of local leadership supported by actions to make infrastructure and 
processes more supportive was also described in the report as key to developing a research 
culture. Again the case study research findings resonate with this as not only was the 
leadership of the chief pharmacist found to be key to developing a departmental culture for 
research but, by each department having in place mechanisms through which pharmacists 
could access internal support and have time to conduct research, the infrastructure and 
processes referred to in the report were also evident at each case study site. Interestingly, it 
was also suggested in the same report that leadership at all levels within the research 
community to be ‘critical’ to driving the research agenda in NHS organisations. This finding also 
aligns with the findings of the case study research as the leadership of the chief pharmacist was 
described by participants in this phase of the research as driving research activity within their 
respective departments. Not only this, the lead pharmacist for research was also cited as either 
driving or encouraging engagement at all case study sites suggesting that leadership for 
research was evident at the case study sites at more than just the level of the chief pharmacist.   
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Likewise, the finding that all pharmacy departments in the case study research had a culture for 
research also resonated with the findings of the report in relation to how strong research 
cultures had been fostered within NHS organisations i.e. board performance reports and other 
communications demonstrating research activity and success, ensuring support was in place 
from R&D, recruitment of people who were pro-research, and having strong leadership. Since 
the report was at Trust level, not all of these mechanisms for fostering a positive research 
culture were identified in the case study research as this was at departmental level. However, 
several of these mechanisms were apparent at some or all of the case study sites. Certainly 
departmental research activity was promoted internally at one of the case study sites (site 4). 
In addition, all of the case study sites had a pharmacist whose role encompassed leadership for 
research and, being research experienced themselves, were able to provide others with access 
to research expertise as well as signpost individuals to other available support within either the 
wider organisation or in academia through the departmental links with local Schools of 
Pharmacy. As these leadership roles were described as being supportive and encouraging of 
research at all of the case study sites, it would also be reasonable to assume the individuals in 
these roles were also ‘pro-research’. Therefore, many of the factors identified in the Cancer 
Research UK commissioned report relating to how strong research cultures had been fostered 
were apparent in the case study research findings.  
Similarly the case study research findings also reflected the findings of the report 
commissioned by the THIS Institute (Dimova et al. 2018) in which the authors reported that a 
combination of organisational factors were identified as supporting an enabling environment. 
They reported these organisational factors to include: leadership that champions research 
motivating staff to contribute to research activities; the need to support individuals through 
training, mentorship and feedback; and having organisational policies and procedures which 
made research feasible and valued. In the case study research, the chief pharmacists and lead 
pharmacists for research at the case study sites were perceived to be supportive of research, 
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which suggests they would champion research, departments all employed individuals with 
research expertise who could advise and mentor staff wanting to undertake research, and, by 
them all having mechanisms in place to allow staff time to undertake research, had 
organisational policies and procedures which made research feasible. At case study site 4, I 
would also suggest the department had policies and procedures in place to make research feel 
valued by integrating research into the business priorities and in so doing use evidence from 
research to inform practice.  
10.2.3 Summary 
The pharmacy departments in the case study research exhibited what were fundamental 
similarities in relation to the contextual domain which was perceived to influence research 
activity. Firstly, they all had a departmental culture for research which was made explicit 
through there being a lead pharmacist for research as a minimum. At some sites the culture 
was also made apparent through the promotion of research opportunities and research being 
undertaken in the department, the existence of departmental research forums, and the 
department having an APU. Making research activity visible in some or all of these ways 
appeared to mean that staff employed in the department felt ‘allowed’ to undertake research. 
Secondly, staff had access to support to undertake research through access to individuals with 
research expertise i.e. the lead pharmacist for research and other research-active staff 
employed in the department. Individuals with research expertise either provided those 
interested in undertaking research with support themselves or they signposted those 
interested in research to other support available either within the Trust or in universities via 
the departmental academic links. Pharmacists at the case study sites were also supported to 
undertake research through mechanisms being in place to allow them time to undertake 
research whether that be through grant funding being used to backfill their roles or research 
being a formal part of their role or job plan, or because research was integrated into the 
departmental priorities. Lastly, at all four case study sites the chief pharmacist was supportive 
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of research and their leadership was key to the department being research active. They all 
appeared to value research and had put in place support for research activity.  
In the final section of this chapter, the key findings of the research are summarised together 
with recommendations to increase research engagement among pharmacists employed in the 
hospital sector in the UK. 
10.3 Key findings and recommendations to engage more hospital pharmacists 
with research  
The recommendations presented below in Table 27 are based on the findings of all three 
elements to this research i.e. the initial study undertaken in part 1 of the DPharm programme, 
and the case study research and survey research undertaken for the main research study in 
part 2.   
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Table 27: Recommendations to increase hospital pharmacists’ engagement with research 
Recommendations Research findings on which 
recommendations are based 
 
Raise awareness among the profession of 
research being core NHS business and a 
professional expectation  
 
There is a reliance on individuals having a 
personal desire to undertake research despite 
there being profession-wide drivers for 
pharmacists to undertake research and a 
requirement for research to be undertaken in 
the NHS (NHS England 2019a, Department of 
Health 2006, Act of parliament 2012, RPS 
2013, RPS 2014a)  
 
Integrate research into the early careers of 
pharmacists to enable individuals to gain the 
necessary knowledge and skills to undertake 
research and instil in them a desire to 
undertake further research in their careers 
Newly-qualified pharmacists perceived to lack 
knowledge and skills to undertake research; 
research experience found to enable 
individuals to gain the knowledge and skills to 
undertake research as well as instilling in 
individuals a desire to undertake further 
research 
 
Raise awareness of funding opportunities 
available to pharmacists 
Funding allows individuals the time to 
undertake research but there is a lack of 
awareness of funding opportunities available 
to pharmacists  
 
Raise awareness of benefits of research to 
improved patient outcomes  
 
Pharmacists lack awareness of the value of 
research in terms of improved patient 
outcomes (Davies 2016, Boaz et al. 2015, 
Downing et al. 2017) 
 
Establish a career structure with clear 
progression for those interested in pursuing a 
career which combines research and practice 
 
Lack of perceived personal benefits to 
undertaking research within the hospital 
sector 
 
Educate pharmacists regarding the ways in 
which they can be involved in research by 
providing clarity regarding the types of 
activities research involvement encompasses 
and clarity regarding the different types of 
research and different types of scientific 
inquiry pharmacists can be involved in or 
undertake 
 
Pharmacists lack an understanding of what 
constitutes research and there is potential for 
confusion between authorship of publications 
and research, between activities classed as 
supporting research delivery and those 
classed as research involvement, and between 
the different types of scientific inquiry 
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In response to the last recommendation relating to the need to educate pharmacists in terms 
of the ways they can be involved in research and the types of scientific inquiry they can 
undertake, I have developed a ‘paradigm’ aimed specifically at pharmacists which aims to 
clarify how members of the profession can engage with research. See Figure 16 below. 
The aim of the paradigm is to make it clear to pharmacists that the level of academic rigour 
required to undertake academic research per se is not necessarily required to undertake other 
forms of scientific inquiry. The idea is that the paradigm allows pharmacists to see they can 
take a stepwise approach to conducting research by starting with a type of inquiry where less 
rigour is needed and then moving upwards towards the more academic-style research. 
Similarly the paradigm makes it clear that pharmacists can be involved in research at different 
levels, with leading studies being the most involved. An example of how a pharmacist might 
collaborate in a study could be by their involvement in a research project as a member of a 
multi-disciplinary team, whereas an example of how a pharmacist might contribute to a study 
could be where a pharmacist acts in the capacity of a principal investigator for a multi-centre 
study.  
The intention would be for the paradigm to be used as an educational tool for research-naïve 
pharmacists interested in undertaking research to help them identify the types of scientific 
inquiry they can be involved in and the ways in which they can be involved. For pharmacists 
who have already begun their research journey, the purpose of the paradigm would be to help 
them identify other ways they could be involved in research or other types of scientific inquiry 
in which they could be involved. By not making reference to practice research in the paradigm, 
the intention is that pharmacists do not feel limited to undertaking research only into the 
practice of pharmacy. Instead the paradigm aligns with the definition of pharmacy research 
suggested by Koshman and Blais (2011) referred to in chapter 2 who suggested pharmacy 
research not to be restricted to practice research, and is commensurate with the definition of 
pharmacists’ involvement in research used throughout this research.   
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Figure 16: Paradigm illustrating the ways pharmacists can undertake research 
  
 
How pharmacists can be involved 
Contributing 
to a study 
led by others 
Collaborating 
with others to 
undertake a study 
Leading 
their own 
study 
Increasing levels of involvement  
 
Types of scientific inquiry pharmacists can undertake 
Audit Quality 
improvement 
Research 
Increasing levels of academic rigour  
Service 
evaluation 
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11 Reflexivity 
Reflexivity is recognition of the influence a researcher brings to the research process (Kuper et 
al. 2008). In this chapter I discuss how my professional background and experience as a 
researcher may have influenced this research.   
Foremost, it is my professional background that has been influential in leading me to conduct 
research in this area. Having spent the majority of my career to date working as a hospital 
pharmacist and in my current role with the NIHR, I have become passionate about pharmacists 
undertaking research. In turn this led me to want to conduct research to explore how to engage 
more pharmacists employed in the hospital sector in the UK with research.  I chose not to 
extend the research to encompass pharmacists working in primary care because of the 
inherent cultural differences between the sectors and, it was only in July 2015, that NHS 
England launched a pilot scheme to significantly increase the number of pharmacists working in 
GP practices by subsidising them to employ pharmacists in patient-facing roles (Pharmaceutical 
Journal, 2015). Therefore I did not extend the research to include community pharmacists or 
pharmacists working in GP practices. 
I recognise that to a certain extent I was an ‘insider’ to the research due to my professional 
background (Dwyer, Buckle 2009). As outlined in chapter 2, I am a pharmacist by profession 
and the majority of my career to date has been spent working as a hospital pharmacist in acute 
secondary care teaching hospital NHS Trusts. In terms of the case study research, I have 
considerable experience of working in what can be assumed to be similar environments to the 
case study participants. Although I did not undertake my own research whilst in these roles, 
nevertheless I was involved with research though my involvement with delivery of clinical trials. 
Also, as outlined in chapter 2, this research was undertaken as part of a Professional Doctorate 
in Pharmacy and during which I continued to practice as a pharmacist in my role as Lead 
Pharmacist for NIHR Clinical Research Network West Midlands. In terms of how this may have 
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influenced the research, in my role with the NIHR I interact on a regular basis with both 
healthcare professionals undertaking research from across multiple disciplines, as well as staff 
involved in research management and governance employed both in Trusts and by the network 
itself. Through this role I am not only aware of the importance of research to the NHS, but have 
also gained insight into some of the barriers preventing staff employed in the NHS from 
engaging with research. Indeed, throughout the course of undertaking the research component 
of the DPharm programme, I have attended meetings or events in my professional capacity as 
Lead Pharmacist for NIHR Clinical Research Network West Midlands where I have been party to 
discussions which have echoed some of the findings of this research. However, it is not only my 
professional background that may have influenced this research but my experience of 
undertaking this research may also have shaped my interpretation of the findings as, for 
example, I have personally experienced some of the barriers and enablers to research 
described by participants in the case study research.  
It is important to consider how both my professional background and research experience may 
have influenced the research (Kuper et al. 2008). For the case study research, the questions 
included in the interview guide may have been influenced by my background and experience 
and, likewise, the themes I identified when analysing the data may also have been so 
influenced. Similarly, some of the findings reported in previous studies may have resonated 
with me more than others which may have also shaped my interpretation of the case study 
findings in the context of the literature. Therefore, as outlined in section 8.1.6, I took steps to 
minimise ‘researcher bias’ i.e. where the researcher may selectively collect and record data or 
base interpretations on personal perspectives (Roberts, Priest 2010). These steps included 
devising interview guides based on previous research findings and which included questions 
that related to the research objectives, and ensuring that probing questions were used to 
explore subjects from the perspectives of participants in depth (Arksey, Knight 1999). To 
analyse the data, the interviews were audio-recorded and transcribed verbatim and ‘constant 
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comparison’ used to ensure the themes identified were grounded in the data (Gray 2014, Smith 
1998). Additionally, case study sites were selected outside of the West Midlands region where I 
did not have a working knowledge of current practice in relation to the phenomena being 
investigated. I was also not overt with participants regarding my role within the NIHR to 
minimise the introduction of bias in the interview data resulting from any perceived power 
participants may have thought I had working for an organisation that funds research in the 
NHS. I introduced myself to participants as a pharmacist undertaking research as part of a 
Professional Doctorate in Pharmacy and did not make any reference to my role in the NIHR in 
participant information leaflets or in any email correspondence I had with participants as I used 
my Keele University email address rather than my NIHR address. To also minimise any 
perceived power imbalances between myself and participants I believed the attire I chose for 
conducting the interviews was, from my personal experience of working as a hospital 
pharmacist, commensurate to that of a pharmacist working in such an environment in that my 
clothes were smart, but not too formal or casual. However, the very fact I was conducting the 
interviews as part of a research project may have influenced participants’ responses due to the 
research subject being research itself. Being research-experienced themselves, participants 
may have been more positive about their research or equally they may have seen me as 
someone who may have appreciated some of the challenges they had incurred leading them to 
be more negative about their experience than they may have been had they thought the 
conversation was not being conducted as part of a research project. There is no possible way I 
could have prevented participants from knowing that the study was being undertaken as a 
research project due to the ethical requirements for conducting research in the NHS in that 
participants are required to be informed they are taking part in a research study, and that 
participants have to consent to taking part. I do not feel that conducting the interviews at 
participants’ workplaces would have influenced their responses particularly as it was only the 
interviews with chief pharmacists that were conducted in the interviewee’s office. Interviews 
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with participants in the pharmacists’ participant group at each site were mostly conducted in 
departmental meeting rooms rather than individuals’ offices. The potential influence of 
conducting interviews at case study sites would more so have been that it enabled more 
individuals to take part than had participants been asked to travel to be interviewed. 
Maintaining the anonymity of participants while at the same time providing enough detail to 
capture the nuance in the data, was also an issue for the case study research. To maintain 
anonymity, particularly when analysing the data pertaining to the contextual domain at the 
case study sites and the influence this had on research activity, was problematic. For example, I 
could not overtly express the opinions of the chief pharmacist or the lead pharmacist for 
research at case study sites as participants at the site would have been able to identify the site, 
and therefore identify the chief pharmacist and lead pharmacist for research. I did consider 
identifying the Trusts that were case study sites. However, although I believe the chief 
pharmacists at these Trusts may have talked openly about their leadership and the support in 
place for pharmacists to undertake research at departmental level had I identified the sites, I 
do not believe they would have talked openly about the culture for research within their Trusts. 
Similarly, I do not believe pharmacists in the pharmacists’ participant groups at case study sites 
would have talked openly had their Trust been identified.   
Reflexivity is referred to in the literature as being an important consideration for qualitative 
research (Kuper et al. 2008), which is why this chapter has focused on the case study research. 
However, I would also argue that my professional background and experience may also have 
influenced the survey research, albeit to a lesser extent, as chief pharmacists in the West 
Midlands who were aware of my role may have responded. To minimise researcher effects in 
relation to the survey, participants were informed that their responses would be anonymised 
meaning that the responses they gave were unlikely to have been influenced by my role to any 
significant degree.   
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In terms of my epistemological position and how this may have influenced my findings, as 
outlined earlier in chapter 7 I believe my worldview aligns to that of pragmatism. Pragmatism, 
as a research paradigm, is based on the proposition that researchers should use all the 
philosophical and/or methodological approaches that works best for the particular research 
problem being investigated (Tashakkori, Teddlie 1998). Therefore, I believe my worldview 
influenced my approach to undertaking the research as it allowed me to combine the use of 
both qualitative and quantitative approaches to address the research question.  
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12 Limitations and future work 
Despite efforts to ensure the research findings were both valid and reliable, as outlined in 
sections 8.1.6 and 9.1.5 in relation to the case study research and survey research respectively, 
limitations to the research still remain. These limitations, and ideas for future work, are 
outlined in this chapter.   
In terms of the validity of the case study research findings, as outlined in section 8.2, it was 
unclear if data saturation was achieved at one of the case study sites due to the small number 
of pharmacists who volunteered at the site. However, I believe data saturation was more than 
likely achieved across the data set in its entirety as no additional themes were found to emerge 
during the data analysis. The case study research findings may also have been skewed due to 
participants being susceptible to social desirability effect making them more likely to provide 
responses which they perceived to be socially acceptable (Bryman 2012). However, this effect 
was potentially minimised by informing participants that their individual responses would be 
anonymised, and the Trusts selected to be case study sites would not be identified in reporting 
of the data. To minimise response bias, case study sites were also purposefully selected to be 
outside of the West Midlands where I was less likely to be known in my professional capacity. 
The transferability of the findings may also be limited as all the Trusts selected to be case study 
sites were all the same type of NHS Trust i.e. acute secondary care teaching hospital NHS Trusts 
based in England which could limit the transferability of the findings to other types of NHS 
Trusts and the devolved nations. Additionally, as all participants in the case study research 
were either research-active themselves, or the chief pharmacist of a research-active pharmacy 
department, the research may not reflect the attitudes and opinions of non-research active 
pharmacists and/or pharmacists working in non-research active departments. However, 
although the response rate to the survey was low, the survey findings generally confirmed the 
case study findings and, as the survey was not limited to chief pharmacists of acute secondary 
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care teaching hospital NHS Trusts but was instead conducted with chief pharmacists of all acute 
secondary care NHS Trusts the case study results can arguably be applied to all secondary care 
NHS Trusts.    
Regarding the survey findings, as a self-administered questionnaire was used as the survey 
instrument, there was no mechanism for independently verifying the validity of the data 
gathered. It was also not possible to prevent an individual completing the questionnaire more 
than once as responses were not linked to email addresses. Likewise, it was not possible to 
prevent individuals completing the survey who were not chief pharmacists. Also in relation to 
the validity of the findings, as with the case study participants, survey respondents may also 
have been vulnerable to the social desirability effect, particularly if they were already aware of 
research being an expected part of professional practice for pharmacists and also an 
expectation of NHS employees. There was also a possibility of self-selection bias in that those 
chief pharmacists who responded to the survey may have had more positive attitudes and 
opinions towards research than those who did not respond (Bryman 2012). In addition, the 
response rate to the survey was relatively low (14.9%). It is therefore difficult to determine how 
representative the findings are of the population of interest i.e. chief pharmacists of acute 
secondary care NHS Trusts.  
In terms of future work, it may be interesting to conduct semi-structured telephone interviews 
with a wider cohort of research active pharmacists and/or chief pharmacists of secondary care 
NHS Trusts to further explore the drivers, barriers and enablers to engagement with more 
granularity than the survey undertaken in this research allowed. It may also be interesting to 
extend the survey to managers of other healthcare professions in secondary care NHS Trusts. If 
similar findings resulted they would indicate that the issues preventing pharmacists engaging 
with research are shared by other health professions, suggesting it would potentially be 
appropriate to take a multi-professional approach to engaging NHS staff with research. It may 
also be interesting to extend the survey to other branches of the profession such as community 
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pharmacists, pharmacists employed in GP practices and pharmacists in other roles to establish 
if the findings of the case study research are evident in other sectors of employment.  
To disseminate the research findings, I intend to feed back the findings to the Association of 
Teaching Hospital Pharmacists chief pharmacist network through which I distributed the 
scoping exercise email survey to identify potential case study sites, in addition to publishing the 
research in relevant academic journals. I also intend to write an article for the NHS England and 
NHS Improvement Chief Pharmacists’ monthly newsletter where the survey was advertised as 
well as sharing a summary of the findings to those who participated in the case study research 
phase of the research. I will also use the findings to engage pharmacists in the West Midlands 
with research through my role with the National Institute for Health Research Clinical Research 
Network by raising awareness of the importance of research and opportunities for involvement 
with pharmacists across the region. As chief pharmacists were found to be key to engaging 
pharmacists employed in the hospital sector, I will also share my findings with the West 
Midlands Chief Pharmacists Network. In relation to the Clinical Research Network I also intend 
to present my research to the Senior Leadership Team of the network in the West Midlands as 
well as share my findings with interested parties at the national level within the network 
through the Clinical Research Network Coordinating Centre.   
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13 Conclusions 
It is apparent from the research that pharmacists practising in secondary care in the UK can be 
research active and that the research pharmacists in this sector are undertaking is not limited 
to audit, service evaluation and quality improvement projects, but also encompasses research 
undertaken with academic rigour. However, research activity within the profession in the 
hospital sector in the UK seems to be the exception rather than the rule. To increase research 
engagement within the profession, it was clear from the case study research that more needs 
to be done to ensure pharmacists value research and understand the benefits of research to 
improving services for patients, and to achieve this pharmacists need to be made aware of how 
research can be used to inform practice. Relating evidence-based practice to evidence-based 
medicine would be one way to achieve this as the impression gained from the case study 
research was that pharmacists were familiar with, and used, evidence from research to inform 
therapeutic decisions concerning medicines and yet, paradoxically, did not apply the same 
principles to informing their practice. Integrating research into practice would be another way 
to encourage pharmacists to use evidence to inform their practice. However, this would seem 
to represent somewhat of a culture change as despite all case study sites being selected on the 
basis of them having ‘high’ research activity levels among pharmacists, only one department 
seemed to have incorporated research into their pharmacy service. In addition to pharmacists 
not valuing research, other drivers for engagement were lacking and included a lack of both 
personal reward and recognition. From talking to participants in the pharmacists group, I felt 
many questioned the point of engaging with research, specifically in relation to personal gain. 
Lack of career progression and lack of recognition of research in the career structure of 
pharmacists appeared to be perceived by participants in this group as representing major 
barriers to engagement, yet chief pharmacists felt research to be an essential requirement for 
pharmacists to attain very senior positions within the health service. The difference in the 
perspectives of these two participant groups perhaps suggests it is the transferable skills gained 
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through research that are valued for senior leadership positions, but that this is not being 
communicated to those in more junior roles.  It was also clear that pharmacists employed in 
the hospital sector were not generally aware of research being a requirement of the NHS, nor 
were they aware of research being a professional expectation of pharmacists by the Royal 
Pharmaceutical Society. Outside of a personal desire to change practice, or a personal interest 
in research, it therefore seemed unclear why hospital pharmacists would incorporate research 
into their practice unless there was direct drive for them to do so from within the department 
in which they were employed. 
To engage more pharmacists in research, there is a need to do more than simply instil in 
individuals a personal desire to undertake research. It was clear from this study that to engage 
with research, pharmacists also need departmental support including being allowed time to 
undertake research and having access to research expertise. At all of the case sites, a 
pharmacist was employed whose role was to lead research. Those in such roles were all 
personally research experienced with doctoral level research qualifications and were able 
therefore to offer support to others. In addition, mechanisms were in place to allow staff time 
to conduct research in the working day, whether through research being a formal part of their 
role or job plan, through backfill arrangements resulting from individuals being awarded 
research funding, or simply through research being an expectation of all pharmacists employed 
in the department. The survey results supported these findings of the case study research.  
Having a departmental research culture was found to be highly influential in terms of research 
activity among pharmacists. Making research visible within the department was found to have 
an important role in developing such a departmental culture by pharmacists feeling ‘allowed’ 
to conduct research. Employing a lead pharmacist for research was also important to achieving 
this. The existence of such roles within the pharmacy departments in the case study research 
gave research a focus within the department as well as offering practical support to individuals 
interested in conducting research. Several individuals in these leadership roles were also 
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credited with driving the departmental research agenda and contributing to the development 
of a culture for research within the department. However, the leadership of the chief 
pharmacist appeared to be key to developing such a culture within a department. At all four 
case study sites the chief pharmacist was described as being supportive of research, and at two 
of the sites was described as encouraging or driving activity. Not only this, having a chief 
pharmacist who was supportive of research appeared to be key to ensuring that the 
mechanisms of support referred to above were in place. In addition, participants in the chief 
pharmacists group in the case study research perceived part of the role of chief pharmacists to 
be to encourage and support pharmacists to undertake research. The significance of the 
leadership of chief pharmacists in determining research activity among pharmacists was also 
supported by the survey.   
Organisational culture and leadership appeared to have a large part to play in influencing 
research activity among pharmacists, certainly at departmental level. The influence of the Trust 
culture was less clear. Reference was made at some sites to the Trust having a culture for 
research making pharmacy-led research ‘easier’ to conduct which implied that a research 
culture at this level within an organisation removed some or all of the contextual barriers. 
However, it certainly did not appear to be a prerequisite for pharmacists to be research active. 
Neither was a requirement for a Trust to be part of an Academic Health Science Centre.  
It was not only organisational factors that were identified as enablers to increased engagement 
as changes pertaining to the profession were also identified. For example, a view widely held 
was that newly-qualified pharmacists lacked the knowledge and skills to conduct research 
suggesting that either research training needs to be emphasised in the undergraduate 
curriculum, or it needs to be included in the early careers training of pharmacists after 
graduation. I would suggest the latter to be more appropriate as having research experience 
seemed to be a consistent theme which had inspired participants who took part in the case 
study research to conduct further research in their careers. Postgraduate qualifications seemed 
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also to be the way that most participants had gained their research skills. This would imply that 
if postgraduate research qualifications could be seen to hold the same key to career 
progression as postgraduate clinical qualifications , or if research could be incorporated more 
into postgraduate clinical qualifications, not only would more pharmacists be inspired to 
undertake research but more would have the skills to do so.  
In summary, to increase engagement with research among pharmacists employed in the 
hospital sector, pharmacists need to be inspired to undertake research and be supported to do 
so. To drive engagement, pharmacists need to value research not only for altruistic reasons but 
because they understand the benefit of research to practice. There also needs to be clear 
personal reward for undertaking research such as a career path for practicing pharmacists in 
the hospital sector interested in research.  In terms of support, pharmacists need to be allowed 
time to conduct research in their day job and also need to have access to individuals with 
research expertise. Having a departmental culture for research is therefore key to driving and 
supporting research among pharmacists. Achieving such a culture within a department seems 
to be reliant on the chief pharmacist being supportive of research. Therefore, to engage more 
pharmacists in the hospital sector with research, the leadership of chief pharmacists is crucial. 
Pharmacists also need to be exposed to research early in their career, not only to allow them to 
develop research knowledge and skills, but also to instil in them a desire to undertake research 
throughout their professional careers.  
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15 Appendices 
Appendix 1: Databases searched using EBSCO, ProQuest and Web of Science 
 
Details of the EBSCO, ProQuest and Web of Science database selections and databases these 
included  
Software package  Database option 
selected  
Databases included in database selection  
EBSCO All pharmacy 
databases 
AMED - The Allied and Complementary  
Medicine Database 
MEDLINE 
PsycINFO PsycARTICLES 
 
ProQuest  Health and medicine 
databases  
MEDLINE 
Physical Education Index 
PILOTS: Published International Literature on 
Traumatic Stress 
TOXLINE 
 
Web of Science Web of Science Core 
Collection (1970-
present) 
Science Citation Index Expanded (1970-
present) 
Social Sciences Citation Index (1970-present) 
Arts & Humanities Citation Index (1975-
present) 
Conference Proceedings Citation Index- 
Science (1990-present) 
Conference Proceedings Citation Index- Social 
Science & Humanities (1990-present) 
Book Citation Index– Science (2005-present) 
Book Citation Index– Social Sciences & 
Humanities (2005-present) 
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Appendix 2: Details of database searches for initial study literature review 
EBSCO database search  
Search number 
  
Search term Results 
1 Pharmacist* (TI) OR Pharmacist* (SU) OR  
Pharmacy* (TI) OR Pharmacy (SU)  
53,697 
2 Attitude* (TI) OR Attitude* (SU) OR  
Opinion* (TI) OR Opinion* (SU) OR   
Perception* (TI) Perception* (SU) OR 
View* (TI) OR View* (SU) 
Perspective* (TI) Perspective* (SU) 
Barrier* (TI) OR Barrier* (SU) 
Facilitator* (TI) OR Facilitator*(SU) 
1,586618 
3 Research* (TI)  310,772 
4 (Pharmacist* (TI) OR Pharmacist* (SU) OR  
Pharmacy* (TI) OR Pharmacy (SU)) AND   
(Attitude* (TI) OR Attitude* (SU) OR  
Opinion* (TI) OR Opinion* (SU) OR   
Perception* (TI) Perception* (SU) OR 
View* (TI) OR View* (SU) 
Perspective* (TI) Perspective* (SU) 
Barrier* (TI) OR Barrier* (SU) 
Facilitator* (TI) OR Facilitator*(SU)) AND  
(Research* (TI))  
91 
Key: TI (title); SU (subject term)  
ProQuest database search  
Search number  
 
Search term* Results 
1 Pharmacist* (TI) OR Pharmacist* (SU) OR  
Pharmacy* (TI) OR Pharmacy (SU)  
51,143 
2 Attitude* (TI) OR Attitude* (SU) OR  
Opinion* (TI) OR Opinion* (SU) OR   
Perception* (TI) Perception* (SU) OR 
View* (TI) OR View* (SU) 
Perspective* (TI) Perspective* (SU) 
Barrier* (TI) OR Barrier* (SU) 
Facilitator* (TI) OR Facilitator*(SU) 
803,552 
3 Research* (TI)  223,529 
4 (Pharmacist* (TI) OR Pharmacist* (SU) OR  
Pharmacy* (TI) OR Pharmacy (SU)) AND   
(Attitude* (TI) OR Attitude* (SU) OR  
Opinion* (TI) OR Opinion* (SU) OR   
Perception* (TI) Perception* (SU) OR 
View* (TI) OR View* (SU) 
Perspective* (TI) Perspective* (SU) 
Barrier* (TI) OR Barrier* (SU) 
Facilitator* (TI) OR Facilitator*(SU)) AND  
(Research* (TI))  
89 
Key: TI (document title); SU (all subjects and indexing)  
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Appendix 2 continued 
 
Web of Science database search  
Search number  
 
Search term Results 
1 Pharmacist* (title) OR Pharmacist* (SU) OR  
Pharmacy* (title) OR Pharmacy (topic)  
49,906 
2 Attitude* (title) OR Attitude* (topic) OR  
Opinion* (title) OR Opinion* (topic) OR   
Perception* (title) Perception* (topic) OR 
View* (title) OR View* (topic) 
Perspective* (title) Perspective* (topic) 
Barrier* (topic) OR Barrier* (topic) 
Facilitator* (title) OR Facilitator*(topic) 
2,597,754 
3 Research* (TI)  514,840 
4 (Pharmacist* (TI) OR Pharmacist* (topic) OR  
Pharmacy* (TI) OR Pharmacy (topic)) AND   
(Attitude* (TI) OR Attitude* (topic) OR  
Opinion* (TI) OR Opinion* (topic) OR   
Perception* (TI) Perception* (topic) OR 
View* (TI) OR View* (topic) 
Perspective* (TI) Perspective* (topic) 
Barrier* (topic) OR Barrier* (topic) 
Facilitator* (TI) OR Facilitator*(topic)) AND  
(Research* (TI))  
171 
Key: TI (title) 
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Appendix 3: Initial study participant information sheet  
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Appendix 3 continued  
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Appendix 4: Initial study consent form 
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Appendix 5: Initial study interview guide 
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Appendix 6: Initial study ethics approval letter 
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Appendix 7: Details of database searches for factors pertaining to the 
contextual domain and research activity among pharmacists  
 
EBSCO database search  
Search 
number 
  
Search term Results 
1 Pharmac*(TI) OR Pharmac* (SU)  3,560,893 
2 Research (TI) OR Research (SU)  939,584 
3 ‘’organisational culture*’’ (TI) OR ‘’organisational culture*’’ (SU)  282 
4 (Pharmac*(TI) OR Pharmac* (SU)) AND  
((Research (TI) OR Research (SU)) AND  
(‘’organisational culture*’’ (TI) OR ‘’organisational culture*’’ (SU)) 
2 
5 Leader* (TI) OR Leader* (SU) 91,995 
6 (Pharmac*(TI) OR Pharmac* (SU)) AND  
((Research (TI) OR Research activit* (SU)) AND  
(Leader* (TI) OR Leader* (SU)) 
135 
7 ‘’model* of support’’(TI) OR ‘’model* of support’’ (SU) 398 
8 (Pharmac*(TI) OR Pharmac* (SU)) AND  
((Research (TI) OR Research activit* (SU)) AND  
‘’model* of support’’(TI) OR ‘’model* of support’’ (SU)) 
1 
Key: TI (title); SU (subject term)  
 
Web of Science database search  
Search 
number 
  
Search term Results 
1 Pharmac*(TI) OR Pharmac* (topic)  865,624 
2 Research (TI) OR Research (topic)  3,593,609 
3 ‘’organisational culture*’’ (TI) OR ‘’organisational culture*’’ (topic) 1715 
4 (Pharmac*(TI) OR Pharmac* (topic)) AND  
(Research (TI) OR Research (topic)) AND  
(‘’organisational culture*’’ (TI) OR ‘’organisational culture*’’ (topic)) 
4 
5 Leader* (TI) OR Leader* (topic) 105,144 
6 (Pharmac*(TI) OR Pharmac* (topic)) AND  
(Research (TI) OR Research (topic)) AND  
(Leader* (TI) OR Leader* (topic)) 
345 
7 ‘’model* of support’’(TI) OR ‘’model* of support’’ (topic) 349 
8 (Pharmac*(TI) OR Pharmac* (topic)) AND  
(Research (TI) OR Research (topic)) AND  
‘’model* of support’’(TI) OR ‘’model* of support’’ (topic)) 
2 
Key: TI (title) 
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Appendix 8: Details of database searches for factors pertaining to the 
contextual domain and research in general 
 
EBSCO database search  
Search 
number  
Search term Results 
1 Research (TI) OR Research (SU)  939,584 
2 ‘’organisational culture*’’ (TI) OR ‘’organisational culture*’’ (SU)  282 
3 ((Research (TI) OR Research (SU)) AND  
(‘’organisational culture*’’ (TI) OR ‘’organisational culture*’’ (SU)) 
41 
4 Leader* (TI) OR Leader* (SU) 91,995 
5 (Research (TI) OR Research (SU)) AND  
(Leader* (TI) OR Leader* (SU)) 
7521 
6 ‘’model* of support’’(TI) OR ‘’model* of support’’ (SU) 398 
7 (Research (TI) OR Research activit* (SU)) AND  
(‘’model* of support’’(TI) OR ‘’model* of support’’ (SU)) 
2 
Key: TI (title); SU (subject term)  
 
Web of Science database search  
Search 
number  
Search term Results 
1 Research (TI) OR Research (topic)  3,593,609 
2 ‘’organisational culture*’’ (TI) OR ‘’organisational culture*’’ (topic) 1715 
3 (Research (TI) OR Research (topic)) AND  
(‘’organisational culture*’’ (TI) OR ‘’organisational culture*’’ (topic)) 
824 
4 Leader* (TI) OR Leader* (topic) 105,144 
5 (Research (TI) OR Research (topic)) AND  
(Leader* (TI) OR Leader* (topic)) 
32,292 
6 ‘’model* of support’’(TI) OR ‘’model* of support’’ (topic) 349 
7 (Research (TI) OR Research (topic)) AND  
(‘’model* of support’’(TI) OR ‘’model* of support’’ (topic)) 
3 
Key: TI (title) 
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Appendix 9: Email survey to identify case study sites  
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Appendix 9 continued 
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Appendix 10: Letter confirming ethics approval not required for scoping 
exercise 
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Appendix 11: Email invitation to chief pharmacists of potential case study sites 
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Appendix 12: Chief pharmacists participant group participant information 
sheet  
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Appendix 12 continued 
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Appendix 12 continued 
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Appendix 13: Chief pharmacists participant group consent form 
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Appendix 14: Email invitation to potential participants in the pharmacists’ 
participant group 
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Appendix 14 continued  
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Appendix 15: Pharmacists participant group participant information sheet  
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Appendix 15 continued 
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Appendix 15 continued  
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Appendix 16: Pharmacists participant group consent form 
 
 
  
325 
Appendix 17: Chief pharmacists participant group interview guide 
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Appendix 17 continued  
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Appendix 18: Pharmacists participant group interview guide 
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Appendix 19: Amended chief pharmacists participant group interview guide 
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Appendix 19 continued 
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Appendix 20: Amended pharmacists participant group interview guide 
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Appendix 21: Original ethics approval letter for case study research  
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Appendix 21 continued 
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Appendix 22: Amended ethics approval letter for case study research  
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Appendix 23: HRA approval letter for case study research  
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Appendix 23 continued  
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Appendix 23 continued  
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Appendix 23 continued  
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Appendix 24: Questions and response formats used in the questionnaire  
 
Survey to explore chief pharmacists’ attitudes and opinions towards hospital pharmacists undertaking research 
Welcome to this survey.  
The purpose of the survey is to establish how widely some of the findings of case study research undertaken to explore hospital pharmacists’ attitudes and 
opinions towards undertaking research are shared among chief pharmacists of acute secondary care NHS Trusts. The research is being undertaken as part of 
a Professional Doctorate in Pharmacy at Keele University. 
The participation information sheet gives further information about the study and outlines what taking part involves. Please ensure that you have read the 
participation information sheet before you decide whether or not you wish to take part.  
You are reminded that no personal data or personally identifiable information will be collected in this survey and all data will therefore be anonymous. You 
are free to withdraw at any point before completing the survey, but you will no longer be able to withdraw once you have submitted your responses. This is 
because your survey responses will not be identifiable because the data collected will be anonymous and deleting your survey responses will therefore not be 
possible. 
If you have any questions regarding the survey or the research itself please contact the chief investigator Julie Shenton at j.j.shenton@keele.ac.uk or 07703 
889359. Alternatively you may wish to contact a member of their supervisory team Prof Ray Fitzpatrick r.fitzpatrick@keele.ac.uk or Dr Alison Gifford 
a.j.gifford@keele.ac.uk  
Thank you in advance for taking time to complete the questionnaire.  
Please note that the term ‘undertaking research’ for the purposes of this study is defined as pharmacists carrying out their own research as opposed to 
managing clinical trials medicines 
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Appendix 24 continued  
Question Number Question 
 
Reponses Instructions for respondent 
1 Your consent to participate  Tick box By ticking this box you are 
confirming that you have read 
the participant information sheet 
and you agree to voluntarily 
participate in this research 
2 How important do you think 
it is that hospital 
pharmacists undertake 
research?  
Very important   
Important 
Neutral (neither important nor unimportant) 
Low importance 
Not important at all   
Select one response  
3 What do you think is the 
most significant motivator 
for hospital pharmacists to 
undertake research? 
Personal desire i.e. an individual’s personal desire to 
undertake research 
Professional expectation i.e. an individual believing 
themselves to be expected to undertake research because 
they are a pharmacist by profession  
Expectation or requirement of their role i.e. an individual 
believing they are expected to undertake research by their 
employing organisation  
Other (please give details) 
Select one response 
 
4 Do you think the 
organisational culture of 
your Trust influences 
whether pharmacists 
undertake research?  
 
The organisational culture of the Trust encourages 
pharmacists to undertake research   
The organisational culture of the Trust has no influence on 
whether pharmacists undertake research   
The organisational culture of the Trust discourages 
pharmacists to undertake research  
Select one response 
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Appendix 24 continued  
 
Question Number 
 
Question 
 
Reponses  Instructions for respondent 
5 Do you think the 
organisational culture of 
your department influences 
whether pharmacists 
undertake research? 
The organisational culture of the department encourages 
pharmacists to undertake research  
The organisational culture of the department has no 
influence on whether pharmacists undertake research 
The organisational culture of the department discourages 
pharmacists to undertake research 
Select one response  
6 What do you think is most 
significant in terms of 
determining the research 
culture of a pharmacy 
department?  
The research culture at Trust level 
The leadership of the chief pharmacist  
The staff themselves  
 
Rank in order of significance with 
1 being the most significant and 3 
being the least significant  
7 As a chief pharmacist do 
you feel able to support 
research activity in your 
department 
 
 
Yes/No 
 
Select one response  
 
Use skip pattern so if the 
respondent answers no to this 
question they are taken to 
question 8, and if they answer 
yes they are taken to question 9 
8 Why do you feel unable to 
support research activity in 
your department?  
Is this because:   
 
You lack capacity within your department to allow 
pharmacists to do anything other than deliver the core 
service 
You lack staff within your department with research expertise 
It is too difficult for pharmacists to access funding  
It is too difficult to backfill posts with grant funding 
Other (please specify)  
Select all that apply 
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Appendix 24 continued  
 
Question Number  
 
Question 
 
Reponses  Instructions for respondent 
9 If you wanted to develop or 
increase research activity 
among pharmacists in your 
department what would 
you put in place?  
A pharmacist whose role it was to lead research  
Provide staff with in house training in research skills 
Establish or further develop links between your department 
and academia 
Support more staff to undertake postgraduate research 
qualifications e.g. a Masters or a PhD/DPharm   
Other (please specify) 
Select all that apply 
10 What do you think 
discourages pharmacists 
from undertaking research?  
Perceived difficulty associated with undertaking research 
Lack of access to individuals with research expertise 
Lack of perceived benefits to their career progression 
Lack of understanding of the benefits of research to 
pharmacy practice 
Other (please specify) 
Select all that apply 
11 What do you think prevents 
pharmacists from 
undertaking research?  
Lack of time  
Lack of research knowledge and skills 
Lack of access to individuals with research expertise 
Difficulty getting funding  
Other (please specify) 
Select all that apply 
12 What do you think would 
enable more pharmacists to 
undertake research? 
 
Them having a better understanding of what research is  
Having access to individuals with research expertise  
Integrating research into pharmacists roles  
More pharmacy-specific funding opportunities 
Having better access to research training   
Other (please specify)  
Select all that apply 
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Appendix 24 continued  
 
Question Number 
 
Question  
 
Reponses Instructions for respondent 
13 What do you think would 
encourage more 
pharmacists to undertake 
research? 
  
Having a clear or clearer career pathway for those interested 
in undertaking research  
More promotion of research opportunities 
Having pharmacists with research experience in the 
department  
Having a pharmacist whose role it is to lead research  
Including a requirement to undertake research in pharmacists 
job descriptions 
Including research in pharmacists appraisals 
Other (please specify)  
Select all that apply 
14 Do you think newly 
qualified pharmacists have 
the knowledge and skills to 
undertake research? 
Yes/No Select one response  
 
Use skip pattern so if the 
respondent answers no to this 
question they are taken to 
question 13, and if they answer 
yes they are taken to question 14.  
15 How do you think additional 
training should be 
delivered?  
Through in-house training i.e. training delivered within the 
pharmacy department  
By incorporating research into postgraduate clinical training 
for pharmacists   
By pharmacists undertaking postgraduate research 
qualifications e.g. a Masters or PhD/DPharm 
Rank in order of preference with 
1 being most preferred option 
and 3 being least preferred 
option 
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Question Number 
 
Question 
 
Reponses Instructions for respondent  
16 Are you personally currently 
undertaking research?  
Yes, as part of a postgraduate clinical qualification e.g. an 
MSc 
Yes, as part of a postgraduate research qualification e.g. a 
Masters or PhD/DPharm 
Yes, a part of a postgraduate management qualification e.g. a 
management diploma or an MBA 
Yes, but outside of a formal postgraduate qualification  
No 
Select all that apply 
17 Have you personally 
undertaken research 
previously in your career? 
Yes, as part of a postgraduate clinical qualification e.g. an 
MSc 
Yes, as part of a postgraduate research qualification e.g. a 
Masters or PhD/DPharm 
Yes, a part of a postgraduate management qualification e.g. a 
management diploma or an MBA 
Yes, but outside of a formal postgraduate qualification  
No 
Select all that apply 
18 Are pharmacists in your 
department actively 
undertaking research at the 
time of completing this 
survey or have pharmacists 
undertaken research in the 
three years previous to the 
time of this survey?  
Yes/No  Select one response 
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Appendix 25: Text included in NHSEI Chief Pharmacists newsletter to invite 
chief pharmacists to participate in the survey 
 
 
  
350 
Appendix 26: Survey participant information sheet  
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Appendix 27: Original ethics approval letter for amendment to include the 
survey 
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Appendix 28: Amended ethics approval letter for amendment to include the 
survey 
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Appendix 28 continued  
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Appendix 29: HRA approval letter for amendment to include the survey 
 
 
